data_2leo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2leo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 CA--C 1.499 -1.015 0 CA-C-O 121.632 0.729 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -104.28 -9.93 18.21 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -61.76 -43.79 98.16 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.73 0.812 . . . . 0.0 111.928 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.1 pt -65.23 -24.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.806 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.648 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 75.9 m-85 -94.13 -22.98 18.13 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 121.815 0.817 . . . . 0.0 109.284 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -69.29 -15.04 63.26 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 125.284 1.434 . . . . 0.0 109.431 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.72 -16.31 60.75 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.357 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -105.28 159.32 29.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.07 139.25 72.03 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.045 1.83 . . . . 0.0 109.784 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.84 -30.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.59 -26.12 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.96 93.26 3.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.786 -0.571 . . . . 0.0 110.908 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.72 113.2 28.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 134.36 31.56 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.287 1.992 . . . . 0.0 111.278 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.8 m -116.99 148.11 41.53 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.302 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.55 158.32 58.17 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.069 1.846 . . . . 0.0 111.283 175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.21 11.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.724 0.773 . . . . 0.0 112.052 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.7 m -94.13 136.42 34.44 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.749 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -105.62 116.31 31.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 96.1 mt -133.47 102.81 12.62 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.35 125.97 18.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.788 1.658 . . . . 0.0 110.949 -176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.06 153.48 36.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.9 t -119.07 128.98 54.84 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 121.036 0.446 . . . . 0.0 110.67 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.22 164.48 30.91 Favored Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.613 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 p -66.26 -14.75 62.45 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.914 0.886 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.24 0.27 52.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.952 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 69.19 31.12 4.09 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.067 1.347 . . . . 0.0 111.711 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.24 128.4 66.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.4 m -84.13 133.31 34.63 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.09 156.57 26.16 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.789 0.435 . . . . 0.0 110.501 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.7 75.74 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 124.193 0.933 . . . . 0.0 114.117 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.8 p30 -171.83 175.7 3.83 Favored 'General case' 0 C--O 1.258 1.532 0 C-N-CA 123.186 0.595 . . . . 0.0 109.61 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.62 76.26 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.2 -48.94 79.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.707 0.289 . . . . 0.0 110.51 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.93 -36.94 83.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.101 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -61.18 -47.39 86.4 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 123.595 0.559 . . . . 0.0 109.555 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.648 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -59.91 -41.61 92.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.968 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.3 m -57.2 -48.37 78.95 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 120.92 0.391 . . . . 0.0 110.35 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -34.4 70.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.772 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 t -62.27 -42.69 99.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.75 -40.6 63.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.23 -46.11 90.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.446 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -93.59 6.08 49.45 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.027 0.441 . . . . 0.0 111.104 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 48.38 71.91 0.32 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 114.872 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.94 65.14 Favored Glycine 0 C--N 1.312 -0.766 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -56.8 -50.48 72.2 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.7 104.58 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.855 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -106.15 -178.65 3.71 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -81.49 128.45 33.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -103.51 -57.31 2.06 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -159.41 161.66 35.62 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.43 157.81 24.81 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 168.55 44.68 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 m -60.92 144.93 52.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.791 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 CA--C 1.5 -0.966 0 CA-C-O 122.022 0.915 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.8 t -102.57 -1.56 30.15 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.929 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -63.41 -44.21 95.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.932 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 pt -72.03 -25.05 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.643 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 88.0 m-85 -84.44 -11.75 55.63 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.947 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 29.2 mtpp -69.28 -14.68 63.08 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.817 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -76.62 -2.99 35.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.686 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -115.03 153.95 47.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 130.58 34.76 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.203 1.935 . . . . 0.0 110.105 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.14 -33.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.86 -26.67 11.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.326 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.72 93.92 3.82 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.132 -0.355 . . . . 0.0 111.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.417 HD11 ' HA ' ' A' ' 68' ' ' THR . 50.7 mt -112.18 117.93 46.85 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.38 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.47 135.55 29.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.647 2.231 . . . . 0.0 111.059 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.78 149.31 53.04 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.244 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.7 162.78 39.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.367 2.045 . . . . 0.0 110.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 pt -83.56 -12.39 11.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.799 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -61.5 126.27 26.76 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -100.21 111.22 23.49 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -121.25 101.0 44.71 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.62 118.34 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.205 1.27 . . . . 0.0 110.935 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.58 143.9 39.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.9 t -107.99 127.14 53.5 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.224 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.31 160.41 28.11 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -56.17 -23.66 36.46 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.964 0.906 . . . . 0.0 112.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -88.38 11.3 17.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.661 0.743 . . . . 0.0 110.372 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 63.63 29.11 15.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.902 1.281 . . . . 0.0 112.654 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mm -103.14 126.13 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.4 m -83.26 124.44 30.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -103.23 144.53 31.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.43 -19.33 68.6 Favored Glycine 0 C--O 1.222 -0.638 0 O-C-N 124.117 0.886 . . . . 0.0 113.676 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 30.7 p30 -170.94 173.5 5.12 Favored 'General case' 0 C--O 1.256 1.423 0 C-N-CA 123.635 0.774 . . . . 0.0 109.095 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.41 64.18 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.347 0.404 . . . . 0.0 110.923 -174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.441 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 44.4 t -54.26 -52.66 60.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.596 0.56 . . . . 0.0 110.199 175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -63.82 -36.72 84.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.043 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -63.39 -49.64 73.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.03 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 43.0 t -59.2 -38.71 80.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.355 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.417 ' HA ' HD11 ' A' ' 43' ' ' ILE . 26.7 m -56.92 -50.06 73.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 110.343 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -71.92 -36.99 70.13 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.2 m -58.04 -43.9 87.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.968 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.86 -42.24 61.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.142 0.496 . . . . 0.0 110.398 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.89 -46.04 85.5 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.321 1.048 . . . . 0.0 111.837 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.1 m -99.66 14.6 29.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 43.92 76.34 0.08 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 114.028 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 78' ' ' GLN . . . 70.94 15.62 74.17 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 115.073 -0.967 . . . . 0.0 114.051 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -72.29 -62.23 1.51 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.73 131.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.435 ' NE2' ' HA2' ' A' ' 75' ' ' GLY . 25.2 mm-40 -129.28 173.17 10.76 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -67.54 112.14 4.53 Favored 'General case' 0 C--N 1.284 -2.255 0 O-C-N 123.941 0.776 . . . . 0.0 109.206 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 tp -86.29 -56.34 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -161.07 162.23 31.56 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.208 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.08 146.96 45.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.79 168.58 38.12 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.75 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -64.45 149.76 47.86 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 122.706 0.402 . . . . 0.0 110.346 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.179 178.765 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t0 . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.4 t -93.69 -17.97 22.64 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 p -61.54 -27.75 68.83 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -77.99 -22.29 13.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 O-C-N 121.987 -0.446 . . . . 0.0 112.034 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 99.1 m-85 -98.9 -19.55 17.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.761 0.791 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.97 -14.93 63.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.39 1.076 . . . . 0.0 110.767 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -83.38 -4.04 58.1 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -100.88 156.88 34.64 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.92 135.29 68.94 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.608 2.205 . . . . 0.0 111.264 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.75 -24.47 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.51 -24.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.851 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.15 93.51 3.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.409 0.623 . . . . 0.0 111.045 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.97 115.83 31.64 Favored Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.28 133.61 31.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.484 1.456 . . . . 0.0 111.102 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.7 m -114.2 141.26 26.1 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.514 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.7 159.19 49.61 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.338 2.025 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 pt -83.57 -13.56 11.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.944 0.402 . . . . 0.0 110.805 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -70.27 132.41 45.67 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 52.8 t80 -96.88 112.83 24.41 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -124.05 98.36 39.27 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.19 126.86 22.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.867 1.711 . . . . 0.0 111.42 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.73 148.72 33.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -117.31 131.01 56.89 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 120.887 0.375 . . . . 0.0 110.329 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 168.36 26.41 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 p -70.91 -8.39 52.57 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.991 0.9 . . . . 0.0 110.745 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.31 -3.61 59.02 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 67.22 27.36 8.43 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.912 1.685 . . . . 0.0 112.725 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.77 133.32 48.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 m -88.24 129.1 35.45 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -107.79 146.99 31.44 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.376 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -62.66 -28.14 71.01 Favored Glycine 0 CA--C 1.499 -0.964 0 O-C-N 124.57 1.169 . . . . 0.0 112.617 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.3 p30 -172.17 170.03 5.31 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 123.145 0.578 . . . . 0.0 109.898 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.12 -29.07 60.17 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.4 t -62.36 -44.36 96.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -70.31 -37.84 74.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.7 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.11 -48.91 78.08 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.633 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.6 t -62.86 -41.51 99.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.652 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.9 m -60.39 -49.69 76.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 109.798 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.3 -37.45 87.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.035 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -65.68 -58.18 6.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.1 -45.65 86.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.132 0.573 . . . . 0.0 111.39 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -57.43 -33.65 68.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.098 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.6 m -105.18 17.77 23.48 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.853 -174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 63.56 22.8 13.34 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 123.392 0.677 . . . . 0.0 112.658 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.86 28.94 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.753 -0.736 . . . . 0.0 113.067 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -57.15 -50.96 71.19 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.214 1.007 . . . . 0.0 108.43 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.59 133.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -117.29 160.85 20.45 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.48 121.49 16.46 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.38 -60.14 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -158.89 156.84 30.31 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -82.72 166.71 18.86 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.03 168.79 42.1 Favored Glycine 0 C--N 1.273 -2.942 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -67.73 146.09 54.11 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.782 -178.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 t70 . . . . . 0 N--CA 1.416 -2.167 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -88.07 -12.47 44.13 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.202 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 m -61.52 -39.66 91.81 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.33 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 pt -67.91 -17.69 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.647 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.0 m-85 -99.07 -5.47 30.21 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -58.82 -21.81 57.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.813 0.445 . . . . 0.0 111.976 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -79.24 4.76 14.03 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -118.93 152.03 51.14 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.37 133.06 46.98 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 121.726 1.617 . . . . 0.0 109.684 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 m -57.62 -24.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.11 -25.33 5.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.004 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.46 93.87 3.98 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.883 0.373 . . . . 0.0 110.808 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.42 117.25 33.13 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.95 133.48 31.34 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.527 1.485 . . . . 0.0 109.725 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.9 m -116.87 150.01 45.08 Favored Pre-proline 0 C--N 1.29 -2.006 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.905 -175.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.18 162.81 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.506 2.138 . . . . 0.0 111.142 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.07 -7.29 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.264 0.554 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -64.68 115.2 5.01 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.585 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -90.21 120.15 31.13 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 88.2 mt -133.72 99.06 14.31 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -62.24 119.92 7.25 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 121.49 1.46 . . . . 0.0 110.954 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.96 152.19 37.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.5 t -114.31 126.21 54.76 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.64 29.15 Favored Glycine 0 N--CA 1.421 -2.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.701 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -51.21 -25.71 5.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.848 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.15 8.32 27.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 69.7 29.92 4.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mm -107.22 124.44 63.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.533 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.5 m -81.47 125.7 30.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.18 155.49 19.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.96 79.16 Favored Glycine 0 N--CA 1.448 -0.533 0 O-C-N 123.868 0.73 . . . . 0.0 113.586 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.8 p30 -171.81 172.68 4.77 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 123.163 0.585 . . . . 0.0 109.764 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.88 76.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.881 0.738 . . . . 0.0 112.945 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 40.7 t -56.25 -50.96 69.83 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.68 0.392 . . . . 0.0 110.47 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -64.45 -36.03 82.84 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.707 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.8 -45.79 92.33 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.845 0.716 . . . . 0.0 109.484 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.7 t -61.36 -41.47 97.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.397 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.2 m -56.72 -53.09 61.8 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.27 77.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 t -58.53 -43.5 89.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 122.934 0.494 . . . . 0.0 110.402 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.41 -39.12 68.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.438 . . . . 0.0 110.784 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -65.32 -39.72 92.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.022 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -87.3 -0.55 56.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.738 0.304 . . . . 0.0 110.832 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 57.73 68.12 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.239 1.416 . . . . 0.0 111.834 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.02 11.96 61.86 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.293 -0.867 . . . . 0.0 114.03 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -80.06 -50.18 10.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.75 117.11 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -125.7 -178.32 4.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -68.87 114.17 6.96 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.15 -54.64 4.02 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -159.95 159.5 32.33 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.335 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.28 157.52 30.72 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 165.86 41.33 Favored Glycine 0 C--N 1.293 -1.84 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 151.44 46.35 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.259 1.565 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.444 -0.756 0 CA-C-O 121.767 0.794 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.78 -2.44 17.33 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -64.62 -41.12 96.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.45 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 pt -68.08 -22.33 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.672 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.5 m-85 -93.12 -8.37 42.83 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.333 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.54 -15.3 60.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.324 0.583 . . . . 0.0 110.31 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -81.93 -2.19 50.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.061 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -123.18 151.19 61.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.19 145.41 78.41 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 121.92 1.747 . . . . 0.0 109.731 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.86 -38.63 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.59 -26.49 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.851 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.17 92.09 3.51 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.114 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.2 mt -122.29 113.81 30.79 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.18 132.52 34.35 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 120.631 0.888 . . . . 0.0 110.091 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.2 m -126.2 144.39 48.91 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.35 162.96 39.76 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.795 1.663 . . . . 0.0 111.196 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 pt -85.96 -1.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.658 0.742 . . . . 0.0 109.724 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -64.17 128.25 34.97 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.987 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -103.08 108.91 20.27 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.1 mt -123.91 97.45 41.1 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.15 118.59 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.694 1.596 . . . . 0.0 111.404 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.27 150.42 33.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.49 126.84 55.4 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.142 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.42 164.82 29.6 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 p -67.9 -4.58 13.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.393 0.616 . . . . 0.0 112.201 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.87 0.63 56.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 70.35 23.44 5.0 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.257 1.423 . . . . 0.0 111.111 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.9 mm -101.82 132.48 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -86.9 120.13 27.85 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.23 152.49 18.8 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.781 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.73 -18.71 77.56 Favored Glycine 0 N--CA 1.441 -0.972 0 O-C-N 124.116 0.885 . . . . 0.0 113.169 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.2 p30 -175.87 173.76 2.26 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 123.565 0.746 . . . . 0.0 109.935 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.48 -33.74 76.58 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.992 0.917 . . . . 0.0 110.673 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -45.98 90.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -65.8 -35.54 81.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.988 0.423 . . . . 0.0 110.614 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.46 -46.62 82.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.186 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 35.8 t -61.33 -40.81 95.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.1 m -57.69 -51.16 70.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.781 0.324 . . . . 0.0 110.197 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.6 -35.96 82.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.522 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t -65.66 -49.7 67.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.519 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.46 -37.97 89.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.265 0.555 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.59 -28.83 68.79 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.42 1.088 . . . . 0.0 110.906 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.0 p -110.45 16.31 21.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.695 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 60.92 24.87 14.88 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.162 0.982 . . . . 0.0 111.639 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.97 31.5 9.84 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.796 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -76.39 -56.78 4.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.99 129.99 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.625 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.26 -179.79 4.17 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -79.68 126.23 30.65 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.59 -52.66 3.85 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -164.52 159.62 19.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.1 153.44 40.79 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.43 172.7 46.93 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.624 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -64.19 146.93 53.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.316 -0.865 0 O-C-N 123.845 0.716 . . . . 0.0 112.235 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 121.842 0.83 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -89.45 -11.18 43.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.489 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -60.91 -40.28 92.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.725 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 45.8 pt -72.95 -21.1 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.764 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.521 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 98.7 m-85 -87.75 -12.47 45.09 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.195 0.522 . . . . 0.0 110.736 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -70.49 -14.76 62.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 23.4 pttm -78.11 -3.59 43.14 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.675 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.66 157.59 34.25 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.2 131.11 43.09 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.274 1.983 . . . . 0.0 110.165 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.53 -24.36 15.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.14 -25.19 5.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.114 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.86 93.79 3.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.882 0.373 . . . . 0.0 110.647 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.405 HD11 ' HG1' ' A' ' 68' ' ' THR . 58.8 mt -118.3 124.49 28.55 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.03 134.07 44.34 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 121.665 1.577 . . . . 0.0 110.554 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.4 m -107.66 140.62 21.74 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.07 163.36 39.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.078 1.852 . . . . 0.0 110.418 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -82.74 -14.54 11.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -64.87 119.41 10.61 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.528 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.3 mt -135.36 96.46 13.87 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -58.4 119.67 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.126 1.884 . . . . 0.0 110.489 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.86 128.61 56.47 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.5 165.95 35.83 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.617 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -57.14 -18.97 17.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.866 1.266 . . . . 0.0 112.117 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.59 6.28 47.86 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.101 0.953 . . . . 0.0 109.841 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.7 OUTLIER 61.1 47.04 7.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 110.847 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.6 mm -120.53 131.91 71.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.2 m -85.14 131.52 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -112.37 153.55 27.1 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.276 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.36 73.87 Favored Glycine 0 N--CA 1.444 -0.828 0 O-C-N 124.014 0.821 . . . . 0.0 113.862 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 34.6 p30 -176.71 -178.67 0.9 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 116.936 0.368 . . . . 0.0 111.344 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -45.74 -51.21 12.92 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 126.47 1.908 . . . . 0.0 111.574 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.5 t -55.51 -53.73 52.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.895 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -63.38 -37.93 89.19 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.096 0.474 . . . . 0.0 111.001 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 tp -67.03 -48.76 67.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.295 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 52.4 t -60.52 -44.46 96.02 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.948 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.405 ' HG1' HD11 ' A' ' 43' ' ' ILE . 72.9 m -58.65 -50.27 74.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.745 0.307 . . . . 0.0 110.869 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.19 -34.16 75.77 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.1 t -63.31 -48.13 79.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.293 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.06 -37.55 81.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.139 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.55 -34.94 79.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.024 0.44 . . . . 0.0 111.498 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -93.79 1.31 56.5 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.128 0.49 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 60.12 25.44 14.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.76 1.224 . . . . 0.0 112.54 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.95 22.69 7.82 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.198 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -72.49 -53.41 12.16 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.96 129.0 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -134.86 -178.72 5.21 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -65.95 119.08 10.71 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -93.31 -60.41 1.79 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -156.84 153.92 29.02 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.48 165.0 24.92 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.05 168.29 40.45 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 147.59 51.84 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.402 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 60.0 m . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.701 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 CA--C 1.479 -1.788 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.26 -6.58 56.68 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.539 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 55.4 m -67.4 -36.93 82.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.054 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.57 -16.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.656 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 76.6 m-85 -109.85 -13.68 14.42 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.397 0.618 . . . . 0.0 109.995 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -71.09 -14.99 62.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.288 1.042 . . . . 0.0 108.329 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 33' ' ' SER . 55.1 mtpt -72.62 -15.21 61.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.16 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.45 152.52 42.77 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.74 133.86 44.21 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.437 1.425 . . . . 0.0 108.687 172.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.16 -25.52 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.46 -26.16 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.777 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.59 93.52 3.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.241 -0.287 . . . . 0.0 111.371 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.58 124.55 26.2 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -77.18 134.89 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.403 1.402 . . . . 0.0 110.484 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -125.81 145.8 53.0 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.83 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.71 152.92 53.02 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.421 2.747 . . . . 0.0 112.336 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 pt -83.85 -17.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -68.76 134.23 49.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.249 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -90.95 110.73 21.98 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.0 mt -124.43 97.53 39.53 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.3 119.18 6.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.047 1.832 . . . . 0.0 111.5 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.43 151.83 29.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.84 128.56 56.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.81 163.28 23.47 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.441 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -57.2 -18.76 17.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.145 0.978 . . . . 0.0 112.349 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.52 3.5 43.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.414 0.626 . . . . 0.0 109.859 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 69.04 26.71 5.55 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.059 1.343 . . . . 0.0 111.723 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.37 134.33 49.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.1 m -86.13 127.27 34.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -105.97 156.08 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.989 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.53 -22.32 78.64 Favored Glycine 0 CA--C 1.501 -0.788 0 O-C-N 123.98 0.8 . . . . 0.0 112.996 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.4 p30 -173.0 169.86 4.58 Favored 'General case' 0 C--O 1.255 1.384 0 C-N-CA 123.684 0.793 . . . . 0.0 109.692 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -27.02 65.19 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.286 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.86 -44.3 97.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -64.7 -40.01 94.64 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.36 -46.75 87.77 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.362 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.3 t -59.77 -38.4 81.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -57.97 -48.6 79.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -67.47 -34.22 76.73 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.004 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 t -65.09 -39.41 93.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.602 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -72.34 -38.65 68.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.13 -43.33 91.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.79 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 58.3 p -92.61 -13.87 28.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.807 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 62.74 75.07 0.41 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 111.75 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.27 8.54 85.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.826 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 64.0 ttt180 -80.46 -62.1 1.78 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.643 0.722 . . . . 0.0 109.51 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.2 118.46 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -132.42 -179.64 5.56 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -68.16 110.47 4.02 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -85.25 -55.69 3.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -159.17 159.81 34.78 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.495 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.96 152.1 38.81 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 168.0 43.63 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 m -57.64 147.5 27.2 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.19 0.596 . . . . 0.0 110.26 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.125 178.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.481 -1.685 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.632 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 26.9 t -93.19 -20.77 20.13 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -54.05 -35.2 61.75 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.645 1.178 . . . . 0.0 113.959 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.55 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.095 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 72.9 m-85 -89.28 -19.8 24.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.1 mtpt -60.48 -14.23 18.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.533 0.733 . . . . 0.0 112.343 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.74 -25.53 61.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -89.8 152.68 46.99 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.83 139.01 82.96 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.124 1.883 . . . . 0.0 110.058 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.1 m -59.2 -15.72 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.35 -25.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.783 0.325 . . . . 0.0 110.627 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.24 93.91 3.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 122.094 -0.379 . . . . 0.0 110.726 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.53 107.97 29.2 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.11 134.36 33.8 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.23 1.953 . . . . 0.0 110.578 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.1 m -114.66 147.02 37.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.038 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -61.8 152.45 74.38 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.294 1.996 . . . . 0.0 110.093 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.59 -7.71 10.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -74.91 133.35 41.81 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -92.31 127.05 37.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.8 mp -131.85 99.17 16.94 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -61.25 118.42 5.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.761 1.641 . . . . 0.0 111.196 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.35 152.13 36.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -117.08 128.2 54.91 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.165 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.38 163.09 28.61 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 m -62.23 -13.99 33.63 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.84 0.856 . . . . 0.0 111.733 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.37 2.37 54.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.074 0.94 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 65.75 24.97 11.44 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.857 1.263 . . . . 0.0 113.401 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.68 130.72 50.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.7 m -86.57 132.71 33.83 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.87 151.46 29.09 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.217 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -24.91 72.64 Favored Glycine 0 C--O 1.218 -0.885 0 O-C-N 124.434 1.084 . . . . 0.0 113.054 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.8 p30 -173.74 173.55 3.3 Favored 'General case' 0 C--O 1.259 1.556 0 C-N-CA 124.061 0.944 . . . . 0.0 109.116 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -26.63 68.28 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.52 0.512 . . . . 0.0 112.088 -174.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 38.6 t -56.5 -48.51 77.03 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.084 0.24 . . . . 0.0 110.803 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -67.57 -32.37 73.07 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.954 0.406 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.53 -46.01 74.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.097 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.0 t -59.2 -44.94 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.335 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -55.25 -48.23 74.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.099 0.476 . . . . 0.0 110.745 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -71.49 -34.81 70.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -65.57 -33.53 76.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.47 -33.37 62.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.27 -50.98 50.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 0.0 110.724 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 p -81.48 -19.89 41.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.525 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.9 t30 63.43 78.91 0.27 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 111.933 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.2 90.29 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.123 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -73.28 -55.81 5.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.293 1.046 . . . . 0.0 109.354 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -94.54 111.79 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-O 121.69 0.757 . . . . 0.0 109.26 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -112.65 -179.61 3.71 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.44 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -77.78 118.37 20.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.43 -56.81 2.9 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -160.48 161.0 32.71 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.604 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.77 151.16 39.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 174.51 43.64 Favored Glycine 0 C--N 1.29 -1.974 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.327 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 m -69.54 152.32 44.94 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.77 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 N--CA 1.436 -1.166 0 CA-C-O 121.944 0.878 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 45.7 t -93.85 -5.06 48.91 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.372 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 3.7 m -65.35 -39.85 92.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.427 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -59.05 -28.0 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.452 0.47 . . . . 0.0 111.848 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.601 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -91.22 -33.05 15.54 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.666 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 50.7 mtmt -62.18 -14.38 37.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 33' ' ' SER . 32.3 mmtp -76.42 -5.89 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.084 0.469 . . . . 0.0 111.142 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.32 156.7 40.74 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 135.49 70.47 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.824 1.683 . . . . 0.0 110.533 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.42 -29.42 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.995 0.918 . . . . 0.0 112.902 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.82 -26.11 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.981 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.02 93.85 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.743 -0.598 . . . . 0.0 111.332 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.2 mt -124.81 132.56 24.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.52 134.51 26.54 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.446 1.431 . . . . 0.0 110.643 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.8 m -116.93 146.43 37.84 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.148 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -59.12 146.64 93.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.103 1.869 . . . . 0.0 110.158 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.9 pt -80.78 -20.6 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -79.89 138.09 37.07 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.729 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -82.66 108.48 16.06 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 81.1 mt -118.67 98.82 51.34 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 120.34 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.285 1.99 . . . . 0.0 111.88 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.12 146.35 34.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.41 128.21 53.87 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.34 159.94 24.45 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 m -61.16 -14.29 23.91 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.652 0.781 . . . . 0.0 112.352 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.93 3.86 40.09 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.819 0.847 . . . . 0.0 109.68 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 65.95 36.5 5.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.217 1.407 . . . . 0.0 111.925 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.5 131.7 71.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.9 m -84.34 122.43 28.91 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -97.73 152.64 18.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.639 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.54 -15.17 72.89 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.0 0.812 . . . . 0.0 114.123 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 173.68 -179.63 0.09 Allowed 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.167 1.387 . . . . 0.0 108.715 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -26.71 62.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.4 t -63.41 -42.27 98.74 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.63 -30.69 68.47 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.153 0.502 . . . . 0.0 110.0 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.4 tp -69.47 -49.08 58.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.601 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 30.9 t -61.55 -46.24 90.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.058 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -59.85 -48.51 81.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 111.15 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.39 -36.67 84.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.101 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -61.87 -44.56 96.58 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.997 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 87.2 mt -69.62 -45.72 67.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.359 0.6 . . . . 0.0 110.209 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -46.81 81.77 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.612 1.165 . . . . 0.0 110.612 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 m -91.62 13.29 18.38 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 55.24 60.1 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.56 76.92 Favored Glycine 0 C--N 1.316 -0.559 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.994 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.93 -51.67 63.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.0 110.359 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.03 122.13 62.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.356 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -105.61 174.78 5.73 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -76.76 119.59 20.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.27 -53.78 4.09 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.067 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -163.3 166.46 23.04 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.236 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.06 149.88 39.04 Favored 'General case' 0 C--O 1.252 1.214 0 O-C-N 123.801 0.688 . . . . 0.0 109.183 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.37 173.95 50.08 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.677 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -65.65 152.24 44.65 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.698 0.399 . . . . 0.0 110.372 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.037 -179.803 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 34.6 t -92.68 -9.34 41.18 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.56 -33.18 72.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.6 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.28 -24.87 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.07 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.698 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 60.3 m-85 -92.05 -9.6 42.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 64.1 mttp -68.98 -14.75 63.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.545 0.688 . . . . 0.0 109.585 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -78.36 -11.05 59.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.534 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -109.98 153.14 43.3 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -64.45 146.72 89.99 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 121.593 1.529 . . . . 0.0 109.415 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.93 -31.66 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 111.383 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.07 -25.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.29 93.76 3.89 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.071 0.462 . . . . 0.0 111.325 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.68 125.59 25.49 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.59 133.61 14.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.559 1.506 . . . . 0.0 110.353 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.3 147.72 66.2 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 159.86 49.06 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 121.995 1.796 . . . . 0.0 112.113 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.69 -12.31 14.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.159 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -66.06 132.69 49.11 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.038 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -94.81 110.03 21.94 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 85.8 mt -122.12 97.32 45.73 Favored Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.58 122.58 11.49 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.698 1.599 . . . . 0.0 111.873 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.15 150.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -115.33 129.77 56.7 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.155 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.62 165.55 28.57 Favored Glycine 0 N--CA 1.427 -1.93 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 p -63.9 -15.0 58.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.166 0.987 . . . . 0.0 112.344 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.84 1.83 51.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.731 0.777 . . . . 0.0 109.276 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 65.86 36.53 6.01 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.452 1.501 . . . . 0.0 111.671 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.96 131.59 64.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.5 m -82.21 124.59 30.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.63 150.48 25.38 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.962 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.93 -15.23 73.9 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.302 1.001 . . . . 0.0 113.865 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 -179.44 170.56 1.33 Allowed 'General case' 0 C--O 1.252 1.19 0 C-N-CA 124.204 1.002 . . . . 0.0 109.633 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -28.68 69.1 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.73 -47.05 82.66 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.068 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -64.95 -35.59 81.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.848 0.356 . . . . 0.0 110.354 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.87 -46.95 88.58 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.001 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 53.8 t -65.09 -34.56 78.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.546 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 m -56.35 -49.46 74.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.91 -37.75 82.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.534 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -59.66 -47.01 87.32 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.66 0.384 . . . . 0.0 110.731 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -72.03 -39.53 69.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -64.69 -30.61 71.63 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.54 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.1 p -100.46 -4.47 28.78 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.24 62.59 1.57 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.306 1.442 . . . . 0.0 112.2 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.28 86.99 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 114.449 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -65.78 -54.99 19.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.43 124.01 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.8 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -137.4 178.44 7.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -62.01 123.04 17.02 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.385 0.674 . . . . 0.0 111.586 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.06 -58.21 1.99 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.74 161.51 37.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.16 153.9 35.84 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.68 173.7 45.65 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.4 m -67.48 149.95 49.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--N 1.308 -1.217 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.606 -178.271 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.428 -1.566 0 CA-C-O 121.833 0.825 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.1 t -97.03 -8.41 30.49 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 49.4 m -69.1 -32.41 71.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.158 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.0 pt -64.98 -28.56 45.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.854 0.359 . . . . 0.0 111.437 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.505 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 82.2 m-85 -89.5 -9.96 48.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.178 0.513 . . . . 0.0 110.523 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' SER . 30.5 mmmt -66.83 -14.57 62.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.718 175.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.35 -15.8 63.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -112.99 151.63 44.27 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.92 144.01 75.06 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 122.038 1.825 . . . . 0.0 110.919 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.96 -38.74 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 124.179 0.992 . . . . 0.0 113.5 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.5 m -79.54 -24.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.11 93.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.882 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mt -125.52 112.84 25.47 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 134.1 35.64 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.661 1.574 . . . . 0.0 109.9 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.6 m -115.55 147.61 39.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.726 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.46 157.42 54.98 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 121.956 1.771 . . . . 0.0 110.439 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.99 -4.06 10.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.323 0.582 . . . . 0.0 110.184 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -64.34 124.67 22.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -88.49 106.86 18.56 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.964 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 83.0 mt -123.4 96.1 44.39 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.17 118.9 5.8 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.304 1.336 . . . . 0.0 110.946 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.57 145.81 33.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.4 t -111.75 123.35 50.05 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 120.915 0.388 . . . . 0.0 110.307 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 169.3 40.51 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 p -66.86 -8.47 29.18 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.06 -0.89 57.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.384 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 65.65 39.5 4.87 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.46 1.104 . . . . 0.0 110.85 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.16 133.03 63.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.541 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 m -89.01 113.14 24.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.69 152.34 19.58 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.315 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.02 73.5 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.835 0.709 . . . . 0.0 113.623 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.2 p30 179.62 176.47 0.66 Allowed 'General case' 0 C--O 1.255 1.371 0 C-N-CA 124.571 1.148 . . . . 0.0 109.165 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -26.71 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.476 0.485 . . . . 0.0 111.597 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.87 -41.04 99.25 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -69.37 -30.37 68.35 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.316 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.88 -49.34 53.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.969 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.4 t -59.51 -47.19 86.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.531 0.733 . . . . 0.0 111.555 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.4 p -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.79 -38.89 90.24 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -62.64 -50.37 71.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.253 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.04 -40.83 95.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 110.777 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -57.47 -45.43 84.83 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.366 1.066 . . . . 0.0 110.635 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -95.66 17.24 15.33 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 47.53 60.28 3.59 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.803 1.641 . . . . 0.0 113.771 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.47 15.15 81.74 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.973 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.89 -60.29 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.02 132.24 33.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.262 0.553 . . . . 0.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -117.88 173.26 6.86 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.164 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -75.85 119.06 19.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.75 -58.23 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -159.53 155.22 26.0 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.386 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -77.36 157.95 30.38 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.04 168.6 40.62 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -66.24 153.68 41.87 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.259 1.597 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.179 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.436 -1.145 0 CA-C-O 121.811 0.815 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 46.2 t -107.78 -5.56 17.26 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.4 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -68.52 -32.39 72.31 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.327 0.651 . . . . 0.0 110.345 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.27 -30.34 42.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.559 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.677 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 85.0 m-85 -90.24 -20.58 22.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.868 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.5 mtpp -62.21 -14.27 36.27 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.437 0.637 . . . . 0.0 112.068 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -81.55 -4.68 56.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.17 152.58 41.17 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.49 134.39 63.61 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.08 1.854 . . . . 0.0 111.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -50.82 -41.23 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 112.744 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.41 -25.62 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.87 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.73 93.15 3.76 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.737 -0.602 . . . . 0.0 111.252 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.58 115.47 37.41 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.76 133.85 41.09 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.04 1.827 . . . . 0.0 110.544 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -118.94 142.62 32.25 Favored Pre-proline 0 C--N 1.293 -1.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.746 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.14 154.44 45.74 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.659 2.239 . . . . 0.0 110.959 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.01 -17.5 11.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 120.979 0.419 . . . . 0.0 110.405 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -65.42 120.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.189 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -85.32 115.85 23.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.44 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.6 mt -128.52 94.53 35.15 Favored Pre-proline 0 C--N 1.288 -2.072 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.32 120.46 8.37 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.911 1.741 . . . . 0.0 111.597 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.31 148.78 30.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -112.62 126.46 55.39 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.33 166.32 30.62 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.227 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -62.17 -12.91 22.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 111.985 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.31 1.27 56.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.755 0.788 . . . . 0.0 109.43 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 68.58 28.54 5.79 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.128 1.371 . . . . 0.0 111.915 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.14 130.01 56.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 m -83.31 119.23 24.34 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.525 0.678 . . . . 0.0 109.59 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.61 151.82 20.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.47 -25.8 72.69 Favored Glycine 0 C--O 1.213 -1.174 0 O-C-N 124.26 0.975 . . . . 0.0 113.535 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.1 p30 -174.67 175.72 2.41 Favored 'General case' 0 C--O 1.256 1.398 0 C-N-CA 123.708 0.803 . . . . 0.0 109.218 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.29 68.19 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.51 0.506 . . . . 0.0 112.133 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 41.6 t -56.53 -52.54 64.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 123.451 0.469 . . . . 0.0 110.125 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -65.84 -32.4 73.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.813 0.34 . . . . 0.0 111.111 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.51 -48.76 73.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.484 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.1 t -61.35 -45.32 94.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.1 m -57.03 -49.34 76.11 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.18 0.514 . . . . 0.0 110.647 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.22 -34.48 76.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.32 -47.75 78.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.58 -38.6 91.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.808 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.1 p -89.6 4.5 49.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.458 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 62.59 30.05 16.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.854 0.862 . . . . 0.0 112.582 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.14 27.8 7.59 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.397 -0.906 . . . . 0.0 114.743 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -76.58 -52.44 9.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.368 1.084 . . . . 0.0 110.793 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.07 119.91 42.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.687 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -106.39 -179.62 3.99 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -80.31 119.1 22.59 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 tp -91.34 -54.26 3.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -160.12 159.7 32.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.682 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -78.96 151.32 31.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.13 170.58 35.09 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.473 -0.87 . . . . 0.0 110.997 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 m -65.99 145.23 56.13 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.824 -0.607 . . . . 0.0 111.295 -177.648 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 N--CA 1.432 -1.366 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 42.3 t -99.46 -7.34 26.19 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m -67.11 -45.03 78.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 pt -69.12 -15.09 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.175 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.8 m-85 -96.42 -11.75 25.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.162 0.506 . . . . 0.0 110.691 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.8 mtpp -75.04 -14.21 60.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.72 -4.09 44.47 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.278 0.561 . . . . 0.0 111.259 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -108.38 159.71 29.77 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.33 145.05 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 121.393 1.395 . . . . 0.0 109.348 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.77 -40.63 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.404 0.621 . . . . 0.0 111.282 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.03 -26.93 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.503 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 92.99 3.64 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.528 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.09 119.64 33.27 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.94 133.66 31.94 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 121.406 1.404 . . . . 0.0 111.206 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.58 139.7 20.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.806 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.52 160.53 35.41 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.383 2.055 . . . . 0.0 110.449 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 pt -91.9 -9.06 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.118 0.485 . . . . 0.0 111.523 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 130.9 39.56 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -85.39 117.1 24.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.6 mt -129.28 97.13 26.36 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.97 118.83 5.75 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.506 1.47 . . . . 0.0 110.43 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.88 145.9 34.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.8 t -110.83 127.6 55.47 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.48 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 78' ' ' GLN . . . -89.99 161.28 29.15 Favored Glycine 0 N--CA 1.421 -2.336 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.608 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m -54.66 -24.45 21.74 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.856 1.262 . . . . 0.0 112.31 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.54 7.19 34.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.701 0.762 . . . . 0.0 110.304 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 68.25 24.6 7.42 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.53 1.132 . . . . 0.0 112.62 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.49 121.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.0 m -81.71 128.34 33.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.61 150.86 26.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.291 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.54 76.11 Favored Glycine 0 N--CA 1.445 -0.706 0 O-C-N 124.104 0.877 . . . . 0.0 113.284 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 28.4 p30 -176.52 175.33 1.76 Allowed 'General case' 0 C--O 1.255 1.383 0 CA-C-O 121.091 0.472 . . . . 0.0 111.645 176.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -44.99 -47.82 11.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.268 2.227 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.7 t -56.23 -44.29 79.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.837 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.118 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.94 -47.29 83.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 50.4 t -62.84 -41.36 99.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.941 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 90.2 m -57.43 -51.61 68.71 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.79 -34.46 75.58 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.515 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -61.69 -46.18 90.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 77.1 mt -68.81 -44.06 74.31 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -54.6 -56.91 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 111.181 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 m -89.47 28.9 1.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 p30 50.54 21.6 0.9 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 126.29 1.836 . . . . 0.0 115.294 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.35 7.41 34.91 Favored Glycine 0 C--N 1.295 -1.74 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.618 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -60.93 -46.36 90.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.976 0.894 . . . . 0.0 109.575 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.5 p -108.19 119.32 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.742 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.407 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 76.3 mt-30 -129.67 -178.6 4.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -65.71 111.46 3.22 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.28 -54.01 4.53 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -162.16 159.81 26.39 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.89 158.54 26.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.99 177.16 42.29 Favored Glycine 0 N--CA 1.416 -2.698 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 m -70.13 152.18 44.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.859 -178.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t0 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.755 0.788 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 43.4 t -93.9 -15.74 24.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -34.82 77.25 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.266 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 pt -65.24 -31.61 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.853 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.3 m-85 -87.71 -16.89 33.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.129 0.49 . . . . 0.0 111.159 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 99.0 mttt -66.81 -14.54 62.77 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.454 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.98 -12.26 60.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.798 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.87 152.1 44.57 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.95 138.74 80.81 Favored 'Trans proline' 0 C--O 1.22 -0.398 0 C-N-CA 122.027 1.818 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.33 -30.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.32 -27.03 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.522 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.38 92.99 3.68 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.116 0.484 . . . . 0.0 111.479 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.09 122.66 25.38 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.83 133.71 24.18 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.037 1.158 . . . . 0.0 110.248 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.8 m -116.74 139.6 25.79 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -61.58 150.49 85.19 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.238 1.959 . . . . 0.0 112.026 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 pt -76.72 -13.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.418 0.628 . . . . 0.0 109.72 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -69.01 137.18 53.46 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.68 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -101.25 113.78 27.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.3 mp -119.76 97.07 49.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.85 118.91 5.85 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.364 1.376 . . . . 0.0 110.299 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.71 146.79 33.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.7 t -109.53 125.81 52.9 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.09 161.58 24.54 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 m -53.3 -24.5 11.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.494 1.118 . . . . 0.0 112.616 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.34 -1.73 38.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.273 0.629 . . . . 0.0 110.576 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 72.49 30.65 1.89 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.853 1.661 . . . . 0.0 110.85 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.74 131.19 61.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.746 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.2 m -81.56 119.21 23.48 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.72 152.32 19.79 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.07 -19.5 78.49 Favored Glycine 0 N--CA 1.443 -0.869 0 O-C-N 124.094 0.871 . . . . 0.0 113.498 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.0 p30 -177.11 177.19 1.28 Allowed 'General case' 0 C--O 1.255 1.393 0 C-N-CA 123.75 0.82 . . . . 0.0 109.54 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -27.93 64.5 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.442 0.463 . . . . 0.0 111.622 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.7 t -55.76 -52.03 65.34 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.364 0.415 . . . . 0.0 109.906 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -65.35 -36.66 84.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.033 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.12 -48.09 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.526 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 46.9 t -59.63 -45.27 92.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.435 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 m -57.53 -47.17 82.73 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.304 0.573 . . . . 0.0 110.59 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.57 -39.33 88.43 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.774 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 t -64.63 -38.7 91.89 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.653 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 93.1 mt -67.57 -37.01 82.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.782 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.52 -43.74 59.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.426 0.632 . . . . 0.0 110.961 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 m -83.5 0.23 47.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.854 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.25 71.01 0.57 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.71 1.204 . . . . 0.0 112.689 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.98 39.66 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.582 -0.736 . . . . 0.0 114.895 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -59.47 -54.46 46.41 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.225 0.536 . . . . 0.0 111.74 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.74 125.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -128.78 -178.63 4.68 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.62 112.09 8.36 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.1 tp -86.12 -48.73 8.34 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -165.1 161.37 19.57 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.417 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.61 147.16 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 165.46 39.85 Favored Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.708 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -61.09 150.82 32.75 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.065 0.546 . . . . 0.0 110.376 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.255 1.363 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 CA--C 1.494 -1.185 0 CA-C-O 122.396 1.093 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 53.9 t -83.17 -17.14 43.93 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.887 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -54.34 -47.07 72.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.172 0.989 . . . . 0.0 111.794 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 pt -68.42 -18.05 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.9 m-85 -94.93 -22.48 17.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 110.012 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.7 mtpt -65.47 -14.41 60.93 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.855 0.862 . . . . 0.0 110.407 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.44 -15.39 63.65 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.518 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.83 161.44 23.25 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.56 153.64 13.63 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.129 2.553 . . . . 0.0 112.554 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.76 -41.6 86.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 123.79 0.836 . . . . 0.0 112.922 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -96.55 -11.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.833 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.53 92.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.698 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.8 mt -124.92 127.79 25.02 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.86 134.07 24.88 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.147 1.231 . . . . 0.0 111.554 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.46 136.92 19.32 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.047 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.08 162.65 39.12 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.128 1.885 . . . . 0.0 110.961 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -86.78 -3.37 8.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.333 0.587 . . . . 0.0 110.639 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.8 127.69 33.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.469 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.25 117.13 29.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 87.2 mt -129.77 95.93 27.81 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.6 118.97 5.88 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.96 1.773 . . . . 0.0 111.474 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.17 153.17 38.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.5 t -119.9 130.1 54.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.41 162.98 27.26 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.36 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -61.26 -16.22 43.19 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.025 0.93 . . . . 0.0 111.59 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.32 1.61 54.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.842 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 68.51 26.41 6.5 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.93 1.292 . . . . 0.0 113.15 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mm -103.87 127.59 57.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.2 m -81.84 138.26 35.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.09 153.36 34.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.503 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.37 -26.18 74.56 Favored Glycine 0 N--CA 1.438 -1.226 0 O-C-N 124.642 1.214 . . . . 0.0 112.979 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.5 p30 -175.36 177.35 1.85 Allowed 'General case' 0 C--O 1.255 1.352 0 C-N-CA 122.501 0.32 . . . . 0.0 110.886 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -47.51 -46.21 27.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.105 1.762 . . . . 0.0 111.626 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.15 -52.32 64.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.79 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -64.53 -38.02 89.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.59 -45.63 89.48 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.731 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 48.1 t -63.28 -44.81 94.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.792 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 m -58.62 -44.92 90.14 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.437 0.637 . . . . 0.0 110.321 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -72.06 -35.51 69.33 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.3 t -62.77 -42.96 99.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.65 -42.3 78.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -58.22 -49.69 76.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.212 0.53 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -89.24 -4.79 58.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.579 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 53.35 67.79 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.611 1.164 . . . . 0.0 113.291 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 3.75 89.27 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-N 115.258 -0.883 . . . . 0.0 115.094 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.13 -47.83 72.83 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.01 94.96 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.176 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -106.07 -178.83 3.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -72.11 121.9 20.04 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.115 0.87 . . . . 0.0 109.347 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.12 -54.85 3.28 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.73 164.19 29.17 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.52 152.22 28.79 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.87 169.36 42.56 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.4 m -69.6 153.27 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.31 -1.128 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.427 -176.056 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.9 t -89.11 -12.75 40.24 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -59.23 -43.54 92.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -63.19 -28.19 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.694 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -88.33 -16.72 32.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.931 0.396 . . . . 0.0 111.323 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 66.9 mttm -69.49 -14.81 63.07 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.739 0.78 . . . . 0.0 109.204 174.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.04 6.31 36.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -120.02 154.09 55.46 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.82 135.04 60.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.676 1.584 . . . . 0.0 109.901 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -52.24 -35.67 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 0.0 112.468 -175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.15 -25.33 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.94 93.59 3.87 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.847 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.22 109.61 35.04 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.248 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.97 135.25 37.08 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 110.475 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.3 m -116.47 149.94 44.61 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.456 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.96 159.21 43.33 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.844 2.362 . . . . 0.0 110.34 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 pt -86.28 -3.07 8.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.107 0.48 . . . . 0.0 111.971 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -82.74 131.1 35.21 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.068 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -88.09 106.24 18.03 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 94.7 mt -117.93 95.16 47.7 Favored Pre-proline 0 C--N 1.285 -2.227 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.3 121.35 9.5 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 121.847 1.698 . . . . 0.0 111.071 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.42 156.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.8 t -120.71 127.07 51.68 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.92 162.12 33.78 Favored Glycine 0 N--CA 1.413 -2.849 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 p -59.69 -20.93 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 125.133 1.373 . . . . 0.0 112.288 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.12 5.11 42.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.495 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 66.35 39.97 3.84 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.884 1.273 . . . . 0.0 111.681 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.57 130.14 72.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.889 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 m -84.51 135.36 34.26 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.576 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.468 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 97.1 m-85 -120.07 156.55 30.75 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.51 -19.35 77.7 Favored Glycine 0 C--O 1.224 -0.481 0 O-C-N 124.25 0.969 . . . . 0.0 113.649 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.9 p30 -177.43 171.97 1.89 Allowed 'General case' 0 C--O 1.256 1.421 0 C-N-CA 123.777 0.831 . . . . 0.0 109.973 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -31.42 72.59 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.2 t -56.82 -53.78 53.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.647 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.78 -32.93 74.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.79 -44.75 95.35 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.086 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.3 t -68.8 -37.09 79.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.077 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 m -58.8 -45.4 89.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.444 0.64 . . . . 0.0 109.803 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.534 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 10.4 tp10 -71.93 -34.14 68.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.392 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.4 t -61.89 -51.05 69.77 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.14 0.576 . . . . 0.0 109.927 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.61 -33.67 76.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.388 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.534 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 59.5 tttp -67.6 -49.73 61.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.998 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -90.21 20.36 4.43 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.6 m120 59.71 34.43 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.35 4.12 71.4 Favored Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.895 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -56.98 -50.06 73.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.551 0.691 . . . . 0.0 111.374 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.59 116.67 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.004 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -137.08 177.76 7.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.67 113.96 2.27 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.975 0.807 . . . . 0.0 113.171 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.92 -58.16 2.33 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -151.6 159.04 44.24 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.88 150.23 30.68 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.33 164.77 40.51 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -62.25 151.53 36.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.085 -0.484 . . . . 0.0 110.616 -177.491 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 35.2 t -98.42 0.58 45.59 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -49.32 61.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.765 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 pt -68.66 -15.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.489 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.718 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 77.6 m-85 -98.33 -14.66 20.08 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.997 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 68.9 mttm -65.51 -14.72 61.64 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.664 0.745 . . . . 0.0 109.759 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.59 -32.45 71.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.441 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -100.58 157.44 33.73 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.005 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.54 142.81 79.54 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.183 1.922 . . . . 0.0 110.191 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.44 -27.08 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.559 0.744 . . . . 0.0 112.935 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -86.31 -26.55 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.061 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.87 97.23 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.167 -0.333 . . . . 0.0 111.219 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.436 HG21 ' SG ' ' A' ' 64' ' ' CYS . 48.5 mt -124.35 108.78 29.26 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.322 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.24 135.11 59.82 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.759 2.306 . . . . 0.0 110.468 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.6 m -124.35 152.65 68.34 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.501 -174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.56 153.2 62.93 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.153 1.902 . . . . 0.0 110.815 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 pt -80.13 -9.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.188 0.518 . . . . 0.0 111.815 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.2 m -81.13 127.43 32.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.68 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -86.21 129.04 34.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 67.9 mt -133.65 100.19 13.72 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.2 119.71 7.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.38 1.386 . . . . 0.0 110.526 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.12 149.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.8 t -114.94 129.98 56.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.029 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 165.13 30.39 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.615 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -54.99 -24.11 22.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.675 1.19 . . . . 0.0 111.641 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.77 7.21 35.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.847 0.832 . . . . 0.0 110.803 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 66.36 24.99 10.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.628 1.171 . . . . 0.0 112.848 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.31 131.46 50.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 m -85.67 128.83 34.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.145 0.498 . . . . 0.0 110.046 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.2 m-85 -110.47 154.93 22.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.309 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.58 -26.96 73.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.2 p30 -178.56 -179.2 0.64 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 117.146 0.473 . . . . 0.0 110.444 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.83 -48.08 20.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.758 1.623 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.436 ' SG ' HG21 ' A' ' 43' ' ' ILE . 43.6 t -61.55 -52.85 62.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.782 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -63.97 -33.82 76.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.452 . . . . 0.0 111.174 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.11 -45.8 79.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.914 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.8 t -64.64 -38.94 92.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.353 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.6 m -57.38 -48.33 79.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.5 tp10 -70.85 -33.89 71.11 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 t -61.82 -40.62 95.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.418 HD21 ' HZ1' ' A' ' 36' ' ' LYS . 95.6 mt -74.13 -40.64 62.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.218 0.324 . . . . 0.0 110.46 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -54.29 -60.2 3.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.406 0.682 . . . . 0.0 111.169 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 m -78.04 -20.88 51.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.351 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.22 84.33 0.12 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 125.438 1.495 . . . . 0.0 113.039 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.19 -29.26 5.68 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.622 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -57.03 -44.69 83.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.714 0.806 . . . . 0.0 111.717 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.682 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -132.69 -178.69 5.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -68.69 113.29 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -89.67 -55.44 3.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -159.8 163.07 34.84 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.8 162.64 19.5 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.48 169.48 45.95 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -66.34 148.78 51.36 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.2 m . . . . . 0 C--N 1.307 -1.255 0 O-C-N 123.347 0.405 . . . . 0.0 110.624 -177.832 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.509 -0.609 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 50.7 t -108.32 -9.66 15.44 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -60.57 -40.82 93.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.752 1.221 . . . . 0.0 111.668 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -70.14 -21.54 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.64 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.8 m-85 -94.08 -20.91 19.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 97.6 mttt -66.69 -14.9 63.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.726 0.774 . . . . 0.0 110.217 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 37' ' ' LYS . 7.8 mtpm? -75.25 -2.34 27.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.648 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -118.0 156.95 49.71 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.16 144.04 85.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.771 1.647 . . . . 0.0 110.659 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.89 -33.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.719 0.808 . . . . 0.0 112.337 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.25 -25.46 9.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.5 93.81 3.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.186 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.56 119.74 25.95 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.91 134.25 21.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.167 1.245 . . . . 0.0 110.947 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.4 m -117.27 148.29 42.25 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.69 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.19 164.26 35.63 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.459 2.106 . . . . 0.0 111.201 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -89.47 -0.34 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.777 0.798 . . . . 0.0 110.145 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 128.64 36.22 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.294 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' CE1' ' HA2' ' A' ' 61' ' ' GLY . 70.7 t80 -96.08 104.39 16.34 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.7 mt -116.86 98.01 51.33 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.14 125.2 16.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.382 1.388 . . . . 0.0 110.94 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.38 150.88 31.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.2 t -117.57 130.49 56.43 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.74 164.9 25.49 Favored Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.656 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -55.18 -23.77 23.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.642 1.177 . . . . 0.0 111.9 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.01 8.56 20.1 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.267 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 64.4 31.16 12.86 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 125.197 1.399 . . . . 0.0 111.337 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.4 131.2 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.167 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -85.06 133.5 34.23 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.416 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.1 m-85 -112.58 151.15 30.39 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 49' ' ' TYR . . . -71.34 -12.29 72.57 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 124.153 0.908 . . . . 0.0 114.303 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -179.35 172.6 1.18 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 124.329 1.052 . . . . 0.0 109.298 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -28.33 67.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 123.761 0.663 . . . . 0.0 112.765 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.05 -50.58 73.52 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.71 -34.51 78.49 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 111.128 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.94 -46.08 83.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.751 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -61.22 -46.17 91.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m -56.35 -47.41 78.88 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.86 0.362 . . . . 0.0 110.146 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.416 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.4 tp10 -68.04 -37.15 81.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.866 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 t -63.63 -43.74 95.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.521 0.729 . . . . 0.0 110.208 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.61 -43.77 68.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.841 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.3 -44.14 75.48 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -94.14 3.43 55.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.049 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 t30 46.27 74.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.961 1.704 . . . . 0.0 113.85 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.15 -3.07 59.24 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 115.113 0.805 . . . . 0.0 115.113 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -60.87 -57.17 13.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.372 0.606 . . . . 0.0 110.609 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.16 124.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -125.68 -178.85 4.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -70.92 121.76 18.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.15 -53.15 3.58 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -161.95 157.99 24.57 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -83.58 164.15 19.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.43 168.72 42.67 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -64.15 151.76 42.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.057 -178.529 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 CA--C 1.487 -1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.2 t -98.96 -5.93 29.68 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -68.46 -39.98 81.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.328 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.11 -16.28 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.502 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.9 m-85 -103.46 -10.99 18.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 98.4 mttt -64.1 -14.79 57.23 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -70.51 -19.6 62.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.864 0.364 . . . . 0.0 111.425 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.58 168.69 10.42 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 6.7 Cg_endo -54.44 160.46 6.86 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.771 2.314 . . . . 0.0 112.069 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.1 -41.82 79.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.29 -13.41 8.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.456 -0.898 . . . . 0.0 113.058 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -124.23 94.06 4.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.484 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.416 HG21 ' HB3' ' A' ' 35' ' ' TYR . 60.9 mt -122.12 130.35 24.75 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.38 134.84 29.81 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.596 1.531 . . . . 0.0 110.43 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.62 155.44 48.82 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.86 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.84 156.93 40.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.374 2.049 . . . . 0.0 111.111 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.47 15.03 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.534 0.683 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -99.76 131.05 45.99 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.41 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 51.8 t80 -89.21 122.3 32.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 93.7 mt -133.26 97.75 16.07 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.25 119.87 7.31 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.703 1.602 . . . . 0.0 111.824 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.92 156.07 38.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.3 t -119.63 125.7 49.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.25 160.6 29.57 Favored Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 m -63.72 -9.53 14.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.121 0.968 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.96 8.2 40.85 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 60.3 44.08 12.87 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 111.599 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -124.4 131.87 72.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 m -84.75 133.61 34.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.68 150.85 32.65 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -61.33 -27.56 67.87 Favored Glycine 0 C--O 1.221 -0.679 0 O-C-N 124.284 0.99 . . . . 0.0 113.569 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.6 p30 -170.99 172.1 5.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 123.487 0.715 . . . . 0.0 109.092 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -28.13 68.28 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.68 -42.26 96.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.737 0.304 . . . . 0.0 110.262 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 110.142 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.74 -42.26 97.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.831 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 41.5 t -60.1 -47.86 84.13 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.83 0.452 . . . . 0.0 111.265 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.411 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 21.7 p -57.36 -46.43 83.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.861 0.362 . . . . 0.0 111.7 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.28 -34.58 70.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.231 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -61.59 -48.24 81.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.74 -43.14 76.5 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.937 0.399 . . . . 0.0 110.596 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -46.85 77.82 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.191 0.996 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 m -92.91 15.83 13.96 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.415 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m120 55.54 30.61 15.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.17 3.38 51.23 Favored Glycine 0 C--N 1.316 -0.53 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.688 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -57.2 -45.0 84.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.344 0.658 . . . . 0.0 110.324 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.22 133.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.215 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -123.36 -179.78 4.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -83.01 110.78 18.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 tp -83.89 -61.34 1.85 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -154.73 161.77 41.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.36 153.92 40.28 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.97 169.55 45.43 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.07 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -63.0 152.65 36.23 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.812 0.445 . . . . 0.0 109.901 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.381 -0.343 . . . . 0.0 110.91 -178.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.428 -1.539 0 CA-C-O 122.343 1.068 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 33.1 t -89.38 -12.31 40.73 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.525 -1.67 . . . . 0.0 108.423 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -51.52 -46.55 63.33 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.34 1.056 . . . . 0.0 112.27 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.2 pt -73.85 -15.48 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.668 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 94.3 m-85 -96.56 -18.36 19.84 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 110.102 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 60.0 mtpt -66.78 -14.59 62.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.453 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -76.39 -19.25 58.32 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.535 0.683 . . . . 0.0 109.394 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 24.1 m-85 -93.96 145.15 29.3 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.59 153.79 76.63 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.089 1.859 . . . . 0.0 111.214 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.27 -25.62 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.128 0.571 . . . . 0.0 112.18 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.52 -25.38 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 O-C-N 121.97 -0.456 . . . . 0.0 111.823 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.21 94.02 3.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.68 108.3 28.71 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.31 134.32 26.57 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 121.951 1.767 . . . . 0.0 111.43 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.9 m -107.53 146.51 33.47 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.915 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.02 153.85 55.01 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.684 2.256 . . . . 0.0 110.882 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.9 pt -75.13 -24.66 17.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.041 0.448 . . . . 0.0 111.8 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 m -77.01 144.15 38.88 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -96.32 128.4 43.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 mp -134.24 104.37 11.38 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.72 120.16 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.438 1.425 . . . . 0.0 110.495 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.58 152.0 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.58 130.24 55.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.06 0.457 . . . . 0.0 110.846 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.94 163.81 28.35 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 p -63.43 -15.23 57.04 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.672 0.789 . . . . 0.0 112.328 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.78 4.71 39.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.607 0.717 . . . . 0.0 109.906 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.19 43.53 6.29 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.721 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.97 129.11 75.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.7 m -85.37 135.56 33.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -115.78 156.43 26.04 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.49 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.81 -22.57 78.23 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.595 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -178.27 174.25 1.33 Allowed 'General case' 0 C--O 1.256 1.423 0 C-N-CA 122.915 0.486 . . . . 0.0 110.369 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -51.62 -35.97 43.98 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.115 1.366 . . . . 0.0 113.547 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.27 -44.08 92.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.48 0.181 . . . . 0.0 111.201 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -68.41 -38.3 81.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.93 -48.85 74.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.1 t -60.01 -38.55 82.97 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.215 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.8 m -57.54 -52.86 63.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.79 -34.34 77.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.646 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -60.68 -46.78 89.05 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.48 -41.16 63.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.7 0.286 . . . . 0.0 110.715 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -63.57 -32.01 73.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -102.68 7.45 39.79 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.792 0.329 . . . . 0.0 111.001 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t30 46.52 75.2 0.12 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.273 1.429 . . . . 0.0 113.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.93 -5.1 26.82 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.579 0.991 . . . . 0.0 115.579 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -57.07 -60.48 3.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.791 0.805 . . . . 0.0 110.128 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.21 121.18 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.83 171.43 9.66 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.14 116.05 10.06 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -88.21 -56.24 3.41 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -161.73 161.7 29.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -82.25 165.64 20.25 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.12 165.09 40.89 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 m -66.55 143.65 56.92 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.311 -1.073 0 C-N-CA 123.103 0.561 . . . . 0.0 112.463 -176.092 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -97.76 113.48 25.27 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.7 147.16 19.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.7 46.75 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -109.17 105.22 14.58 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.91 106.67 3.26 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 m -121.67 86.58 45.19 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -88.97 91.74 0.38 Allowed 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.684 2.256 . . . . 0.0 110.13 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -102.14 143.33 32.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.269 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -136.81 113.52 10.28 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.21 169.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.48 103.57 5.66 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.01 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -104.28 -9.93 18.21 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -61.76 -43.79 98.16 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.73 0.812 . . . . 0.0 111.928 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.1 pt -65.23 -24.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.806 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.648 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 75.9 m-85 -94.13 -22.98 18.13 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 121.815 0.817 . . . . 0.0 109.284 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -69.29 -15.04 63.26 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 125.284 1.434 . . . . 0.0 109.431 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.72 -16.31 60.75 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.357 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -105.28 159.32 29.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.07 139.25 72.03 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.045 1.83 . . . . 0.0 109.784 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.84 -30.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.59 -26.12 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.96 93.26 3.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.786 -0.571 . . . . 0.0 110.908 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.72 113.2 28.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 134.36 31.56 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.287 1.992 . . . . 0.0 111.278 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.8 m -116.99 148.11 41.53 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.302 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.55 158.32 58.17 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.069 1.846 . . . . 0.0 111.283 175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.21 11.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.724 0.773 . . . . 0.0 112.052 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.7 m -94.13 136.42 34.44 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.749 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -105.62 116.31 31.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 96.1 mt -133.47 102.81 12.62 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.35 125.97 18.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.788 1.658 . . . . 0.0 110.949 -176.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.06 153.48 36.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.9 t -119.07 128.98 54.84 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 121.036 0.446 . . . . 0.0 110.67 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.22 164.48 30.91 Favored Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.613 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 p -66.26 -14.75 62.45 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.914 0.886 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.24 0.27 52.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.952 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 69.19 31.12 4.09 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.067 1.347 . . . . 0.0 111.711 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.24 128.4 66.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.4 m -84.13 133.31 34.63 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.09 156.57 26.16 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.789 0.435 . . . . 0.0 110.501 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.7 75.74 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 124.193 0.933 . . . . 0.0 114.117 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.8 p30 -171.83 175.7 3.83 Favored 'General case' 0 C--O 1.258 1.532 0 C-N-CA 123.186 0.595 . . . . 0.0 109.61 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.62 76.26 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.2 -48.94 79.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.707 0.289 . . . . 0.0 110.51 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.93 -36.94 83.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.101 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -61.18 -47.39 86.4 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 123.595 0.559 . . . . 0.0 109.555 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.648 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -59.91 -41.61 92.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.968 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.3 m -57.2 -48.37 78.95 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 120.92 0.391 . . . . 0.0 110.35 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -34.4 70.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.772 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 t -62.27 -42.69 99.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.75 -40.6 63.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.23 -46.11 90.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.446 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -93.59 6.08 49.45 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.027 0.441 . . . . 0.0 111.104 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 48.38 71.91 0.32 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 114.872 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.94 65.14 Favored Glycine 0 C--N 1.312 -0.766 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -56.8 -50.48 72.2 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.7 104.58 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.855 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -106.15 -178.65 3.71 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -81.49 128.45 33.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -103.51 -57.31 2.06 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -159.41 161.66 35.62 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.43 157.81 24.81 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 168.55 44.68 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 m -60.92 144.93 52.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.791 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.44 -0.928 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -39.81 29.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.44 -57.21 0.07 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -155.74 97.84 1.87 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.603 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -94.16 -39.86 10.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp 67.06 157.74 0.12 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 125.231 1.413 . . . . 0.0 113.075 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 t -91.11 111.34 47.99 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -78.85 103.12 1.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 121.619 1.546 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.75 96.24 8.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.981 0.896 . . . . 0.0 109.88 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -144.54 167.74 21.8 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.62 151.15 10.28 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.35 109.18 19.36 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.022 0.915 . . . . 0.0 110.897 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.8 t -102.57 -1.56 30.15 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.929 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -63.41 -44.21 95.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.932 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 pt -72.03 -25.05 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.643 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 88.0 m-85 -84.44 -11.75 55.63 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.947 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 29.2 mtpp -69.28 -14.68 63.08 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.817 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -76.62 -2.99 35.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.686 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -115.03 153.95 47.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 130.58 34.76 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.203 1.935 . . . . 0.0 110.105 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.14 -33.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.86 -26.67 11.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.326 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.72 93.92 3.82 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.132 -0.355 . . . . 0.0 111.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.417 HD11 ' HA ' ' A' ' 68' ' ' THR . 50.7 mt -112.18 117.93 46.85 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.38 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.47 135.55 29.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.647 2.231 . . . . 0.0 111.059 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.78 149.31 53.04 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.244 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.7 162.78 39.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.367 2.045 . . . . 0.0 110.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 pt -83.56 -12.39 11.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.799 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -61.5 126.27 26.76 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -100.21 111.22 23.49 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -121.25 101.0 44.71 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.62 118.34 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.205 1.27 . . . . 0.0 110.935 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.58 143.9 39.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.9 t -107.99 127.14 53.5 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.224 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.31 160.41 28.11 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -56.17 -23.66 36.46 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.964 0.906 . . . . 0.0 112.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -88.38 11.3 17.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.661 0.743 . . . . 0.0 110.372 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 63.63 29.11 15.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.902 1.281 . . . . 0.0 112.654 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mm -103.14 126.13 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.4 m -83.26 124.44 30.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -103.23 144.53 31.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.43 -19.33 68.6 Favored Glycine 0 C--O 1.222 -0.638 0 O-C-N 124.117 0.886 . . . . 0.0 113.676 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 30.7 p30 -170.94 173.5 5.12 Favored 'General case' 0 C--O 1.256 1.423 0 C-N-CA 123.635 0.774 . . . . 0.0 109.095 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.41 64.18 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.347 0.404 . . . . 0.0 110.923 -174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.441 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 44.4 t -54.26 -52.66 60.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.596 0.56 . . . . 0.0 110.199 175.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -63.82 -36.72 84.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.043 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -63.39 -49.64 73.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.03 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 43.0 t -59.2 -38.71 80.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.355 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.417 ' HA ' HD11 ' A' ' 43' ' ' ILE . 26.7 m -56.92 -50.06 73.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 110.343 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -71.92 -36.99 70.13 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.2 m -58.04 -43.9 87.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.968 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.86 -42.24 61.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.142 0.496 . . . . 0.0 110.398 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.89 -46.04 85.5 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.321 1.048 . . . . 0.0 111.837 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.1 m -99.66 14.6 29.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 43.92 76.34 0.08 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 114.028 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA2' ' NE2' ' A' ' 78' ' ' GLN . . . 70.94 15.62 74.17 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 115.073 -0.967 . . . . 0.0 114.051 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -72.29 -62.23 1.51 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.73 131.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.435 ' NE2' ' HA2' ' A' ' 75' ' ' GLY . 25.2 mm-40 -129.28 173.17 10.76 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -67.54 112.14 4.53 Favored 'General case' 0 C--N 1.284 -2.255 0 O-C-N 123.941 0.776 . . . . 0.0 109.206 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 tp -86.29 -56.34 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -161.07 162.23 31.56 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.208 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.08 146.96 45.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.79 168.58 38.12 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.75 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -64.45 149.76 47.86 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 122.706 0.402 . . . . 0.0 110.346 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.179 178.765 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.243 0.752 0 CA-C-O 121.127 0.489 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' C ' ' H ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -76.27 166.96 22.7 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.873 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 75.62 -29.19 0.18 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.201 1.4 . . . . 0.0 111.95 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.87 126.06 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 113.22 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.2 m -145.63 32.28 1.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.32 -21.61 45.66 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.255 1.026 . . . . 0.0 108.455 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 m -132.65 148.19 68.55 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.01 86.05 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 121.64 1.56 . . . . 0.0 109.111 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -62.36 135.57 57.51 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.58 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HD3' ' HB3' ' A' ' 79' ' ' PHE . 5.0 tppt? -143.31 157.12 44.74 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.99 144.22 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.5 97.41 7.12 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.4 t -93.69 -17.97 22.64 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 p -61.54 -27.75 68.83 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -77.99 -22.29 13.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 O-C-N 121.987 -0.446 . . . . 0.0 112.034 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 99.1 m-85 -98.9 -19.55 17.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.761 0.791 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.97 -14.93 63.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.39 1.076 . . . . 0.0 110.767 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -83.38 -4.04 58.1 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -100.88 156.88 34.64 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.92 135.29 68.94 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.608 2.205 . . . . 0.0 111.264 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.75 -24.47 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.51 -24.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.851 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.15 93.51 3.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.409 0.623 . . . . 0.0 111.045 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.97 115.83 31.64 Favored Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.28 133.61 31.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.484 1.456 . . . . 0.0 111.102 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.7 m -114.2 141.26 26.1 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.514 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.7 159.19 49.61 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.338 2.025 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 pt -83.57 -13.56 11.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.944 0.402 . . . . 0.0 110.805 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -70.27 132.41 45.67 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.413 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 52.8 t80 -96.88 112.83 24.41 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -124.05 98.36 39.27 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.19 126.86 22.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.867 1.711 . . . . 0.0 111.42 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.73 148.72 33.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -117.31 131.01 56.89 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 120.887 0.375 . . . . 0.0 110.329 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 168.36 26.41 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 p -70.91 -8.39 52.57 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.991 0.9 . . . . 0.0 110.745 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.31 -3.61 59.02 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 67.22 27.36 8.43 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.912 1.685 . . . . 0.0 112.725 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.77 133.32 48.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 m -88.24 129.1 35.45 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -107.79 146.99 31.44 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.376 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -62.66 -28.14 71.01 Favored Glycine 0 CA--C 1.499 -0.964 0 O-C-N 124.57 1.169 . . . . 0.0 112.617 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.3 p30 -172.17 170.03 5.31 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 123.145 0.578 . . . . 0.0 109.898 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.12 -29.07 60.17 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.4 t -62.36 -44.36 96.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -70.31 -37.84 74.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.7 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.11 -48.91 78.08 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.633 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.6 t -62.86 -41.51 99.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.652 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.9 m -60.39 -49.69 76.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 109.798 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.3 -37.45 87.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.035 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -65.68 -58.18 6.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.1 -45.65 86.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.132 0.573 . . . . 0.0 111.39 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -57.43 -33.65 68.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.098 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.6 m -105.18 17.77 23.48 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.853 -174.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 63.56 22.8 13.34 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 123.392 0.677 . . . . 0.0 112.658 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.86 28.94 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.753 -0.736 . . . . 0.0 113.067 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -57.15 -50.96 71.19 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.214 1.007 . . . . 0.0 108.43 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.59 133.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -117.29 160.85 20.45 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 66.2 t80 -68.48 121.49 16.46 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.38 -60.14 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -158.89 156.84 30.31 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -82.72 166.71 18.86 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.03 168.79 42.1 Favored Glycine 0 C--N 1.273 -2.942 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -67.73 146.09 54.11 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.782 -178.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.74 96.74 7.52 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.03 -172.64 2.87 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 71.7 -66.66 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.566 1.546 . . . . 0.0 112.876 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 p -78.29 -162.66 0.37 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 122.904 0.481 . . . . 0.0 109.939 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.41 77.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.937 0.875 . . . . 0.0 108.748 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.5 m -160.61 83.87 2.01 Favored Pre-proline 0 C--N 1.301 -1.51 0 C-N-CA 125.783 1.633 . . . . 0.0 108.239 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -89.33 78.56 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.451 2.1 . . . . 0.0 108.696 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.74 139.41 53.33 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 121.81 0.814 . . . . 0.0 112.306 -173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.11 176.46 8.64 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.462 HG21 ' HB2' ' A' ' 63' ' ' GLU . 5.5 p -66.72 130.94 32.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.37 96.36 9.53 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 117.299 -1.761 . . . . 0.0 107.479 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -88.07 -12.47 44.13 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.202 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 m -61.52 -39.66 91.81 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.33 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 pt -67.91 -17.69 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.647 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.0 m-85 -99.07 -5.47 30.21 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -58.82 -21.81 57.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.813 0.445 . . . . 0.0 111.976 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -79.24 4.76 14.03 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -118.93 152.03 51.14 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.37 133.06 46.98 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 121.726 1.617 . . . . 0.0 109.684 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 m -57.62 -24.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.11 -25.33 5.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.004 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.46 93.87 3.98 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.883 0.373 . . . . 0.0 110.808 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.42 117.25 33.13 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.95 133.48 31.34 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.527 1.485 . . . . 0.0 109.725 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.9 m -116.87 150.01 45.08 Favored Pre-proline 0 C--N 1.29 -2.006 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.905 -175.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.18 162.81 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.506 2.138 . . . . 0.0 111.142 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.07 -7.29 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.264 0.554 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -64.68 115.2 5.01 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.585 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -90.21 120.15 31.13 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 88.2 mt -133.72 99.06 14.31 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -62.24 119.92 7.25 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 121.49 1.46 . . . . 0.0 110.954 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.96 152.19 37.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.5 t -114.31 126.21 54.76 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.64 29.15 Favored Glycine 0 N--CA 1.421 -2.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.701 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -51.21 -25.71 5.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.848 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.15 8.32 27.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 69.7 29.92 4.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mm -107.22 124.44 63.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.533 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.5 m -81.47 125.7 30.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.18 155.49 19.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.96 79.16 Favored Glycine 0 N--CA 1.448 -0.533 0 O-C-N 123.868 0.73 . . . . 0.0 113.586 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.8 p30 -171.81 172.68 4.77 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 123.163 0.585 . . . . 0.0 109.764 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.52 -33.88 76.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.881 0.738 . . . . 0.0 112.945 -177.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 40.7 t -56.25 -50.96 69.83 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.68 0.392 . . . . 0.0 110.47 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -64.45 -36.03 82.84 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.707 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.8 -45.79 92.33 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.845 0.716 . . . . 0.0 109.484 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.7 t -61.36 -41.47 97.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.397 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.2 m -56.72 -53.09 61.8 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.27 77.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 t -58.53 -43.5 89.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 122.934 0.494 . . . . 0.0 110.402 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -72.41 -39.12 68.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.438 . . . . 0.0 110.784 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -65.32 -39.72 92.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.022 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -87.3 -0.55 56.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.738 0.304 . . . . 0.0 110.832 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 57.73 68.12 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.239 1.416 . . . . 0.0 111.834 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.02 11.96 61.86 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.293 -0.867 . . . . 0.0 114.03 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -80.06 -50.18 10.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.75 117.11 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -125.7 -178.32 4.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -68.87 114.17 6.96 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.15 -54.64 4.02 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -159.95 159.5 32.33 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.335 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.28 157.52 30.72 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 165.86 41.33 Favored Glycine 0 C--N 1.293 -1.84 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 151.44 46.35 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.259 1.565 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.02 -76.86 0.52 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.52 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.58 -174.07 3.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.9 -154.71 0.33 Allowed 'General case' 0 C--O 1.251 1.167 0 O-C-N 123.839 0.712 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -127.66 111.32 13.59 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.65 83.3 6.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.662 0.744 . . . . 0.0 109.748 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -78.16 138.8 60.4 Favored Pre-proline 0 N--CA 1.423 -1.797 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.402 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.33 95.33 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.879 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 62.4 tttp -61.39 108.13 0.89 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -96.91 144.16 27.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.643 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.73 159.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.77 116.54 15.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.767 0.794 . . . . 0.0 111.122 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.78 -2.44 17.33 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -64.62 -41.12 96.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.45 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 pt -68.08 -22.33 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.672 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.5 m-85 -93.12 -8.37 42.83 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.333 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.54 -15.3 60.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.324 0.583 . . . . 0.0 110.31 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -81.93 -2.19 50.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.061 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -123.18 151.19 61.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.19 145.41 78.41 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 121.92 1.747 . . . . 0.0 109.731 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.86 -38.63 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.59 -26.49 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.851 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.17 92.09 3.51 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.114 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.2 mt -122.29 113.81 30.79 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.18 132.52 34.35 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 120.631 0.888 . . . . 0.0 110.091 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.2 m -126.2 144.39 48.91 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.35 162.96 39.76 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.795 1.663 . . . . 0.0 111.196 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 pt -85.96 -1.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.658 0.742 . . . . 0.0 109.724 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -64.17 128.25 34.97 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.987 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -103.08 108.91 20.27 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.1 mt -123.91 97.45 41.1 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.15 118.59 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.694 1.596 . . . . 0.0 111.404 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.27 150.42 33.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.49 126.84 55.4 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.142 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.42 164.82 29.6 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 p -67.9 -4.58 13.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.393 0.616 . . . . 0.0 112.201 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.87 0.63 56.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 70.35 23.44 5.0 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.257 1.423 . . . . 0.0 111.111 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.9 mm -101.82 132.48 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -86.9 120.13 27.85 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.23 152.49 18.8 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.781 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.73 -18.71 77.56 Favored Glycine 0 N--CA 1.441 -0.972 0 O-C-N 124.116 0.885 . . . . 0.0 113.169 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.2 p30 -175.87 173.76 2.26 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 123.565 0.746 . . . . 0.0 109.935 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.48 -33.74 76.58 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.992 0.917 . . . . 0.0 110.673 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -45.98 90.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -65.8 -35.54 81.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.988 0.423 . . . . 0.0 110.614 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.46 -46.62 82.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.186 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 35.8 t -61.33 -40.81 95.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.1 m -57.69 -51.16 70.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.781 0.324 . . . . 0.0 110.197 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.6 -35.96 82.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.522 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t -65.66 -49.7 67.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.519 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.46 -37.97 89.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.265 0.555 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.59 -28.83 68.79 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.42 1.088 . . . . 0.0 110.906 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.0 p -110.45 16.31 21.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.695 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 60.92 24.87 14.88 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.162 0.982 . . . . 0.0 111.639 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.97 31.5 9.84 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.796 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -76.39 -56.78 4.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.99 129.99 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.625 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.26 -179.79 4.17 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 74.2 t80 -79.68 126.23 30.65 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.59 -52.66 3.85 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -164.52 159.62 19.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.1 153.44 40.79 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.43 172.7 46.93 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.624 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -64.19 146.93 53.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.316 -0.865 0 O-C-N 123.845 0.716 . . . . 0.0 112.235 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.011 0.434 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.33 160.69 32.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.362 -170.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.27 79.1 1.2 Allowed 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.42 -28.74 1.84 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.041 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -79.73 -12.45 59.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -127.84 150.13 49.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 m -62.9 120.34 59.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.46 145.87 66.33 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.453 2.102 . . . . 0.0 111.963 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.6 128.79 36.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 18.9 ptpt -141.96 170.85 14.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.569 0.699 . . . . 0.0 112.201 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 79' ' ' PHE . 11.3 p -81.56 151.96 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.75 94.34 5.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -89.45 -11.18 43.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.489 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -60.91 -40.28 92.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.725 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 45.8 pt -72.95 -21.1 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.764 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.521 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 98.7 m-85 -87.75 -12.47 45.09 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.195 0.522 . . . . 0.0 110.736 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -70.49 -14.76 62.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 23.4 pttm -78.11 -3.59 43.14 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.675 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.66 157.59 34.25 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.2 131.11 43.09 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.274 1.983 . . . . 0.0 110.165 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.53 -24.36 15.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.14 -25.19 5.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.114 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.86 93.79 3.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.882 0.373 . . . . 0.0 110.647 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.405 HD11 ' HG1' ' A' ' 68' ' ' THR . 58.8 mt -118.3 124.49 28.55 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.03 134.07 44.34 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 121.665 1.577 . . . . 0.0 110.554 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.4 m -107.66 140.62 21.74 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.07 163.36 39.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.078 1.852 . . . . 0.0 110.418 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -82.74 -14.54 11.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -64.87 119.41 10.61 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.528 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.3 mt -135.36 96.46 13.87 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -58.4 119.67 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.126 1.884 . . . . 0.0 110.489 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.86 128.61 56.47 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.5 165.95 35.83 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.617 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -57.14 -18.97 17.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.866 1.266 . . . . 0.0 112.117 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.59 6.28 47.86 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.101 0.953 . . . . 0.0 109.841 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.7 OUTLIER 61.1 47.04 7.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 110.847 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.6 mm -120.53 131.91 71.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.2 m -85.14 131.52 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -112.37 153.55 27.1 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.276 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.36 73.87 Favored Glycine 0 N--CA 1.444 -0.828 0 O-C-N 124.014 0.821 . . . . 0.0 113.862 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 34.6 p30 -176.71 -178.67 0.9 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 116.936 0.368 . . . . 0.0 111.344 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -45.74 -51.21 12.92 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 126.47 1.908 . . . . 0.0 111.574 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.5 t -55.51 -53.73 52.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.895 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -63.38 -37.93 89.19 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.096 0.474 . . . . 0.0 111.001 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 tp -67.03 -48.76 67.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.295 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 52.4 t -60.52 -44.46 96.02 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.948 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.405 ' HG1' HD11 ' A' ' 43' ' ' ILE . 72.9 m -58.65 -50.27 74.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.745 0.307 . . . . 0.0 110.869 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.19 -34.16 75.77 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.1 t -63.31 -48.13 79.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.293 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.06 -37.55 81.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.139 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.55 -34.94 79.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.024 0.44 . . . . 0.0 111.498 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -93.79 1.31 56.5 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.128 0.49 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 60.12 25.44 14.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.76 1.224 . . . . 0.0 112.54 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.95 22.69 7.82 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.198 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -72.49 -53.41 12.16 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.96 129.0 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -134.86 -178.72 5.21 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.472 ' CD2' ' HA ' ' A' ' 29' ' ' LYS . 65.7 t80 -65.95 119.08 10.71 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -93.31 -60.41 1.79 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -156.84 153.92 29.02 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.48 165.0 24.92 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.05 168.29 40.45 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 147.59 51.84 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.402 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 60.0 m . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.701 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.91 85.91 5.72 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.447 0.642 . . . . 0.0 111.181 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.43 85.9 0.73 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.52 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.05 -80.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -88.39 13.64 11.34 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.3 mt 71.37 -69.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.973 0.909 . . . . 0.0 109.011 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.4 m -95.35 134.43 24.45 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -71.67 78.35 1.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.432 1.421 . . . . 0.0 111.393 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -133.47 105.92 7.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.284 1.04 . . . . 0.0 112.839 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 96.9 mttt -151.14 168.98 23.0 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 169.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.42 125.39 26.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.07 105.5 8.19 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.26 -6.58 56.68 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.539 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 55.4 m -67.4 -36.93 82.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.054 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.57 -16.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.656 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 76.6 m-85 -109.85 -13.68 14.42 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.397 0.618 . . . . 0.0 109.995 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -71.09 -14.99 62.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.288 1.042 . . . . 0.0 108.329 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 33' ' ' SER . 55.1 mtpt -72.62 -15.21 61.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.16 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.45 152.52 42.77 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.74 133.86 44.21 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.437 1.425 . . . . 0.0 108.687 172.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.16 -25.52 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.46 -26.16 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.777 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.59 93.52 3.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.241 -0.287 . . . . 0.0 111.371 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.58 124.55 26.2 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -77.18 134.89 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.403 1.402 . . . . 0.0 110.484 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -125.81 145.8 53.0 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.83 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.71 152.92 53.02 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.421 2.747 . . . . 0.0 112.336 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 pt -83.85 -17.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -68.76 134.23 49.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.249 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -90.95 110.73 21.98 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.0 mt -124.43 97.53 39.53 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.3 119.18 6.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.047 1.832 . . . . 0.0 111.5 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.43 151.83 29.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.84 128.56 56.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.81 163.28 23.47 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.441 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -57.2 -18.76 17.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.145 0.978 . . . . 0.0 112.349 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.52 3.5 43.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.414 0.626 . . . . 0.0 109.859 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 69.04 26.71 5.55 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.059 1.343 . . . . 0.0 111.723 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.37 134.33 49.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.1 m -86.13 127.27 34.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -105.97 156.08 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.989 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.53 -22.32 78.64 Favored Glycine 0 CA--C 1.501 -0.788 0 O-C-N 123.98 0.8 . . . . 0.0 112.996 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.4 p30 -173.0 169.86 4.58 Favored 'General case' 0 C--O 1.255 1.384 0 C-N-CA 123.684 0.793 . . . . 0.0 109.692 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -27.02 65.19 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.286 -175.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.86 -44.3 97.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -64.7 -40.01 94.64 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.36 -46.75 87.77 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.362 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.656 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.3 t -59.77 -38.4 81.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -57.97 -48.6 79.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -67.47 -34.22 76.73 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.004 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 t -65.09 -39.41 93.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.602 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -72.34 -38.65 68.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.13 -43.33 91.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.79 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 58.3 p -92.61 -13.87 28.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.807 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 62.74 75.07 0.41 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 111.75 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.27 8.54 85.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.826 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 64.0 ttt180 -80.46 -62.1 1.78 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.643 0.722 . . . . 0.0 109.51 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.2 118.46 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -132.42 -179.64 5.56 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.537 ' CD2' ' HA ' ' A' ' 29' ' ' LYS . 62.0 t80 -68.16 110.47 4.02 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -85.25 -55.69 3.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -159.17 159.81 34.78 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.495 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.96 152.1 38.81 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 168.0 43.63 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.4 m -57.64 147.5 27.2 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.19 0.596 . . . . 0.0 110.26 176.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.125 178.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 120.821 0.343 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.45 156.69 20.48 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 70.33 -61.71 0.45 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.459 1.104 . . . . 0.0 109.271 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.97 91.15 4.01 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 m -97.53 -14.27 21.17 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.85 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -164.51 151.8 11.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.402 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -116.52 86.64 18.73 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -87.44 103.88 0.55 Allowed 'Trans proline' 0 N--CA 1.43 -2.256 0 C-N-CA 122.196 1.931 . . . . 0.0 113.675 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -116.53 130.65 56.87 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -143.51 156.25 44.57 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 63' ' ' GLU . 5.4 p -68.38 106.63 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.429 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.14 93.62 5.22 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.632 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 26.9 t -93.19 -20.77 20.13 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -54.05 -35.2 61.75 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.645 1.178 . . . . 0.0 113.959 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.55 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.095 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.561 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 72.9 m-85 -89.28 -19.8 24.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.1 mtpt -60.48 -14.23 18.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.533 0.733 . . . . 0.0 112.343 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.74 -25.53 61.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -89.8 152.68 46.99 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.83 139.01 82.96 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.124 1.883 . . . . 0.0 110.058 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.1 m -59.2 -15.72 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.35 -25.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.783 0.325 . . . . 0.0 110.627 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.24 93.91 3.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 122.094 -0.379 . . . . 0.0 110.726 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.6 mt -124.53 107.97 29.2 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.11 134.36 33.8 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.23 1.953 . . . . 0.0 110.578 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.1 m -114.66 147.02 37.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.038 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -61.8 152.45 74.38 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.294 1.996 . . . . 0.0 110.093 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.59 -7.71 10.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -74.91 133.35 41.81 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -92.31 127.05 37.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.8 mp -131.85 99.17 16.94 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -61.25 118.42 5.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.761 1.641 . . . . 0.0 111.196 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.35 152.13 36.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -117.08 128.2 54.91 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.165 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.38 163.09 28.61 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 m -62.23 -13.99 33.63 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.84 0.856 . . . . 0.0 111.733 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.37 2.37 54.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.074 0.94 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 65.75 24.97 11.44 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.857 1.263 . . . . 0.0 113.401 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.68 130.72 50.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.7 m -86.57 132.71 33.83 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.87 151.46 29.09 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.217 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -24.91 72.64 Favored Glycine 0 C--O 1.218 -0.885 0 O-C-N 124.434 1.084 . . . . 0.0 113.054 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.8 p30 -173.74 173.55 3.3 Favored 'General case' 0 C--O 1.259 1.556 0 C-N-CA 124.061 0.944 . . . . 0.0 109.116 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.12 -26.63 68.28 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.52 0.512 . . . . 0.0 112.088 -174.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 38.6 t -56.5 -48.51 77.03 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.084 0.24 . . . . 0.0 110.803 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -67.57 -32.37 73.07 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.954 0.406 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.53 -46.01 74.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.097 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.561 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.0 t -59.2 -44.94 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.335 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -55.25 -48.23 74.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.099 0.476 . . . . 0.0 110.745 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -71.49 -34.81 70.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -65.57 -33.53 76.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.47 -33.37 62.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.27 -50.98 50.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 0.0 110.724 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 p -81.48 -19.89 41.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.525 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.9 t30 63.43 78.91 0.27 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 111.933 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.2 90.29 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.123 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -73.28 -55.81 5.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.293 1.046 . . . . 0.0 109.354 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -94.54 111.79 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-O 121.69 0.757 . . . . 0.0 109.26 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -112.65 -179.61 3.71 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.44 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -77.78 118.37 20.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.43 -56.81 2.9 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -160.48 161.0 32.71 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.604 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.77 151.16 39.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 174.51 43.64 Favored Glycine 0 C--N 1.29 -1.974 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.327 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 m -69.54 152.32 44.94 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.77 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.36 75.22 10.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -170.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.74 -15.64 18.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.98 168.28 23.51 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.5 m 63.07 37.04 11.87 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.581 0.753 . . . . 0.0 111.029 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.42 138.86 45.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -136.47 153.74 76.38 Favored Pre-proline 0 C--N 1.284 -2.26 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.26 40.23 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 124.094 3.196 . . . . 0.0 115.801 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -86.83 106.09 17.48 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -162.97 154.98 18.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.45 148.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.62 108.97 5.94 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.732 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 45.7 t -93.85 -5.06 48.91 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.372 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 3.7 m -65.35 -39.85 92.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.427 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -59.05 -28.0 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.452 0.47 . . . . 0.0 111.848 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.601 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -91.22 -33.05 15.54 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.666 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 50.7 mtmt -62.18 -14.38 37.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 33' ' ' SER . 32.3 mmtp -76.42 -5.89 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.084 0.469 . . . . 0.0 111.142 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.32 156.7 40.74 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 135.49 70.47 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.824 1.683 . . . . 0.0 110.533 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.42 -29.42 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.995 0.918 . . . . 0.0 112.902 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.82 -26.11 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.981 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.02 93.85 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.743 -0.598 . . . . 0.0 111.332 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.2 mt -124.81 132.56 24.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.52 134.51 26.54 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.446 1.431 . . . . 0.0 110.643 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.8 m -116.93 146.43 37.84 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.148 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -59.12 146.64 93.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.103 1.869 . . . . 0.0 110.158 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.9 pt -80.78 -20.6 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -79.89 138.09 37.07 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.729 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -82.66 108.48 16.06 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 81.1 mt -118.67 98.82 51.34 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 120.34 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.285 1.99 . . . . 0.0 111.88 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.12 146.35 34.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.41 128.21 53.87 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.34 159.94 24.45 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 m -61.16 -14.29 23.91 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.652 0.781 . . . . 0.0 112.352 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.93 3.86 40.09 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.819 0.847 . . . . 0.0 109.68 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 65.95 36.5 5.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.217 1.407 . . . . 0.0 111.925 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.5 131.7 71.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.9 m -84.34 122.43 28.91 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -97.73 152.64 18.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.639 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.54 -15.17 72.89 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.0 0.812 . . . . 0.0 114.123 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 173.68 -179.63 0.09 Allowed 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.167 1.387 . . . . 0.0 108.715 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -26.71 62.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 44.4 t -63.41 -42.27 98.74 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.63 -30.69 68.47 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.153 0.502 . . . . 0.0 110.0 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.4 tp -69.47 -49.08 58.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.601 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 30.9 t -61.55 -46.24 90.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.058 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.6 p -59.85 -48.51 81.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 111.15 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.39 -36.67 84.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.101 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -61.87 -44.56 96.58 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.997 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 87.2 mt -69.62 -45.72 67.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.359 0.6 . . . . 0.0 110.209 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -46.81 81.77 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.612 1.165 . . . . 0.0 110.612 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 m -91.62 13.29 18.38 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 55.24 60.1 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.56 76.92 Favored Glycine 0 C--N 1.316 -0.559 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.994 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.93 -51.67 63.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.0 110.359 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.03 122.13 62.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.356 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -105.61 174.78 5.73 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 91.2 t80 -76.76 119.59 20.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.27 -53.78 4.09 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.067 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -163.3 166.46 23.04 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.236 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.06 149.88 39.04 Favored 'General case' 0 C--O 1.252 1.214 0 O-C-N 123.801 0.688 . . . . 0.0 109.183 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.37 173.95 50.08 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.677 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -65.65 152.24 44.65 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.698 0.399 . . . . 0.0 110.372 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.037 -179.803 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 120.912 0.386 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.36 -22.13 25.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.384 0.611 . . . . 0.0 110.155 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.27 129.9 54.24 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.12 35.72 0.8 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.501 0.667 . . . . 0.0 109.944 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.6 p -83.88 6.83 20.14 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.7 0.8 . . . . 0.0 111.806 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.08 84.99 7.26 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.516 0.674 . . . . 0.0 109.548 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 28' ' ' LYS . 20.1 m -89.08 132.72 37.03 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.99 34.46 0.4 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 123.574 2.849 . . . . 0.0 113.481 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 26' ' ' SER . 63.1 tttp -102.22 138.02 39.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -133.82 175.82 9.11 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.45 134.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -89.66 94.6 9.91 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 34.6 t -92.68 -9.34 41.18 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.56 -33.18 72.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.6 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.28 -24.87 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.07 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.698 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 60.3 m-85 -92.05 -9.6 42.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 64.1 mttp -68.98 -14.75 63.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.545 0.688 . . . . 0.0 109.585 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -78.36 -11.05 59.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.534 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -109.98 153.14 43.3 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -64.45 146.72 89.99 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 121.593 1.529 . . . . 0.0 109.415 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.93 -31.66 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 111.383 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.07 -25.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.29 93.76 3.89 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.071 0.462 . . . . 0.0 111.325 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.6 mt -124.68 125.59 25.49 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.59 133.61 14.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.559 1.506 . . . . 0.0 110.353 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.3 147.72 66.2 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 159.86 49.06 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 121.995 1.796 . . . . 0.0 112.113 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.69 -12.31 14.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.159 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -66.06 132.69 49.11 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.038 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -94.81 110.03 21.94 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 85.8 mt -122.12 97.32 45.73 Favored Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.58 122.58 11.49 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.698 1.599 . . . . 0.0 111.873 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.15 150.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -115.33 129.77 56.7 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.155 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.62 165.55 28.57 Favored Glycine 0 N--CA 1.427 -1.93 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 p -63.9 -15.0 58.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.166 0.987 . . . . 0.0 112.344 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.84 1.83 51.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.731 0.777 . . . . 0.0 109.276 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 65.86 36.53 6.01 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.452 1.501 . . . . 0.0 111.671 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.96 131.59 64.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.5 m -82.21 124.59 30.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.63 150.48 25.38 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.962 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.93 -15.23 73.9 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.302 1.001 . . . . 0.0 113.865 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.519 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 -179.44 170.56 1.33 Allowed 'General case' 0 C--O 1.252 1.19 0 C-N-CA 124.204 1.002 . . . . 0.0 109.633 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -28.68 69.1 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.73 -47.05 82.66 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.068 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -64.95 -35.59 81.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.848 0.356 . . . . 0.0 110.354 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.87 -46.95 88.58 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.001 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 53.8 t -65.09 -34.56 78.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.546 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 m -56.35 -49.46 74.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.91 -37.75 82.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.534 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -59.66 -47.01 87.32 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.66 0.384 . . . . 0.0 110.731 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -72.03 -39.53 69.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -64.69 -30.61 71.63 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.54 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.1 p -100.46 -4.47 28.78 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.24 62.59 1.57 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.306 1.442 . . . . 0.0 112.2 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.28 86.99 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 114.449 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -65.78 -54.99 19.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.43 124.01 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.8 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -137.4 178.44 7.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -62.01 123.04 17.02 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.385 0.674 . . . . 0.0 111.586 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.06 -58.21 1.99 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.74 161.51 37.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.16 153.9 35.84 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.68 173.7 45.65 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.4 m -67.48 149.95 49.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--N 1.308 -1.217 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.606 -178.271 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.158 0.504 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -93.39 89.85 6.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.04 14.8 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.22 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.614 1.166 . . . . 0.0 111.756 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 m -170.47 157.62 6.05 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 125.27 1.428 . . . . 0.0 107.267 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 25' ' ' LEU . 1.4 pt? -102.19 97.51 7.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -132.56 129.51 21.41 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.504 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -172.81 1.64 Allowed 'Trans proline' 0 C--O 1.25 1.105 0 C-N-CA 122.359 2.039 . . . . 0.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.13 120.91 32.46 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.31 141.29 16.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.13 102.74 14.14 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.972 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.1 t -97.03 -8.41 30.49 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 49.4 m -69.1 -32.41 71.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.158 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.0 pt -64.98 -28.56 45.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.854 0.359 . . . . 0.0 111.437 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.505 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 82.2 m-85 -89.5 -9.96 48.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.178 0.513 . . . . 0.0 110.523 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' SER . 30.5 mmmt -66.83 -14.57 62.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.718 175.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.35 -15.8 63.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -112.99 151.63 44.27 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.92 144.01 75.06 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 122.038 1.825 . . . . 0.0 110.919 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.96 -38.74 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 124.179 0.992 . . . . 0.0 113.5 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.5 m -79.54 -24.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.11 93.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.882 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.6 mt -125.52 112.84 25.47 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 134.1 35.64 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.661 1.574 . . . . 0.0 109.9 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.6 m -115.55 147.61 39.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.726 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.46 157.42 54.98 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 121.956 1.771 . . . . 0.0 110.439 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.99 -4.06 10.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.323 0.582 . . . . 0.0 110.184 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -64.34 124.67 22.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -88.49 106.86 18.56 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.964 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 83.0 mt -123.4 96.1 44.39 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.17 118.9 5.8 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.304 1.336 . . . . 0.0 110.946 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.57 145.81 33.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.4 t -111.75 123.35 50.05 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 120.915 0.388 . . . . 0.0 110.307 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 169.3 40.51 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 p -66.86 -8.47 29.18 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.06 -0.89 57.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.384 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 65.65 39.5 4.87 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.46 1.104 . . . . 0.0 110.85 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.16 133.03 63.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.541 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 m -89.01 113.14 24.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.69 152.34 19.58 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.315 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.02 73.5 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.835 0.709 . . . . 0.0 113.623 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.2 p30 179.62 176.47 0.66 Allowed 'General case' 0 C--O 1.255 1.371 0 C-N-CA 124.571 1.148 . . . . 0.0 109.165 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -26.71 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.476 0.485 . . . . 0.0 111.597 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.87 -41.04 99.25 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -69.37 -30.37 68.35 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.316 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.88 -49.34 53.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.969 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.4 t -59.51 -47.19 86.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.531 0.733 . . . . 0.0 111.555 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.4 p -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.79 -38.89 90.24 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -62.64 -50.37 71.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.253 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.04 -40.83 95.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 110.777 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -57.47 -45.43 84.83 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.366 1.066 . . . . 0.0 110.635 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -95.66 17.24 15.33 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 47.53 60.28 3.59 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.803 1.641 . . . . 0.0 113.771 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.47 15.15 81.74 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.973 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.89 -60.29 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.02 132.24 33.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.262 0.553 . . . . 0.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -117.88 173.26 6.86 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.164 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -75.85 119.06 19.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.75 -58.23 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -159.53 155.22 26.0 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.386 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -77.36 157.95 30.38 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.04 168.6 40.62 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -66.24 153.68 41.87 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.259 1.597 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.179 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 120.92 0.391 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -113.81 135.57 53.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.955 -0.466 . . . . 0.0 110.044 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 107.36 12.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 68.55 -178.61 0.22 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.703 1.201 . . . . 0.0 112.216 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -92.85 2.52 56.72 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.749 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.7 mt 64.85 -162.25 0.27 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.977 0.911 . . . . 0.0 110.007 -177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 28' ' ' LYS . 16.5 p -117.35 101.99 52.49 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.77 34.69 0.38 Allowed 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.228 2.619 . . . . 0.0 107.804 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 26' ' ' SER . 87.8 tttt -67.66 129.22 39.22 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.192 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HA ' ' HB3' ' A' ' 79' ' ' PHE . 18.2 ptpt -142.33 176.21 9.17 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.884 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.74 150.86 14.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.0 124.38 26.86 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.07 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 46.2 t -107.78 -5.56 17.26 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.4 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -68.52 -32.39 72.31 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.327 0.651 . . . . 0.0 110.345 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.27 -30.34 42.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.559 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.677 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 85.0 m-85 -90.24 -20.58 22.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.868 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.5 mtpp -62.21 -14.27 36.27 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.437 0.637 . . . . 0.0 112.068 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -81.55 -4.68 56.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.17 152.58 41.17 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.49 134.39 63.61 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.08 1.854 . . . . 0.0 111.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -50.82 -41.23 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 112.744 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.41 -25.62 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.87 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.73 93.15 3.76 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.737 -0.602 . . . . 0.0 111.252 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.58 115.47 37.41 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.76 133.85 41.09 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.04 1.827 . . . . 0.0 110.544 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -118.94 142.62 32.25 Favored Pre-proline 0 C--N 1.293 -1.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.746 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.14 154.44 45.74 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.659 2.239 . . . . 0.0 110.959 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.01 -17.5 11.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 120.979 0.419 . . . . 0.0 110.405 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -65.42 120.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.189 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -85.32 115.85 23.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.44 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.6 mt -128.52 94.53 35.15 Favored Pre-proline 0 C--N 1.288 -2.072 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.32 120.46 8.37 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.911 1.741 . . . . 0.0 111.597 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.31 148.78 30.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -112.62 126.46 55.39 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.33 166.32 30.62 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.227 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -62.17 -12.91 22.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 111.985 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.31 1.27 56.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.755 0.788 . . . . 0.0 109.43 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 68.58 28.54 5.79 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.128 1.371 . . . . 0.0 111.915 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.14 130.01 56.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 m -83.31 119.23 24.34 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.525 0.678 . . . . 0.0 109.59 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.61 151.82 20.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.47 -25.8 72.69 Favored Glycine 0 C--O 1.213 -1.174 0 O-C-N 124.26 0.975 . . . . 0.0 113.535 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.1 p30 -174.67 175.72 2.41 Favored 'General case' 0 C--O 1.256 1.398 0 C-N-CA 123.708 0.803 . . . . 0.0 109.218 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.29 68.19 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.51 0.506 . . . . 0.0 112.133 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 41.6 t -56.53 -52.54 64.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 123.451 0.469 . . . . 0.0 110.125 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -65.84 -32.4 73.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.813 0.34 . . . . 0.0 111.111 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.51 -48.76 73.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.484 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.677 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.1 t -61.35 -45.32 94.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.1 m -57.03 -49.34 76.11 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.18 0.514 . . . . 0.0 110.647 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.22 -34.48 76.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.32 -47.75 78.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.58 -38.6 91.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.808 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.1 p -89.6 4.5 49.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.458 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 62.59 30.05 16.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.854 0.862 . . . . 0.0 112.582 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.14 27.8 7.59 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.397 -0.906 . . . . 0.0 114.743 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -76.58 -52.44 9.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.368 1.084 . . . . 0.0 110.793 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.07 119.91 42.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.687 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -106.39 -179.62 3.99 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.461 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 66.1 t80 -80.31 119.1 22.59 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 tp -91.34 -54.26 3.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -160.12 159.7 32.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.682 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -78.96 151.32 31.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.13 170.58 35.09 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.473 -0.87 . . . . 0.0 110.997 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 m -65.99 145.23 56.13 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.824 -0.607 . . . . 0.0 111.295 -177.648 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.226 -0.134 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -67.93 -37.3 81.49 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.57 129.9 54.43 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HB1' ' O ' ' A' ' 26' ' ' SER . . . -123.01 11.51 9.57 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.08 0.467 . . . . 0.0 110.205 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 m 68.2 -79.89 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.444 1.098 . . . . 0.0 113.428 172.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mp -83.48 -1.09 52.83 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.306 0.574 . . . . 0.0 111.176 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.531 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 2.9 p -146.4 123.33 5.88 Favored Pre-proline 0 N--CA 1.422 -1.858 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.245 176.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.25 -172.93 1.13 Allowed 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 121.907 1.738 . . . . 0.0 110.357 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.35 96.48 10.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.477 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.89 142.26 35.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.257 -175.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 p -58.81 139.43 18.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.176 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -88.58 106.84 18.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 42.3 t -99.46 -7.34 26.19 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m -67.11 -45.03 78.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 pt -69.12 -15.09 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.175 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.46 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.8 m-85 -96.42 -11.75 25.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.162 0.506 . . . . 0.0 110.691 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.8 mtpp -75.04 -14.21 60.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.72 -4.09 44.47 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.278 0.561 . . . . 0.0 111.259 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -108.38 159.71 29.77 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.33 145.05 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 121.393 1.395 . . . . 0.0 109.348 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.77 -40.63 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.404 0.621 . . . . 0.0 111.282 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.03 -26.93 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.503 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 92.99 3.64 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.528 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.09 119.64 33.27 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.94 133.66 31.94 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 121.406 1.404 . . . . 0.0 111.206 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.58 139.7 20.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.806 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.52 160.53 35.41 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.383 2.055 . . . . 0.0 110.449 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 pt -91.9 -9.06 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.118 0.485 . . . . 0.0 111.523 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 130.9 39.56 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -85.39 117.1 24.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.6 mt -129.28 97.13 26.36 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.97 118.83 5.75 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.506 1.47 . . . . 0.0 110.43 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.88 145.9 34.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.8 t -110.83 127.6 55.47 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.48 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 78' ' ' GLN . . . -89.99 161.28 29.15 Favored Glycine 0 N--CA 1.421 -2.336 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.608 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m -54.66 -24.45 21.74 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.856 1.262 . . . . 0.0 112.31 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.54 7.19 34.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.701 0.762 . . . . 0.0 110.304 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 68.25 24.6 7.42 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.53 1.132 . . . . 0.0 112.62 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.49 121.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.0 m -81.71 128.34 33.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.61 150.86 26.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.291 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.54 76.11 Favored Glycine 0 N--CA 1.445 -0.706 0 O-C-N 124.104 0.877 . . . . 0.0 113.284 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 28.4 p30 -176.52 175.33 1.76 Allowed 'General case' 0 C--O 1.255 1.383 0 CA-C-O 121.091 0.472 . . . . 0.0 111.645 176.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -44.99 -47.82 11.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.268 2.227 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.7 t -56.23 -44.29 79.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.837 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.118 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.94 -47.29 83.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 50.4 t -62.84 -41.36 99.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.941 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 90.2 m -57.43 -51.61 68.71 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.79 -34.46 75.58 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.515 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -61.69 -46.18 90.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 77.1 mt -68.81 -44.06 74.31 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -54.6 -56.91 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 111.181 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 m -89.47 28.9 1.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 p30 50.54 21.6 0.9 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 126.29 1.836 . . . . 0.0 115.294 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.35 7.41 34.91 Favored Glycine 0 C--N 1.295 -1.74 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.618 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -60.93 -46.36 90.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.976 0.894 . . . . 0.0 109.575 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.5 p -108.19 119.32 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.742 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.407 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 76.3 mt-30 -129.67 -178.6 4.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -65.71 111.46 3.22 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.28 -54.01 4.53 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -162.16 159.81 26.39 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.89 158.54 26.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.99 177.16 42.29 Favored Glycine 0 N--CA 1.416 -2.698 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 m -70.13 152.18 44.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.859 -178.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.19 133.66 40.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.667 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 57.09 78.38 0.23 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.66 1.225 . . . . 0.0 112.979 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.19 98.37 6.57 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 m -132.53 150.94 52.08 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.92 130.36 35.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 28' ' ' LYS . 45.7 m -157.15 157.95 30.77 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -69.88 40.49 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.629 2.886 . . . . 0.0 111.516 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 26' ' ' SER . 85.2 tttt -93.04 148.89 21.62 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.555 1.542 . . . . 0.0 108.531 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 4.0 ttmp? -77.61 151.12 34.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.4 128.19 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.342 0 O-C-N 124.391 1.057 . . . . 0.0 111.386 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -76.6 94.26 3.73 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.755 0.788 . . . . 0.0 109.69 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 43.4 t -93.9 -15.74 24.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -34.82 77.25 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.266 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 pt -65.24 -31.61 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.853 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.3 m-85 -87.71 -16.89 33.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.129 0.49 . . . . 0.0 111.159 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 99.0 mttt -66.81 -14.54 62.77 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.454 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.98 -12.26 60.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.798 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.87 152.1 44.57 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.95 138.74 80.81 Favored 'Trans proline' 0 C--O 1.22 -0.398 0 C-N-CA 122.027 1.818 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.33 -30.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.32 -27.03 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.522 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.38 92.99 3.68 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.116 0.484 . . . . 0.0 111.479 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.09 122.66 25.38 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.83 133.71 24.18 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.037 1.158 . . . . 0.0 110.248 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.8 m -116.74 139.6 25.79 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -61.58 150.49 85.19 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.238 1.959 . . . . 0.0 112.026 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 pt -76.72 -13.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.418 0.628 . . . . 0.0 109.72 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -69.01 137.18 53.46 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.68 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -101.25 113.78 27.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.3 mp -119.76 97.07 49.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.85 118.91 5.85 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.364 1.376 . . . . 0.0 110.299 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.71 146.79 33.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.7 t -109.53 125.81 52.9 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.09 161.58 24.54 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 m -53.3 -24.5 11.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.494 1.118 . . . . 0.0 112.616 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.34 -1.73 38.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.273 0.629 . . . . 0.0 110.576 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 72.49 30.65 1.89 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.853 1.661 . . . . 0.0 110.85 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.74 131.19 61.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.746 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.2 m -81.56 119.21 23.48 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.72 152.32 19.79 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.07 -19.5 78.49 Favored Glycine 0 N--CA 1.443 -0.869 0 O-C-N 124.094 0.871 . . . . 0.0 113.498 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.0 p30 -177.11 177.19 1.28 Allowed 'General case' 0 C--O 1.255 1.393 0 C-N-CA 123.75 0.82 . . . . 0.0 109.54 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -27.93 64.5 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.442 0.463 . . . . 0.0 111.622 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.7 t -55.76 -52.03 65.34 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.364 0.415 . . . . 0.0 109.906 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -65.35 -36.66 84.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.033 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.12 -48.09 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.526 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 46.9 t -59.63 -45.27 92.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.435 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 m -57.53 -47.17 82.73 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.304 0.573 . . . . 0.0 110.59 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.57 -39.33 88.43 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.774 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 t -64.63 -38.7 91.89 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.653 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 93.1 mt -67.57 -37.01 82.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.782 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.52 -43.74 59.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.426 0.632 . . . . 0.0 110.961 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 m -83.5 0.23 47.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.854 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.25 71.01 0.57 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.71 1.204 . . . . 0.0 112.689 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.98 39.66 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.582 -0.736 . . . . 0.0 114.895 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -59.47 -54.46 46.41 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.225 0.536 . . . . 0.0 111.74 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.74 125.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -128.78 -178.63 4.68 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.62 112.09 8.36 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.1 tp -86.12 -48.73 8.34 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -165.1 161.37 19.57 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.417 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.61 147.16 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 165.46 39.85 Favored Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.708 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -61.09 150.82 32.75 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.065 0.546 . . . . 0.0 110.376 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.255 1.363 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -111.33 66.91 0.63 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -175.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.78 75.64 10.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.353 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -171.35 -71.2 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.885 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.7 t 61.5 72.82 0.5 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.399 1.095 . . . . 0.0 108.36 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.91 -48.29 31.84 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.493 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t -146.55 116.25 4.59 Favored Pre-proline 0 N--CA 1.417 -2.096 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.63 86.69 1.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.861 1.707 . . . . 0.0 110.137 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.15 105.65 9.51 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.43 141.73 43.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.821 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 p -83.27 155.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 102.726 -3.064 . . . . 0.0 102.726 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.14 94.45 6.01 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.322 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.522 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 53.9 t -83.17 -17.14 43.93 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.887 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -54.34 -47.07 72.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.172 0.989 . . . . 0.0 111.794 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 pt -68.42 -18.05 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.9 m-85 -94.93 -22.48 17.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 110.012 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.7 mtpt -65.47 -14.41 60.93 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.855 0.862 . . . . 0.0 110.407 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.44 -15.39 63.65 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.518 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.83 161.44 23.25 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.56 153.64 13.63 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.129 2.553 . . . . 0.0 112.554 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.76 -41.6 86.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 123.79 0.836 . . . . 0.0 112.922 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -96.55 -11.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.833 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.53 92.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.698 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.8 mt -124.92 127.79 25.02 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.86 134.07 24.88 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.147 1.231 . . . . 0.0 111.554 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.46 136.92 19.32 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.047 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.08 162.65 39.12 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.128 1.885 . . . . 0.0 110.961 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -86.78 -3.37 8.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.333 0.587 . . . . 0.0 110.639 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.8 127.69 33.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.469 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.25 117.13 29.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 87.2 mt -129.77 95.93 27.81 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.6 118.97 5.88 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.96 1.773 . . . . 0.0 111.474 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.17 153.17 38.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.5 t -119.9 130.1 54.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.41 162.98 27.26 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.36 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -61.26 -16.22 43.19 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.025 0.93 . . . . 0.0 111.59 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.32 1.61 54.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.842 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 68.51 26.41 6.5 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.93 1.292 . . . . 0.0 113.15 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mm -103.87 127.59 57.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.2 m -81.84 138.26 35.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.09 153.36 34.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.503 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.37 -26.18 74.56 Favored Glycine 0 N--CA 1.438 -1.226 0 O-C-N 124.642 1.214 . . . . 0.0 112.979 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.5 p30 -175.36 177.35 1.85 Allowed 'General case' 0 C--O 1.255 1.352 0 C-N-CA 122.501 0.32 . . . . 0.0 110.886 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -47.51 -46.21 27.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.105 1.762 . . . . 0.0 111.626 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.15 -52.32 64.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.79 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -64.53 -38.02 89.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.59 -45.63 89.48 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.731 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 48.1 t -63.28 -44.81 94.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.792 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 m -58.62 -44.92 90.14 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.437 0.637 . . . . 0.0 110.321 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -72.06 -35.51 69.33 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.3 t -62.77 -42.96 99.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.65 -42.3 78.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -58.22 -49.69 76.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.212 0.53 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -89.24 -4.79 58.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.579 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 53.35 67.79 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.611 1.164 . . . . 0.0 113.291 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 3.75 89.27 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-N 115.258 -0.883 . . . . 0.0 115.094 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.13 -47.83 72.83 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.01 94.96 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.176 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -106.07 -178.83 3.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -72.11 121.9 20.04 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.115 0.87 . . . . 0.0 109.347 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.12 -54.85 3.28 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.73 164.19 29.17 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.52 152.22 28.79 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.87 169.36 42.56 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.4 m -69.6 153.27 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.31 -1.128 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.427 -176.056 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.94 0.4 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.39 101.34 2.51 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.582 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.99 -170.84 0.18 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 70.49 10.06 7.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.311 1.044 . . . . 0.0 112.831 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 91.36 3.5 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -88.13 110.67 20.84 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.258 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.3 t -98.06 114.52 65.21 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.14 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.957 2.438 . . . . 0.0 112.288 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -110.97 109.71 19.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -149.18 155.43 40.62 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 79' ' ' PHE . 28.5 m -84.89 153.03 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.03 102.84 15.19 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.9 t -89.11 -12.75 40.24 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 m -59.23 -43.54 92.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -63.19 -28.19 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.694 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -88.33 -16.72 32.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.931 0.396 . . . . 0.0 111.323 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 66.9 mttm -69.49 -14.81 63.07 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.739 0.78 . . . . 0.0 109.204 174.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.04 6.31 36.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -120.02 154.09 55.46 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.82 135.04 60.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.676 1.584 . . . . 0.0 109.901 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -52.24 -35.67 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 0.0 112.468 -175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.15 -25.33 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.94 93.59 3.87 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.847 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.2 mt -121.22 109.61 35.04 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.248 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.97 135.25 37.08 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 110.475 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.3 m -116.47 149.94 44.61 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.456 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.96 159.21 43.33 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.844 2.362 . . . . 0.0 110.34 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 pt -86.28 -3.07 8.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.107 0.48 . . . . 0.0 111.971 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -82.74 131.1 35.21 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.068 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -88.09 106.24 18.03 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 94.7 mt -117.93 95.16 47.7 Favored Pre-proline 0 C--N 1.285 -2.227 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.3 121.35 9.5 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 121.847 1.698 . . . . 0.0 111.071 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.42 156.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.8 t -120.71 127.07 51.68 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.92 162.12 33.78 Favored Glycine 0 N--CA 1.413 -2.849 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 p -59.69 -20.93 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 125.133 1.373 . . . . 0.0 112.288 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.12 5.11 42.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.495 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 66.35 39.97 3.84 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.884 1.273 . . . . 0.0 111.681 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.57 130.14 72.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.889 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.4 m -84.51 135.36 34.26 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.576 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.468 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 97.1 m-85 -120.07 156.55 30.75 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.51 -19.35 77.7 Favored Glycine 0 C--O 1.224 -0.481 0 O-C-N 124.25 0.969 . . . . 0.0 113.649 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.9 p30 -177.43 171.97 1.89 Allowed 'General case' 0 C--O 1.256 1.421 0 C-N-CA 123.777 0.831 . . . . 0.0 109.973 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -31.42 72.59 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 37.2 t -56.82 -53.78 53.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.647 174.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.78 -32.93 74.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.79 -44.75 95.35 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.086 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.3 t -68.8 -37.09 79.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.077 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.0 m -58.8 -45.4 89.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.444 0.64 . . . . 0.0 109.803 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.534 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 10.4 tp10 -71.93 -34.14 68.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.392 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.4 t -61.89 -51.05 69.77 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.14 0.576 . . . . 0.0 109.927 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.61 -33.67 76.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.388 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.534 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 59.5 tttp -67.6 -49.73 61.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.998 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -90.21 20.36 4.43 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.6 m120 59.71 34.43 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.35 4.12 71.4 Favored Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.895 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -56.98 -50.06 73.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.551 0.691 . . . . 0.0 111.374 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.59 116.67 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.004 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -137.08 177.76 7.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.47 ' CD1' HG13 ' A' ' 30' ' ' VAL . 72.5 t80 -58.67 113.96 2.27 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.975 0.807 . . . . 0.0 113.171 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.92 -58.16 2.33 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -151.6 159.04 44.24 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.88 150.23 30.68 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.33 164.77 40.51 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.5 m -62.25 151.53 36.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.085 -0.484 . . . . 0.0 110.616 -177.491 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.511 -0.538 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.5 mm-40 -106.82 167.19 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.07 -58.09 2.59 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.414 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.58 0.64 56.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.672 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 17.1 m -120.08 118.32 30.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.439 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 2.4 pt? -74.88 167.9 20.98 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -94.4 109.01 40.36 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-O 120.78 0.324 . . . . 0.0 110.164 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 6.2 Cg_exo -78.65 -175.77 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.225 1.95 . . . . 0.0 109.716 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -133.63 146.52 50.99 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.223 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -130.43 175.87 8.61 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.24 140.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.45 105.99 8.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.648 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.619 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 35.2 t -98.42 0.58 45.59 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -49.32 61.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.765 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 pt -68.66 -15.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.489 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.718 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 77.6 m-85 -98.33 -14.66 20.08 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.997 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.619 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 68.9 mttm -65.51 -14.72 61.64 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.664 0.745 . . . . 0.0 109.759 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.59 -32.45 71.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.441 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -100.58 157.44 33.73 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.005 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.54 142.81 79.54 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.183 1.922 . . . . 0.0 110.191 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.44 -27.08 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.559 0.744 . . . . 0.0 112.935 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -86.31 -26.55 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.061 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.87 97.23 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.167 -0.333 . . . . 0.0 111.219 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG21 ' SG ' ' A' ' 64' ' ' CYS . 48.5 mt -124.35 108.78 29.26 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.322 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.24 135.11 59.82 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.759 2.306 . . . . 0.0 110.468 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.6 m -124.35 152.65 68.34 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.501 -174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.56 153.2 62.93 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.153 1.902 . . . . 0.0 110.815 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 pt -80.13 -9.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.188 0.518 . . . . 0.0 111.815 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.2 m -81.13 127.43 32.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.68 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -86.21 129.04 34.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 67.9 mt -133.65 100.19 13.72 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.2 119.71 7.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.38 1.386 . . . . 0.0 110.526 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.12 149.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.8 t -114.94 129.98 56.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.029 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 165.13 30.39 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.615 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -54.99 -24.11 22.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.675 1.19 . . . . 0.0 111.641 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.77 7.21 35.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.847 0.832 . . . . 0.0 110.803 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 66.36 24.99 10.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.628 1.171 . . . . 0.0 112.848 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.31 131.46 50.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 m -85.67 128.83 34.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.145 0.498 . . . . 0.0 110.046 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.2 m-85 -110.47 154.93 22.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.309 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.58 -26.96 73.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.2 p30 -178.56 -179.2 0.64 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 117.146 0.473 . . . . 0.0 110.444 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.83 -48.08 20.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.758 1.623 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.436 ' SG ' HG21 ' A' ' 43' ' ' ILE . 43.6 t -61.55 -52.85 62.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.782 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -63.97 -33.82 76.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.452 . . . . 0.0 111.174 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.11 -45.8 79.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.914 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.8 t -64.64 -38.94 92.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.353 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.6 m -57.38 -48.33 79.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.5 tp10 -70.85 -33.89 71.11 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 t -61.82 -40.62 95.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.418 HD21 ' HZ1' ' A' ' 36' ' ' LYS . 95.6 mt -74.13 -40.64 62.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.218 0.324 . . . . 0.0 110.46 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -54.29 -60.2 3.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.406 0.682 . . . . 0.0 111.169 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 m -78.04 -20.88 51.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.351 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.22 84.33 0.12 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 125.438 1.495 . . . . 0.0 113.039 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.19 -29.26 5.68 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.622 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -57.03 -44.69 83.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.714 0.806 . . . . 0.0 111.717 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.682 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -132.69 -178.69 5.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -68.69 113.29 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -89.67 -55.44 3.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -159.8 163.07 34.84 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.8 162.64 19.5 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.48 169.48 45.95 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -66.34 148.78 51.36 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.2 m . . . . . 0 C--N 1.307 -1.255 0 O-C-N 123.347 0.405 . . . . 0.0 110.624 -177.832 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.24 120.45 34.51 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.26 -61.73 2.12 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 123.941 0.775 . . . . 0.0 112.659 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.42 147.49 31.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.776 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.9 t -143.55 128.48 18.45 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.44 108.15 3.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.638 0.733 . . . . 0.0 110.342 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -133.23 170.32 11.69 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.81 -170.97 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.27 0 C-N-CA 121.773 1.648 . . . . 0.0 111.914 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 79' ' ' PHE . 55.0 tptt -75.02 151.9 38.73 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -109.47 160.14 16.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.375 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.08 162.42 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.27 110.17 9.39 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 50.7 t -108.32 -9.66 15.44 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -60.57 -40.82 93.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.752 1.221 . . . . 0.0 111.668 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -70.14 -21.54 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.64 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.8 m-85 -94.08 -20.91 19.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 97.6 mttt -66.69 -14.9 63.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.726 0.774 . . . . 0.0 110.217 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 37' ' ' LYS . 7.8 mtpm? -75.25 -2.34 27.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.648 177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -118.0 156.95 49.71 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.16 144.04 85.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.771 1.647 . . . . 0.0 110.659 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.89 -33.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.719 0.808 . . . . 0.0 112.337 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.25 -25.46 9.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.5 93.81 3.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.186 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.56 119.74 25.95 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.91 134.25 21.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.167 1.245 . . . . 0.0 110.947 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.4 m -117.27 148.29 42.25 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.69 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.19 164.26 35.63 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.459 2.106 . . . . 0.0 111.201 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -89.47 -0.34 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.777 0.798 . . . . 0.0 110.145 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 128.64 36.22 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.294 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' CE1' ' HA2' ' A' ' 61' ' ' GLY . 70.7 t80 -96.08 104.39 16.34 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.7 mt -116.86 98.01 51.33 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.14 125.2 16.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.382 1.388 . . . . 0.0 110.94 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.38 150.88 31.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.2 t -117.57 130.49 56.43 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.74 164.9 25.49 Favored Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.656 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -55.18 -23.77 23.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.642 1.177 . . . . 0.0 111.9 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.01 8.56 20.1 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.267 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 64.4 31.16 12.86 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 125.197 1.399 . . . . 0.0 111.337 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.4 131.2 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.167 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -85.06 133.5 34.23 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.416 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.1 m-85 -112.58 151.15 30.39 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' A' ' 49' ' ' TYR . . . -71.34 -12.29 72.57 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 124.153 0.908 . . . . 0.0 114.303 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -179.35 172.6 1.18 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 124.329 1.052 . . . . 0.0 109.298 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -28.33 67.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 123.761 0.663 . . . . 0.0 112.765 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.05 -50.58 73.52 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.71 -34.51 78.49 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 111.128 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.94 -46.08 83.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.751 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -61.22 -46.17 91.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m -56.35 -47.41 78.88 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.86 0.362 . . . . 0.0 110.146 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.4 tp10 -68.04 -37.15 81.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.866 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 t -63.63 -43.74 95.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.521 0.729 . . . . 0.0 110.208 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.2 mt -70.61 -43.77 68.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.841 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.3 -44.14 75.48 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -94.14 3.43 55.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.049 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 t30 46.27 74.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.961 1.704 . . . . 0.0 113.85 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.15 -3.07 59.24 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 115.113 0.805 . . . . 0.0 115.113 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -60.87 -57.17 13.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.372 0.606 . . . . 0.0 110.609 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.16 124.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -125.68 -178.85 4.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 80.8 t80 -70.92 121.76 18.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.15 -53.15 3.58 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -161.95 157.99 24.57 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -83.58 164.15 19.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.43 168.72 42.67 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -64.15 151.76 42.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.057 -178.529 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.241 0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.14 146.45 20.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -49.79 6.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.84 99.81 2.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.843 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -84.03 120.33 26.0 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.73 -20.86 52.78 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.505 0.669 . . . . 0.0 110.466 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 p -107.59 130.99 22.05 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.08 99.98 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.3 2.0 . . . . 0.0 108.439 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -81.99 143.93 31.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.158 0.98 . . . . 0.0 113.116 -171.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.09 177.33 4.67 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 63' ' ' GLU . 7.6 p -69.91 126.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.517 177.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.45 101.8 12.31 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.54 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.2 t -98.96 -5.93 29.68 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -68.46 -39.98 81.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.328 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.11 -16.28 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.502 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.9 m-85 -103.46 -10.99 18.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 98.4 mttt -64.1 -14.79 57.23 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -70.51 -19.6 62.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.864 0.364 . . . . 0.0 111.425 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -95.58 168.69 10.42 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.537 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 6.7 Cg_endo -54.44 160.46 6.86 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.771 2.314 . . . . 0.0 112.069 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.1 -41.82 79.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.29 -13.41 8.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.456 -0.898 . . . . 0.0 113.058 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -124.23 94.06 4.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.484 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.416 HG21 ' HB3' ' A' ' 35' ' ' TYR . 60.9 mt -122.12 130.35 24.75 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.38 134.84 29.81 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.596 1.531 . . . . 0.0 110.43 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.62 155.44 48.82 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.86 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.84 156.93 40.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.374 2.049 . . . . 0.0 111.111 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.47 15.03 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.534 0.683 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -99.76 131.05 45.99 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.41 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 51.8 t80 -89.21 122.3 32.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 93.7 mt -133.26 97.75 16.07 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.25 119.87 7.31 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.703 1.602 . . . . 0.0 111.824 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.92 156.07 38.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.3 t -119.63 125.7 49.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.25 160.6 29.57 Favored Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 m -63.72 -9.53 14.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.121 0.968 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.96 8.2 40.85 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 60.3 44.08 12.87 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 111.599 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -124.4 131.87 72.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 m -84.75 133.61 34.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.68 150.85 32.65 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -61.33 -27.56 67.87 Favored Glycine 0 C--O 1.221 -0.679 0 O-C-N 124.284 0.99 . . . . 0.0 113.569 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.6 p30 -170.99 172.1 5.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 123.487 0.715 . . . . 0.0 109.092 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -66.57 -28.13 68.28 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.68 -42.26 96.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.737 0.304 . . . . 0.0 110.262 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 110.142 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.74 -42.26 97.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.831 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 41.5 t -60.1 -47.86 84.13 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.83 0.452 . . . . 0.0 111.265 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.411 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 21.7 p -57.36 -46.43 83.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.861 0.362 . . . . 0.0 111.7 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.28 -34.58 70.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.231 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -61.59 -48.24 81.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.74 -43.14 76.5 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.937 0.399 . . . . 0.0 110.596 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -46.85 77.82 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.191 0.996 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 m -92.91 15.83 13.96 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.415 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m120 55.54 30.61 15.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.17 3.38 51.23 Favored Glycine 0 C--N 1.316 -0.53 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.688 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -57.2 -45.0 84.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.344 0.658 . . . . 0.0 110.324 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.22 133.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.215 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -123.36 -179.78 4.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -83.01 110.78 18.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 tp -83.89 -61.34 1.85 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -154.73 161.77 41.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.36 153.92 40.28 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.97 169.55 45.43 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.07 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -63.0 152.65 36.23 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.812 0.445 . . . . 0.0 109.901 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.381 -0.343 . . . . 0.0 110.91 -178.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.94 -38.56 88.93 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.7 32.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.64 59.99 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 117.766 0.257 . . . . 0.0 111.247 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m 70.58 176.11 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.902 1.281 . . . . 0.0 110.103 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.85 -21.87 46.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.552 0.692 . . . . 0.0 109.538 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -151.11 145.15 17.78 Favored Pre-proline 0 N--CA 1.433 -1.325 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.52 116.55 3.41 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 121.888 1.726 . . . . 0.0 108.178 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -115.43 140.27 49.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -90.27 176.03 6.89 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.95 118.17 12.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.591 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.34 95.12 7.52 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.343 1.068 . . . . 0.0 108.502 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 33.1 t -89.38 -12.31 40.73 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.525 -1.67 . . . . 0.0 108.423 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -51.52 -46.55 63.33 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.34 1.056 . . . . 0.0 112.27 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.2 pt -73.85 -15.48 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.668 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 94.3 m-85 -96.56 -18.36 19.84 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 110.102 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 60.0 mtpt -66.78 -14.59 62.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.453 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -76.39 -19.25 58.32 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.535 0.683 . . . . 0.0 109.394 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 24.1 m-85 -93.96 145.15 29.3 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.59 153.79 76.63 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.089 1.859 . . . . 0.0 111.214 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.27 -25.62 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.128 0.571 . . . . 0.0 112.18 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.52 -25.38 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 O-C-N 121.97 -0.456 . . . . 0.0 111.823 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.21 94.02 3.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.68 108.3 28.71 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.31 134.32 26.57 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 121.951 1.767 . . . . 0.0 111.43 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.9 m -107.53 146.51 33.47 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.915 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.02 153.85 55.01 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.684 2.256 . . . . 0.0 110.882 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.9 pt -75.13 -24.66 17.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.041 0.448 . . . . 0.0 111.8 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 m -77.01 144.15 38.88 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -96.32 128.4 43.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 mp -134.24 104.37 11.38 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.72 120.16 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.438 1.425 . . . . 0.0 110.495 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.58 152.0 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.58 130.24 55.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.06 0.457 . . . . 0.0 110.846 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.94 163.81 28.35 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 p -63.43 -15.23 57.04 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.672 0.789 . . . . 0.0 112.328 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.78 4.71 39.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.607 0.717 . . . . 0.0 109.906 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.19 43.53 6.29 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.721 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.97 129.11 75.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.7 m -85.37 135.56 33.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -115.78 156.43 26.04 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.49 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.81 -22.57 78.23 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.595 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -178.27 174.25 1.33 Allowed 'General case' 0 C--O 1.256 1.423 0 C-N-CA 122.915 0.486 . . . . 0.0 110.369 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -51.62 -35.97 43.98 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.115 1.366 . . . . 0.0 113.547 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.27 -44.08 92.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.48 0.181 . . . . 0.0 111.201 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -68.41 -38.3 81.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.93 -48.85 74.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.1 t -60.01 -38.55 82.97 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.215 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.8 m -57.54 -52.86 63.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.79 -34.34 77.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.646 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -60.68 -46.78 89.05 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt -73.48 -41.16 63.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.7 0.286 . . . . 0.0 110.715 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -63.57 -32.01 73.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -102.68 7.45 39.79 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.792 0.329 . . . . 0.0 111.001 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t30 46.52 75.2 0.12 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.273 1.429 . . . . 0.0 113.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.93 -5.1 26.82 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.579 0.991 . . . . 0.0 115.579 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -57.07 -60.48 3.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.791 0.805 . . . . 0.0 110.128 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.21 121.18 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.83 171.43 9.66 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.14 116.05 10.06 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -88.21 -56.24 3.41 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -161.73 161.7 29.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -82.25 165.64 20.25 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.12 165.09 40.89 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 m -66.55 143.65 56.92 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.311 -1.073 0 C-N-CA 123.103 0.561 . . . . 0.0 112.463 -176.092 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 CA--C 1.499 -1.015 0 CA-C-O 121.632 0.729 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -104.28 -9.93 18.21 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -61.76 -43.79 98.16 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.73 0.812 . . . . 0.0 111.928 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.1 pt -65.23 -24.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.806 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 75.9 m-85 -94.13 -22.98 18.13 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 121.815 0.817 . . . . 0.0 109.284 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -69.29 -15.04 63.26 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 125.284 1.434 . . . . 0.0 109.431 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.72 -16.31 60.75 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.357 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -105.28 159.32 29.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.07 139.25 72.03 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.045 1.83 . . . . 0.0 109.784 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.84 -30.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.59 -26.12 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.96 93.26 3.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.786 -0.571 . . . . 0.0 110.908 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.72 113.2 28.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 134.36 31.56 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.287 1.992 . . . . 0.0 111.278 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.8 m -116.99 148.11 41.53 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.302 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.55 158.32 58.17 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.069 1.846 . . . . 0.0 111.283 175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.21 11.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.724 0.773 . . . . 0.0 112.052 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.7 m -94.13 136.42 34.44 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.749 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -105.62 116.31 31.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 96.1 mt -133.47 102.81 12.62 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.35 125.97 18.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.788 1.658 . . . . 0.0 110.949 -176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.06 153.48 36.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.9 t -119.07 128.98 54.84 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 121.036 0.446 . . . . 0.0 110.67 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.22 164.48 30.91 Favored Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.613 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 p -66.26 -14.75 62.45 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.914 0.886 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.24 0.27 52.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.952 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 69.19 31.12 4.09 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.067 1.347 . . . . 0.0 111.711 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.24 128.4 66.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.4 m -84.13 133.31 34.63 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.09 156.57 26.16 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.789 0.435 . . . . 0.0 110.501 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.7 75.74 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 124.193 0.933 . . . . 0.0 114.117 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.8 p30 -171.83 175.7 3.83 Favored 'General case' 0 C--O 1.258 1.532 0 C-N-CA 123.186 0.595 . . . . 0.0 109.61 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.62 76.26 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.2 -48.94 79.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.707 0.289 . . . . 0.0 110.51 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.93 -36.94 83.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.101 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -61.18 -47.39 86.4 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 123.595 0.559 . . . . 0.0 109.555 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -59.91 -41.61 92.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.968 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.3 m -57.2 -48.37 78.95 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 120.92 0.391 . . . . 0.0 110.35 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -34.4 70.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.772 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 t -62.27 -42.69 99.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.75 -40.6 63.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.23 -46.11 90.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.446 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -93.59 6.08 49.45 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.027 0.441 . . . . 0.0 111.104 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 48.38 71.91 0.32 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 114.872 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.94 65.14 Favored Glycine 0 C--N 1.312 -0.766 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -56.8 -50.48 72.2 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.7 104.58 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.855 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -106.15 -178.65 3.71 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -81.49 128.45 33.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -103.51 -57.31 2.06 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -159.41 161.66 35.62 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.43 157.81 24.81 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 168.55 44.68 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 m -60.92 144.93 52.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.791 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 CA--C 1.5 -0.966 0 CA-C-O 122.022 0.915 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.8 t -102.57 -1.56 30.15 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.929 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -63.41 -44.21 95.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.932 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 pt -72.03 -25.05 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 88.0 m-85 -84.44 -11.75 55.63 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.947 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 29.2 mtpp -69.28 -14.68 63.08 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.817 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -76.62 -2.99 35.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.686 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -115.03 153.95 47.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 130.58 34.76 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.203 1.935 . . . . 0.0 110.105 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.14 -33.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.86 -26.67 11.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.326 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.72 93.92 3.82 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.132 -0.355 . . . . 0.0 111.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 68' ' ' THR . 50.7 mt -112.18 117.93 46.85 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.38 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.47 135.55 29.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.647 2.231 . . . . 0.0 111.059 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.78 149.31 53.04 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.244 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.7 162.78 39.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.367 2.045 . . . . 0.0 110.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 pt -83.56 -12.39 11.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.799 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -61.5 126.27 26.76 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -100.21 111.22 23.49 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -121.25 101.0 44.71 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.62 118.34 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.205 1.27 . . . . 0.0 110.935 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.58 143.9 39.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.9 t -107.99 127.14 53.5 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.224 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.31 160.41 28.11 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -56.17 -23.66 36.46 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.964 0.906 . . . . 0.0 112.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -88.38 11.3 17.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.661 0.743 . . . . 0.0 110.372 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 63.63 29.11 15.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.902 1.281 . . . . 0.0 112.654 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mm -103.14 126.13 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.4 m -83.26 124.44 30.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -103.23 144.53 31.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.43 -19.33 68.6 Favored Glycine 0 C--O 1.222 -0.638 0 O-C-N 124.117 0.886 . . . . 0.0 113.676 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 30.7 p30 -170.94 173.5 5.12 Favored 'General case' 0 C--O 1.256 1.423 0 C-N-CA 123.635 0.774 . . . . 0.0 109.095 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.41 64.18 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.347 0.404 . . . . 0.0 110.923 -174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 44.4 t -54.26 -52.66 60.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.596 0.56 . . . . 0.0 110.199 175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -63.82 -36.72 84.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.043 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -63.39 -49.64 73.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.03 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 43.0 t -59.2 -38.71 80.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.355 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 43' ' ' ILE . 26.7 m -56.92 -50.06 73.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 110.343 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -71.92 -36.99 70.13 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.2 m -58.04 -43.9 87.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.968 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.86 -42.24 61.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.142 0.496 . . . . 0.0 110.398 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.89 -46.04 85.5 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.321 1.048 . . . . 0.0 111.837 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.1 m -99.66 14.6 29.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 43.92 76.34 0.08 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 114.028 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 78' ' ' GLN . . . 70.94 15.62 74.17 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 115.073 -0.967 . . . . 0.0 114.051 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -72.29 -62.23 1.51 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.73 131.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.443 ' NE2' ' HA2' ' A' ' 75' ' ' GLY . 25.2 mm-40 -129.28 173.17 10.76 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -67.54 112.14 4.53 Favored 'General case' 0 C--N 1.284 -2.255 0 O-C-N 123.941 0.776 . . . . 0.0 109.206 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 tp -86.29 -56.34 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -161.07 162.23 31.56 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.208 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.08 146.96 45.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.79 168.58 38.12 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.75 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -64.45 149.76 47.86 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 122.706 0.402 . . . . 0.0 110.346 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.179 178.765 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t0 . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.4 t -93.69 -17.97 22.64 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 p -61.54 -27.75 68.83 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -77.99 -22.29 13.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 O-C-N 121.987 -0.446 . . . . 0.0 112.034 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 99.1 m-85 -98.9 -19.55 17.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.761 0.791 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.97 -14.93 63.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.39 1.076 . . . . 0.0 110.767 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -83.38 -4.04 58.1 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -100.88 156.88 34.64 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.92 135.29 68.94 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.608 2.205 . . . . 0.0 111.264 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.75 -24.47 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.51 -24.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.851 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.15 93.51 3.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.409 0.623 . . . . 0.0 111.045 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.97 115.83 31.64 Favored Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.28 133.61 31.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.484 1.456 . . . . 0.0 111.102 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.7 m -114.2 141.26 26.1 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.514 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.7 159.19 49.61 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.338 2.025 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 pt -83.57 -13.56 11.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.944 0.402 . . . . 0.0 110.805 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -70.27 132.41 45.67 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.45 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 52.8 t80 -96.88 112.83 24.41 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -124.05 98.36 39.27 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.19 126.86 22.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.867 1.711 . . . . 0.0 111.42 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.73 148.72 33.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -117.31 131.01 56.89 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 120.887 0.375 . . . . 0.0 110.329 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 168.36 26.41 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 p -70.91 -8.39 52.57 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.991 0.9 . . . . 0.0 110.745 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.31 -3.61 59.02 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 67.22 27.36 8.43 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.912 1.685 . . . . 0.0 112.725 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.77 133.32 48.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 m -88.24 129.1 35.45 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -107.79 146.99 31.44 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.376 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -62.66 -28.14 71.01 Favored Glycine 0 CA--C 1.499 -0.964 0 O-C-N 124.57 1.169 . . . . 0.0 112.617 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.3 p30 -172.17 170.03 5.31 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 123.145 0.578 . . . . 0.0 109.898 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.12 -29.07 60.17 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.4 t -62.36 -44.36 96.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -70.31 -37.84 74.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.7 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.11 -48.91 78.08 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.633 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.6 t -62.86 -41.51 99.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.652 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.9 m -60.39 -49.69 76.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 109.798 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.3 -37.45 87.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.035 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -65.68 -58.18 6.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.1 -45.65 86.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.132 0.573 . . . . 0.0 111.39 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 33.8 ttpt -57.43 -33.65 68.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.098 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.6 m -105.18 17.77 23.48 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.853 -174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 63.56 22.8 13.34 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 123.392 0.677 . . . . 0.0 112.658 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.86 28.94 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.753 -0.736 . . . . 0.0 113.067 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -57.15 -50.96 71.19 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.214 1.007 . . . . 0.0 108.43 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.59 133.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -117.29 160.85 20.45 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.48 121.49 16.46 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.38 -60.14 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -158.89 156.84 30.31 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -82.72 166.71 18.86 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.03 168.79 42.1 Favored Glycine 0 C--N 1.273 -2.942 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -67.73 146.09 54.11 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.782 -178.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 t70 . . . . . 0 N--CA 1.416 -2.167 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -88.07 -12.47 44.13 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.202 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 m -61.52 -39.66 91.81 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.33 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 pt -67.91 -17.69 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.655 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.0 m-85 -99.07 -5.47 30.21 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -58.82 -21.81 57.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.813 0.445 . . . . 0.0 111.976 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -79.24 4.76 14.03 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -118.93 152.03 51.14 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.37 133.06 46.98 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 121.726 1.617 . . . . 0.0 109.684 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 71' ' ' LEU . 15.1 m -57.62 -24.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -171.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.11 -25.33 5.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.004 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.46 93.87 3.98 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.883 0.373 . . . . 0.0 110.808 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 68' ' ' THR . 56.0 mt -119.42 117.25 33.13 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.95 133.48 31.34 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.527 1.485 . . . . 0.0 109.725 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.9 m -116.87 150.01 45.08 Favored Pre-proline 0 C--N 1.29 -2.006 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.905 -175.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.18 162.81 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.506 2.138 . . . . 0.0 111.142 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.07 -7.29 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.264 0.554 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -64.68 115.2 5.01 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.585 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -90.21 120.15 31.13 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 88.2 mt -133.72 99.06 14.31 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -62.24 119.92 7.25 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 121.49 1.46 . . . . 0.0 110.954 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.96 152.19 37.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.5 t -114.31 126.21 54.76 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.64 29.15 Favored Glycine 0 N--CA 1.421 -2.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.701 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -51.21 -25.71 5.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.848 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.15 8.32 27.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 69.7 29.92 4.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mm -107.22 124.44 63.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.533 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.5 m -81.47 125.7 30.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.18 155.49 19.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.96 79.16 Favored Glycine 0 N--CA 1.448 -0.533 0 O-C-N 123.868 0.73 . . . . 0.0 113.586 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.8 p30 -171.81 172.68 4.77 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 123.163 0.585 . . . . 0.0 109.764 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.88 76.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.881 0.738 . . . . 0.0 112.945 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 40.7 t -56.25 -50.96 69.83 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.68 0.392 . . . . 0.0 110.47 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -64.45 -36.03 82.84 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.707 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.8 -45.79 92.33 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.845 0.716 . . . . 0.0 109.484 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.7 t -61.36 -41.47 97.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.397 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.441 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 m -56.72 -53.09 61.8 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.27 77.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 t -58.53 -43.5 89.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 122.934 0.494 . . . . 0.0 110.402 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD13 HG12 ' A' ' 40' ' ' VAL . 86.2 mt -72.41 -39.12 68.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.438 . . . . 0.0 110.784 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -65.32 -39.72 92.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.022 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -87.3 -0.55 56.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.738 0.304 . . . . 0.0 110.832 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 57.73 68.12 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.239 1.416 . . . . 0.0 111.834 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.02 11.96 61.86 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.293 -0.867 . . . . 0.0 114.03 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -80.06 -50.18 10.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.75 117.11 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -125.7 -178.32 4.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -68.87 114.17 6.96 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.15 -54.64 4.02 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -159.95 159.5 32.33 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.335 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.28 157.52 30.72 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 165.86 41.33 Favored Glycine 0 C--N 1.293 -1.84 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 151.44 46.35 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.259 1.565 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.444 -0.756 0 CA-C-O 121.767 0.794 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.78 -2.44 17.33 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -64.62 -41.12 96.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.45 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 pt -68.08 -22.33 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.682 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.5 m-85 -93.12 -8.37 42.83 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.333 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.54 -15.3 60.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.324 0.583 . . . . 0.0 110.31 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -81.93 -2.19 50.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.061 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -123.18 151.19 61.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.19 145.41 78.41 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 121.92 1.747 . . . . 0.0 109.731 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.86 -38.63 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.59 -26.49 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.851 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.17 92.09 3.51 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.114 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.2 mt -122.29 113.81 30.79 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.18 132.52 34.35 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 120.631 0.888 . . . . 0.0 110.091 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.2 m -126.2 144.39 48.91 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.35 162.96 39.76 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.795 1.663 . . . . 0.0 111.196 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 pt -85.96 -1.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.658 0.742 . . . . 0.0 109.724 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -64.17 128.25 34.97 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.987 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -103.08 108.91 20.27 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.1 mt -123.91 97.45 41.1 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.15 118.59 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.694 1.596 . . . . 0.0 111.404 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.27 150.42 33.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.49 126.84 55.4 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.142 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.42 164.82 29.6 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 p -67.9 -4.58 13.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.393 0.616 . . . . 0.0 112.201 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.87 0.63 56.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 70.35 23.44 5.0 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.257 1.423 . . . . 0.0 111.111 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.9 mm -101.82 132.48 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -86.9 120.13 27.85 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.23 152.49 18.8 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.781 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.73 -18.71 77.56 Favored Glycine 0 N--CA 1.441 -0.972 0 O-C-N 124.116 0.885 . . . . 0.0 113.169 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.2 p30 -175.87 173.76 2.26 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 123.565 0.746 . . . . 0.0 109.935 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.48 -33.74 76.58 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.992 0.917 . . . . 0.0 110.673 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -45.98 90.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -65.8 -35.54 81.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.988 0.423 . . . . 0.0 110.614 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.46 -46.62 82.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.186 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 35.8 t -61.33 -40.81 95.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.1 m -57.69 -51.16 70.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.781 0.324 . . . . 0.0 110.197 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.6 -35.96 82.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.522 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t -65.66 -49.7 67.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.519 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.46 -37.97 89.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.265 0.555 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.59 -28.83 68.79 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.42 1.088 . . . . 0.0 110.906 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.0 p -110.45 16.31 21.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.695 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 60.92 24.87 14.88 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.162 0.982 . . . . 0.0 111.639 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.97 31.5 9.84 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.796 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -76.39 -56.78 4.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.99 129.99 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.625 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.26 -179.79 4.17 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -79.68 126.23 30.65 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.59 -52.66 3.85 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -164.52 159.62 19.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.1 153.44 40.79 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.43 172.7 46.93 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.624 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -64.19 146.93 53.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.316 -0.865 0 O-C-N 123.845 0.716 . . . . 0.0 112.235 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 121.842 0.83 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -89.45 -11.18 43.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.489 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -60.91 -40.28 92.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.725 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 45.8 pt -72.95 -21.1 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.764 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 98.7 m-85 -87.75 -12.47 45.09 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.195 0.522 . . . . 0.0 110.736 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -70.49 -14.76 62.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 23.4 pttm -78.11 -3.59 43.14 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.675 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.66 157.59 34.25 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.2 131.11 43.09 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.274 1.983 . . . . 0.0 110.165 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.53 -24.36 15.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.14 -25.19 5.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.114 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.86 93.79 3.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.882 0.373 . . . . 0.0 110.647 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.3 124.49 28.55 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.03 134.07 44.34 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 121.665 1.577 . . . . 0.0 110.554 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.4 m -107.66 140.62 21.74 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.07 163.36 39.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.078 1.852 . . . . 0.0 110.418 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -82.74 -14.54 11.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -64.87 119.41 10.61 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.528 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.3 mt -135.36 96.46 13.87 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -58.4 119.67 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.126 1.884 . . . . 0.0 110.489 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.86 128.61 56.47 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.5 165.95 35.83 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.617 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -57.14 -18.97 17.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.866 1.266 . . . . 0.0 112.117 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.59 6.28 47.86 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.101 0.953 . . . . 0.0 109.841 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.7 OUTLIER 61.1 47.04 7.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 110.847 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.6 mm -120.53 131.91 71.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.2 m -85.14 131.52 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -112.37 153.55 27.1 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.276 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.36 73.87 Favored Glycine 0 N--CA 1.444 -0.828 0 O-C-N 124.014 0.821 . . . . 0.0 113.862 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 34.6 p30 -176.71 -178.67 0.9 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 116.936 0.368 . . . . 0.0 111.344 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 29.4 mt-10 -45.74 -51.21 12.92 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 126.47 1.908 . . . . 0.0 111.574 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.5 t -55.51 -53.73 52.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.895 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -63.38 -37.93 89.19 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.096 0.474 . . . . 0.0 111.001 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 tp -67.03 -48.76 67.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.295 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 52.4 t -60.52 -44.46 96.02 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.948 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.9 m -58.65 -50.27 74.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.745 0.307 . . . . 0.0 110.869 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.19 -34.16 75.77 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.1 t -63.31 -48.13 79.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.293 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.06 -37.55 81.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.139 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.55 -34.94 79.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.024 0.44 . . . . 0.0 111.498 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -93.79 1.31 56.5 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.128 0.49 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 60.12 25.44 14.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.76 1.224 . . . . 0.0 112.54 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.95 22.69 7.82 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.198 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -72.49 -53.41 12.16 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.96 129.0 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -134.86 -178.72 5.21 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -65.95 119.08 10.71 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -93.31 -60.41 1.79 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -156.84 153.92 29.02 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.48 165.0 24.92 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.05 168.29 40.45 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 147.59 51.84 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 60.0 m . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.701 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 CA--C 1.479 -1.788 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.26 -6.58 56.68 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.539 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 55.4 m -67.4 -36.93 82.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.054 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.57 -16.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.666 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 76.6 m-85 -109.85 -13.68 14.42 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.397 0.618 . . . . 0.0 109.995 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -71.09 -14.99 62.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.288 1.042 . . . . 0.0 108.329 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 33' ' ' SER . 55.1 mtpt -72.62 -15.21 61.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.16 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.45 152.52 42.77 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.74 133.86 44.21 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.437 1.425 . . . . 0.0 108.687 172.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.16 -25.52 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.46 -26.16 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.777 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.59 93.52 3.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.241 -0.287 . . . . 0.0 111.371 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.58 124.55 26.2 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -77.18 134.89 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.403 1.402 . . . . 0.0 110.484 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -125.81 145.8 53.0 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.83 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.71 152.92 53.02 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.421 2.747 . . . . 0.0 112.336 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 pt -83.85 -17.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -68.76 134.23 49.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.249 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -90.95 110.73 21.98 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.0 mt -124.43 97.53 39.53 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.3 119.18 6.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.047 1.832 . . . . 0.0 111.5 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.43 151.83 29.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.84 128.56 56.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.81 163.28 23.47 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.441 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -57.2 -18.76 17.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.145 0.978 . . . . 0.0 112.349 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.52 3.5 43.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.414 0.626 . . . . 0.0 109.859 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 69.04 26.71 5.55 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.059 1.343 . . . . 0.0 111.723 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.37 134.33 49.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 84' ' ' SER . 67.1 m -86.13 127.27 34.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -105.97 156.08 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.989 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.53 -22.32 78.64 Favored Glycine 0 CA--C 1.501 -0.788 0 O-C-N 123.98 0.8 . . . . 0.0 112.996 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.4 p30 -173.0 169.86 4.58 Favored 'General case' 0 C--O 1.255 1.384 0 C-N-CA 123.684 0.793 . . . . 0.0 109.692 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.13 -27.02 65.19 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.286 -175.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.86 -44.3 97.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -64.7 -40.01 94.64 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.36 -46.75 87.77 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.362 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.3 t -59.77 -38.4 81.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -57.97 -48.6 79.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -67.47 -34.22 76.73 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.004 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 t -65.09 -39.41 93.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.602 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -72.34 -38.65 68.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.13 -43.33 91.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.79 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 58.3 p -92.61 -13.87 28.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.807 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 62.74 75.07 0.41 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 111.75 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.27 8.54 85.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.826 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 64.0 ttt180 -80.46 -62.1 1.78 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.643 0.722 . . . . 0.0 109.51 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.2 118.46 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -132.42 -179.64 5.56 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -68.16 110.47 4.02 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -85.25 -55.69 3.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -159.17 159.81 34.78 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.495 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.96 152.1 38.81 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 168.0 43.63 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 59' ' ' THR . 25.4 m -57.64 147.5 27.2 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.19 0.596 . . . . 0.0 110.26 176.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.125 178.191 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.481 -1.685 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.64 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 26.9 t -93.19 -20.77 20.13 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -54.05 -35.2 61.75 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.645 1.178 . . . . 0.0 113.959 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.55 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.095 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 72.9 m-85 -89.28 -19.8 24.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.1 mtpt -60.48 -14.23 18.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.533 0.733 . . . . 0.0 112.343 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.74 -25.53 61.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -89.8 152.68 46.99 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.83 139.01 82.96 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.124 1.883 . . . . 0.0 110.058 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.1 m -59.2 -15.72 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.35 -25.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.783 0.325 . . . . 0.0 110.627 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.24 93.91 3.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 122.094 -0.379 . . . . 0.0 110.726 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 68' ' ' THR . 55.6 mt -124.53 107.97 29.2 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.11 134.36 33.8 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.23 1.953 . . . . 0.0 110.578 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.1 m -114.66 147.02 37.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.038 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -61.8 152.45 74.38 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.294 1.996 . . . . 0.0 110.093 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.59 -7.71 10.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -74.91 133.35 41.81 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -92.31 127.05 37.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.8 mp -131.85 99.17 16.94 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -61.25 118.42 5.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.761 1.641 . . . . 0.0 111.196 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.35 152.13 36.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -117.08 128.2 54.91 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.165 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.38 163.09 28.61 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 m -62.23 -13.99 33.63 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.84 0.856 . . . . 0.0 111.733 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.37 2.37 54.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.074 0.94 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 65.75 24.97 11.44 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.857 1.263 . . . . 0.0 113.401 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.68 130.72 50.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.7 m -86.57 132.71 33.83 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.87 151.46 29.09 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.217 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -24.91 72.64 Favored Glycine 0 C--O 1.218 -0.885 0 O-C-N 124.434 1.084 . . . . 0.0 113.054 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.8 p30 -173.74 173.55 3.3 Favored 'General case' 0 C--O 1.259 1.556 0 C-N-CA 124.061 0.944 . . . . 0.0 109.116 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -26.63 68.28 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.52 0.512 . . . . 0.0 112.088 -174.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.45 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 38.6 t -56.5 -48.51 77.03 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.084 0.24 . . . . 0.0 110.803 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -67.57 -32.37 73.07 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.954 0.406 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.53 -46.01 74.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.097 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.0 t -59.2 -44.94 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.335 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.427 ' HA ' HD12 ' A' ' 43' ' ' ILE . 29.3 m -55.25 -48.23 74.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.099 0.476 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -71.49 -34.81 70.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -65.57 -33.53 76.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 36' ' ' LYS . 92.4 mt -74.47 -33.37 62.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.27 -50.98 50.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 0.0 110.724 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 p -81.48 -19.89 41.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.525 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.9 t30 63.43 78.91 0.27 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 111.933 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.2 90.29 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.123 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -73.28 -55.81 5.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.293 1.046 . . . . 0.0 109.354 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -94.54 111.79 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-O 121.69 0.757 . . . . 0.0 109.26 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -112.65 -179.61 3.71 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.44 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -77.78 118.37 20.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.43 -56.81 2.9 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -160.48 161.0 32.71 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.604 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.77 151.16 39.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 174.51 43.64 Favored Glycine 0 C--N 1.29 -1.974 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.327 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 m -69.54 152.32 44.94 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.77 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 N--CA 1.436 -1.166 0 CA-C-O 121.944 0.878 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 45.7 t -93.85 -5.06 48.91 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.372 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 3.7 m -65.35 -39.85 92.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.427 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -59.05 -28.0 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.452 0.47 . . . . 0.0 111.848 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.619 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -91.22 -33.05 15.54 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.666 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 50.7 mtmt -62.18 -14.38 37.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 33' ' ' SER . 32.3 mmtp -76.42 -5.89 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.084 0.469 . . . . 0.0 111.142 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.32 156.7 40.74 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 135.49 70.47 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.824 1.683 . . . . 0.0 110.533 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.42 -29.42 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.995 0.918 . . . . 0.0 112.902 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.82 -26.11 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.981 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.02 93.85 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.743 -0.598 . . . . 0.0 111.332 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 68' ' ' THR . 45.2 mt -124.81 132.56 24.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.52 134.51 26.54 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.446 1.431 . . . . 0.0 110.643 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.8 m -116.93 146.43 37.84 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.148 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 64' ' ' CYS . 9.0 Cg_endo -59.12 146.64 93.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.103 1.869 . . . . 0.0 110.158 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.9 pt -80.78 -20.6 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -79.89 138.09 37.07 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.729 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -82.66 108.48 16.06 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 81.1 mt -118.67 98.82 51.34 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 120.34 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.285 1.99 . . . . 0.0 111.88 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.12 146.35 34.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.41 128.21 53.87 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.34 159.94 24.45 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 m -61.16 -14.29 23.91 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.652 0.781 . . . . 0.0 112.352 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.93 3.86 40.09 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.819 0.847 . . . . 0.0 109.68 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 65.95 36.5 5.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.217 1.407 . . . . 0.0 111.925 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.5 131.7 71.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.9 m -84.34 122.43 28.91 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -97.73 152.64 18.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.639 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.54 -15.17 72.89 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.0 0.812 . . . . 0.0 114.123 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 173.68 -179.63 0.09 Allowed 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.167 1.387 . . . . 0.0 108.715 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -26.71 62.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.408 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 44.4 t -63.41 -42.27 98.74 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.63 -30.69 68.47 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.153 0.502 . . . . 0.0 110.0 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.4 tp -69.47 -49.08 58.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 30.9 t -61.55 -46.24 90.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.058 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.461 HG22 HD12 ' A' ' 43' ' ' ILE . 17.6 p -59.85 -48.51 81.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 111.15 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.39 -36.67 84.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.101 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -61.87 -44.56 96.58 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.997 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 87.2 mt -69.62 -45.72 67.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.359 0.6 . . . . 0.0 110.209 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -46.81 81.77 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.612 1.165 . . . . 0.0 110.612 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 m -91.62 13.29 18.38 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 55.24 60.1 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.56 76.92 Favored Glycine 0 C--N 1.316 -0.559 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.994 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.93 -51.67 63.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.0 110.359 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.03 122.13 62.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.356 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -105.61 174.78 5.73 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -76.76 119.59 20.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.27 -53.78 4.09 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.067 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -163.3 166.46 23.04 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.236 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.06 149.88 39.04 Favored 'General case' 0 C--O 1.252 1.214 0 O-C-N 123.801 0.688 . . . . 0.0 109.183 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.37 173.95 50.08 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.677 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -65.65 152.24 44.65 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.698 0.399 . . . . 0.0 110.372 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.037 -179.803 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 34.6 t -92.68 -9.34 41.18 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.56 -33.18 72.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.6 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.28 -24.87 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.07 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 60.3 m-85 -92.05 -9.6 42.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 64.1 mttp -68.98 -14.75 63.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.545 0.688 . . . . 0.0 109.585 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -78.36 -11.05 59.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.534 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -109.98 153.14 43.3 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -64.45 146.72 89.99 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 121.593 1.529 . . . . 0.0 109.415 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.93 -31.66 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 111.383 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.07 -25.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.29 93.76 3.89 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.071 0.462 . . . . 0.0 111.325 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 64.6 mt -124.68 125.59 25.49 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 3.0 Cg_exo -76.59 133.61 14.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.559 1.506 . . . . 0.0 110.353 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.3 147.72 66.2 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 159.86 49.06 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 121.995 1.796 . . . . 0.0 112.113 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.69 -12.31 14.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.159 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -66.06 132.69 49.11 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.038 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -94.81 110.03 21.94 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 85.8 mt -122.12 97.32 45.73 Favored Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.58 122.58 11.49 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.698 1.599 . . . . 0.0 111.873 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.15 150.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -115.33 129.77 56.7 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.155 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.62 165.55 28.57 Favored Glycine 0 N--CA 1.427 -1.93 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 p -63.9 -15.0 58.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.166 0.987 . . . . 0.0 112.344 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.84 1.83 51.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.731 0.777 . . . . 0.0 109.276 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 65.86 36.53 6.01 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.452 1.501 . . . . 0.0 111.671 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.96 131.59 64.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 84' ' ' SER . 79.5 m -82.21 124.59 30.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.63 150.48 25.38 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.962 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.93 -15.23 73.9 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.302 1.001 . . . . 0.0 113.865 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 -179.44 170.56 1.33 Allowed 'General case' 0 C--O 1.252 1.19 0 C-N-CA 124.204 1.002 . . . . 0.0 109.633 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -28.68 69.1 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.73 -47.05 82.66 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.068 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -64.95 -35.59 81.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.848 0.356 . . . . 0.0 110.354 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.87 -46.95 88.58 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.001 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 53.8 t -65.09 -34.56 78.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.546 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 m -56.35 -49.46 74.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.91 -37.75 82.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.534 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -59.66 -47.01 87.32 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.66 0.384 . . . . 0.0 110.731 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -72.03 -39.53 69.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -64.69 -30.61 71.63 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.54 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 79.1 p -100.46 -4.47 28.78 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.24 62.59 1.57 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.306 1.442 . . . . 0.0 112.2 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.28 86.99 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 114.449 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 30.0 ttt180 -65.78 -54.99 19.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.43 124.01 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.8 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -137.4 178.44 7.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -62.01 123.04 17.02 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.385 0.674 . . . . 0.0 111.586 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.06 -58.21 1.99 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.74 161.51 37.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.16 153.9 35.84 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.68 173.7 45.65 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 59' ' ' THR . 15.4 m -67.48 149.95 49.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--N 1.308 -1.217 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.606 -178.271 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.428 -1.566 0 CA-C-O 121.833 0.825 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.1 t -97.03 -8.41 30.49 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.1 -32.41 71.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.158 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.0 pt -64.98 -28.56 45.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.854 0.359 . . . . 0.0 111.437 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 82.2 m-85 -89.5 -9.96 48.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.178 0.513 . . . . 0.0 110.523 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.83 -14.57 62.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.718 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.35 -15.8 63.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 43' ' ' ILE . 81.9 m-85 -112.99 151.63 44.27 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.92 144.01 75.06 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 122.038 1.825 . . . . 0.0 110.919 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.96 -38.74 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 124.179 0.992 . . . . 0.0 113.5 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.5 m -79.54 -24.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.11 93.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.882 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 68' ' ' THR . 37.6 mt -125.52 112.84 25.47 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 134.1 35.64 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.661 1.574 . . . . 0.0 109.9 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.6 m -115.55 147.61 39.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.726 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.46 157.42 54.98 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 121.956 1.771 . . . . 0.0 110.439 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.99 -4.06 10.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.323 0.582 . . . . 0.0 110.184 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -64.34 124.67 22.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -88.49 106.86 18.56 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.964 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 83.0 mt -123.4 96.1 44.39 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.17 118.9 5.8 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.304 1.336 . . . . 0.0 110.946 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.57 145.81 33.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.4 t -111.75 123.35 50.05 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 120.915 0.388 . . . . 0.0 110.307 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 169.3 40.51 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 p -66.86 -8.47 29.18 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.06 -0.89 57.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.384 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 65.65 39.5 4.87 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.46 1.104 . . . . 0.0 110.85 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.16 133.03 63.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.541 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 m -89.01 113.14 24.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.69 152.34 19.58 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.315 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.02 73.5 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.835 0.709 . . . . 0.0 113.623 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.2 p30 179.62 176.47 0.66 Allowed 'General case' 0 C--O 1.255 1.371 0 C-N-CA 124.571 1.148 . . . . 0.0 109.165 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -26.71 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.476 0.485 . . . . 0.0 111.597 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.87 -41.04 99.25 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -69.37 -30.37 68.35 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.316 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.88 -49.34 53.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.969 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.4 t -59.51 -47.19 86.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.531 0.733 . . . . 0.0 111.555 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 43' ' ' ILE . 5.4 p -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.79 -38.89 90.24 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -62.64 -50.37 71.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.253 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.04 -40.83 95.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 110.777 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -57.47 -45.43 84.83 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.366 1.066 . . . . 0.0 110.635 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -95.66 17.24 15.33 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 47.53 60.28 3.59 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.803 1.641 . . . . 0.0 113.771 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.47 15.15 81.74 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.973 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.89 -60.29 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.02 132.24 33.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.262 0.553 . . . . 0.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -117.88 173.26 6.86 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.164 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -75.85 119.06 19.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.75 -58.23 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -159.53 155.22 26.0 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.386 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -77.36 157.95 30.38 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.04 168.6 40.62 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -66.24 153.68 41.87 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.259 1.597 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.179 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.436 -1.145 0 CA-C-O 121.811 0.815 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 46.2 t -107.78 -5.56 17.26 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.4 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -68.52 -32.39 72.31 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.327 0.651 . . . . 0.0 110.345 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.27 -30.34 42.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.559 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 85.0 m-85 -90.24 -20.58 22.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.868 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.5 mtpp -62.21 -14.27 36.27 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.437 0.637 . . . . 0.0 112.068 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -81.55 -4.68 56.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.17 152.58 41.17 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.49 134.39 63.61 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.08 1.854 . . . . 0.0 111.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -50.82 -41.23 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 112.744 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.41 -25.62 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.87 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.73 93.15 3.76 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.737 -0.602 . . . . 0.0 111.252 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.58 115.47 37.41 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.76 133.85 41.09 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.04 1.827 . . . . 0.0 110.544 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -118.94 142.62 32.25 Favored Pre-proline 0 C--N 1.293 -1.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.746 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.14 154.44 45.74 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.659 2.239 . . . . 0.0 110.959 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.01 -17.5 11.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 120.979 0.419 . . . . 0.0 110.405 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -65.42 120.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.189 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -85.32 115.85 23.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.44 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.6 mt -128.52 94.53 35.15 Favored Pre-proline 0 C--N 1.288 -2.072 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.32 120.46 8.37 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.911 1.741 . . . . 0.0 111.597 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.31 148.78 30.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -112.62 126.46 55.39 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.33 166.32 30.62 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.227 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -62.17 -12.91 22.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 111.985 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.31 1.27 56.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.755 0.788 . . . . 0.0 109.43 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 68.58 28.54 5.79 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.128 1.371 . . . . 0.0 111.915 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.14 130.01 56.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 m -83.31 119.23 24.34 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.525 0.678 . . . . 0.0 109.59 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.61 151.82 20.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.47 -25.8 72.69 Favored Glycine 0 C--O 1.213 -1.174 0 O-C-N 124.26 0.975 . . . . 0.0 113.535 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.1 p30 -174.67 175.72 2.41 Favored 'General case' 0 C--O 1.256 1.398 0 C-N-CA 123.708 0.803 . . . . 0.0 109.218 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.29 68.19 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.51 0.506 . . . . 0.0 112.133 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 41.6 t -56.53 -52.54 64.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 123.451 0.469 . . . . 0.0 110.125 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -65.84 -32.4 73.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.813 0.34 . . . . 0.0 111.111 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.51 -48.76 73.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.484 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.1 t -61.35 -45.32 94.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.1 m -57.03 -49.34 76.11 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.18 0.514 . . . . 0.0 110.647 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.22 -34.48 76.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.32 -47.75 78.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.58 -38.6 91.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.808 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.1 p -89.6 4.5 49.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.458 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 62.59 30.05 16.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.854 0.862 . . . . 0.0 112.582 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.14 27.8 7.59 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.397 -0.906 . . . . 0.0 114.743 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -76.58 -52.44 9.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.368 1.084 . . . . 0.0 110.793 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.07 119.91 42.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.687 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -106.39 -179.62 3.99 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -80.31 119.1 22.59 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 tp -91.34 -54.26 3.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -160.12 159.7 32.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.682 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -78.96 151.32 31.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.13 170.58 35.09 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.473 -0.87 . . . . 0.0 110.997 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 m -65.99 145.23 56.13 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.824 -0.607 . . . . 0.0 111.295 -177.648 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 N--CA 1.432 -1.366 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 42.3 t -99.46 -7.34 26.19 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m -67.11 -45.03 78.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 pt -69.12 -15.09 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.175 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.478 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.8 m-85 -96.42 -11.75 25.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.162 0.506 . . . . 0.0 110.691 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.8 mtpp -75.04 -14.21 60.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.72 -4.09 44.47 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.278 0.561 . . . . 0.0 111.259 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -108.38 159.71 29.77 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.33 145.05 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 121.393 1.395 . . . . 0.0 109.348 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.77 -40.63 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.404 0.621 . . . . 0.0 111.282 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.03 -26.93 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.503 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 92.99 3.64 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.528 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.09 119.64 33.27 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.94 133.66 31.94 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 121.406 1.404 . . . . 0.0 111.206 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.58 139.7 20.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.806 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.52 160.53 35.41 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.383 2.055 . . . . 0.0 110.449 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 pt -91.9 -9.06 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.118 0.485 . . . . 0.0 111.523 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 130.9 39.56 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -85.39 117.1 24.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.6 mt -129.28 97.13 26.36 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.97 118.83 5.75 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.506 1.47 . . . . 0.0 110.43 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.88 145.9 34.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.8 t -110.83 127.6 55.47 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.48 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 78' ' ' GLN . . . -89.99 161.28 29.15 Favored Glycine 0 N--CA 1.421 -2.336 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.608 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m -54.66 -24.45 21.74 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.856 1.262 . . . . 0.0 112.31 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.54 7.19 34.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.701 0.762 . . . . 0.0 110.304 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 68.25 24.6 7.42 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.53 1.132 . . . . 0.0 112.62 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.49 121.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.0 m -81.71 128.34 33.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.61 150.86 26.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.291 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.54 76.11 Favored Glycine 0 N--CA 1.445 -0.706 0 O-C-N 124.104 0.877 . . . . 0.0 113.284 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 28.4 p30 -176.52 175.33 1.76 Allowed 'General case' 0 C--O 1.255 1.383 0 CA-C-O 121.091 0.472 . . . . 0.0 111.645 176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 49.2 mt-10 -44.99 -47.82 11.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.268 2.227 . . . . 0.0 112.609 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.7 t -56.23 -44.29 79.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.837 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.118 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.94 -47.29 83.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 50.4 t -62.84 -41.36 99.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.941 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 90.2 m -57.43 -51.61 68.71 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.79 -34.46 75.58 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.515 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -61.69 -46.18 90.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 77.1 mt -68.81 -44.06 74.31 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -54.6 -56.91 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 111.181 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 m -89.47 28.9 1.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 p30 50.54 21.6 0.9 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 126.29 1.836 . . . . 0.0 115.294 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.35 7.41 34.91 Favored Glycine 0 C--N 1.295 -1.74 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.618 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -60.93 -46.36 90.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.976 0.894 . . . . 0.0 109.575 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.5 p -108.19 119.32 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.742 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 76.3 mt-30 -129.67 -178.6 4.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -65.71 111.46 3.22 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.28 -54.01 4.53 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -162.16 159.81 26.39 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.89 158.54 26.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.99 177.16 42.29 Favored Glycine 0 N--CA 1.416 -2.698 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 m -70.13 152.18 44.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.859 -178.811 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t0 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.755 0.788 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 43.4 t -93.9 -15.74 24.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -34.82 77.25 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.266 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 pt -65.24 -31.61 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.853 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.3 m-85 -87.71 -16.89 33.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.129 0.49 . . . . 0.0 111.159 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 99.0 mttt -66.81 -14.54 62.77 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.454 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.98 -12.26 60.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.798 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.87 152.1 44.57 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.95 138.74 80.81 Favored 'Trans proline' 0 C--O 1.22 -0.398 0 C-N-CA 122.027 1.818 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.33 -30.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.32 -27.03 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.522 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.38 92.99 3.68 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.116 0.484 . . . . 0.0 111.479 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.09 122.66 25.38 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.83 133.71 24.18 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.037 1.158 . . . . 0.0 110.248 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.8 m -116.74 139.6 25.79 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -61.58 150.49 85.19 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.238 1.959 . . . . 0.0 112.026 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 pt -76.72 -13.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.418 0.628 . . . . 0.0 109.72 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -69.01 137.18 53.46 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.68 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -101.25 113.78 27.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.3 mp -119.76 97.07 49.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.85 118.91 5.85 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.364 1.376 . . . . 0.0 110.299 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.71 146.79 33.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.7 t -109.53 125.81 52.9 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.09 161.58 24.54 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 m -53.3 -24.5 11.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.494 1.118 . . . . 0.0 112.616 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.34 -1.73 38.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.273 0.629 . . . . 0.0 110.576 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 72.49 30.65 1.89 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.853 1.661 . . . . 0.0 110.85 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.74 131.19 61.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.746 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.2 m -81.56 119.21 23.48 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.72 152.32 19.79 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.07 -19.5 78.49 Favored Glycine 0 N--CA 1.443 -0.869 0 O-C-N 124.094 0.871 . . . . 0.0 113.498 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.0 p30 -177.11 177.19 1.28 Allowed 'General case' 0 C--O 1.255 1.393 0 C-N-CA 123.75 0.82 . . . . 0.0 109.54 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -27.93 64.5 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.442 0.463 . . . . 0.0 111.622 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.7 t -55.76 -52.03 65.34 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.364 0.415 . . . . 0.0 109.906 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -65.35 -36.66 84.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.033 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.12 -48.09 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.526 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 46.9 t -59.63 -45.27 92.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.435 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 m -57.53 -47.17 82.73 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.304 0.573 . . . . 0.0 110.59 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.57 -39.33 88.43 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.774 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 t -64.63 -38.7 91.89 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.653 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 93.1 mt -67.57 -37.01 82.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.782 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.52 -43.74 59.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.426 0.632 . . . . 0.0 110.961 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 m -83.5 0.23 47.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.854 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.25 71.01 0.57 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.71 1.204 . . . . 0.0 112.689 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.98 39.66 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.582 -0.736 . . . . 0.0 114.895 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -59.47 -54.46 46.41 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.225 0.536 . . . . 0.0 111.74 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.74 125.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -128.78 -178.63 4.68 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.62 112.09 8.36 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.1 tp -86.12 -48.73 8.34 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -165.1 161.37 19.57 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.417 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.61 147.16 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 165.46 39.85 Favored Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.708 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -61.09 150.82 32.75 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.065 0.546 . . . . 0.0 110.376 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.255 1.363 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 CA--C 1.494 -1.185 0 CA-C-O 122.396 1.093 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 53.9 t -83.17 -17.14 43.93 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.887 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -54.34 -47.07 72.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.172 0.989 . . . . 0.0 111.794 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 pt -68.42 -18.05 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.9 m-85 -94.93 -22.48 17.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 110.012 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.7 mtpt -65.47 -14.41 60.93 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.855 0.862 . . . . 0.0 110.407 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.44 -15.39 63.65 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.518 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.83 161.44 23.25 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.56 153.64 13.63 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.129 2.553 . . . . 0.0 112.554 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.76 -41.6 86.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 123.79 0.836 . . . . 0.0 112.922 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -96.55 -11.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.833 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.53 92.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.698 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 35' ' ' TYR . 67.8 mt -124.92 127.79 25.02 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.86 134.07 24.88 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.147 1.231 . . . . 0.0 111.554 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.46 136.92 19.32 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.047 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.08 162.65 39.12 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.128 1.885 . . . . 0.0 110.961 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -86.78 -3.37 8.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.333 0.587 . . . . 0.0 110.639 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.8 127.69 33.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.469 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.25 117.13 29.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 87.2 mt -129.77 95.93 27.81 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.6 118.97 5.88 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.96 1.773 . . . . 0.0 111.474 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.17 153.17 38.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.5 t -119.9 130.1 54.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.41 162.98 27.26 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.36 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -61.26 -16.22 43.19 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.025 0.93 . . . . 0.0 111.59 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.32 1.61 54.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.842 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 68.51 26.41 6.5 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.93 1.292 . . . . 0.0 113.15 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mm -103.87 127.59 57.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.2 m -81.84 138.26 35.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.09 153.36 34.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.503 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.37 -26.18 74.56 Favored Glycine 0 N--CA 1.438 -1.226 0 O-C-N 124.642 1.214 . . . . 0.0 112.979 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.5 p30 -175.36 177.35 1.85 Allowed 'General case' 0 C--O 1.255 1.352 0 C-N-CA 122.501 0.32 . . . . 0.0 110.886 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -47.51 -46.21 27.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.105 1.762 . . . . 0.0 111.626 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.15 -52.32 64.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.79 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -64.53 -38.02 89.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.59 -45.63 89.48 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.731 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 48.1 t -63.28 -44.81 94.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.792 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 m -58.62 -44.92 90.14 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.437 0.637 . . . . 0.0 110.321 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -72.06 -35.51 69.33 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.3 t -62.77 -42.96 99.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.428 HD21 ' HG2' ' A' ' 36' ' ' LYS . 89.2 mt -68.65 -42.3 78.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -58.22 -49.69 76.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.212 0.53 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -89.24 -4.79 58.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.579 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 53.35 67.79 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.611 1.164 . . . . 0.0 113.291 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 3.75 89.27 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-N 115.258 -0.883 . . . . 0.0 115.094 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.13 -47.83 72.83 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.01 94.96 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.176 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -106.07 -178.83 3.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -72.11 121.9 20.04 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.115 0.87 . . . . 0.0 109.347 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.12 -54.85 3.28 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.73 164.19 29.17 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.52 152.22 28.79 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.87 169.36 42.56 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.4 m -69.6 153.27 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.31 -1.128 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.427 -176.056 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.9 t -89.11 -12.75 40.24 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 22.9 m -59.23 -43.54 92.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -63.19 -28.19 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -88.33 -16.72 32.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.931 0.396 . . . . 0.0 111.323 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 66.9 mttm -69.49 -14.81 63.07 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.739 0.78 . . . . 0.0 109.204 174.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.04 6.31 36.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 44.4 m-85 -120.02 154.09 55.46 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.82 135.04 60.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.676 1.584 . . . . 0.0 109.901 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -52.24 -35.67 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 0.0 112.468 -175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.15 -25.33 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.94 93.59 3.87 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.847 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 68' ' ' THR . 67.2 mt -121.22 109.61 35.04 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.248 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.97 135.25 37.08 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 110.475 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.3 m -116.47 149.94 44.61 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.456 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.96 159.21 43.33 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.844 2.362 . . . . 0.0 110.34 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 pt -86.28 -3.07 8.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.107 0.48 . . . . 0.0 111.971 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -82.74 131.1 35.21 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.068 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -88.09 106.24 18.03 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 94.7 mt -117.93 95.16 47.7 Favored Pre-proline 0 C--N 1.285 -2.227 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.3 121.35 9.5 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 121.847 1.698 . . . . 0.0 111.071 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.42 156.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.8 t -120.71 127.07 51.68 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.92 162.12 33.78 Favored Glycine 0 N--CA 1.413 -2.849 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 p -59.69 -20.93 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 125.133 1.373 . . . . 0.0 112.288 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.12 5.11 42.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.495 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 66.35 39.97 3.84 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.884 1.273 . . . . 0.0 111.681 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.57 130.14 72.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.889 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 84' ' ' SER . 70.4 m -84.51 135.36 34.26 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.576 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 97.1 m-85 -120.07 156.55 30.75 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.51 -19.35 77.7 Favored Glycine 0 C--O 1.224 -0.481 0 O-C-N 124.25 0.969 . . . . 0.0 113.649 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.9 p30 -177.43 171.97 1.89 Allowed 'General case' 0 C--O 1.256 1.421 0 C-N-CA 123.777 0.831 . . . . 0.0 109.973 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -31.42 72.59 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 37.2 t -56.82 -53.78 53.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.647 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.78 -32.93 74.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.79 -44.75 95.35 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.086 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.3 t -68.8 -37.09 79.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.077 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 43' ' ' ILE . 28.0 m -58.8 -45.4 89.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.444 0.64 . . . . 0.0 109.803 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 10.4 tp10 -71.93 -34.14 68.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.392 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.4 t -61.89 -51.05 69.77 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.14 0.576 . . . . 0.0 109.927 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.61 -33.67 76.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.388 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.538 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 59.5 tttp -67.6 -49.73 61.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.998 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -90.21 20.36 4.43 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.6 m120 59.71 34.43 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.35 4.12 71.4 Favored Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.895 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -56.98 -50.06 73.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.551 0.691 . . . . 0.0 111.374 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.59 116.67 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.004 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -137.08 177.76 7.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.67 113.96 2.27 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.975 0.807 . . . . 0.0 113.171 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.92 -58.16 2.33 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -151.6 159.04 44.24 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.88 150.23 30.68 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.33 164.77 40.51 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.405 ' HA ' HG23 ' A' ' 59' ' ' THR . 16.5 m -62.25 151.53 36.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.085 -0.484 . . . . 0.0 110.616 -177.491 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 35.2 t -98.42 0.58 45.59 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -49.32 61.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.765 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 pt -68.66 -15.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.489 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.734 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 77.6 m-85 -98.33 -14.66 20.08 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.997 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 68.9 mttm -65.51 -14.72 61.64 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.664 0.745 . . . . 0.0 109.759 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.59 -32.45 71.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.441 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 43' ' ' ILE . 49.8 m-85 -100.58 157.44 33.73 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.005 -173.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.54 142.81 79.54 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.183 1.922 . . . . 0.0 110.191 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.44 -27.08 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.559 0.744 . . . . 0.0 112.935 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -86.31 -26.55 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.061 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.87 97.23 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.167 -0.333 . . . . 0.0 111.219 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.432 HG22 ' SG ' ' A' ' 64' ' ' CYS . 48.5 mt -124.35 108.78 29.26 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.322 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.24 135.11 59.82 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.759 2.306 . . . . 0.0 110.468 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.6 m -124.35 152.65 68.34 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.501 -174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.56 153.2 62.93 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.153 1.902 . . . . 0.0 110.815 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 pt -80.13 -9.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.188 0.518 . . . . 0.0 111.815 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.2 m -81.13 127.43 32.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.68 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -86.21 129.04 34.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 67.9 mt -133.65 100.19 13.72 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.2 119.71 7.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.38 1.386 . . . . 0.0 110.526 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.12 149.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.8 t -114.94 129.98 56.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.029 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 165.13 30.39 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.615 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -54.99 -24.11 22.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.675 1.19 . . . . 0.0 111.641 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.77 7.21 35.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.847 0.832 . . . . 0.0 110.803 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 66.36 24.99 10.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.628 1.171 . . . . 0.0 112.848 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.31 131.46 50.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 m -85.67 128.83 34.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.145 0.498 . . . . 0.0 110.046 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.2 m-85 -110.47 154.93 22.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.309 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.58 -26.96 73.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.2 p30 -178.56 -179.2 0.64 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 117.146 0.473 . . . . 0.0 110.444 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.83 -48.08 20.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.758 1.623 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 43' ' ' ILE . 43.6 t -61.55 -52.85 62.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.782 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -63.97 -33.82 76.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.452 . . . . 0.0 111.174 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.11 -45.8 79.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.914 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.8 t -64.64 -38.94 92.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.353 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.6 m -57.38 -48.33 79.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.5 tp10 -70.85 -33.89 71.11 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 t -61.82 -40.62 95.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.13 -40.64 62.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.218 0.324 . . . . 0.0 110.46 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -54.29 -60.2 3.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.406 0.682 . . . . 0.0 111.169 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 m -78.04 -20.88 51.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.351 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.22 84.33 0.12 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 125.438 1.495 . . . . 0.0 113.039 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.19 -29.26 5.68 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.622 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -57.03 -44.69 83.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.714 0.806 . . . . 0.0 111.717 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.682 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -132.69 -178.69 5.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -68.69 113.29 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -89.67 -55.44 3.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -159.8 163.07 34.84 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.8 162.64 19.5 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.48 169.48 45.95 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -66.34 148.78 51.36 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.2 m . . . . . 0 C--N 1.307 -1.255 0 O-C-N 123.347 0.405 . . . . 0.0 110.624 -177.832 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.509 -0.609 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 50.7 t -108.32 -9.66 15.44 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -60.57 -40.82 93.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.752 1.221 . . . . 0.0 111.668 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -70.14 -21.54 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.8 m-85 -94.08 -20.91 19.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 97.6 mttt -66.69 -14.9 63.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.726 0.774 . . . . 0.0 110.217 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -75.25 -2.34 27.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.648 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -118.0 156.95 49.71 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.16 144.04 85.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.771 1.647 . . . . 0.0 110.659 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.89 -33.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.719 0.808 . . . . 0.0 112.337 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.25 -25.46 9.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.5 93.81 3.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.186 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.56 119.74 25.95 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.91 134.25 21.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.167 1.245 . . . . 0.0 110.947 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.4 m -117.27 148.29 42.25 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.69 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.19 164.26 35.63 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.459 2.106 . . . . 0.0 111.201 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -89.47 -0.34 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.777 0.798 . . . . 0.0 110.145 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 128.64 36.22 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.294 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 61' ' ' GLY . 70.7 t80 -96.08 104.39 16.34 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.7 mt -116.86 98.01 51.33 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.14 125.2 16.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.382 1.388 . . . . 0.0 110.94 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.38 150.88 31.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.2 t -117.57 130.49 56.43 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.74 164.9 25.49 Favored Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.656 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -55.18 -23.77 23.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.642 1.177 . . . . 0.0 111.9 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.01 8.56 20.1 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.267 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 64.4 31.16 12.86 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 125.197 1.399 . . . . 0.0 111.337 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.4 131.2 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.167 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -85.06 133.5 34.23 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.1 m-85 -112.58 151.15 30.39 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 49' ' ' TYR . . . -71.34 -12.29 72.57 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 124.153 0.908 . . . . 0.0 114.303 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -179.35 172.6 1.18 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 124.329 1.052 . . . . 0.0 109.298 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -28.33 67.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 123.761 0.663 . . . . 0.0 112.765 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.05 -50.58 73.52 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.71 -34.51 78.49 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 111.128 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.94 -46.08 83.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.751 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -61.22 -46.17 91.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m -56.35 -47.41 78.88 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.86 0.362 . . . . 0.0 110.146 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.4 tp10 -68.04 -37.15 81.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.866 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 t -63.63 -43.74 95.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.521 0.729 . . . . 0.0 110.208 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HE2' ' A' ' 36' ' ' LYS . 88.2 mt -70.61 -43.77 68.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.841 178.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 86.0 tttt -55.3 -44.14 75.48 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -94.14 3.43 55.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.049 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 t30 46.27 74.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.961 1.704 . . . . 0.0 113.85 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.15 -3.07 59.24 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 115.113 0.805 . . . . 0.0 115.113 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -60.87 -57.17 13.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.372 0.606 . . . . 0.0 110.609 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.16 124.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -125.68 -178.85 4.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -70.92 121.76 18.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.15 -53.15 3.58 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -161.95 157.99 24.57 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -83.58 164.15 19.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.43 168.72 42.67 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -64.15 151.76 42.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.057 -178.529 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 CA--C 1.487 -1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.2 t -98.96 -5.93 29.68 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -68.46 -39.98 81.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.328 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.11 -16.28 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.518 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.9 m-85 -103.46 -10.99 18.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 98.4 mttt -64.1 -14.79 57.23 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -70.51 -19.6 62.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.864 0.364 . . . . 0.0 111.425 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 90.8 m-85 -95.58 168.69 10.42 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 6.7 Cg_endo -54.44 160.46 6.86 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.771 2.314 . . . . 0.0 112.069 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.1 -41.82 79.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.29 -13.41 8.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.456 -0.898 . . . . 0.0 113.058 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -124.23 94.06 4.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.484 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 35' ' ' TYR . 60.9 mt -122.12 130.35 24.75 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.38 134.84 29.81 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.596 1.531 . . . . 0.0 110.43 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.62 155.44 48.82 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.86 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.84 156.93 40.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.374 2.049 . . . . 0.0 111.111 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.47 15.03 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.534 0.683 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -99.76 131.05 45.99 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 51.8 t80 -89.21 122.3 32.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 93.7 mt -133.26 97.75 16.07 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.25 119.87 7.31 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.703 1.602 . . . . 0.0 111.824 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.92 156.07 38.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.3 t -119.63 125.7 49.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.25 160.6 29.57 Favored Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 m -63.72 -9.53 14.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.121 0.968 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.96 8.2 40.85 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 60.3 44.08 12.87 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 111.599 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -124.4 131.87 72.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 m -84.75 133.61 34.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.68 150.85 32.65 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -61.33 -27.56 67.87 Favored Glycine 0 C--O 1.221 -0.679 0 O-C-N 124.284 0.99 . . . . 0.0 113.569 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.6 p30 -170.99 172.1 5.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 123.487 0.715 . . . . 0.0 109.092 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -28.13 68.28 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.68 -42.26 96.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.737 0.304 . . . . 0.0 110.262 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 110.142 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.74 -42.26 97.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.831 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 41.5 t -60.1 -47.86 84.13 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.83 0.452 . . . . 0.0 111.265 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.424 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 21.7 p -57.36 -46.43 83.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.861 0.362 . . . . 0.0 111.7 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.28 -34.58 70.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.231 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -61.59 -48.24 81.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.74 -43.14 76.5 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.937 0.399 . . . . 0.0 110.596 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -46.85 77.82 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.191 0.996 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 m -92.91 15.83 13.96 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.415 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m120 55.54 30.61 15.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.17 3.38 51.23 Favored Glycine 0 C--N 1.316 -0.53 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.688 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -57.2 -45.0 84.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.344 0.658 . . . . 0.0 110.324 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.22 133.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.215 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -123.36 -179.78 4.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -83.01 110.78 18.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 tp -83.89 -61.34 1.85 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -154.73 161.77 41.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.36 153.92 40.28 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.97 169.55 45.43 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.07 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -63.0 152.65 36.23 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.812 0.445 . . . . 0.0 109.901 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.381 -0.343 . . . . 0.0 110.91 -178.762 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.428 -1.539 0 CA-C-O 122.343 1.068 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 33.1 t -89.38 -12.31 40.73 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.525 -1.67 . . . . 0.0 108.423 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -51.52 -46.55 63.33 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.34 1.056 . . . . 0.0 112.27 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.2 pt -73.85 -15.48 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.678 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 94.3 m-85 -96.56 -18.36 19.84 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 110.102 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 60.0 mtpt -66.78 -14.59 62.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.453 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -76.39 -19.25 58.32 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.535 0.683 . . . . 0.0 109.394 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 24.1 m-85 -93.96 145.15 29.3 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 42' ' ' ALA . 37.3 Cg_endo -65.59 153.79 76.63 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.089 1.859 . . . . 0.0 111.214 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.27 -25.62 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.128 0.571 . . . . 0.0 112.18 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.52 -25.38 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 O-C-N 121.97 -0.456 . . . . 0.0 111.823 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 39' ' ' PRO . . . -126.21 94.02 3.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.68 108.3 28.71 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.31 134.32 26.57 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 121.951 1.767 . . . . 0.0 111.43 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.9 m -107.53 146.51 33.47 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.915 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.02 153.85 55.01 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.684 2.256 . . . . 0.0 110.882 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.9 pt -75.13 -24.66 17.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.041 0.448 . . . . 0.0 111.8 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 m -77.01 144.15 38.88 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -96.32 128.4 43.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 mp -134.24 104.37 11.38 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.72 120.16 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.438 1.425 . . . . 0.0 110.495 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.58 152.0 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.58 130.24 55.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.06 0.457 . . . . 0.0 110.846 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.94 163.81 28.35 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 p -63.43 -15.23 57.04 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.672 0.789 . . . . 0.0 112.328 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.78 4.71 39.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.607 0.717 . . . . 0.0 109.906 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.19 43.53 6.29 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.721 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.97 129.11 75.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.7 m -85.37 135.56 33.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -115.78 156.43 26.04 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.49 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.81 -22.57 78.23 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.595 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -178.27 174.25 1.33 Allowed 'General case' 0 C--O 1.256 1.423 0 C-N-CA 122.915 0.486 . . . . 0.0 110.369 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -51.62 -35.97 43.98 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.115 1.366 . . . . 0.0 113.547 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.27 -44.08 92.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.48 0.181 . . . . 0.0 111.201 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -68.41 -38.3 81.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.93 -48.85 74.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.1 t -60.01 -38.55 82.97 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.215 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.8 m -57.54 -52.86 63.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.79 -34.34 77.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.646 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -60.68 -46.78 89.05 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 36' ' ' LYS . 84.7 mt -73.48 -41.16 63.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.7 0.286 . . . . 0.0 110.715 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -63.57 -32.01 73.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -102.68 7.45 39.79 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.792 0.329 . . . . 0.0 111.001 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t30 46.52 75.2 0.12 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.273 1.429 . . . . 0.0 113.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.93 -5.1 26.82 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.579 0.991 . . . . 0.0 115.579 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -57.07 -60.48 3.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.791 0.805 . . . . 0.0 110.128 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.21 121.18 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -123.83 171.43 9.66 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.14 116.05 10.06 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -88.21 -56.24 3.41 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -161.73 161.7 29.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -82.25 165.64 20.25 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.12 165.09 40.89 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 m -66.55 143.65 56.92 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.311 -1.073 0 C-N-CA 123.103 0.561 . . . . 0.0 112.463 -176.092 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -97.76 113.48 25.27 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.7 147.16 19.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.7 46.75 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -109.17 105.22 14.58 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.91 106.67 3.26 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 m -121.67 86.58 45.19 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -88.97 91.74 0.38 Allowed 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.684 2.256 . . . . 0.0 110.13 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -102.14 143.33 32.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.269 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -136.81 113.52 10.28 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.21 169.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.48 103.57 5.66 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.01 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -104.28 -9.93 18.21 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -61.76 -43.79 98.16 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.73 0.812 . . . . 0.0 111.928 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.1 pt -65.23 -24.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.806 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 75.9 m-85 -94.13 -22.98 18.13 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 121.815 0.817 . . . . 0.0 109.284 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -69.29 -15.04 63.26 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 125.284 1.434 . . . . 0.0 109.431 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.72 -16.31 60.75 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.357 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -105.28 159.32 29.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.07 139.25 72.03 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.045 1.83 . . . . 0.0 109.784 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.84 -30.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.59 -26.12 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.96 93.26 3.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.786 -0.571 . . . . 0.0 110.908 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.72 113.2 28.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 134.36 31.56 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.287 1.992 . . . . 0.0 111.278 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.8 m -116.99 148.11 41.53 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.302 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.55 158.32 58.17 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.069 1.846 . . . . 0.0 111.283 175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.21 11.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.724 0.773 . . . . 0.0 112.052 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.7 m -94.13 136.42 34.44 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.749 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -105.62 116.31 31.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 96.1 mt -133.47 102.81 12.62 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.35 125.97 18.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.788 1.658 . . . . 0.0 110.949 -176.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.06 153.48 36.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.9 t -119.07 128.98 54.84 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 121.036 0.446 . . . . 0.0 110.67 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.22 164.48 30.91 Favored Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.613 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 p -66.26 -14.75 62.45 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.914 0.886 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.24 0.27 52.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.952 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 69.19 31.12 4.09 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.067 1.347 . . . . 0.0 111.711 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.24 128.4 66.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.4 m -84.13 133.31 34.63 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.09 156.57 26.16 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.789 0.435 . . . . 0.0 110.501 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.7 75.74 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 124.193 0.933 . . . . 0.0 114.117 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.8 p30 -171.83 175.7 3.83 Favored 'General case' 0 C--O 1.258 1.532 0 C-N-CA 123.186 0.595 . . . . 0.0 109.61 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.62 76.26 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.2 -48.94 79.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.707 0.289 . . . . 0.0 110.51 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.93 -36.94 83.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.101 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -61.18 -47.39 86.4 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 123.595 0.559 . . . . 0.0 109.555 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -59.91 -41.61 92.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.968 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.3 m -57.2 -48.37 78.95 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 120.92 0.391 . . . . 0.0 110.35 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -34.4 70.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.772 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 t -62.27 -42.69 99.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.75 -40.6 63.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.23 -46.11 90.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.446 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -93.59 6.08 49.45 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.027 0.441 . . . . 0.0 111.104 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 48.38 71.91 0.32 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 114.872 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.94 65.14 Favored Glycine 0 C--N 1.312 -0.766 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -56.8 -50.48 72.2 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.7 104.58 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.855 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -106.15 -178.65 3.71 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -81.49 128.45 33.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -103.51 -57.31 2.06 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -159.41 161.66 35.62 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.43 157.81 24.81 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 168.55 44.68 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 m -60.92 144.93 52.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.791 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.44 -0.928 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.93 -39.81 29.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.44 -57.21 0.07 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -155.74 97.84 1.87 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.603 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -94.16 -39.86 10.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp 67.06 157.74 0.12 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 125.231 1.413 . . . . 0.0 113.075 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 t -91.11 111.34 47.99 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -78.85 103.12 1.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 121.619 1.546 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.75 96.24 8.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.981 0.896 . . . . 0.0 109.88 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -144.54 167.74 21.8 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 63' ' ' GLU . 6.3 p -65.62 151.15 10.28 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.35 109.18 19.36 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.022 0.915 . . . . 0.0 110.897 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.8 t -102.57 -1.56 30.15 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.929 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -63.41 -44.21 95.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.932 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 pt -72.03 -25.05 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 88.0 m-85 -84.44 -11.75 55.63 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.947 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 29.2 mtpp -69.28 -14.68 63.08 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.817 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -76.62 -2.99 35.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.686 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -115.03 153.95 47.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 130.58 34.76 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.203 1.935 . . . . 0.0 110.105 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.14 -33.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.86 -26.67 11.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.326 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.72 93.92 3.82 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.132 -0.355 . . . . 0.0 111.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 68' ' ' THR . 50.7 mt -112.18 117.93 46.85 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.38 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.47 135.55 29.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.647 2.231 . . . . 0.0 111.059 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.78 149.31 53.04 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.244 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.7 162.78 39.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.367 2.045 . . . . 0.0 110.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 pt -83.56 -12.39 11.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.799 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -61.5 126.27 26.76 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -100.21 111.22 23.49 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -121.25 101.0 44.71 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.62 118.34 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.205 1.27 . . . . 0.0 110.935 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.58 143.9 39.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.9 t -107.99 127.14 53.5 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.224 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.31 160.41 28.11 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -56.17 -23.66 36.46 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.964 0.906 . . . . 0.0 112.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -88.38 11.3 17.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.661 0.743 . . . . 0.0 110.372 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 63.63 29.11 15.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.902 1.281 . . . . 0.0 112.654 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mm -103.14 126.13 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.4 m -83.26 124.44 30.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -103.23 144.53 31.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.43 -19.33 68.6 Favored Glycine 0 C--O 1.222 -0.638 0 O-C-N 124.117 0.886 . . . . 0.0 113.676 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 30.7 p30 -170.94 173.5 5.12 Favored 'General case' 0 C--O 1.256 1.423 0 C-N-CA 123.635 0.774 . . . . 0.0 109.095 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.5 -27.41 64.18 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.347 0.404 . . . . 0.0 110.923 -174.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 44.4 t -54.26 -52.66 60.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.596 0.56 . . . . 0.0 110.199 175.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -63.82 -36.72 84.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.043 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -63.39 -49.64 73.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.03 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 43.0 t -59.2 -38.71 80.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.355 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 43' ' ' ILE . 26.7 m -56.92 -50.06 73.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 110.343 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -71.92 -36.99 70.13 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.2 m -58.04 -43.9 87.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.968 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.86 -42.24 61.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.142 0.496 . . . . 0.0 110.398 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.89 -46.04 85.5 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.321 1.048 . . . . 0.0 111.837 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.1 m -99.66 14.6 29.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 43.92 76.34 0.08 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 114.028 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 78' ' ' GLN . . . 70.94 15.62 74.17 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 115.073 -0.967 . . . . 0.0 114.051 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -72.29 -62.23 1.51 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.73 131.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.443 ' NE2' ' HA2' ' A' ' 75' ' ' GLY . 25.2 mm-40 -129.28 173.17 10.76 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -67.54 112.14 4.53 Favored 'General case' 0 C--N 1.284 -2.255 0 O-C-N 123.941 0.776 . . . . 0.0 109.206 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 tp -86.29 -56.34 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -161.07 162.23 31.56 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.208 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.08 146.96 45.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.79 168.58 38.12 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.75 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -64.45 149.76 47.86 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 122.706 0.402 . . . . 0.0 110.346 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.179 178.765 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.243 0.752 0 CA-C-O 121.127 0.489 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -76.27 166.96 22.7 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.873 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 75.62 -29.19 0.18 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.201 1.4 . . . . 0.0 111.95 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.87 126.06 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 113.22 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.2 m -145.63 32.28 1.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.32 -21.61 45.66 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.255 1.026 . . . . 0.0 108.455 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 m -132.65 148.19 68.55 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.01 86.05 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 121.64 1.56 . . . . 0.0 109.111 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -62.36 135.57 57.51 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.58 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD3' ' HB3' ' A' ' 79' ' ' PHE . 5.0 tppt? -143.31 157.12 44.74 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.99 144.22 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.5 97.41 7.12 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.4 t -93.69 -17.97 22.64 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 p -61.54 -27.75 68.83 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -77.99 -22.29 13.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 O-C-N 121.987 -0.446 . . . . 0.0 112.034 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 99.1 m-85 -98.9 -19.55 17.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.761 0.791 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.97 -14.93 63.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.39 1.076 . . . . 0.0 110.767 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -83.38 -4.04 58.1 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -100.88 156.88 34.64 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.92 135.29 68.94 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.608 2.205 . . . . 0.0 111.264 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.75 -24.47 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.51 -24.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.851 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.15 93.51 3.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.409 0.623 . . . . 0.0 111.045 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.97 115.83 31.64 Favored Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.28 133.61 31.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.484 1.456 . . . . 0.0 111.102 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.7 m -114.2 141.26 26.1 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.514 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.7 159.19 49.61 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.338 2.025 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 pt -83.57 -13.56 11.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.944 0.402 . . . . 0.0 110.805 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -70.27 132.41 45.67 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.45 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 52.8 t80 -96.88 112.83 24.41 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -124.05 98.36 39.27 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.19 126.86 22.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.867 1.711 . . . . 0.0 111.42 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.73 148.72 33.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -117.31 131.01 56.89 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 120.887 0.375 . . . . 0.0 110.329 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 168.36 26.41 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 p -70.91 -8.39 52.57 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.991 0.9 . . . . 0.0 110.745 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.31 -3.61 59.02 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 67.22 27.36 8.43 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.912 1.685 . . . . 0.0 112.725 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.77 133.32 48.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 m -88.24 129.1 35.45 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -107.79 146.99 31.44 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.376 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -62.66 -28.14 71.01 Favored Glycine 0 CA--C 1.499 -0.964 0 O-C-N 124.57 1.169 . . . . 0.0 112.617 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.3 p30 -172.17 170.03 5.31 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 123.145 0.578 . . . . 0.0 109.898 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.12 -29.07 60.17 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.4 t -62.36 -44.36 96.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -70.31 -37.84 74.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.7 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.11 -48.91 78.08 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.633 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.6 t -62.86 -41.51 99.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.652 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.9 m -60.39 -49.69 76.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 109.798 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.3 -37.45 87.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.035 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -65.68 -58.18 6.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.1 -45.65 86.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.132 0.573 . . . . 0.0 111.39 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 33.8 ttpt -57.43 -33.65 68.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.098 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.6 m -105.18 17.77 23.48 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.853 -174.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 63.56 22.8 13.34 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 123.392 0.677 . . . . 0.0 112.658 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.86 28.94 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.753 -0.736 . . . . 0.0 113.067 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -57.15 -50.96 71.19 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.214 1.007 . . . . 0.0 108.43 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.59 133.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -117.29 160.85 20.45 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.463 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 66.2 t80 -68.48 121.49 16.46 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.38 -60.14 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -158.89 156.84 30.31 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -82.72 166.71 18.86 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.03 168.79 42.1 Favored Glycine 0 C--N 1.273 -2.942 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -67.73 146.09 54.11 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.782 -178.851 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.74 96.74 7.52 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.03 -172.64 2.87 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 71.7 -66.66 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.566 1.546 . . . . 0.0 112.876 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 p -78.29 -162.66 0.37 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 122.904 0.481 . . . . 0.0 109.939 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.41 77.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.937 0.875 . . . . 0.0 108.748 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.5 m -160.61 83.87 2.01 Favored Pre-proline 0 C--N 1.301 -1.51 0 C-N-CA 125.783 1.633 . . . . 0.0 108.239 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -89.33 78.56 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.451 2.1 . . . . 0.0 108.696 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.74 139.41 53.33 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 121.81 0.814 . . . . 0.0 112.306 -173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.11 176.46 8.64 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 63' ' ' GLU . 5.5 p -66.72 130.94 32.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.37 96.36 9.53 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 117.299 -1.761 . . . . 0.0 107.479 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -88.07 -12.47 44.13 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.202 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 m -61.52 -39.66 91.81 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.33 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 pt -67.91 -17.69 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.655 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.0 m-85 -99.07 -5.47 30.21 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -58.82 -21.81 57.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.813 0.445 . . . . 0.0 111.976 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -79.24 4.76 14.03 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -118.93 152.03 51.14 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.37 133.06 46.98 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 121.726 1.617 . . . . 0.0 109.684 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 71' ' ' LEU . 15.1 m -57.62 -24.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -171.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.11 -25.33 5.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.004 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.46 93.87 3.98 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.883 0.373 . . . . 0.0 110.808 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 68' ' ' THR . 56.0 mt -119.42 117.25 33.13 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.95 133.48 31.34 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.527 1.485 . . . . 0.0 109.725 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.9 m -116.87 150.01 45.08 Favored Pre-proline 0 C--N 1.29 -2.006 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.905 -175.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.18 162.81 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.506 2.138 . . . . 0.0 111.142 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.07 -7.29 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.264 0.554 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -64.68 115.2 5.01 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.585 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -90.21 120.15 31.13 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 88.2 mt -133.72 99.06 14.31 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -62.24 119.92 7.25 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 121.49 1.46 . . . . 0.0 110.954 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.96 152.19 37.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.5 t -114.31 126.21 54.76 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.64 29.15 Favored Glycine 0 N--CA 1.421 -2.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.701 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -51.21 -25.71 5.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.848 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.15 8.32 27.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 69.7 29.92 4.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mm -107.22 124.44 63.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.533 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.5 m -81.47 125.7 30.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.18 155.49 19.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.96 79.16 Favored Glycine 0 N--CA 1.448 -0.533 0 O-C-N 123.868 0.73 . . . . 0.0 113.586 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.8 p30 -171.81 172.68 4.77 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 123.163 0.585 . . . . 0.0 109.764 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.639 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.52 -33.88 76.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.881 0.738 . . . . 0.0 112.945 -177.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 40.7 t -56.25 -50.96 69.83 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.68 0.392 . . . . 0.0 110.47 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -64.45 -36.03 82.84 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.707 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.8 -45.79 92.33 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.845 0.716 . . . . 0.0 109.484 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.7 t -61.36 -41.47 97.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.397 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.441 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 m -56.72 -53.09 61.8 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.27 77.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 t -58.53 -43.5 89.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 122.934 0.494 . . . . 0.0 110.402 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD13 HG12 ' A' ' 40' ' ' VAL . 86.2 mt -72.41 -39.12 68.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.438 . . . . 0.0 110.784 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -65.32 -39.72 92.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.022 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -87.3 -0.55 56.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.738 0.304 . . . . 0.0 110.832 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 57.73 68.12 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.239 1.416 . . . . 0.0 111.834 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.02 11.96 61.86 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.293 -0.867 . . . . 0.0 114.03 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -80.06 -50.18 10.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.75 117.11 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -125.7 -178.32 4.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' HB2' HG12 ' A' ' 30' ' ' VAL . 57.8 t80 -68.87 114.17 6.96 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.15 -54.64 4.02 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -159.95 159.5 32.33 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.335 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.28 157.52 30.72 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 165.86 41.33 Favored Glycine 0 C--N 1.293 -1.84 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 151.44 46.35 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.259 1.565 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.02 -76.86 0.52 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.52 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.58 -174.07 3.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.9 -154.71 0.33 Allowed 'General case' 0 C--O 1.251 1.167 0 O-C-N 123.839 0.712 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -127.66 111.32 13.59 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.65 83.3 6.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.662 0.744 . . . . 0.0 109.748 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -78.16 138.8 60.4 Favored Pre-proline 0 N--CA 1.423 -1.797 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.402 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.33 95.33 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.879 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 62.4 tttp -61.39 108.13 0.89 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -96.91 144.16 27.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.643 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.73 159.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.77 116.54 15.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.767 0.794 . . . . 0.0 111.122 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.78 -2.44 17.33 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -64.62 -41.12 96.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.45 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 pt -68.08 -22.33 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.682 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.5 m-85 -93.12 -8.37 42.83 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.333 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.54 -15.3 60.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.324 0.583 . . . . 0.0 110.31 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -81.93 -2.19 50.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.061 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -123.18 151.19 61.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.19 145.41 78.41 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 121.92 1.747 . . . . 0.0 109.731 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.86 -38.63 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.59 -26.49 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.851 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.17 92.09 3.51 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.114 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.2 mt -122.29 113.81 30.79 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.18 132.52 34.35 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 120.631 0.888 . . . . 0.0 110.091 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.2 m -126.2 144.39 48.91 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.35 162.96 39.76 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.795 1.663 . . . . 0.0 111.196 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 pt -85.96 -1.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.658 0.742 . . . . 0.0 109.724 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -64.17 128.25 34.97 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.987 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -103.08 108.91 20.27 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.1 mt -123.91 97.45 41.1 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.15 118.59 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.694 1.596 . . . . 0.0 111.404 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.27 150.42 33.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.49 126.84 55.4 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.142 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.42 164.82 29.6 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 p -67.9 -4.58 13.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.393 0.616 . . . . 0.0 112.201 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.87 0.63 56.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 70.35 23.44 5.0 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.257 1.423 . . . . 0.0 111.111 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.9 mm -101.82 132.48 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -86.9 120.13 27.85 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.23 152.49 18.8 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.781 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.73 -18.71 77.56 Favored Glycine 0 N--CA 1.441 -0.972 0 O-C-N 124.116 0.885 . . . . 0.0 113.169 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.2 p30 -175.87 173.76 2.26 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 123.565 0.746 . . . . 0.0 109.935 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.48 -33.74 76.58 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.992 0.917 . . . . 0.0 110.673 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -45.98 90.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -65.8 -35.54 81.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.988 0.423 . . . . 0.0 110.614 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.46 -46.62 82.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.186 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 35.8 t -61.33 -40.81 95.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.1 m -57.69 -51.16 70.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.781 0.324 . . . . 0.0 110.197 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.6 -35.96 82.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.522 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t -65.66 -49.7 67.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.519 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.46 -37.97 89.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.265 0.555 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.59 -28.83 68.79 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.42 1.088 . . . . 0.0 110.906 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.0 p -110.45 16.31 21.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.695 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 60.92 24.87 14.88 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.162 0.982 . . . . 0.0 111.639 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.97 31.5 9.84 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.796 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -76.39 -56.78 4.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.99 129.99 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.625 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.26 -179.79 4.17 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 74.2 t80 -79.68 126.23 30.65 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.59 -52.66 3.85 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -164.52 159.62 19.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.1 153.44 40.79 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.43 172.7 46.93 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.624 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -64.19 146.93 53.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.316 -0.865 0 O-C-N 123.845 0.716 . . . . 0.0 112.235 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.011 0.434 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.33 160.69 32.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.362 -170.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.27 79.1 1.2 Allowed 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.42 -28.74 1.84 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.041 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -79.73 -12.45 59.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -127.84 150.13 49.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 m -62.9 120.34 59.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.46 145.87 66.33 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.453 2.102 . . . . 0.0 111.963 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.6 128.79 36.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 18.9 ptpt -141.96 170.85 14.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.569 0.699 . . . . 0.0 112.201 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.422 ' HB ' ' CD1' ' A' ' 79' ' ' PHE . 11.3 p -81.56 151.96 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.75 94.34 5.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -89.45 -11.18 43.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.489 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -60.91 -40.28 92.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.725 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 45.8 pt -72.95 -21.1 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.764 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 98.7 m-85 -87.75 -12.47 45.09 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.195 0.522 . . . . 0.0 110.736 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -70.49 -14.76 62.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 23.4 pttm -78.11 -3.59 43.14 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.675 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.66 157.59 34.25 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.2 131.11 43.09 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.274 1.983 . . . . 0.0 110.165 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.53 -24.36 15.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.14 -25.19 5.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.114 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.86 93.79 3.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.882 0.373 . . . . 0.0 110.647 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.3 124.49 28.55 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.03 134.07 44.34 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 121.665 1.577 . . . . 0.0 110.554 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.4 m -107.66 140.62 21.74 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.07 163.36 39.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.078 1.852 . . . . 0.0 110.418 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -82.74 -14.54 11.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -64.87 119.41 10.61 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.528 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.3 mt -135.36 96.46 13.87 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -58.4 119.67 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.126 1.884 . . . . 0.0 110.489 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.86 128.61 56.47 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.5 165.95 35.83 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.617 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -57.14 -18.97 17.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.866 1.266 . . . . 0.0 112.117 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.59 6.28 47.86 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.101 0.953 . . . . 0.0 109.841 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.7 OUTLIER 61.1 47.04 7.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 110.847 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.6 mm -120.53 131.91 71.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.2 m -85.14 131.52 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -112.37 153.55 27.1 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.276 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.36 73.87 Favored Glycine 0 N--CA 1.444 -0.828 0 O-C-N 124.014 0.821 . . . . 0.0 113.862 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 34.6 p30 -176.71 -178.67 0.9 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 116.936 0.368 . . . . 0.0 111.344 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 29.4 mt-10 -45.74 -51.21 12.92 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 126.47 1.908 . . . . 0.0 111.574 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.5 t -55.51 -53.73 52.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.895 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -63.38 -37.93 89.19 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.096 0.474 . . . . 0.0 111.001 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 tp -67.03 -48.76 67.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.295 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 52.4 t -60.52 -44.46 96.02 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.948 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.9 m -58.65 -50.27 74.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.745 0.307 . . . . 0.0 110.869 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.19 -34.16 75.77 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.1 t -63.31 -48.13 79.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.293 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.06 -37.55 81.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.139 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.55 -34.94 79.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.024 0.44 . . . . 0.0 111.498 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -93.79 1.31 56.5 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.128 0.49 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 60.12 25.44 14.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.76 1.224 . . . . 0.0 112.54 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.95 22.69 7.82 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.198 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -72.49 -53.41 12.16 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.96 129.0 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -134.86 -178.72 5.21 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 29' ' ' LYS . 65.7 t80 -65.95 119.08 10.71 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -93.31 -60.41 1.79 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -156.84 153.92 29.02 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.48 165.0 24.92 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.05 168.29 40.45 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 147.59 51.84 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 60.0 m . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.701 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.91 85.91 5.72 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.447 0.642 . . . . 0.0 111.181 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.43 85.9 0.73 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.52 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.05 -80.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -88.39 13.64 11.34 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.3 mt 71.37 -69.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.973 0.909 . . . . 0.0 109.011 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.4 m -95.35 134.43 24.45 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -71.67 78.35 1.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.432 1.421 . . . . 0.0 111.393 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -133.47 105.92 7.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.284 1.04 . . . . 0.0 112.839 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 96.9 mttt -151.14 168.98 23.0 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 169.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.42 125.39 26.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.07 105.5 8.19 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.26 -6.58 56.68 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.539 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 55.4 m -67.4 -36.93 82.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.054 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.57 -16.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.666 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 76.6 m-85 -109.85 -13.68 14.42 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.397 0.618 . . . . 0.0 109.995 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -71.09 -14.99 62.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.288 1.042 . . . . 0.0 108.329 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 33' ' ' SER . 55.1 mtpt -72.62 -15.21 61.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.16 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.45 152.52 42.77 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.74 133.86 44.21 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.437 1.425 . . . . 0.0 108.687 172.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.16 -25.52 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.46 -26.16 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.777 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.59 93.52 3.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.241 -0.287 . . . . 0.0 111.371 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.58 124.55 26.2 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -77.18 134.89 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.403 1.402 . . . . 0.0 110.484 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -125.81 145.8 53.0 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.83 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.71 152.92 53.02 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.421 2.747 . . . . 0.0 112.336 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 pt -83.85 -17.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -68.76 134.23 49.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.249 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -90.95 110.73 21.98 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.0 mt -124.43 97.53 39.53 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.3 119.18 6.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.047 1.832 . . . . 0.0 111.5 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.43 151.83 29.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.84 128.56 56.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.81 163.28 23.47 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.441 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -57.2 -18.76 17.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.145 0.978 . . . . 0.0 112.349 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.52 3.5 43.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.414 0.626 . . . . 0.0 109.859 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 69.04 26.71 5.55 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.059 1.343 . . . . 0.0 111.723 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.37 134.33 49.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 84' ' ' SER . 67.1 m -86.13 127.27 34.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -105.97 156.08 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.989 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.53 -22.32 78.64 Favored Glycine 0 CA--C 1.501 -0.788 0 O-C-N 123.98 0.8 . . . . 0.0 112.996 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.4 p30 -173.0 169.86 4.58 Favored 'General case' 0 C--O 1.255 1.384 0 C-N-CA 123.684 0.793 . . . . 0.0 109.692 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.13 -27.02 65.19 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.286 -175.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.86 -44.3 97.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -64.7 -40.01 94.64 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.36 -46.75 87.77 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.362 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.3 t -59.77 -38.4 81.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -57.97 -48.6 79.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -67.47 -34.22 76.73 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.004 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 t -65.09 -39.41 93.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.602 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -72.34 -38.65 68.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.13 -43.33 91.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.79 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 58.3 p -92.61 -13.87 28.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.807 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 62.74 75.07 0.41 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 111.75 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.27 8.54 85.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.826 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 64.0 ttt180 -80.46 -62.1 1.78 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.643 0.722 . . . . 0.0 109.51 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.2 118.46 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -132.42 -179.64 5.56 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 29' ' ' LYS . 62.0 t80 -68.16 110.47 4.02 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -85.25 -55.69 3.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -159.17 159.81 34.78 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.495 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.96 152.1 38.81 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 168.0 43.63 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 59' ' ' THR . 25.4 m -57.64 147.5 27.2 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.19 0.596 . . . . 0.0 110.26 176.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.125 178.191 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 120.821 0.343 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.45 156.69 20.48 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 70.33 -61.71 0.45 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.459 1.104 . . . . 0.0 109.271 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.97 91.15 4.01 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 m -97.53 -14.27 21.17 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.85 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -164.51 151.8 11.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.402 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -116.52 86.64 18.73 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -87.44 103.88 0.55 Allowed 'Trans proline' 0 N--CA 1.43 -2.256 0 C-N-CA 122.196 1.931 . . . . 0.0 113.675 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -116.53 130.65 56.87 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -143.51 156.25 44.57 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 63' ' ' GLU . 5.4 p -68.38 106.63 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.429 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.14 93.62 5.22 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.64 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 26.9 t -93.19 -20.77 20.13 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -54.05 -35.2 61.75 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.645 1.178 . . . . 0.0 113.959 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.55 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.095 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 72.9 m-85 -89.28 -19.8 24.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.1 mtpt -60.48 -14.23 18.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.533 0.733 . . . . 0.0 112.343 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.74 -25.53 61.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -89.8 152.68 46.99 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.83 139.01 82.96 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.124 1.883 . . . . 0.0 110.058 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.1 m -59.2 -15.72 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.35 -25.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.783 0.325 . . . . 0.0 110.627 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.24 93.91 3.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 122.094 -0.379 . . . . 0.0 110.726 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 68' ' ' THR . 55.6 mt -124.53 107.97 29.2 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.11 134.36 33.8 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.23 1.953 . . . . 0.0 110.578 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.1 m -114.66 147.02 37.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.038 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -61.8 152.45 74.38 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.294 1.996 . . . . 0.0 110.093 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.59 -7.71 10.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -74.91 133.35 41.81 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -92.31 127.05 37.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.8 mp -131.85 99.17 16.94 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -61.25 118.42 5.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.761 1.641 . . . . 0.0 111.196 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.35 152.13 36.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -117.08 128.2 54.91 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.165 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.38 163.09 28.61 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 m -62.23 -13.99 33.63 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.84 0.856 . . . . 0.0 111.733 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.37 2.37 54.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.074 0.94 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 65.75 24.97 11.44 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.857 1.263 . . . . 0.0 113.401 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.68 130.72 50.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.7 m -86.57 132.71 33.83 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.87 151.46 29.09 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.217 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -24.91 72.64 Favored Glycine 0 C--O 1.218 -0.885 0 O-C-N 124.434 1.084 . . . . 0.0 113.054 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.8 p30 -173.74 173.55 3.3 Favored 'General case' 0 C--O 1.259 1.556 0 C-N-CA 124.061 0.944 . . . . 0.0 109.116 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.12 -26.63 68.28 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.52 0.512 . . . . 0.0 112.088 -174.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.45 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 38.6 t -56.5 -48.51 77.03 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.084 0.24 . . . . 0.0 110.803 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -67.57 -32.37 73.07 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.954 0.406 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.53 -46.01 74.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.097 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.0 t -59.2 -44.94 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.335 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.427 ' HA ' HD12 ' A' ' 43' ' ' ILE . 29.3 m -55.25 -48.23 74.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.099 0.476 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -71.49 -34.81 70.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -65.57 -33.53 76.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 36' ' ' LYS . 92.4 mt -74.47 -33.37 62.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.27 -50.98 50.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 0.0 110.724 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 p -81.48 -19.89 41.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.525 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.9 t30 63.43 78.91 0.27 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 111.933 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.2 90.29 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.123 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -73.28 -55.81 5.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.293 1.046 . . . . 0.0 109.354 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -94.54 111.79 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-O 121.69 0.757 . . . . 0.0 109.26 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -112.65 -179.61 3.71 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.44 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -77.78 118.37 20.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.43 -56.81 2.9 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -160.48 161.0 32.71 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.604 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.77 151.16 39.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 174.51 43.64 Favored Glycine 0 C--N 1.29 -1.974 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.327 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 m -69.54 152.32 44.94 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.77 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.36 75.22 10.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -170.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.74 -15.64 18.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.98 168.28 23.51 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.5 m 63.07 37.04 11.87 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.581 0.753 . . . . 0.0 111.029 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.42 138.86 45.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -136.47 153.74 76.38 Favored Pre-proline 0 C--N 1.284 -2.26 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.26 40.23 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 124.094 3.196 . . . . 0.0 115.801 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -86.83 106.09 17.48 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -162.97 154.98 18.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.45 148.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.62 108.97 5.94 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.732 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 45.7 t -93.85 -5.06 48.91 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.372 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 3.7 m -65.35 -39.85 92.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.427 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -59.05 -28.0 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.452 0.47 . . . . 0.0 111.848 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.619 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -91.22 -33.05 15.54 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.666 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 50.7 mtmt -62.18 -14.38 37.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 33' ' ' SER . 32.3 mmtp -76.42 -5.89 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.084 0.469 . . . . 0.0 111.142 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.32 156.7 40.74 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 135.49 70.47 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.824 1.683 . . . . 0.0 110.533 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.42 -29.42 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.995 0.918 . . . . 0.0 112.902 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.82 -26.11 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.981 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.02 93.85 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.743 -0.598 . . . . 0.0 111.332 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 68' ' ' THR . 45.2 mt -124.81 132.56 24.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.52 134.51 26.54 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.446 1.431 . . . . 0.0 110.643 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.8 m -116.93 146.43 37.84 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.148 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 64' ' ' CYS . 9.0 Cg_endo -59.12 146.64 93.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.103 1.869 . . . . 0.0 110.158 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.9 pt -80.78 -20.6 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -79.89 138.09 37.07 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.729 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -82.66 108.48 16.06 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 81.1 mt -118.67 98.82 51.34 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 120.34 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.285 1.99 . . . . 0.0 111.88 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.12 146.35 34.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.41 128.21 53.87 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.34 159.94 24.45 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 m -61.16 -14.29 23.91 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.652 0.781 . . . . 0.0 112.352 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.93 3.86 40.09 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.819 0.847 . . . . 0.0 109.68 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 65.95 36.5 5.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.217 1.407 . . . . 0.0 111.925 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.5 131.7 71.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.9 m -84.34 122.43 28.91 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -97.73 152.64 18.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.639 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.54 -15.17 72.89 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.0 0.812 . . . . 0.0 114.123 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 173.68 -179.63 0.09 Allowed 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.167 1.387 . . . . 0.0 108.715 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -26.71 62.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.408 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 44.4 t -63.41 -42.27 98.74 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.63 -30.69 68.47 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.153 0.502 . . . . 0.0 110.0 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.4 tp -69.47 -49.08 58.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 30.9 t -61.55 -46.24 90.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.058 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.461 HG22 HD12 ' A' ' 43' ' ' ILE . 17.6 p -59.85 -48.51 81.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 111.15 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.39 -36.67 84.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.101 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -61.87 -44.56 96.58 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.997 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 87.2 mt -69.62 -45.72 67.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.359 0.6 . . . . 0.0 110.209 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -46.81 81.77 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.612 1.165 . . . . 0.0 110.612 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 m -91.62 13.29 18.38 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 55.24 60.1 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.56 76.92 Favored Glycine 0 C--N 1.316 -0.559 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.994 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.93 -51.67 63.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.0 110.359 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.03 122.13 62.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.356 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -105.61 174.78 5.73 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 91.2 t80 -76.76 119.59 20.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.27 -53.78 4.09 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.067 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -163.3 166.46 23.04 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.236 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.06 149.88 39.04 Favored 'General case' 0 C--O 1.252 1.214 0 O-C-N 123.801 0.688 . . . . 0.0 109.183 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.37 173.95 50.08 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.677 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -65.65 152.24 44.65 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.698 0.399 . . . . 0.0 110.372 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.037 -179.803 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 120.912 0.386 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.36 -22.13 25.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.384 0.611 . . . . 0.0 110.155 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.27 129.9 54.24 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.12 35.72 0.8 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.501 0.667 . . . . 0.0 109.944 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.6 p -83.88 6.83 20.14 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.7 0.8 . . . . 0.0 111.806 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.08 84.99 7.26 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.516 0.674 . . . . 0.0 109.548 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -89.08 132.72 37.03 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.99 34.46 0.4 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 123.574 2.849 . . . . 0.0 113.481 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -102.22 138.02 39.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -133.82 175.82 9.11 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.45 134.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -89.66 94.6 9.91 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 34.6 t -92.68 -9.34 41.18 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.56 -33.18 72.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.6 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.28 -24.87 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.07 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 60.3 m-85 -92.05 -9.6 42.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 64.1 mttp -68.98 -14.75 63.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.545 0.688 . . . . 0.0 109.585 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -78.36 -11.05 59.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.534 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -109.98 153.14 43.3 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -64.45 146.72 89.99 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 121.593 1.529 . . . . 0.0 109.415 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.93 -31.66 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 111.383 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.07 -25.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.29 93.76 3.89 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.071 0.462 . . . . 0.0 111.325 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 64.6 mt -124.68 125.59 25.49 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 3.0 Cg_exo -76.59 133.61 14.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.559 1.506 . . . . 0.0 110.353 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.3 147.72 66.2 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 159.86 49.06 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 121.995 1.796 . . . . 0.0 112.113 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.69 -12.31 14.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.159 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -66.06 132.69 49.11 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.038 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -94.81 110.03 21.94 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 85.8 mt -122.12 97.32 45.73 Favored Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.58 122.58 11.49 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.698 1.599 . . . . 0.0 111.873 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.15 150.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -115.33 129.77 56.7 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.155 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.62 165.55 28.57 Favored Glycine 0 N--CA 1.427 -1.93 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 p -63.9 -15.0 58.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.166 0.987 . . . . 0.0 112.344 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.84 1.83 51.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.731 0.777 . . . . 0.0 109.276 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 65.86 36.53 6.01 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.452 1.501 . . . . 0.0 111.671 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.96 131.59 64.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 84' ' ' SER . 79.5 m -82.21 124.59 30.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.63 150.48 25.38 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.962 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.93 -15.23 73.9 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.302 1.001 . . . . 0.0 113.865 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 -179.44 170.56 1.33 Allowed 'General case' 0 C--O 1.252 1.19 0 C-N-CA 124.204 1.002 . . . . 0.0 109.633 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -28.68 69.1 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.73 -47.05 82.66 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.068 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -64.95 -35.59 81.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.848 0.356 . . . . 0.0 110.354 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.87 -46.95 88.58 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.001 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 53.8 t -65.09 -34.56 78.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.546 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 m -56.35 -49.46 74.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.91 -37.75 82.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.534 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -59.66 -47.01 87.32 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.66 0.384 . . . . 0.0 110.731 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -72.03 -39.53 69.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -64.69 -30.61 71.63 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.54 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 79.1 p -100.46 -4.47 28.78 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.24 62.59 1.57 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.306 1.442 . . . . 0.0 112.2 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.28 86.99 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 114.449 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 30.0 ttt180 -65.78 -54.99 19.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.43 124.01 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.8 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -137.4 178.44 7.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -62.01 123.04 17.02 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.385 0.674 . . . . 0.0 111.586 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.06 -58.21 1.99 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.74 161.51 37.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.16 153.9 35.84 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.68 173.7 45.65 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 59' ' ' THR . 15.4 m -67.48 149.95 49.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--N 1.308 -1.217 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.606 -178.271 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.158 0.504 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -93.39 89.85 6.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.04 14.8 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.22 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.614 1.166 . . . . 0.0 111.756 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 m -170.47 157.62 6.05 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 125.27 1.428 . . . . 0.0 107.267 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 25' ' ' LEU . 1.4 pt? -102.19 97.51 7.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -132.56 129.51 21.41 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.504 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -172.81 1.64 Allowed 'Trans proline' 0 C--O 1.25 1.105 0 C-N-CA 122.359 2.039 . . . . 0.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.13 120.91 32.46 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.31 141.29 16.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.13 102.74 14.14 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.972 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.1 t -97.03 -8.41 30.49 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.1 -32.41 71.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.158 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.0 pt -64.98 -28.56 45.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.854 0.359 . . . . 0.0 111.437 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 82.2 m-85 -89.5 -9.96 48.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.178 0.513 . . . . 0.0 110.523 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.83 -14.57 62.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.718 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.35 -15.8 63.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 43' ' ' ILE . 81.9 m-85 -112.99 151.63 44.27 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.92 144.01 75.06 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 122.038 1.825 . . . . 0.0 110.919 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.96 -38.74 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 124.179 0.992 . . . . 0.0 113.5 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.5 m -79.54 -24.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.11 93.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.882 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 68' ' ' THR . 37.6 mt -125.52 112.84 25.47 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 134.1 35.64 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.661 1.574 . . . . 0.0 109.9 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.6 m -115.55 147.61 39.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.726 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.46 157.42 54.98 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 121.956 1.771 . . . . 0.0 110.439 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.99 -4.06 10.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.323 0.582 . . . . 0.0 110.184 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -64.34 124.67 22.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -88.49 106.86 18.56 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.964 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 83.0 mt -123.4 96.1 44.39 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.17 118.9 5.8 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.304 1.336 . . . . 0.0 110.946 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.57 145.81 33.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.4 t -111.75 123.35 50.05 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 120.915 0.388 . . . . 0.0 110.307 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 169.3 40.51 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 p -66.86 -8.47 29.18 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.06 -0.89 57.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.384 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 65.65 39.5 4.87 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.46 1.104 . . . . 0.0 110.85 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.16 133.03 63.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.541 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 m -89.01 113.14 24.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.69 152.34 19.58 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.315 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.02 73.5 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.835 0.709 . . . . 0.0 113.623 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.2 p30 179.62 176.47 0.66 Allowed 'General case' 0 C--O 1.255 1.371 0 C-N-CA 124.571 1.148 . . . . 0.0 109.165 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -26.71 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.476 0.485 . . . . 0.0 111.597 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.87 -41.04 99.25 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -69.37 -30.37 68.35 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.316 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.88 -49.34 53.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.969 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.4 t -59.51 -47.19 86.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.531 0.733 . . . . 0.0 111.555 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 43' ' ' ILE . 5.4 p -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.79 -38.89 90.24 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -62.64 -50.37 71.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.253 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.04 -40.83 95.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 110.777 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -57.47 -45.43 84.83 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.366 1.066 . . . . 0.0 110.635 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -95.66 17.24 15.33 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 47.53 60.28 3.59 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.803 1.641 . . . . 0.0 113.771 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.47 15.15 81.74 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.973 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.89 -60.29 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.02 132.24 33.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.262 0.553 . . . . 0.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -117.88 173.26 6.86 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.164 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -75.85 119.06 19.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.75 -58.23 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -159.53 155.22 26.0 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.386 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -77.36 157.95 30.38 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.04 168.6 40.62 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -66.24 153.68 41.87 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.259 1.597 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.179 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 120.92 0.391 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -113.81 135.57 53.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.955 -0.466 . . . . 0.0 110.044 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 107.36 12.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 68.55 -178.61 0.22 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.703 1.201 . . . . 0.0 112.216 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -92.85 2.52 56.72 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.749 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.7 mt 64.85 -162.25 0.27 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.977 0.911 . . . . 0.0 110.007 -177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 28' ' ' LYS . 16.5 p -117.35 101.99 52.49 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.77 34.69 0.38 Allowed 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.228 2.619 . . . . 0.0 107.804 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 26' ' ' SER . 87.8 tttt -67.66 129.22 39.22 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.192 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 79' ' ' PHE . 18.2 ptpt -142.33 176.21 9.17 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.884 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.74 150.86 14.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.0 124.38 26.86 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.07 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 46.2 t -107.78 -5.56 17.26 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.4 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -68.52 -32.39 72.31 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.327 0.651 . . . . 0.0 110.345 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.27 -30.34 42.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.559 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 85.0 m-85 -90.24 -20.58 22.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.868 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.5 mtpp -62.21 -14.27 36.27 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.437 0.637 . . . . 0.0 112.068 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -81.55 -4.68 56.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.17 152.58 41.17 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.49 134.39 63.61 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.08 1.854 . . . . 0.0 111.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -50.82 -41.23 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 112.744 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.41 -25.62 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.87 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.73 93.15 3.76 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.737 -0.602 . . . . 0.0 111.252 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.58 115.47 37.41 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.76 133.85 41.09 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.04 1.827 . . . . 0.0 110.544 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -118.94 142.62 32.25 Favored Pre-proline 0 C--N 1.293 -1.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.746 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.14 154.44 45.74 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.659 2.239 . . . . 0.0 110.959 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.01 -17.5 11.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 120.979 0.419 . . . . 0.0 110.405 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -65.42 120.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.189 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -85.32 115.85 23.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.44 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.6 mt -128.52 94.53 35.15 Favored Pre-proline 0 C--N 1.288 -2.072 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.32 120.46 8.37 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.911 1.741 . . . . 0.0 111.597 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.31 148.78 30.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -112.62 126.46 55.39 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.33 166.32 30.62 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.227 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -62.17 -12.91 22.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 111.985 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.31 1.27 56.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.755 0.788 . . . . 0.0 109.43 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 68.58 28.54 5.79 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.128 1.371 . . . . 0.0 111.915 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.14 130.01 56.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 m -83.31 119.23 24.34 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.525 0.678 . . . . 0.0 109.59 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.61 151.82 20.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.47 -25.8 72.69 Favored Glycine 0 C--O 1.213 -1.174 0 O-C-N 124.26 0.975 . . . . 0.0 113.535 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.1 p30 -174.67 175.72 2.41 Favored 'General case' 0 C--O 1.256 1.398 0 C-N-CA 123.708 0.803 . . . . 0.0 109.218 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.29 68.19 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.51 0.506 . . . . 0.0 112.133 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 41.6 t -56.53 -52.54 64.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 123.451 0.469 . . . . 0.0 110.125 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -65.84 -32.4 73.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.813 0.34 . . . . 0.0 111.111 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.51 -48.76 73.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.484 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.1 t -61.35 -45.32 94.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.1 m -57.03 -49.34 76.11 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.18 0.514 . . . . 0.0 110.647 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.22 -34.48 76.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.32 -47.75 78.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.58 -38.6 91.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.808 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.1 p -89.6 4.5 49.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.458 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 62.59 30.05 16.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.854 0.862 . . . . 0.0 112.582 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.14 27.8 7.59 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.397 -0.906 . . . . 0.0 114.743 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -76.58 -52.44 9.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.368 1.084 . . . . 0.0 110.793 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.07 119.91 42.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.687 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -106.39 -179.62 3.99 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 66.1 t80 -80.31 119.1 22.59 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 tp -91.34 -54.26 3.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -160.12 159.7 32.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.682 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -78.96 151.32 31.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.13 170.58 35.09 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.473 -0.87 . . . . 0.0 110.997 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 m -65.99 145.23 56.13 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.824 -0.607 . . . . 0.0 111.295 -177.648 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.226 -0.134 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -67.93 -37.3 81.49 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.57 129.9 54.43 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . -123.01 11.51 9.57 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.08 0.467 . . . . 0.0 110.205 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 m 68.2 -79.89 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.444 1.098 . . . . 0.0 113.428 172.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mp -83.48 -1.09 52.83 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.306 0.574 . . . . 0.0 111.176 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 2.9 p -146.4 123.33 5.88 Favored Pre-proline 0 N--CA 1.422 -1.858 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.245 176.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.25 -172.93 1.13 Allowed 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 121.907 1.738 . . . . 0.0 110.357 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.35 96.48 10.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.477 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.89 142.26 35.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.257 -175.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 79' ' ' PHE . 14.3 p -58.81 139.43 18.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.176 -177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -88.58 106.84 18.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 42.3 t -99.46 -7.34 26.19 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m -67.11 -45.03 78.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 pt -69.12 -15.09 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.175 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.478 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.8 m-85 -96.42 -11.75 25.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.162 0.506 . . . . 0.0 110.691 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.8 mtpp -75.04 -14.21 60.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.72 -4.09 44.47 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.278 0.561 . . . . 0.0 111.259 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -108.38 159.71 29.77 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.33 145.05 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 121.393 1.395 . . . . 0.0 109.348 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.77 -40.63 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.404 0.621 . . . . 0.0 111.282 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.03 -26.93 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.503 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 92.99 3.64 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.528 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.09 119.64 33.27 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.94 133.66 31.94 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 121.406 1.404 . . . . 0.0 111.206 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.58 139.7 20.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.806 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.52 160.53 35.41 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.383 2.055 . . . . 0.0 110.449 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 pt -91.9 -9.06 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.118 0.485 . . . . 0.0 111.523 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 130.9 39.56 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -85.39 117.1 24.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.6 mt -129.28 97.13 26.36 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.97 118.83 5.75 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.506 1.47 . . . . 0.0 110.43 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.88 145.9 34.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.8 t -110.83 127.6 55.47 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.48 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 78' ' ' GLN . . . -89.99 161.28 29.15 Favored Glycine 0 N--CA 1.421 -2.336 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.608 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m -54.66 -24.45 21.74 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.856 1.262 . . . . 0.0 112.31 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.54 7.19 34.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.701 0.762 . . . . 0.0 110.304 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 68.25 24.6 7.42 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.53 1.132 . . . . 0.0 112.62 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.49 121.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.0 m -81.71 128.34 33.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.61 150.86 26.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.291 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.54 76.11 Favored Glycine 0 N--CA 1.445 -0.706 0 O-C-N 124.104 0.877 . . . . 0.0 113.284 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 28.4 p30 -176.52 175.33 1.76 Allowed 'General case' 0 C--O 1.255 1.383 0 CA-C-O 121.091 0.472 . . . . 0.0 111.645 176.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 49.2 mt-10 -44.99 -47.82 11.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.268 2.227 . . . . 0.0 112.609 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.7 t -56.23 -44.29 79.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.837 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.118 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.94 -47.29 83.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 50.4 t -62.84 -41.36 99.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.941 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 90.2 m -57.43 -51.61 68.71 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.79 -34.46 75.58 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.515 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -61.69 -46.18 90.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 77.1 mt -68.81 -44.06 74.31 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -54.6 -56.91 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 111.181 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 m -89.47 28.9 1.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 p30 50.54 21.6 0.9 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 126.29 1.836 . . . . 0.0 115.294 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.35 7.41 34.91 Favored Glycine 0 C--N 1.295 -1.74 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.618 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -60.93 -46.36 90.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.976 0.894 . . . . 0.0 109.575 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.5 p -108.19 119.32 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.742 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 76.3 mt-30 -129.67 -178.6 4.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.461 ' HB2' HG12 ' A' ' 30' ' ' VAL . 75.4 t80 -65.71 111.46 3.22 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.28 -54.01 4.53 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -162.16 159.81 26.39 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.89 158.54 26.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.99 177.16 42.29 Favored Glycine 0 N--CA 1.416 -2.698 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 m -70.13 152.18 44.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.859 -178.811 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.19 133.66 40.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.667 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 57.09 78.38 0.23 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.66 1.225 . . . . 0.0 112.979 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.19 98.37 6.57 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 m -132.53 150.94 52.08 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.92 130.36 35.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 28' ' ' LYS . 45.7 m -157.15 157.95 30.77 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -69.88 40.49 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.629 2.886 . . . . 0.0 111.516 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 85.2 tttt -93.04 148.89 21.62 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.555 1.542 . . . . 0.0 108.531 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 4.0 ttmp? -77.61 151.12 34.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.4 128.19 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.342 0 O-C-N 124.391 1.057 . . . . 0.0 111.386 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -76.6 94.26 3.73 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.755 0.788 . . . . 0.0 109.69 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 43.4 t -93.9 -15.74 24.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -34.82 77.25 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.266 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 pt -65.24 -31.61 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.853 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.3 m-85 -87.71 -16.89 33.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.129 0.49 . . . . 0.0 111.159 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 99.0 mttt -66.81 -14.54 62.77 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.454 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.98 -12.26 60.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.798 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.87 152.1 44.57 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.95 138.74 80.81 Favored 'Trans proline' 0 C--O 1.22 -0.398 0 C-N-CA 122.027 1.818 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.33 -30.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.32 -27.03 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.522 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.38 92.99 3.68 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.116 0.484 . . . . 0.0 111.479 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.09 122.66 25.38 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.83 133.71 24.18 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.037 1.158 . . . . 0.0 110.248 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.8 m -116.74 139.6 25.79 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -61.58 150.49 85.19 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.238 1.959 . . . . 0.0 112.026 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 pt -76.72 -13.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.418 0.628 . . . . 0.0 109.72 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -69.01 137.18 53.46 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.68 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -101.25 113.78 27.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.3 mp -119.76 97.07 49.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.85 118.91 5.85 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.364 1.376 . . . . 0.0 110.299 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.71 146.79 33.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.7 t -109.53 125.81 52.9 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.09 161.58 24.54 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 m -53.3 -24.5 11.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.494 1.118 . . . . 0.0 112.616 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.34 -1.73 38.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.273 0.629 . . . . 0.0 110.576 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 72.49 30.65 1.89 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.853 1.661 . . . . 0.0 110.85 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.74 131.19 61.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.746 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.2 m -81.56 119.21 23.48 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.72 152.32 19.79 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.07 -19.5 78.49 Favored Glycine 0 N--CA 1.443 -0.869 0 O-C-N 124.094 0.871 . . . . 0.0 113.498 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.0 p30 -177.11 177.19 1.28 Allowed 'General case' 0 C--O 1.255 1.393 0 C-N-CA 123.75 0.82 . . . . 0.0 109.54 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -27.93 64.5 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.442 0.463 . . . . 0.0 111.622 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.7 t -55.76 -52.03 65.34 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.364 0.415 . . . . 0.0 109.906 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -65.35 -36.66 84.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.033 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.12 -48.09 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.526 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 46.9 t -59.63 -45.27 92.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.435 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 m -57.53 -47.17 82.73 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.304 0.573 . . . . 0.0 110.59 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.57 -39.33 88.43 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.774 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 t -64.63 -38.7 91.89 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.653 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 93.1 mt -67.57 -37.01 82.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.782 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.52 -43.74 59.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.426 0.632 . . . . 0.0 110.961 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 m -83.5 0.23 47.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.854 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.25 71.01 0.57 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.71 1.204 . . . . 0.0 112.689 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.98 39.66 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.582 -0.736 . . . . 0.0 114.895 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -59.47 -54.46 46.41 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.225 0.536 . . . . 0.0 111.74 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.74 125.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -128.78 -178.63 4.68 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.62 112.09 8.36 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.1 tp -86.12 -48.73 8.34 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -165.1 161.37 19.57 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.417 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.61 147.16 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 165.46 39.85 Favored Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.708 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -61.09 150.82 32.75 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.065 0.546 . . . . 0.0 110.376 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.255 1.363 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -111.33 66.91 0.63 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -175.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.78 75.64 10.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.353 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -171.35 -71.2 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.885 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.7 t 61.5 72.82 0.5 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.399 1.095 . . . . 0.0 108.36 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.91 -48.29 31.84 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.493 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t -146.55 116.25 4.59 Favored Pre-proline 0 N--CA 1.417 -2.096 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.63 86.69 1.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.861 1.707 . . . . 0.0 110.137 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.15 105.65 9.51 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.43 141.73 43.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.821 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 p -83.27 155.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 102.726 -3.064 . . . . 0.0 102.726 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.14 94.45 6.01 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.322 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 53.9 t -83.17 -17.14 43.93 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.887 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -54.34 -47.07 72.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.172 0.989 . . . . 0.0 111.794 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 pt -68.42 -18.05 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.9 m-85 -94.93 -22.48 17.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 110.012 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.7 mtpt -65.47 -14.41 60.93 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.855 0.862 . . . . 0.0 110.407 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.44 -15.39 63.65 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.518 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.83 161.44 23.25 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.56 153.64 13.63 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.129 2.553 . . . . 0.0 112.554 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.76 -41.6 86.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 123.79 0.836 . . . . 0.0 112.922 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -96.55 -11.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.833 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.53 92.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.698 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 35' ' ' TYR . 67.8 mt -124.92 127.79 25.02 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.86 134.07 24.88 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.147 1.231 . . . . 0.0 111.554 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.46 136.92 19.32 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.047 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.08 162.65 39.12 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.128 1.885 . . . . 0.0 110.961 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -86.78 -3.37 8.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.333 0.587 . . . . 0.0 110.639 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.8 127.69 33.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.469 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.25 117.13 29.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 87.2 mt -129.77 95.93 27.81 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.6 118.97 5.88 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.96 1.773 . . . . 0.0 111.474 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.17 153.17 38.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.5 t -119.9 130.1 54.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.41 162.98 27.26 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.36 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -61.26 -16.22 43.19 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.025 0.93 . . . . 0.0 111.59 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.32 1.61 54.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.842 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 68.51 26.41 6.5 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.93 1.292 . . . . 0.0 113.15 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mm -103.87 127.59 57.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.2 m -81.84 138.26 35.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.09 153.36 34.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.503 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.37 -26.18 74.56 Favored Glycine 0 N--CA 1.438 -1.226 0 O-C-N 124.642 1.214 . . . . 0.0 112.979 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.5 p30 -175.36 177.35 1.85 Allowed 'General case' 0 C--O 1.255 1.352 0 C-N-CA 122.501 0.32 . . . . 0.0 110.886 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -47.51 -46.21 27.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.105 1.762 . . . . 0.0 111.626 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.15 -52.32 64.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.79 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -64.53 -38.02 89.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.59 -45.63 89.48 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.731 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 48.1 t -63.28 -44.81 94.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.792 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 m -58.62 -44.92 90.14 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.437 0.637 . . . . 0.0 110.321 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -72.06 -35.51 69.33 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.3 t -62.77 -42.96 99.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD21 ' HG2' ' A' ' 36' ' ' LYS . 89.2 mt -68.65 -42.3 78.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -58.22 -49.69 76.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.212 0.53 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -89.24 -4.79 58.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.579 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 53.35 67.79 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.611 1.164 . . . . 0.0 113.291 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 3.75 89.27 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-N 115.258 -0.883 . . . . 0.0 115.094 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.13 -47.83 72.83 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.01 94.96 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.176 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -106.07 -178.83 3.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -72.11 121.9 20.04 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.115 0.87 . . . . 0.0 109.347 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.12 -54.85 3.28 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.73 164.19 29.17 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.52 152.22 28.79 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.87 169.36 42.56 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.4 m -69.6 153.27 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.31 -1.128 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.427 -176.056 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.94 0.4 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.39 101.34 2.51 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.582 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.99 -170.84 0.18 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 70.49 10.06 7.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.311 1.044 . . . . 0.0 112.831 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 91.36 3.5 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -88.13 110.67 20.84 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.258 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.3 t -98.06 114.52 65.21 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.14 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.957 2.438 . . . . 0.0 112.288 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -110.97 109.71 19.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -149.18 155.43 40.62 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG13 ' CD1' ' A' ' 79' ' ' PHE . 28.5 m -84.89 153.03 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.03 102.84 15.19 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.9 t -89.11 -12.75 40.24 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 22.9 m -59.23 -43.54 92.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -63.19 -28.19 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -88.33 -16.72 32.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.931 0.396 . . . . 0.0 111.323 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 66.9 mttm -69.49 -14.81 63.07 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.739 0.78 . . . . 0.0 109.204 174.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.04 6.31 36.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 44.4 m-85 -120.02 154.09 55.46 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.82 135.04 60.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.676 1.584 . . . . 0.0 109.901 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -52.24 -35.67 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 0.0 112.468 -175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.15 -25.33 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.94 93.59 3.87 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.847 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 68' ' ' THR . 67.2 mt -121.22 109.61 35.04 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.248 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.97 135.25 37.08 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 110.475 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.3 m -116.47 149.94 44.61 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.456 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.96 159.21 43.33 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.844 2.362 . . . . 0.0 110.34 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 pt -86.28 -3.07 8.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.107 0.48 . . . . 0.0 111.971 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -82.74 131.1 35.21 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.068 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -88.09 106.24 18.03 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 94.7 mt -117.93 95.16 47.7 Favored Pre-proline 0 C--N 1.285 -2.227 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.3 121.35 9.5 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 121.847 1.698 . . . . 0.0 111.071 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.42 156.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.8 t -120.71 127.07 51.68 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.92 162.12 33.78 Favored Glycine 0 N--CA 1.413 -2.849 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 p -59.69 -20.93 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 125.133 1.373 . . . . 0.0 112.288 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.12 5.11 42.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.495 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 66.35 39.97 3.84 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.884 1.273 . . . . 0.0 111.681 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.57 130.14 72.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.889 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 84' ' ' SER . 70.4 m -84.51 135.36 34.26 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.576 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 97.1 m-85 -120.07 156.55 30.75 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.51 -19.35 77.7 Favored Glycine 0 C--O 1.224 -0.481 0 O-C-N 124.25 0.969 . . . . 0.0 113.649 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.9 p30 -177.43 171.97 1.89 Allowed 'General case' 0 C--O 1.256 1.421 0 C-N-CA 123.777 0.831 . . . . 0.0 109.973 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -31.42 72.59 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 37.2 t -56.82 -53.78 53.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.647 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.78 -32.93 74.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.79 -44.75 95.35 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.086 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.3 t -68.8 -37.09 79.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.077 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 43' ' ' ILE . 28.0 m -58.8 -45.4 89.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.444 0.64 . . . . 0.0 109.803 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 10.4 tp10 -71.93 -34.14 68.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.392 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.4 t -61.89 -51.05 69.77 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.14 0.576 . . . . 0.0 109.927 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.61 -33.67 76.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.388 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 59.5 tttp -67.6 -49.73 61.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.998 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -90.21 20.36 4.43 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.6 m120 59.71 34.43 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.35 4.12 71.4 Favored Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.895 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -56.98 -50.06 73.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.551 0.691 . . . . 0.0 111.374 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.59 116.67 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.004 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -137.08 177.76 7.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 30' ' ' VAL . 72.5 t80 -58.67 113.96 2.27 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.975 0.807 . . . . 0.0 113.171 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.92 -58.16 2.33 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -151.6 159.04 44.24 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.88 150.23 30.68 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.33 164.77 40.51 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.405 ' HA ' HG23 ' A' ' 59' ' ' THR . 16.5 m -62.25 151.53 36.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.085 -0.484 . . . . 0.0 110.616 -177.491 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.511 -0.538 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.5 mm-40 -106.82 167.19 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.07 -58.09 2.59 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.414 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.58 0.64 56.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.672 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 17.1 m -120.08 118.32 30.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 2.4 pt? -74.88 167.9 20.98 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -94.4 109.01 40.36 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-O 120.78 0.324 . . . . 0.0 110.164 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 6.2 Cg_exo -78.65 -175.77 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.225 1.95 . . . . 0.0 109.716 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -133.63 146.52 50.99 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.223 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -130.43 175.87 8.61 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.24 140.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.45 105.99 8.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.648 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 35.2 t -98.42 0.58 45.59 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -49.32 61.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.765 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 pt -68.66 -15.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.489 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.734 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 77.6 m-85 -98.33 -14.66 20.08 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.997 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 68.9 mttm -65.51 -14.72 61.64 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.664 0.745 . . . . 0.0 109.759 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.59 -32.45 71.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.441 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 43' ' ' ILE . 49.8 m-85 -100.58 157.44 33.73 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.005 -173.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.54 142.81 79.54 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.183 1.922 . . . . 0.0 110.191 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.44 -27.08 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.559 0.744 . . . . 0.0 112.935 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -86.31 -26.55 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.061 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.87 97.23 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.167 -0.333 . . . . 0.0 111.219 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.432 HG22 ' SG ' ' A' ' 64' ' ' CYS . 48.5 mt -124.35 108.78 29.26 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.322 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.24 135.11 59.82 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.759 2.306 . . . . 0.0 110.468 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.6 m -124.35 152.65 68.34 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.501 -174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.56 153.2 62.93 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.153 1.902 . . . . 0.0 110.815 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 pt -80.13 -9.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.188 0.518 . . . . 0.0 111.815 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.2 m -81.13 127.43 32.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.68 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -86.21 129.04 34.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 67.9 mt -133.65 100.19 13.72 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.2 119.71 7.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.38 1.386 . . . . 0.0 110.526 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.12 149.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.8 t -114.94 129.98 56.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.029 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 165.13 30.39 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.615 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -54.99 -24.11 22.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.675 1.19 . . . . 0.0 111.641 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.77 7.21 35.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.847 0.832 . . . . 0.0 110.803 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 66.36 24.99 10.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.628 1.171 . . . . 0.0 112.848 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.31 131.46 50.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 m -85.67 128.83 34.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.145 0.498 . . . . 0.0 110.046 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.2 m-85 -110.47 154.93 22.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.309 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.58 -26.96 73.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.2 p30 -178.56 -179.2 0.64 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 117.146 0.473 . . . . 0.0 110.444 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.83 -48.08 20.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.758 1.623 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 43' ' ' ILE . 43.6 t -61.55 -52.85 62.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.782 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -63.97 -33.82 76.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.452 . . . . 0.0 111.174 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.11 -45.8 79.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.914 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.8 t -64.64 -38.94 92.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.353 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.6 m -57.38 -48.33 79.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.5 tp10 -70.85 -33.89 71.11 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 t -61.82 -40.62 95.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.13 -40.64 62.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.218 0.324 . . . . 0.0 110.46 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -54.29 -60.2 3.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.406 0.682 . . . . 0.0 111.169 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 m -78.04 -20.88 51.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.351 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.22 84.33 0.12 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 125.438 1.495 . . . . 0.0 113.039 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.19 -29.26 5.68 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.622 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -57.03 -44.69 83.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.714 0.806 . . . . 0.0 111.717 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.682 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -132.69 -178.69 5.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -68.69 113.29 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -89.67 -55.44 3.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -159.8 163.07 34.84 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.8 162.64 19.5 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.48 169.48 45.95 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -66.34 148.78 51.36 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.2 m . . . . . 0 C--N 1.307 -1.255 0 O-C-N 123.347 0.405 . . . . 0.0 110.624 -177.832 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.24 120.45 34.51 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.26 -61.73 2.12 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 123.941 0.775 . . . . 0.0 112.659 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.42 147.49 31.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.776 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.9 t -143.55 128.48 18.45 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.44 108.15 3.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.638 0.733 . . . . 0.0 110.342 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -133.23 170.32 11.69 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.81 -170.97 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.27 0 C-N-CA 121.773 1.648 . . . . 0.0 111.914 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 79' ' ' PHE . 55.0 tptt -75.02 151.9 38.73 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -109.47 160.14 16.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.375 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.08 162.42 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.27 110.17 9.39 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 50.7 t -108.32 -9.66 15.44 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -60.57 -40.82 93.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.752 1.221 . . . . 0.0 111.668 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -70.14 -21.54 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.8 m-85 -94.08 -20.91 19.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 97.6 mttt -66.69 -14.9 63.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.726 0.774 . . . . 0.0 110.217 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -75.25 -2.34 27.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.648 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -118.0 156.95 49.71 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.16 144.04 85.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.771 1.647 . . . . 0.0 110.659 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.89 -33.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.719 0.808 . . . . 0.0 112.337 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.25 -25.46 9.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.5 93.81 3.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.186 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.56 119.74 25.95 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.91 134.25 21.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.167 1.245 . . . . 0.0 110.947 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.4 m -117.27 148.29 42.25 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.69 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.19 164.26 35.63 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.459 2.106 . . . . 0.0 111.201 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -89.47 -0.34 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.777 0.798 . . . . 0.0 110.145 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 128.64 36.22 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.294 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 61' ' ' GLY . 70.7 t80 -96.08 104.39 16.34 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.7 mt -116.86 98.01 51.33 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.14 125.2 16.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.382 1.388 . . . . 0.0 110.94 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.38 150.88 31.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.2 t -117.57 130.49 56.43 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.74 164.9 25.49 Favored Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.656 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -55.18 -23.77 23.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.642 1.177 . . . . 0.0 111.9 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.01 8.56 20.1 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.267 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 64.4 31.16 12.86 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 125.197 1.399 . . . . 0.0 111.337 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.4 131.2 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.167 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -85.06 133.5 34.23 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.1 m-85 -112.58 151.15 30.39 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 49' ' ' TYR . . . -71.34 -12.29 72.57 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 124.153 0.908 . . . . 0.0 114.303 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -179.35 172.6 1.18 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 124.329 1.052 . . . . 0.0 109.298 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -28.33 67.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 123.761 0.663 . . . . 0.0 112.765 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.05 -50.58 73.52 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.71 -34.51 78.49 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 111.128 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.94 -46.08 83.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.751 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -61.22 -46.17 91.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m -56.35 -47.41 78.88 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.86 0.362 . . . . 0.0 110.146 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.4 tp10 -68.04 -37.15 81.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.866 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 t -63.63 -43.74 95.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.521 0.729 . . . . 0.0 110.208 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HE2' ' A' ' 36' ' ' LYS . 88.2 mt -70.61 -43.77 68.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.841 178.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 86.0 tttt -55.3 -44.14 75.48 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -94.14 3.43 55.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.049 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 t30 46.27 74.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.961 1.704 . . . . 0.0 113.85 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.15 -3.07 59.24 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 115.113 0.805 . . . . 0.0 115.113 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -60.87 -57.17 13.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.372 0.606 . . . . 0.0 110.609 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.16 124.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -125.68 -178.85 4.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 80.8 t80 -70.92 121.76 18.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.15 -53.15 3.58 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -161.95 157.99 24.57 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -83.58 164.15 19.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.43 168.72 42.67 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -64.15 151.76 42.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.057 -178.529 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.241 0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.14 146.45 20.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -49.79 6.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.84 99.81 2.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.843 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -84.03 120.33 26.0 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.73 -20.86 52.78 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.505 0.669 . . . . 0.0 110.466 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 8.8 p -107.59 130.99 22.05 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 12.0 Cg_exo -70.08 99.98 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.3 2.0 . . . . 0.0 108.439 174.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -81.99 143.93 31.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.158 0.98 . . . . 0.0 113.116 -171.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.09 177.33 4.67 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 63' ' ' GLU . 7.6 p -69.91 126.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.517 177.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.45 101.8 12.31 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.2 t -98.96 -5.93 29.68 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -68.46 -39.98 81.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.328 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.11 -16.28 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.518 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.9 m-85 -103.46 -10.99 18.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 98.4 mttt -64.1 -14.79 57.23 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -70.51 -19.6 62.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.864 0.364 . . . . 0.0 111.425 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 90.8 m-85 -95.58 168.69 10.42 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 6.7 Cg_endo -54.44 160.46 6.86 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.771 2.314 . . . . 0.0 112.069 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.1 -41.82 79.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.29 -13.41 8.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.456 -0.898 . . . . 0.0 113.058 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -124.23 94.06 4.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.484 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 35' ' ' TYR . 60.9 mt -122.12 130.35 24.75 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.38 134.84 29.81 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.596 1.531 . . . . 0.0 110.43 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.62 155.44 48.82 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.86 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.84 156.93 40.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.374 2.049 . . . . 0.0 111.111 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.47 15.03 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.534 0.683 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -99.76 131.05 45.99 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 51.8 t80 -89.21 122.3 32.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 93.7 mt -133.26 97.75 16.07 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.25 119.87 7.31 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.703 1.602 . . . . 0.0 111.824 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.92 156.07 38.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.3 t -119.63 125.7 49.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.25 160.6 29.57 Favored Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 m -63.72 -9.53 14.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.121 0.968 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.96 8.2 40.85 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 60.3 44.08 12.87 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 111.599 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -124.4 131.87 72.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 m -84.75 133.61 34.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.68 150.85 32.65 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -61.33 -27.56 67.87 Favored Glycine 0 C--O 1.221 -0.679 0 O-C-N 124.284 0.99 . . . . 0.0 113.569 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.6 p30 -170.99 172.1 5.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 123.487 0.715 . . . . 0.0 109.092 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -66.57 -28.13 68.28 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.68 -42.26 96.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.737 0.304 . . . . 0.0 110.262 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 110.142 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.74 -42.26 97.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.831 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 41.5 t -60.1 -47.86 84.13 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.83 0.452 . . . . 0.0 111.265 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.424 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 21.7 p -57.36 -46.43 83.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.861 0.362 . . . . 0.0 111.7 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.28 -34.58 70.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.231 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -61.59 -48.24 81.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.74 -43.14 76.5 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.937 0.399 . . . . 0.0 110.596 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -46.85 77.82 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.191 0.996 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 m -92.91 15.83 13.96 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.415 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m120 55.54 30.61 15.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.17 3.38 51.23 Favored Glycine 0 C--N 1.316 -0.53 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.688 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -57.2 -45.0 84.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.344 0.658 . . . . 0.0 110.324 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.22 133.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.215 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -123.36 -179.78 4.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -83.01 110.78 18.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 tp -83.89 -61.34 1.85 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -154.73 161.77 41.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.36 153.92 40.28 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.97 169.55 45.43 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.07 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -63.0 152.65 36.23 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.812 0.445 . . . . 0.0 109.901 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.381 -0.343 . . . . 0.0 110.91 -178.762 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.94 -38.56 88.93 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.7 32.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.64 59.99 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 117.766 0.257 . . . . 0.0 111.247 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m 70.58 176.11 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.902 1.281 . . . . 0.0 110.103 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.85 -21.87 46.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.552 0.692 . . . . 0.0 109.538 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -151.11 145.15 17.78 Favored Pre-proline 0 N--CA 1.433 -1.325 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.52 116.55 3.41 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 121.888 1.726 . . . . 0.0 108.178 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -115.43 140.27 49.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -90.27 176.03 6.89 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 79' ' ' PHE . 11.1 p -68.95 118.17 12.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.591 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.34 95.12 7.52 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.343 1.068 . . . . 0.0 108.502 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 33.1 t -89.38 -12.31 40.73 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.525 -1.67 . . . . 0.0 108.423 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -51.52 -46.55 63.33 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.34 1.056 . . . . 0.0 112.27 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.2 pt -73.85 -15.48 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.678 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 94.3 m-85 -96.56 -18.36 19.84 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 110.102 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 60.0 mtpt -66.78 -14.59 62.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.453 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -76.39 -19.25 58.32 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.535 0.683 . . . . 0.0 109.394 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 24.1 m-85 -93.96 145.15 29.3 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 42' ' ' ALA . 37.3 Cg_endo -65.59 153.79 76.63 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.089 1.859 . . . . 0.0 111.214 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.27 -25.62 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.128 0.571 . . . . 0.0 112.18 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.52 -25.38 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 O-C-N 121.97 -0.456 . . . . 0.0 111.823 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 39' ' ' PRO . . . -126.21 94.02 3.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.68 108.3 28.71 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.31 134.32 26.57 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 121.951 1.767 . . . . 0.0 111.43 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.9 m -107.53 146.51 33.47 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.915 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.02 153.85 55.01 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.684 2.256 . . . . 0.0 110.882 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.9 pt -75.13 -24.66 17.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.041 0.448 . . . . 0.0 111.8 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 m -77.01 144.15 38.88 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -96.32 128.4 43.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 mp -134.24 104.37 11.38 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.72 120.16 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.438 1.425 . . . . 0.0 110.495 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.58 152.0 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.58 130.24 55.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.06 0.457 . . . . 0.0 110.846 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.94 163.81 28.35 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 p -63.43 -15.23 57.04 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.672 0.789 . . . . 0.0 112.328 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.78 4.71 39.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.607 0.717 . . . . 0.0 109.906 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.19 43.53 6.29 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.721 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.97 129.11 75.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.7 m -85.37 135.56 33.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -115.78 156.43 26.04 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.49 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.81 -22.57 78.23 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.595 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -178.27 174.25 1.33 Allowed 'General case' 0 C--O 1.256 1.423 0 C-N-CA 122.915 0.486 . . . . 0.0 110.369 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -51.62 -35.97 43.98 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.115 1.366 . . . . 0.0 113.547 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.27 -44.08 92.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.48 0.181 . . . . 0.0 111.201 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -68.41 -38.3 81.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.93 -48.85 74.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.1 t -60.01 -38.55 82.97 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.215 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.8 m -57.54 -52.86 63.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.79 -34.34 77.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.646 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -60.68 -46.78 89.05 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 36' ' ' LYS . 84.7 mt -73.48 -41.16 63.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.7 0.286 . . . . 0.0 110.715 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -63.57 -32.01 73.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -102.68 7.45 39.79 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.792 0.329 . . . . 0.0 111.001 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t30 46.52 75.2 0.12 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.273 1.429 . . . . 0.0 113.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.93 -5.1 26.82 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.579 0.991 . . . . 0.0 115.579 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -57.07 -60.48 3.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.791 0.805 . . . . 0.0 110.128 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.21 121.18 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -123.83 171.43 9.66 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' HB2' HG12 ' A' ' 30' ' ' VAL . 49.8 t80 -70.14 116.05 10.06 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -88.21 -56.24 3.41 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -161.73 161.7 29.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -82.25 165.64 20.25 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.12 165.09 40.89 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 m -66.55 143.65 56.92 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.311 -1.073 0 C-N-CA 123.103 0.561 . . . . 0.0 112.463 -176.092 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 CA--C 1.499 -1.015 0 CA-C-O 121.632 0.729 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -104.28 -9.93 18.21 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -61.76 -43.79 98.16 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.73 0.812 . . . . 0.0 111.928 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.1 pt -65.23 -24.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.806 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 75.9 m-85 -94.13 -22.98 18.13 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 121.815 0.817 . . . . 0.0 109.284 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -69.29 -15.04 63.26 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 125.284 1.434 . . . . 0.0 109.431 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.72 -16.31 60.75 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.357 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -105.28 159.32 29.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.07 139.25 72.03 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.045 1.83 . . . . 0.0 109.784 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.84 -30.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.59 -26.12 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.96 93.26 3.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.786 -0.571 . . . . 0.0 110.908 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.72 113.2 28.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 134.36 31.56 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.287 1.992 . . . . 0.0 111.278 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.8 m -116.99 148.11 41.53 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.302 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.55 158.32 58.17 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.069 1.846 . . . . 0.0 111.283 175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.21 11.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.724 0.773 . . . . 0.0 112.052 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.7 m -94.13 136.42 34.44 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.749 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -105.62 116.31 31.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 96.1 mt -133.47 102.81 12.62 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.35 125.97 18.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.788 1.658 . . . . 0.0 110.949 -176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.06 153.48 36.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.9 t -119.07 128.98 54.84 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 121.036 0.446 . . . . 0.0 110.67 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.22 164.48 30.91 Favored Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.613 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 p -66.26 -14.75 62.45 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.914 0.886 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.24 0.27 52.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.952 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 69.19 31.12 4.09 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.067 1.347 . . . . 0.0 111.711 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.24 128.4 66.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.4 m -84.13 133.31 34.63 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.09 156.57 26.16 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.789 0.435 . . . . 0.0 110.501 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.7 75.74 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 124.193 0.933 . . . . 0.0 114.117 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.8 p30 -171.83 175.7 3.83 Favored 'General case' 0 C--O 1.258 1.532 0 C-N-CA 123.186 0.595 . . . . 0.0 109.61 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.62 76.26 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.2 -48.94 79.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.707 0.289 . . . . 0.0 110.51 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.93 -36.94 83.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.101 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -61.18 -47.39 86.4 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 123.595 0.559 . . . . 0.0 109.555 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -59.91 -41.61 92.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.968 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.3 m -57.2 -48.37 78.95 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 120.92 0.391 . . . . 0.0 110.35 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -34.4 70.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.772 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 t -62.27 -42.69 99.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.75 -40.6 63.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.23 -46.11 90.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.446 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -93.59 6.08 49.45 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.027 0.441 . . . . 0.0 111.104 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 48.38 71.91 0.32 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 114.872 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.94 65.14 Favored Glycine 0 C--N 1.312 -0.766 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -56.8 -50.48 72.2 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.7 104.58 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.855 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -106.15 -178.65 3.71 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -81.49 128.45 33.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -103.51 -57.31 2.06 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -159.41 161.66 35.62 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.43 157.81 24.81 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 168.55 44.68 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 m -60.92 144.93 52.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.791 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 . . . . . 0 CA--C 1.5 -0.966 0 CA-C-O 122.022 0.915 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.8 t -102.57 -1.56 30.15 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.929 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -63.41 -44.21 95.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.932 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 pt -72.03 -25.05 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 88.0 m-85 -84.44 -11.75 55.63 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.947 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 29.2 mtpp -69.28 -14.68 63.08 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.817 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -76.62 -2.99 35.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.686 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -115.03 153.95 47.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 130.58 34.76 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.203 1.935 . . . . 0.0 110.105 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.14 -33.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.86 -26.67 11.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.326 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.72 93.92 3.82 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.132 -0.355 . . . . 0.0 111.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 68' ' ' THR . 50.7 mt -112.18 117.93 46.85 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.38 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.47 135.55 29.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.647 2.231 . . . . 0.0 111.059 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.78 149.31 53.04 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.244 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.7 162.78 39.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.367 2.045 . . . . 0.0 110.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 pt -83.56 -12.39 11.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.799 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -61.5 126.27 26.76 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -100.21 111.22 23.49 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -121.25 101.0 44.71 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.62 118.34 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.205 1.27 . . . . 0.0 110.935 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.58 143.9 39.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.9 t -107.99 127.14 53.5 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.224 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.31 160.41 28.11 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -56.17 -23.66 36.46 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.964 0.906 . . . . 0.0 112.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -88.38 11.3 17.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.661 0.743 . . . . 0.0 110.372 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 63.63 29.11 15.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.902 1.281 . . . . 0.0 112.654 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mm -103.14 126.13 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.4 m -83.26 124.44 30.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -103.23 144.53 31.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.43 -19.33 68.6 Favored Glycine 0 C--O 1.222 -0.638 0 O-C-N 124.117 0.886 . . . . 0.0 113.676 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 30.7 p30 -170.94 173.5 5.12 Favored 'General case' 0 C--O 1.256 1.423 0 C-N-CA 123.635 0.774 . . . . 0.0 109.095 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.41 64.18 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.347 0.404 . . . . 0.0 110.923 -174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 44.4 t -54.26 -52.66 60.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.596 0.56 . . . . 0.0 110.199 175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -63.82 -36.72 84.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.043 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -63.39 -49.64 73.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.03 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 43.0 t -59.2 -38.71 80.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.355 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 43' ' ' ILE . 26.7 m -56.92 -50.06 73.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 110.343 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -71.92 -36.99 70.13 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.2 m -58.04 -43.9 87.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.968 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.86 -42.24 61.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.142 0.496 . . . . 0.0 110.398 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.89 -46.04 85.5 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.321 1.048 . . . . 0.0 111.837 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.1 m -99.66 14.6 29.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 43.92 76.34 0.08 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 114.028 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 78' ' ' GLN . . . 70.94 15.62 74.17 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 115.073 -0.967 . . . . 0.0 114.051 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -72.29 -62.23 1.51 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.73 131.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.443 ' NE2' ' HA2' ' A' ' 75' ' ' GLY . 25.2 mm-40 -129.28 173.17 10.76 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -67.54 112.14 4.53 Favored 'General case' 0 C--N 1.284 -2.255 0 O-C-N 123.941 0.776 . . . . 0.0 109.206 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 tp -86.29 -56.34 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -161.07 162.23 31.56 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.208 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.08 146.96 45.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.79 168.58 38.12 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.75 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -64.45 149.76 47.86 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 122.706 0.402 . . . . 0.0 110.346 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.179 178.765 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t0 . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.4 t -93.69 -17.97 22.64 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 p -61.54 -27.75 68.83 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -77.99 -22.29 13.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 O-C-N 121.987 -0.446 . . . . 0.0 112.034 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 99.1 m-85 -98.9 -19.55 17.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.761 0.791 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.97 -14.93 63.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.39 1.076 . . . . 0.0 110.767 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -83.38 -4.04 58.1 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -100.88 156.88 34.64 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.92 135.29 68.94 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.608 2.205 . . . . 0.0 111.264 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.75 -24.47 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.51 -24.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.851 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.15 93.51 3.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.409 0.623 . . . . 0.0 111.045 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.97 115.83 31.64 Favored Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.28 133.61 31.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.484 1.456 . . . . 0.0 111.102 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.7 m -114.2 141.26 26.1 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.514 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.7 159.19 49.61 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.338 2.025 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 pt -83.57 -13.56 11.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.944 0.402 . . . . 0.0 110.805 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -70.27 132.41 45.67 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.45 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 52.8 t80 -96.88 112.83 24.41 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -124.05 98.36 39.27 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.19 126.86 22.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.867 1.711 . . . . 0.0 111.42 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.73 148.72 33.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -117.31 131.01 56.89 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 120.887 0.375 . . . . 0.0 110.329 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 168.36 26.41 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 p -70.91 -8.39 52.57 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.991 0.9 . . . . 0.0 110.745 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.31 -3.61 59.02 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 67.22 27.36 8.43 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.912 1.685 . . . . 0.0 112.725 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.77 133.32 48.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 m -88.24 129.1 35.45 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -107.79 146.99 31.44 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.376 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -62.66 -28.14 71.01 Favored Glycine 0 CA--C 1.499 -0.964 0 O-C-N 124.57 1.169 . . . . 0.0 112.617 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.3 p30 -172.17 170.03 5.31 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 123.145 0.578 . . . . 0.0 109.898 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.12 -29.07 60.17 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.4 t -62.36 -44.36 96.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -70.31 -37.84 74.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.7 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.11 -48.91 78.08 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.633 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.6 t -62.86 -41.51 99.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.652 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.9 m -60.39 -49.69 76.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 109.798 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.3 -37.45 87.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.035 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -65.68 -58.18 6.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.1 -45.65 86.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.132 0.573 . . . . 0.0 111.39 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 33.8 ttpt -57.43 -33.65 68.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.098 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.6 m -105.18 17.77 23.48 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.853 -174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 63.56 22.8 13.34 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 123.392 0.677 . . . . 0.0 112.658 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.86 28.94 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.753 -0.736 . . . . 0.0 113.067 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -57.15 -50.96 71.19 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.214 1.007 . . . . 0.0 108.43 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.59 133.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -117.29 160.85 20.45 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.48 121.49 16.46 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.38 -60.14 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -158.89 156.84 30.31 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -82.72 166.71 18.86 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.03 168.79 42.1 Favored Glycine 0 C--N 1.273 -2.942 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -67.73 146.09 54.11 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.782 -178.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 t70 . . . . . 0 N--CA 1.416 -2.167 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -88.07 -12.47 44.13 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.202 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 m -61.52 -39.66 91.81 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.33 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 pt -67.91 -17.69 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.655 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.0 m-85 -99.07 -5.47 30.21 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -58.82 -21.81 57.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.813 0.445 . . . . 0.0 111.976 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -79.24 4.76 14.03 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -118.93 152.03 51.14 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.37 133.06 46.98 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 121.726 1.617 . . . . 0.0 109.684 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 71' ' ' LEU . 15.1 m -57.62 -24.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -171.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.11 -25.33 5.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.004 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.46 93.87 3.98 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.883 0.373 . . . . 0.0 110.808 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 68' ' ' THR . 56.0 mt -119.42 117.25 33.13 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.95 133.48 31.34 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.527 1.485 . . . . 0.0 109.725 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.9 m -116.87 150.01 45.08 Favored Pre-proline 0 C--N 1.29 -2.006 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.905 -175.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.18 162.81 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.506 2.138 . . . . 0.0 111.142 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.07 -7.29 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.264 0.554 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -64.68 115.2 5.01 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.585 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -90.21 120.15 31.13 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 88.2 mt -133.72 99.06 14.31 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -62.24 119.92 7.25 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 121.49 1.46 . . . . 0.0 110.954 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.96 152.19 37.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.5 t -114.31 126.21 54.76 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.64 29.15 Favored Glycine 0 N--CA 1.421 -2.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.701 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -51.21 -25.71 5.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.848 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.15 8.32 27.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 69.7 29.92 4.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mm -107.22 124.44 63.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.533 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.5 m -81.47 125.7 30.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.18 155.49 19.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.96 79.16 Favored Glycine 0 N--CA 1.448 -0.533 0 O-C-N 123.868 0.73 . . . . 0.0 113.586 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.8 p30 -171.81 172.68 4.77 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 123.163 0.585 . . . . 0.0 109.764 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.88 76.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.881 0.738 . . . . 0.0 112.945 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 40.7 t -56.25 -50.96 69.83 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.68 0.392 . . . . 0.0 110.47 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -64.45 -36.03 82.84 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.707 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.8 -45.79 92.33 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.845 0.716 . . . . 0.0 109.484 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.7 t -61.36 -41.47 97.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.397 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.441 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 m -56.72 -53.09 61.8 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.27 77.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 t -58.53 -43.5 89.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 122.934 0.494 . . . . 0.0 110.402 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD13 HG12 ' A' ' 40' ' ' VAL . 86.2 mt -72.41 -39.12 68.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.438 . . . . 0.0 110.784 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -65.32 -39.72 92.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.022 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -87.3 -0.55 56.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.738 0.304 . . . . 0.0 110.832 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 57.73 68.12 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.239 1.416 . . . . 0.0 111.834 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.02 11.96 61.86 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.293 -0.867 . . . . 0.0 114.03 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -80.06 -50.18 10.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.75 117.11 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -125.7 -178.32 4.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -68.87 114.17 6.96 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.15 -54.64 4.02 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -159.95 159.5 32.33 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.335 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.28 157.52 30.72 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 165.86 41.33 Favored Glycine 0 C--N 1.293 -1.84 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 151.44 46.35 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.259 1.565 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.2 t70 . . . . . 0 N--CA 1.444 -0.756 0 CA-C-O 121.767 0.794 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.78 -2.44 17.33 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -64.62 -41.12 96.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.45 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 pt -68.08 -22.33 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.682 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.5 m-85 -93.12 -8.37 42.83 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.333 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.54 -15.3 60.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.324 0.583 . . . . 0.0 110.31 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -81.93 -2.19 50.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.061 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -123.18 151.19 61.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.19 145.41 78.41 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 121.92 1.747 . . . . 0.0 109.731 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.86 -38.63 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.59 -26.49 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.851 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.17 92.09 3.51 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.114 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.2 mt -122.29 113.81 30.79 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.18 132.52 34.35 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 120.631 0.888 . . . . 0.0 110.091 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.2 m -126.2 144.39 48.91 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.35 162.96 39.76 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.795 1.663 . . . . 0.0 111.196 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 pt -85.96 -1.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.658 0.742 . . . . 0.0 109.724 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -64.17 128.25 34.97 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.987 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -103.08 108.91 20.27 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.1 mt -123.91 97.45 41.1 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.15 118.59 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.694 1.596 . . . . 0.0 111.404 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.27 150.42 33.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.49 126.84 55.4 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.142 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.42 164.82 29.6 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 p -67.9 -4.58 13.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.393 0.616 . . . . 0.0 112.201 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.87 0.63 56.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 70.35 23.44 5.0 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.257 1.423 . . . . 0.0 111.111 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.9 mm -101.82 132.48 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -86.9 120.13 27.85 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.23 152.49 18.8 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.781 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.73 -18.71 77.56 Favored Glycine 0 N--CA 1.441 -0.972 0 O-C-N 124.116 0.885 . . . . 0.0 113.169 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.2 p30 -175.87 173.76 2.26 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 123.565 0.746 . . . . 0.0 109.935 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.48 -33.74 76.58 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.992 0.917 . . . . 0.0 110.673 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -45.98 90.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -65.8 -35.54 81.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.988 0.423 . . . . 0.0 110.614 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.46 -46.62 82.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.186 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 35.8 t -61.33 -40.81 95.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.1 m -57.69 -51.16 70.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.781 0.324 . . . . 0.0 110.197 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.6 -35.96 82.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.522 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t -65.66 -49.7 67.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.519 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.46 -37.97 89.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.265 0.555 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.59 -28.83 68.79 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.42 1.088 . . . . 0.0 110.906 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.0 p -110.45 16.31 21.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.695 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 60.92 24.87 14.88 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.162 0.982 . . . . 0.0 111.639 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.97 31.5 9.84 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.796 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -76.39 -56.78 4.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.99 129.99 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.625 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.26 -179.79 4.17 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -79.68 126.23 30.65 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.59 -52.66 3.85 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -164.52 159.62 19.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.1 153.44 40.79 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.43 172.7 46.93 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.624 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -64.19 146.93 53.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.316 -0.865 0 O-C-N 123.845 0.716 . . . . 0.0 112.235 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 121.842 0.83 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -89.45 -11.18 43.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.489 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -60.91 -40.28 92.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.725 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 45.8 pt -72.95 -21.1 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.764 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 98.7 m-85 -87.75 -12.47 45.09 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.195 0.522 . . . . 0.0 110.736 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -70.49 -14.76 62.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 23.4 pttm -78.11 -3.59 43.14 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.675 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.66 157.59 34.25 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.2 131.11 43.09 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.274 1.983 . . . . 0.0 110.165 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.53 -24.36 15.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.14 -25.19 5.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.114 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.86 93.79 3.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.882 0.373 . . . . 0.0 110.647 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.3 124.49 28.55 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.03 134.07 44.34 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 121.665 1.577 . . . . 0.0 110.554 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.4 m -107.66 140.62 21.74 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.07 163.36 39.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.078 1.852 . . . . 0.0 110.418 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -82.74 -14.54 11.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -64.87 119.41 10.61 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.528 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.3 mt -135.36 96.46 13.87 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -58.4 119.67 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.126 1.884 . . . . 0.0 110.489 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.86 128.61 56.47 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.5 165.95 35.83 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.617 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -57.14 -18.97 17.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.866 1.266 . . . . 0.0 112.117 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.59 6.28 47.86 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.101 0.953 . . . . 0.0 109.841 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.7 OUTLIER 61.1 47.04 7.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 110.847 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.6 mm -120.53 131.91 71.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.2 m -85.14 131.52 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -112.37 153.55 27.1 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.276 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.36 73.87 Favored Glycine 0 N--CA 1.444 -0.828 0 O-C-N 124.014 0.821 . . . . 0.0 113.862 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 34.6 p30 -176.71 -178.67 0.9 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 116.936 0.368 . . . . 0.0 111.344 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 29.4 mt-10 -45.74 -51.21 12.92 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 126.47 1.908 . . . . 0.0 111.574 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.5 t -55.51 -53.73 52.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.895 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -63.38 -37.93 89.19 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.096 0.474 . . . . 0.0 111.001 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 tp -67.03 -48.76 67.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.295 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 52.4 t -60.52 -44.46 96.02 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.948 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.9 m -58.65 -50.27 74.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.745 0.307 . . . . 0.0 110.869 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.19 -34.16 75.77 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.1 t -63.31 -48.13 79.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.293 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.06 -37.55 81.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.139 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.55 -34.94 79.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.024 0.44 . . . . 0.0 111.498 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -93.79 1.31 56.5 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.128 0.49 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 60.12 25.44 14.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.76 1.224 . . . . 0.0 112.54 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.95 22.69 7.82 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.198 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -72.49 -53.41 12.16 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.96 129.0 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -134.86 -178.72 5.21 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -65.95 119.08 10.71 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -93.31 -60.41 1.79 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -156.84 153.92 29.02 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.48 165.0 24.92 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.05 168.29 40.45 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 147.59 51.84 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 60.0 m . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.701 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 CA--C 1.479 -1.788 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.26 -6.58 56.68 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.539 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 55.4 m -67.4 -36.93 82.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.054 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.57 -16.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.666 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 76.6 m-85 -109.85 -13.68 14.42 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.397 0.618 . . . . 0.0 109.995 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -71.09 -14.99 62.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.288 1.042 . . . . 0.0 108.329 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 33' ' ' SER . 55.1 mtpt -72.62 -15.21 61.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.16 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.45 152.52 42.77 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.74 133.86 44.21 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.437 1.425 . . . . 0.0 108.687 172.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.16 -25.52 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.46 -26.16 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.777 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.59 93.52 3.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.241 -0.287 . . . . 0.0 111.371 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.58 124.55 26.2 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -77.18 134.89 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.403 1.402 . . . . 0.0 110.484 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -125.81 145.8 53.0 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.83 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.71 152.92 53.02 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.421 2.747 . . . . 0.0 112.336 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 pt -83.85 -17.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -68.76 134.23 49.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.249 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -90.95 110.73 21.98 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.0 mt -124.43 97.53 39.53 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.3 119.18 6.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.047 1.832 . . . . 0.0 111.5 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.43 151.83 29.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.84 128.56 56.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.81 163.28 23.47 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.441 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -57.2 -18.76 17.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.145 0.978 . . . . 0.0 112.349 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.52 3.5 43.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.414 0.626 . . . . 0.0 109.859 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 69.04 26.71 5.55 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.059 1.343 . . . . 0.0 111.723 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.37 134.33 49.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 84' ' ' SER . 67.1 m -86.13 127.27 34.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -105.97 156.08 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.989 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.53 -22.32 78.64 Favored Glycine 0 CA--C 1.501 -0.788 0 O-C-N 123.98 0.8 . . . . 0.0 112.996 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.4 p30 -173.0 169.86 4.58 Favored 'General case' 0 C--O 1.255 1.384 0 C-N-CA 123.684 0.793 . . . . 0.0 109.692 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.13 -27.02 65.19 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.286 -175.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.86 -44.3 97.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -64.7 -40.01 94.64 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.36 -46.75 87.77 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.362 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.3 t -59.77 -38.4 81.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -57.97 -48.6 79.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -67.47 -34.22 76.73 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.004 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 t -65.09 -39.41 93.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.602 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -72.34 -38.65 68.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.13 -43.33 91.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.79 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 58.3 p -92.61 -13.87 28.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.807 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 62.74 75.07 0.41 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 111.75 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.27 8.54 85.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.826 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 64.0 ttt180 -80.46 -62.1 1.78 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.643 0.722 . . . . 0.0 109.51 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.2 118.46 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -132.42 -179.64 5.56 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -68.16 110.47 4.02 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -85.25 -55.69 3.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -159.17 159.81 34.78 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.495 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.96 152.1 38.81 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 168.0 43.63 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 59' ' ' THR . 25.4 m -57.64 147.5 27.2 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.19 0.596 . . . . 0.0 110.26 176.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.125 178.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.481 -1.685 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.64 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 26.9 t -93.19 -20.77 20.13 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -54.05 -35.2 61.75 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.645 1.178 . . . . 0.0 113.959 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.55 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.095 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 72.9 m-85 -89.28 -19.8 24.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.1 mtpt -60.48 -14.23 18.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.533 0.733 . . . . 0.0 112.343 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.74 -25.53 61.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -89.8 152.68 46.99 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.83 139.01 82.96 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.124 1.883 . . . . 0.0 110.058 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.1 m -59.2 -15.72 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.35 -25.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.783 0.325 . . . . 0.0 110.627 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.24 93.91 3.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 122.094 -0.379 . . . . 0.0 110.726 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 68' ' ' THR . 55.6 mt -124.53 107.97 29.2 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.11 134.36 33.8 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.23 1.953 . . . . 0.0 110.578 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.1 m -114.66 147.02 37.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.038 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -61.8 152.45 74.38 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.294 1.996 . . . . 0.0 110.093 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.59 -7.71 10.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -74.91 133.35 41.81 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -92.31 127.05 37.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.8 mp -131.85 99.17 16.94 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -61.25 118.42 5.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.761 1.641 . . . . 0.0 111.196 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.35 152.13 36.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -117.08 128.2 54.91 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.165 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.38 163.09 28.61 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 m -62.23 -13.99 33.63 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.84 0.856 . . . . 0.0 111.733 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.37 2.37 54.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.074 0.94 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 65.75 24.97 11.44 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.857 1.263 . . . . 0.0 113.401 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.68 130.72 50.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.7 m -86.57 132.71 33.83 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.87 151.46 29.09 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.217 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -24.91 72.64 Favored Glycine 0 C--O 1.218 -0.885 0 O-C-N 124.434 1.084 . . . . 0.0 113.054 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.8 p30 -173.74 173.55 3.3 Favored 'General case' 0 C--O 1.259 1.556 0 C-N-CA 124.061 0.944 . . . . 0.0 109.116 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -26.63 68.28 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.52 0.512 . . . . 0.0 112.088 -174.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.45 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 38.6 t -56.5 -48.51 77.03 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.084 0.24 . . . . 0.0 110.803 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -67.57 -32.37 73.07 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.954 0.406 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.53 -46.01 74.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.097 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.0 t -59.2 -44.94 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.335 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.427 ' HA ' HD12 ' A' ' 43' ' ' ILE . 29.3 m -55.25 -48.23 74.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.099 0.476 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -71.49 -34.81 70.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -65.57 -33.53 76.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 36' ' ' LYS . 92.4 mt -74.47 -33.37 62.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.27 -50.98 50.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 0.0 110.724 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 p -81.48 -19.89 41.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.525 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.9 t30 63.43 78.91 0.27 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 111.933 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.2 90.29 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.123 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -73.28 -55.81 5.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.293 1.046 . . . . 0.0 109.354 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -94.54 111.79 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-O 121.69 0.757 . . . . 0.0 109.26 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -112.65 -179.61 3.71 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.44 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -77.78 118.37 20.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.43 -56.81 2.9 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -160.48 161.0 32.71 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.604 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.77 151.16 39.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 174.51 43.64 Favored Glycine 0 C--N 1.29 -1.974 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.327 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 m -69.54 152.32 44.94 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.77 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 N--CA 1.436 -1.166 0 CA-C-O 121.944 0.878 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 45.7 t -93.85 -5.06 48.91 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.372 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 3.7 m -65.35 -39.85 92.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.427 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -59.05 -28.0 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.452 0.47 . . . . 0.0 111.848 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.619 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -91.22 -33.05 15.54 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.666 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 50.7 mtmt -62.18 -14.38 37.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 33' ' ' SER . 32.3 mmtp -76.42 -5.89 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.084 0.469 . . . . 0.0 111.142 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.32 156.7 40.74 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 135.49 70.47 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.824 1.683 . . . . 0.0 110.533 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.42 -29.42 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.995 0.918 . . . . 0.0 112.902 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.82 -26.11 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.981 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.02 93.85 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.743 -0.598 . . . . 0.0 111.332 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 68' ' ' THR . 45.2 mt -124.81 132.56 24.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.52 134.51 26.54 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.446 1.431 . . . . 0.0 110.643 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.8 m -116.93 146.43 37.84 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.148 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 64' ' ' CYS . 9.0 Cg_endo -59.12 146.64 93.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.103 1.869 . . . . 0.0 110.158 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.9 pt -80.78 -20.6 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -79.89 138.09 37.07 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.729 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -82.66 108.48 16.06 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 81.1 mt -118.67 98.82 51.34 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 120.34 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.285 1.99 . . . . 0.0 111.88 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.12 146.35 34.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.41 128.21 53.87 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.34 159.94 24.45 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 m -61.16 -14.29 23.91 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.652 0.781 . . . . 0.0 112.352 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.93 3.86 40.09 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.819 0.847 . . . . 0.0 109.68 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 65.95 36.5 5.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.217 1.407 . . . . 0.0 111.925 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.5 131.7 71.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.9 m -84.34 122.43 28.91 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -97.73 152.64 18.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.639 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.54 -15.17 72.89 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.0 0.812 . . . . 0.0 114.123 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 173.68 -179.63 0.09 Allowed 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.167 1.387 . . . . 0.0 108.715 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -26.71 62.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.408 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 44.4 t -63.41 -42.27 98.74 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.63 -30.69 68.47 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.153 0.502 . . . . 0.0 110.0 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.4 tp -69.47 -49.08 58.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 30.9 t -61.55 -46.24 90.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.058 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.461 HG22 HD12 ' A' ' 43' ' ' ILE . 17.6 p -59.85 -48.51 81.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 111.15 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.39 -36.67 84.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.101 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -61.87 -44.56 96.58 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.997 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 87.2 mt -69.62 -45.72 67.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.359 0.6 . . . . 0.0 110.209 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -46.81 81.77 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.612 1.165 . . . . 0.0 110.612 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 m -91.62 13.29 18.38 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 55.24 60.1 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.56 76.92 Favored Glycine 0 C--N 1.316 -0.559 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.994 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.93 -51.67 63.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.0 110.359 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.03 122.13 62.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.356 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -105.61 174.78 5.73 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -76.76 119.59 20.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.27 -53.78 4.09 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.067 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -163.3 166.46 23.04 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.236 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.06 149.88 39.04 Favored 'General case' 0 C--O 1.252 1.214 0 O-C-N 123.801 0.688 . . . . 0.0 109.183 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.37 173.95 50.08 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.677 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -65.65 152.24 44.65 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.698 0.399 . . . . 0.0 110.372 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.037 -179.803 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.482 -1.647 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 34.6 t -92.68 -9.34 41.18 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.56 -33.18 72.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.6 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.28 -24.87 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.07 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 60.3 m-85 -92.05 -9.6 42.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 64.1 mttp -68.98 -14.75 63.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.545 0.688 . . . . 0.0 109.585 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -78.36 -11.05 59.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.534 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -109.98 153.14 43.3 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -64.45 146.72 89.99 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 121.593 1.529 . . . . 0.0 109.415 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.93 -31.66 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 111.383 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.07 -25.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.29 93.76 3.89 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.071 0.462 . . . . 0.0 111.325 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 64.6 mt -124.68 125.59 25.49 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 3.0 Cg_exo -76.59 133.61 14.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.559 1.506 . . . . 0.0 110.353 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.3 147.72 66.2 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 159.86 49.06 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 121.995 1.796 . . . . 0.0 112.113 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.69 -12.31 14.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.159 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -66.06 132.69 49.11 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.038 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -94.81 110.03 21.94 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 85.8 mt -122.12 97.32 45.73 Favored Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.58 122.58 11.49 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.698 1.599 . . . . 0.0 111.873 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.15 150.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -115.33 129.77 56.7 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.155 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.62 165.55 28.57 Favored Glycine 0 N--CA 1.427 -1.93 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 p -63.9 -15.0 58.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.166 0.987 . . . . 0.0 112.344 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.84 1.83 51.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.731 0.777 . . . . 0.0 109.276 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 65.86 36.53 6.01 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.452 1.501 . . . . 0.0 111.671 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.96 131.59 64.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 84' ' ' SER . 79.5 m -82.21 124.59 30.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.63 150.48 25.38 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.962 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.93 -15.23 73.9 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.302 1.001 . . . . 0.0 113.865 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 -179.44 170.56 1.33 Allowed 'General case' 0 C--O 1.252 1.19 0 C-N-CA 124.204 1.002 . . . . 0.0 109.633 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -28.68 69.1 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.73 -47.05 82.66 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.068 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -64.95 -35.59 81.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.848 0.356 . . . . 0.0 110.354 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.87 -46.95 88.58 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.001 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 53.8 t -65.09 -34.56 78.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.546 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 m -56.35 -49.46 74.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.91 -37.75 82.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.534 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -59.66 -47.01 87.32 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.66 0.384 . . . . 0.0 110.731 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -72.03 -39.53 69.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -64.69 -30.61 71.63 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.54 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 79.1 p -100.46 -4.47 28.78 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.24 62.59 1.57 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.306 1.442 . . . . 0.0 112.2 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.28 86.99 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 114.449 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 30.0 ttt180 -65.78 -54.99 19.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.43 124.01 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.8 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -137.4 178.44 7.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -62.01 123.04 17.02 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.385 0.674 . . . . 0.0 111.586 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.06 -58.21 1.99 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.74 161.51 37.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.16 153.9 35.84 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.68 173.7 45.65 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 59' ' ' THR . 15.4 m -67.48 149.95 49.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--N 1.308 -1.217 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.606 -178.271 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.428 -1.566 0 CA-C-O 121.833 0.825 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.1 t -97.03 -8.41 30.49 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.1 -32.41 71.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.158 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.0 pt -64.98 -28.56 45.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.854 0.359 . . . . 0.0 111.437 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 82.2 m-85 -89.5 -9.96 48.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.178 0.513 . . . . 0.0 110.523 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.83 -14.57 62.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.718 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.35 -15.8 63.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 43' ' ' ILE . 81.9 m-85 -112.99 151.63 44.27 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.92 144.01 75.06 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 122.038 1.825 . . . . 0.0 110.919 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.96 -38.74 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 124.179 0.992 . . . . 0.0 113.5 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.5 m -79.54 -24.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.11 93.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.882 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 68' ' ' THR . 37.6 mt -125.52 112.84 25.47 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 134.1 35.64 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.661 1.574 . . . . 0.0 109.9 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.6 m -115.55 147.61 39.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.726 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.46 157.42 54.98 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 121.956 1.771 . . . . 0.0 110.439 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.99 -4.06 10.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.323 0.582 . . . . 0.0 110.184 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -64.34 124.67 22.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -88.49 106.86 18.56 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.964 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 83.0 mt -123.4 96.1 44.39 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.17 118.9 5.8 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.304 1.336 . . . . 0.0 110.946 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.57 145.81 33.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.4 t -111.75 123.35 50.05 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 120.915 0.388 . . . . 0.0 110.307 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 169.3 40.51 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 p -66.86 -8.47 29.18 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.06 -0.89 57.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.384 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 65.65 39.5 4.87 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.46 1.104 . . . . 0.0 110.85 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.16 133.03 63.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.541 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 m -89.01 113.14 24.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.69 152.34 19.58 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.315 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.02 73.5 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.835 0.709 . . . . 0.0 113.623 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.2 p30 179.62 176.47 0.66 Allowed 'General case' 0 C--O 1.255 1.371 0 C-N-CA 124.571 1.148 . . . . 0.0 109.165 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -26.71 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.476 0.485 . . . . 0.0 111.597 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.87 -41.04 99.25 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -69.37 -30.37 68.35 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.316 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.88 -49.34 53.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.969 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.4 t -59.51 -47.19 86.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.531 0.733 . . . . 0.0 111.555 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 43' ' ' ILE . 5.4 p -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.79 -38.89 90.24 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -62.64 -50.37 71.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.253 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.04 -40.83 95.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 110.777 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -57.47 -45.43 84.83 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.366 1.066 . . . . 0.0 110.635 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -95.66 17.24 15.33 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 47.53 60.28 3.59 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.803 1.641 . . . . 0.0 113.771 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.47 15.15 81.74 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.973 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.89 -60.29 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.02 132.24 33.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.262 0.553 . . . . 0.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -117.88 173.26 6.86 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.164 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -75.85 119.06 19.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.75 -58.23 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -159.53 155.22 26.0 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.386 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -77.36 157.95 30.38 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.04 168.6 40.62 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -66.24 153.68 41.87 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.259 1.597 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.179 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 . . . . . 0 N--CA 1.436 -1.145 0 CA-C-O 121.811 0.815 . . . . 0.0 112.07 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 46.2 t -107.78 -5.56 17.26 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.4 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -68.52 -32.39 72.31 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.327 0.651 . . . . 0.0 110.345 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.27 -30.34 42.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.559 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 85.0 m-85 -90.24 -20.58 22.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.868 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.5 mtpp -62.21 -14.27 36.27 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.437 0.637 . . . . 0.0 112.068 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -81.55 -4.68 56.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.17 152.58 41.17 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.49 134.39 63.61 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.08 1.854 . . . . 0.0 111.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -50.82 -41.23 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 112.744 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.41 -25.62 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.87 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.73 93.15 3.76 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.737 -0.602 . . . . 0.0 111.252 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.58 115.47 37.41 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.76 133.85 41.09 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.04 1.827 . . . . 0.0 110.544 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -118.94 142.62 32.25 Favored Pre-proline 0 C--N 1.293 -1.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.746 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.14 154.44 45.74 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.659 2.239 . . . . 0.0 110.959 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.01 -17.5 11.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 120.979 0.419 . . . . 0.0 110.405 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -65.42 120.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.189 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -85.32 115.85 23.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.44 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.6 mt -128.52 94.53 35.15 Favored Pre-proline 0 C--N 1.288 -2.072 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.32 120.46 8.37 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.911 1.741 . . . . 0.0 111.597 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.31 148.78 30.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -112.62 126.46 55.39 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.33 166.32 30.62 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.227 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -62.17 -12.91 22.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 111.985 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.31 1.27 56.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.755 0.788 . . . . 0.0 109.43 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 68.58 28.54 5.79 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.128 1.371 . . . . 0.0 111.915 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.14 130.01 56.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 m -83.31 119.23 24.34 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.525 0.678 . . . . 0.0 109.59 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.61 151.82 20.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.47 -25.8 72.69 Favored Glycine 0 C--O 1.213 -1.174 0 O-C-N 124.26 0.975 . . . . 0.0 113.535 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.1 p30 -174.67 175.72 2.41 Favored 'General case' 0 C--O 1.256 1.398 0 C-N-CA 123.708 0.803 . . . . 0.0 109.218 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.29 68.19 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.51 0.506 . . . . 0.0 112.133 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 41.6 t -56.53 -52.54 64.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 123.451 0.469 . . . . 0.0 110.125 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -65.84 -32.4 73.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.813 0.34 . . . . 0.0 111.111 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.51 -48.76 73.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.484 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.1 t -61.35 -45.32 94.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.1 m -57.03 -49.34 76.11 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.18 0.514 . . . . 0.0 110.647 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.22 -34.48 76.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.32 -47.75 78.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.58 -38.6 91.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.808 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.1 p -89.6 4.5 49.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.458 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 62.59 30.05 16.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.854 0.862 . . . . 0.0 112.582 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.14 27.8 7.59 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.397 -0.906 . . . . 0.0 114.743 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -76.58 -52.44 9.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.368 1.084 . . . . 0.0 110.793 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.07 119.91 42.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.687 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -106.39 -179.62 3.99 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -80.31 119.1 22.59 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 tp -91.34 -54.26 3.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -160.12 159.7 32.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.682 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -78.96 151.32 31.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.13 170.58 35.09 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.473 -0.87 . . . . 0.0 110.997 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 m -65.99 145.23 56.13 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.824 -0.607 . . . . 0.0 111.295 -177.648 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 . . . . . 0 N--CA 1.432 -1.366 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 42.3 t -99.46 -7.34 26.19 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m -67.11 -45.03 78.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 pt -69.12 -15.09 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.175 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.478 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.8 m-85 -96.42 -11.75 25.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.162 0.506 . . . . 0.0 110.691 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.8 mtpp -75.04 -14.21 60.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.72 -4.09 44.47 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.278 0.561 . . . . 0.0 111.259 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -108.38 159.71 29.77 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.33 145.05 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 121.393 1.395 . . . . 0.0 109.348 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.77 -40.63 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.404 0.621 . . . . 0.0 111.282 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.03 -26.93 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.503 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 92.99 3.64 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.528 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.09 119.64 33.27 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.94 133.66 31.94 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 121.406 1.404 . . . . 0.0 111.206 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.58 139.7 20.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.806 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.52 160.53 35.41 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.383 2.055 . . . . 0.0 110.449 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 pt -91.9 -9.06 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.118 0.485 . . . . 0.0 111.523 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 130.9 39.56 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -85.39 117.1 24.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.6 mt -129.28 97.13 26.36 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.97 118.83 5.75 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.506 1.47 . . . . 0.0 110.43 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.88 145.9 34.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.8 t -110.83 127.6 55.47 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.48 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 78' ' ' GLN . . . -89.99 161.28 29.15 Favored Glycine 0 N--CA 1.421 -2.336 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.608 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m -54.66 -24.45 21.74 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.856 1.262 . . . . 0.0 112.31 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.54 7.19 34.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.701 0.762 . . . . 0.0 110.304 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 68.25 24.6 7.42 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.53 1.132 . . . . 0.0 112.62 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.49 121.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.0 m -81.71 128.34 33.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.61 150.86 26.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.291 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.54 76.11 Favored Glycine 0 N--CA 1.445 -0.706 0 O-C-N 124.104 0.877 . . . . 0.0 113.284 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 28.4 p30 -176.52 175.33 1.76 Allowed 'General case' 0 C--O 1.255 1.383 0 CA-C-O 121.091 0.472 . . . . 0.0 111.645 176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 49.2 mt-10 -44.99 -47.82 11.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.268 2.227 . . . . 0.0 112.609 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.7 t -56.23 -44.29 79.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.837 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.118 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.94 -47.29 83.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 50.4 t -62.84 -41.36 99.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.941 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 90.2 m -57.43 -51.61 68.71 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.79 -34.46 75.58 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.515 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -61.69 -46.18 90.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 77.1 mt -68.81 -44.06 74.31 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -54.6 -56.91 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 111.181 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 m -89.47 28.9 1.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 p30 50.54 21.6 0.9 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 126.29 1.836 . . . . 0.0 115.294 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.35 7.41 34.91 Favored Glycine 0 C--N 1.295 -1.74 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.618 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -60.93 -46.36 90.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.976 0.894 . . . . 0.0 109.575 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.5 p -108.19 119.32 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.742 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 76.3 mt-30 -129.67 -178.6 4.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -65.71 111.46 3.22 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.28 -54.01 4.53 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -162.16 159.81 26.39 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.89 158.54 26.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.99 177.16 42.29 Favored Glycine 0 N--CA 1.416 -2.698 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 m -70.13 152.18 44.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.859 -178.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t0 . . . . . 0 N--CA 1.443 -0.787 0 CA-C-O 121.755 0.788 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 43.4 t -93.9 -15.74 24.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -34.82 77.25 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.266 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 pt -65.24 -31.61 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.853 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.479 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.3 m-85 -87.71 -16.89 33.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.129 0.49 . . . . 0.0 111.159 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 99.0 mttt -66.81 -14.54 62.77 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.454 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.98 -12.26 60.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.798 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.87 152.1 44.57 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.95 138.74 80.81 Favored 'Trans proline' 0 C--O 1.22 -0.398 0 C-N-CA 122.027 1.818 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.33 -30.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.32 -27.03 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.522 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.38 92.99 3.68 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.116 0.484 . . . . 0.0 111.479 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.09 122.66 25.38 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.83 133.71 24.18 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.037 1.158 . . . . 0.0 110.248 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.8 m -116.74 139.6 25.79 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -61.58 150.49 85.19 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.238 1.959 . . . . 0.0 112.026 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 pt -76.72 -13.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.418 0.628 . . . . 0.0 109.72 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -69.01 137.18 53.46 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.68 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -101.25 113.78 27.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.3 mp -119.76 97.07 49.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.85 118.91 5.85 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.364 1.376 . . . . 0.0 110.299 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.71 146.79 33.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.7 t -109.53 125.81 52.9 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.09 161.58 24.54 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 m -53.3 -24.5 11.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.494 1.118 . . . . 0.0 112.616 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.34 -1.73 38.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.273 0.629 . . . . 0.0 110.576 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 72.49 30.65 1.89 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.853 1.661 . . . . 0.0 110.85 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.74 131.19 61.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.746 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.2 m -81.56 119.21 23.48 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.72 152.32 19.79 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.07 -19.5 78.49 Favored Glycine 0 N--CA 1.443 -0.869 0 O-C-N 124.094 0.871 . . . . 0.0 113.498 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.0 p30 -177.11 177.19 1.28 Allowed 'General case' 0 C--O 1.255 1.393 0 C-N-CA 123.75 0.82 . . . . 0.0 109.54 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -27.93 64.5 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.442 0.463 . . . . 0.0 111.622 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.7 t -55.76 -52.03 65.34 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.364 0.415 . . . . 0.0 109.906 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -65.35 -36.66 84.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.033 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.12 -48.09 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.526 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 46.9 t -59.63 -45.27 92.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.435 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 m -57.53 -47.17 82.73 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.304 0.573 . . . . 0.0 110.59 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.57 -39.33 88.43 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.774 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 t -64.63 -38.7 91.89 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.653 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 93.1 mt -67.57 -37.01 82.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.782 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.52 -43.74 59.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.426 0.632 . . . . 0.0 110.961 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 m -83.5 0.23 47.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.854 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.25 71.01 0.57 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.71 1.204 . . . . 0.0 112.689 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.98 39.66 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.582 -0.736 . . . . 0.0 114.895 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -59.47 -54.46 46.41 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.225 0.536 . . . . 0.0 111.74 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.74 125.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -128.78 -178.63 4.68 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.62 112.09 8.36 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.1 tp -86.12 -48.73 8.34 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -165.1 161.37 19.57 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.417 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.61 147.16 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 165.46 39.85 Favored Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.708 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -61.09 150.82 32.75 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.065 0.546 . . . . 0.0 110.376 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.255 1.363 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 . . . . . 0 CA--C 1.494 -1.185 0 CA-C-O 122.396 1.093 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 53.9 t -83.17 -17.14 43.93 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.887 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -54.34 -47.07 72.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.172 0.989 . . . . 0.0 111.794 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 pt -68.42 -18.05 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.9 m-85 -94.93 -22.48 17.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 110.012 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.7 mtpt -65.47 -14.41 60.93 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.855 0.862 . . . . 0.0 110.407 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.44 -15.39 63.65 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.518 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.83 161.44 23.25 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.56 153.64 13.63 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.129 2.553 . . . . 0.0 112.554 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.76 -41.6 86.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 123.79 0.836 . . . . 0.0 112.922 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -96.55 -11.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.833 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.53 92.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.698 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 35' ' ' TYR . 67.8 mt -124.92 127.79 25.02 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.86 134.07 24.88 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.147 1.231 . . . . 0.0 111.554 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.46 136.92 19.32 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.047 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.08 162.65 39.12 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.128 1.885 . . . . 0.0 110.961 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -86.78 -3.37 8.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.333 0.587 . . . . 0.0 110.639 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.8 127.69 33.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.469 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.25 117.13 29.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 87.2 mt -129.77 95.93 27.81 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.6 118.97 5.88 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.96 1.773 . . . . 0.0 111.474 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.17 153.17 38.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.5 t -119.9 130.1 54.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.41 162.98 27.26 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.36 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -61.26 -16.22 43.19 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.025 0.93 . . . . 0.0 111.59 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.32 1.61 54.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.842 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 68.51 26.41 6.5 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.93 1.292 . . . . 0.0 113.15 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mm -103.87 127.59 57.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.2 m -81.84 138.26 35.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.09 153.36 34.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.503 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.37 -26.18 74.56 Favored Glycine 0 N--CA 1.438 -1.226 0 O-C-N 124.642 1.214 . . . . 0.0 112.979 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.5 p30 -175.36 177.35 1.85 Allowed 'General case' 0 C--O 1.255 1.352 0 C-N-CA 122.501 0.32 . . . . 0.0 110.886 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -47.51 -46.21 27.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.105 1.762 . . . . 0.0 111.626 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.15 -52.32 64.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.79 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -64.53 -38.02 89.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.59 -45.63 89.48 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.731 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 48.1 t -63.28 -44.81 94.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.792 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 m -58.62 -44.92 90.14 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.437 0.637 . . . . 0.0 110.321 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -72.06 -35.51 69.33 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.3 t -62.77 -42.96 99.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.428 HD21 ' HG2' ' A' ' 36' ' ' LYS . 89.2 mt -68.65 -42.3 78.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -58.22 -49.69 76.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.212 0.53 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -89.24 -4.79 58.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.579 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 53.35 67.79 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.611 1.164 . . . . 0.0 113.291 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 3.75 89.27 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-N 115.258 -0.883 . . . . 0.0 115.094 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.13 -47.83 72.83 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.01 94.96 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.176 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -106.07 -178.83 3.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -72.11 121.9 20.04 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.115 0.87 . . . . 0.0 109.347 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.12 -54.85 3.28 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.73 164.19 29.17 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.52 152.22 28.79 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.87 169.36 42.56 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.4 m -69.6 153.27 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.31 -1.128 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.427 -176.056 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.9 t -89.11 -12.75 40.24 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 22.9 m -59.23 -43.54 92.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -63.19 -28.19 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -88.33 -16.72 32.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.931 0.396 . . . . 0.0 111.323 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 66.9 mttm -69.49 -14.81 63.07 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.739 0.78 . . . . 0.0 109.204 174.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.04 6.31 36.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 44.4 m-85 -120.02 154.09 55.46 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.82 135.04 60.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.676 1.584 . . . . 0.0 109.901 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -52.24 -35.67 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 0.0 112.468 -175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.15 -25.33 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.94 93.59 3.87 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.847 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 68' ' ' THR . 67.2 mt -121.22 109.61 35.04 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.248 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.97 135.25 37.08 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 110.475 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.3 m -116.47 149.94 44.61 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.456 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.96 159.21 43.33 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.844 2.362 . . . . 0.0 110.34 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 pt -86.28 -3.07 8.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.107 0.48 . . . . 0.0 111.971 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -82.74 131.1 35.21 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.068 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -88.09 106.24 18.03 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 94.7 mt -117.93 95.16 47.7 Favored Pre-proline 0 C--N 1.285 -2.227 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.3 121.35 9.5 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 121.847 1.698 . . . . 0.0 111.071 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.42 156.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.8 t -120.71 127.07 51.68 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.92 162.12 33.78 Favored Glycine 0 N--CA 1.413 -2.849 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 p -59.69 -20.93 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 125.133 1.373 . . . . 0.0 112.288 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.12 5.11 42.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.495 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 66.35 39.97 3.84 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.884 1.273 . . . . 0.0 111.681 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.57 130.14 72.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.889 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 84' ' ' SER . 70.4 m -84.51 135.36 34.26 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.576 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 97.1 m-85 -120.07 156.55 30.75 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.51 -19.35 77.7 Favored Glycine 0 C--O 1.224 -0.481 0 O-C-N 124.25 0.969 . . . . 0.0 113.649 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.9 p30 -177.43 171.97 1.89 Allowed 'General case' 0 C--O 1.256 1.421 0 C-N-CA 123.777 0.831 . . . . 0.0 109.973 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -31.42 72.59 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 37.2 t -56.82 -53.78 53.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.647 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.78 -32.93 74.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.79 -44.75 95.35 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.086 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.3 t -68.8 -37.09 79.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.077 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 43' ' ' ILE . 28.0 m -58.8 -45.4 89.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.444 0.64 . . . . 0.0 109.803 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 10.4 tp10 -71.93 -34.14 68.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.392 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.4 t -61.89 -51.05 69.77 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.14 0.576 . . . . 0.0 109.927 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.61 -33.67 76.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.388 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.538 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 59.5 tttp -67.6 -49.73 61.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.998 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -90.21 20.36 4.43 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.6 m120 59.71 34.43 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.35 4.12 71.4 Favored Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.895 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -56.98 -50.06 73.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.551 0.691 . . . . 0.0 111.374 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.59 116.67 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.004 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -137.08 177.76 7.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -58.67 113.96 2.27 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.975 0.807 . . . . 0.0 113.171 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.92 -58.16 2.33 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -151.6 159.04 44.24 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.88 150.23 30.68 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.33 164.77 40.51 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.405 ' HA ' HG23 ' A' ' 59' ' ' THR . 16.5 m -62.25 151.53 36.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.085 -0.484 . . . . 0.0 110.616 -177.491 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 35.2 t -98.42 0.58 45.59 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -49.32 61.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.765 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 pt -68.66 -15.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.489 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.734 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 77.6 m-85 -98.33 -14.66 20.08 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.997 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 68.9 mttm -65.51 -14.72 61.64 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.664 0.745 . . . . 0.0 109.759 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.59 -32.45 71.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.441 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 43' ' ' ILE . 49.8 m-85 -100.58 157.44 33.73 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.005 -173.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.54 142.81 79.54 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.183 1.922 . . . . 0.0 110.191 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.44 -27.08 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.559 0.744 . . . . 0.0 112.935 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -86.31 -26.55 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.061 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.87 97.23 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.167 -0.333 . . . . 0.0 111.219 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.432 HG22 ' SG ' ' A' ' 64' ' ' CYS . 48.5 mt -124.35 108.78 29.26 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.322 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.24 135.11 59.82 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.759 2.306 . . . . 0.0 110.468 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.6 m -124.35 152.65 68.34 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.501 -174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.56 153.2 62.93 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.153 1.902 . . . . 0.0 110.815 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 pt -80.13 -9.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.188 0.518 . . . . 0.0 111.815 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.2 m -81.13 127.43 32.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.68 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -86.21 129.04 34.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 67.9 mt -133.65 100.19 13.72 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.2 119.71 7.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.38 1.386 . . . . 0.0 110.526 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.12 149.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.8 t -114.94 129.98 56.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.029 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 165.13 30.39 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.615 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -54.99 -24.11 22.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.675 1.19 . . . . 0.0 111.641 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.77 7.21 35.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.847 0.832 . . . . 0.0 110.803 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 66.36 24.99 10.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.628 1.171 . . . . 0.0 112.848 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.31 131.46 50.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 m -85.67 128.83 34.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.145 0.498 . . . . 0.0 110.046 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.429 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.2 m-85 -110.47 154.93 22.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.309 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.58 -26.96 73.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.2 p30 -178.56 -179.2 0.64 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 117.146 0.473 . . . . 0.0 110.444 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.83 -48.08 20.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.758 1.623 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 43' ' ' ILE . 43.6 t -61.55 -52.85 62.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.782 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -63.97 -33.82 76.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.452 . . . . 0.0 111.174 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.11 -45.8 79.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.914 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.8 t -64.64 -38.94 92.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.353 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.6 m -57.38 -48.33 79.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.5 tp10 -70.85 -33.89 71.11 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 t -61.82 -40.62 95.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.13 -40.64 62.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.218 0.324 . . . . 0.0 110.46 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -54.29 -60.2 3.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.406 0.682 . . . . 0.0 111.169 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 m -78.04 -20.88 51.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.351 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.22 84.33 0.12 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 125.438 1.495 . . . . 0.0 113.039 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.19 -29.26 5.68 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.622 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -57.03 -44.69 83.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.714 0.806 . . . . 0.0 111.717 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.682 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -132.69 -178.69 5.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -68.69 113.29 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -89.67 -55.44 3.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -159.8 163.07 34.84 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.8 162.64 19.5 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.48 169.48 45.95 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -66.34 148.78 51.36 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.2 m . . . . . 0 C--N 1.307 -1.255 0 O-C-N 123.347 0.405 . . . . 0.0 110.624 -177.832 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 . . . . . 0 CA--C 1.509 -0.609 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 50.7 t -108.32 -9.66 15.44 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -60.57 -40.82 93.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.752 1.221 . . . . 0.0 111.668 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -70.14 -21.54 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.8 m-85 -94.08 -20.91 19.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 97.6 mttt -66.69 -14.9 63.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.726 0.774 . . . . 0.0 110.217 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -75.25 -2.34 27.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.648 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -118.0 156.95 49.71 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.16 144.04 85.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.771 1.647 . . . . 0.0 110.659 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.89 -33.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.719 0.808 . . . . 0.0 112.337 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.25 -25.46 9.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.5 93.81 3.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.186 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.56 119.74 25.95 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.91 134.25 21.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.167 1.245 . . . . 0.0 110.947 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.4 m -117.27 148.29 42.25 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.69 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.19 164.26 35.63 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.459 2.106 . . . . 0.0 111.201 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -89.47 -0.34 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.777 0.798 . . . . 0.0 110.145 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 128.64 36.22 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.294 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 61' ' ' GLY . 70.7 t80 -96.08 104.39 16.34 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.7 mt -116.86 98.01 51.33 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.14 125.2 16.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.382 1.388 . . . . 0.0 110.94 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.38 150.88 31.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.2 t -117.57 130.49 56.43 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.74 164.9 25.49 Favored Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.656 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -55.18 -23.77 23.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.642 1.177 . . . . 0.0 111.9 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.01 8.56 20.1 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.267 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 64.4 31.16 12.86 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 125.197 1.399 . . . . 0.0 111.337 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.4 131.2 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.167 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -85.06 133.5 34.23 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.1 m-85 -112.58 151.15 30.39 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 49' ' ' TYR . . . -71.34 -12.29 72.57 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 124.153 0.908 . . . . 0.0 114.303 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -179.35 172.6 1.18 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 124.329 1.052 . . . . 0.0 109.298 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -28.33 67.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 123.761 0.663 . . . . 0.0 112.765 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.05 -50.58 73.52 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.71 -34.51 78.49 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 111.128 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.94 -46.08 83.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.751 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -61.22 -46.17 91.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m -56.35 -47.41 78.88 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.86 0.362 . . . . 0.0 110.146 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.4 tp10 -68.04 -37.15 81.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.866 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 t -63.63 -43.74 95.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.521 0.729 . . . . 0.0 110.208 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HE2' ' A' ' 36' ' ' LYS . 88.2 mt -70.61 -43.77 68.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.841 178.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 86.0 tttt -55.3 -44.14 75.48 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -94.14 3.43 55.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.049 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 t30 46.27 74.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.961 1.704 . . . . 0.0 113.85 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.15 -3.07 59.24 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 115.113 0.805 . . . . 0.0 115.113 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -60.87 -57.17 13.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.372 0.606 . . . . 0.0 110.609 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.16 124.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -125.68 -178.85 4.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -70.92 121.76 18.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.15 -53.15 3.58 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -161.95 157.99 24.57 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -83.58 164.15 19.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.43 168.72 42.67 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -64.15 151.76 42.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.057 -178.529 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 CA--C 1.487 -1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.2 t -98.96 -5.93 29.68 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -68.46 -39.98 81.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.328 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.11 -16.28 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.518 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.9 m-85 -103.46 -10.99 18.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 98.4 mttt -64.1 -14.79 57.23 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -70.51 -19.6 62.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.864 0.364 . . . . 0.0 111.425 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 90.8 m-85 -95.58 168.69 10.42 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 6.7 Cg_endo -54.44 160.46 6.86 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.771 2.314 . . . . 0.0 112.069 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.1 -41.82 79.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.29 -13.41 8.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.456 -0.898 . . . . 0.0 113.058 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -124.23 94.06 4.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.484 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 35' ' ' TYR . 60.9 mt -122.12 130.35 24.75 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.38 134.84 29.81 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.596 1.531 . . . . 0.0 110.43 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.62 155.44 48.82 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.86 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.84 156.93 40.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.374 2.049 . . . . 0.0 111.111 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.47 15.03 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.534 0.683 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -99.76 131.05 45.99 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 51.8 t80 -89.21 122.3 32.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 93.7 mt -133.26 97.75 16.07 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.25 119.87 7.31 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.703 1.602 . . . . 0.0 111.824 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.92 156.07 38.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.3 t -119.63 125.7 49.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.25 160.6 29.57 Favored Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 m -63.72 -9.53 14.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.121 0.968 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.96 8.2 40.85 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 60.3 44.08 12.87 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 111.599 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -124.4 131.87 72.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 m -84.75 133.61 34.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.68 150.85 32.65 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -61.33 -27.56 67.87 Favored Glycine 0 C--O 1.221 -0.679 0 O-C-N 124.284 0.99 . . . . 0.0 113.569 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.6 p30 -170.99 172.1 5.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 123.487 0.715 . . . . 0.0 109.092 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.57 -28.13 68.28 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.68 -42.26 96.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.737 0.304 . . . . 0.0 110.262 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 110.142 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.74 -42.26 97.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.831 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 41.5 t -60.1 -47.86 84.13 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.83 0.452 . . . . 0.0 111.265 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.424 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 21.7 p -57.36 -46.43 83.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.861 0.362 . . . . 0.0 111.7 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.28 -34.58 70.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.231 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -61.59 -48.24 81.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.74 -43.14 76.5 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.937 0.399 . . . . 0.0 110.596 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -46.85 77.82 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.191 0.996 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 m -92.91 15.83 13.96 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.415 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m120 55.54 30.61 15.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.17 3.38 51.23 Favored Glycine 0 C--N 1.316 -0.53 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.688 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -57.2 -45.0 84.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.344 0.658 . . . . 0.0 110.324 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.22 133.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.215 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -123.36 -179.78 4.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -83.01 110.78 18.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 tp -83.89 -61.34 1.85 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -154.73 161.77 41.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.36 153.92 40.28 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.97 169.55 45.43 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.07 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -63.0 152.65 36.23 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.812 0.445 . . . . 0.0 109.901 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.381 -0.343 . . . . 0.0 110.91 -178.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.428 -1.539 0 CA-C-O 122.343 1.068 . . . . 0.0 108.502 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 33.1 t -89.38 -12.31 40.73 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.525 -1.67 . . . . 0.0 108.423 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -51.52 -46.55 63.33 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.34 1.056 . . . . 0.0 112.27 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.2 pt -73.85 -15.48 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.678 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 94.3 m-85 -96.56 -18.36 19.84 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 110.102 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 60.0 mtpt -66.78 -14.59 62.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.453 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -76.39 -19.25 58.32 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.535 0.683 . . . . 0.0 109.394 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 24.1 m-85 -93.96 145.15 29.3 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 42' ' ' ALA . 37.3 Cg_endo -65.59 153.79 76.63 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.089 1.859 . . . . 0.0 111.214 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.27 -25.62 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.128 0.571 . . . . 0.0 112.18 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.52 -25.38 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 O-C-N 121.97 -0.456 . . . . 0.0 111.823 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 39' ' ' PRO . . . -126.21 94.02 3.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.68 108.3 28.71 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.31 134.32 26.57 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 121.951 1.767 . . . . 0.0 111.43 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.9 m -107.53 146.51 33.47 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.915 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.02 153.85 55.01 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.684 2.256 . . . . 0.0 110.882 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.9 pt -75.13 -24.66 17.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.041 0.448 . . . . 0.0 111.8 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 m -77.01 144.15 38.88 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -96.32 128.4 43.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 mp -134.24 104.37 11.38 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.72 120.16 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.438 1.425 . . . . 0.0 110.495 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.58 152.0 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.58 130.24 55.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.06 0.457 . . . . 0.0 110.846 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.94 163.81 28.35 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 p -63.43 -15.23 57.04 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.672 0.789 . . . . 0.0 112.328 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.78 4.71 39.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.607 0.717 . . . . 0.0 109.906 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.19 43.53 6.29 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.721 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.97 129.11 75.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.7 m -85.37 135.56 33.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -115.78 156.43 26.04 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.49 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.81 -22.57 78.23 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.595 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -178.27 174.25 1.33 Allowed 'General case' 0 C--O 1.256 1.423 0 C-N-CA 122.915 0.486 . . . . 0.0 110.369 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -51.62 -35.97 43.98 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.115 1.366 . . . . 0.0 113.547 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.27 -44.08 92.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.48 0.181 . . . . 0.0 111.201 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -68.41 -38.3 81.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.93 -48.85 74.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.1 t -60.01 -38.55 82.97 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.215 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.8 m -57.54 -52.86 63.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.79 -34.34 77.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.646 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -60.68 -46.78 89.05 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 36' ' ' LYS . 84.7 mt -73.48 -41.16 63.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.7 0.286 . . . . 0.0 110.715 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -63.57 -32.01 73.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -102.68 7.45 39.79 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.792 0.329 . . . . 0.0 111.001 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t30 46.52 75.2 0.12 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.273 1.429 . . . . 0.0 113.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.93 -5.1 26.82 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.579 0.991 . . . . 0.0 115.579 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -57.07 -60.48 3.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.791 0.805 . . . . 0.0 110.128 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.21 121.18 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.448 ' HA ' HE21 ' A' ' 78' ' ' GLN . 0.1 OUTLIER -123.83 171.43 9.66 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -177.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -70.14 116.05 10.06 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -88.21 -56.24 3.41 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -161.73 161.7 29.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -82.25 165.64 20.25 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.12 165.09 40.89 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 m -66.55 143.65 56.92 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.311 -1.073 0 C-N-CA 123.103 0.561 . . . . 0.0 112.463 -176.092 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -97.76 113.48 25.27 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.7 147.16 19.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.98 -44.7 46.75 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -109.17 105.22 14.58 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.91 106.67 3.26 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.2 m -121.67 86.58 45.19 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -88.97 91.74 0.38 Allowed 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.684 2.256 . . . . 0.0 110.13 176.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -102.14 143.33 32.09 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.269 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -136.81 113.52 10.28 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.21 169.81 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.48 103.57 5.66 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 118.815 -1.154 . . . . 0.0 110.01 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.3 t -104.28 -9.93 18.21 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.8 m -61.76 -43.79 98.16 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 123.73 0.812 . . . . 0.0 111.928 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.1 pt -65.23 -24.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.806 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.66 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 75.9 m-85 -94.13 -22.98 18.13 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 121.815 0.817 . . . . 0.0 109.284 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -69.29 -15.04 63.26 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 125.284 1.434 . . . . 0.0 109.431 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -74.72 -16.31 60.75 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.357 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -105.28 159.32 29.83 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.07 139.25 72.03 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.045 1.83 . . . . 0.0 109.784 173.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.84 -30.18 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.59 -26.12 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.229 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.96 93.26 3.78 Favored 'General case' 0 N--CA 1.44 -0.931 0 O-C-N 121.786 -0.571 . . . . 0.0 110.908 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.72 113.2 28.79 Favored Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.07 134.36 31.56 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.287 1.992 . . . . 0.0 111.278 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 95.8 m -116.99 148.11 41.53 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.302 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.55 158.32 58.17 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.069 1.846 . . . . 0.0 111.283 175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.21 11.57 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.724 0.773 . . . . 0.0 112.052 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.7 m -94.13 136.42 34.44 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.749 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -105.62 116.31 31.72 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 96.1 mt -133.47 102.81 12.62 Favored Pre-proline 0 C--N 1.287 -2.124 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.35 125.97 18.18 Favored 'Trans proline' 0 N--CA 1.441 -1.597 0 C-N-CA 121.788 1.658 . . . . 0.0 110.949 -176.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.06 153.48 36.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.9 t -119.07 128.98 54.84 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 121.036 0.446 . . . . 0.0 110.67 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.22 164.48 30.91 Favored Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.613 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.0 p -66.26 -14.75 62.45 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 123.914 0.886 . . . . 0.0 111.213 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -85.24 0.27 52.42 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.901 -1.045 . . . . 0.0 108.952 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 69.19 31.12 4.09 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.067 1.347 . . . . 0.0 111.711 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.24 128.4 66.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.4 m -84.13 133.31 34.63 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -116.09 156.57 26.16 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 122.789 0.435 . . . . 0.0 110.501 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.61 -29.7 75.74 Favored Glycine 0 C--N 1.336 0.554 0 O-C-N 124.193 0.933 . . . . 0.0 114.117 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.8 p30 -171.83 175.7 3.83 Favored 'General case' 0 C--O 1.258 1.532 0 C-N-CA 123.186 0.595 . . . . 0.0 109.61 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.62 76.26 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.2 -48.94 79.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.707 0.289 . . . . 0.0 110.51 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.93 -36.94 83.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.101 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -61.18 -47.39 86.4 Favored 'General case' 0 C--O 1.216 -0.663 0 O-C-N 123.595 0.559 . . . . 0.0 109.555 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -59.91 -41.61 92.06 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.968 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.3 m -57.2 -48.37 78.95 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 120.92 0.391 . . . . 0.0 110.35 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -34.4 70.19 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.772 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.6 t -62.27 -42.69 99.56 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.75 -40.6 63.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.88 0.371 . . . . 0.0 110.539 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -62.23 -46.11 90.31 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.446 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 m -93.59 6.08 49.45 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.027 0.441 . . . . 0.0 111.104 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 48.38 71.91 0.32 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.37 1.468 . . . . 0.0 114.872 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.16 1.94 65.14 Favored Glycine 0 C--N 1.312 -0.766 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -56.8 -50.48 72.2 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.7 104.58 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-N 114.471 -1.241 . . . . 0.0 108.855 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -106.15 -178.65 3.71 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -81.49 128.45 33.9 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -103.51 -57.31 2.06 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.522 0.677 . . . . 0.0 109.252 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -159.41 161.66 35.62 Favored 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.43 157.81 24.81 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.62 168.55 44.68 Favored Glycine 0 C--N 1.292 -1.913 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.0 m -60.92 144.93 52.08 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.7 m . . . . . 0 C--O 1.25 1.112 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.791 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.44 -0.928 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.93 -39.81 29.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -158.44 -57.21 0.07 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -155.74 97.84 1.87 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.603 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.1 m -94.16 -39.86 10.34 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp 67.06 157.74 0.12 Allowed 'General case' 0 C--O 1.244 0.782 0 C-N-CA 125.231 1.413 . . . . 0.0 113.075 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 t -91.11 111.34 47.99 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -78.85 103.12 1.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 121.619 1.546 . . . . 0.0 111.2 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -82.75 96.24 8.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.981 0.896 . . . . 0.0 109.88 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -144.54 167.74 21.8 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 63' ' ' GLU . 6.3 p -65.62 151.15 10.28 Favored 'Isoleucine or valine' 0 C--O 1.254 1.341 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -87.35 109.18 19.36 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.022 0.915 . . . . 0.0 110.897 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.8 t -102.57 -1.56 30.15 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.663 -1.153 . . . . 0.0 107.929 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -63.41 -44.21 95.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.932 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.5 pt -72.03 -25.05 23.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 88.0 m-85 -84.44 -11.75 55.63 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.947 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 29.2 mtpp -69.28 -14.68 63.08 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.817 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -76.62 -2.99 35.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.686 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -115.03 153.95 47.13 Favored Pre-proline 0 N--CA 1.428 -1.565 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.23 130.58 34.76 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.203 1.935 . . . . 0.0 110.105 174.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.14 -33.1 19.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.3 p -80.86 -26.67 11.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.326 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.72 93.92 3.82 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 122.132 -0.355 . . . . 0.0 111.343 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 68' ' ' THR . 50.7 mt -112.18 117.93 46.85 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.38 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.47 135.55 29.02 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.647 2.231 . . . . 0.0 111.059 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.9 m -121.78 149.31 53.04 Favored Pre-proline 0 C--N 1.3 -1.558 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.244 -173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.7 162.78 39.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.367 2.045 . . . . 0.0 110.541 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.7 pt -83.56 -12.39 11.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.799 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -61.5 126.27 26.76 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -100.21 111.22 23.49 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -121.25 101.0 44.71 Favored Pre-proline 0 C--N 1.296 -1.723 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.62 118.34 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 121.205 1.27 . . . . 0.0 110.935 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.58 143.9 39.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.9 t -107.99 127.14 53.5 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.224 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.31 160.41 28.11 Favored Glycine 0 N--CA 1.42 -2.393 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -56.17 -23.66 36.46 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.964 0.906 . . . . 0.0 112.045 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -88.38 11.3 17.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.661 0.743 . . . . 0.0 110.372 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 63.63 29.11 15.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.902 1.281 . . . . 0.0 112.654 176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.3 mm -103.14 126.13 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.4 m -83.26 124.44 30.58 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -103.23 144.53 31.21 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.43 -19.33 68.6 Favored Glycine 0 C--O 1.222 -0.638 0 O-C-N 124.117 0.886 . . . . 0.0 113.676 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 30.7 p30 -170.94 173.5 5.12 Favored 'General case' 0 C--O 1.256 1.423 0 C-N-CA 123.635 0.774 . . . . 0.0 109.095 176.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HB2' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -70.5 -27.41 64.18 Favored 'General case' 0 C--N 1.312 -1.042 0 O-C-N 123.347 0.404 . . . . 0.0 110.923 -174.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.455 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 44.4 t -54.26 -52.66 60.69 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.596 0.56 . . . . 0.0 110.199 175.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -63.82 -36.72 84.84 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.043 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -63.39 -49.64 73.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.03 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 43.0 t -59.2 -38.71 80.57 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.355 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.501 ' HA ' HD12 ' A' ' 43' ' ' ILE . 26.7 m -56.92 -50.06 73.73 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.927 0.394 . . . . 0.0 110.343 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -71.92 -36.99 70.13 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.013 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.2 m -58.04 -43.9 87.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.968 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.86 -42.24 61.07 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.142 0.496 . . . . 0.0 110.398 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -57.89 -46.04 85.5 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.321 1.048 . . . . 0.0 111.837 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.1 m -99.66 14.6 29.52 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.984 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.8 t30 43.92 76.34 0.08 Allowed 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 114.028 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.443 ' HA2' ' NE2' ' A' ' 78' ' ' GLN . . . 70.94 15.62 74.17 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 115.073 -0.967 . . . . 0.0 114.051 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -72.29 -62.23 1.51 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.73 131.47 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.443 ' NE2' ' HA2' ' A' ' 75' ' ' GLY . 25.2 mm-40 -129.28 173.17 10.76 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -67.54 112.14 4.53 Favored 'General case' 0 C--N 1.284 -2.255 0 O-C-N 123.941 0.776 . . . . 0.0 109.206 174.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 tp -86.29 -56.34 3.49 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -161.07 162.23 31.56 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.208 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.08 146.96 45.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 175.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.79 168.58 38.12 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.75 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -64.45 149.76 47.86 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 122.706 0.402 . . . . 0.0 110.346 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 118.61 -0.71 . . . . 0.0 109.179 178.765 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t . . . . . 0 C--O 1.243 0.752 0 CA-C-O 121.127 0.489 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' C ' ' H ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -76.27 166.96 22.7 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.873 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 75.62 -29.19 0.18 Allowed 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.201 1.4 . . . . 0.0 111.95 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 21' ' ' GLU . . . 71.87 126.06 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.746 1.618 . . . . 0.0 113.22 175.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.2 m -145.63 32.28 1.06 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.32 -21.61 45.66 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 122.255 1.026 . . . . 0.0 108.455 -178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.1 m -132.65 148.19 68.55 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.01 86.05 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 121.64 1.56 . . . . 0.0 109.111 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -62.36 135.57 57.51 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.58 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HD3' ' HB3' ' A' ' 79' ' ' PHE . 5.0 tppt? -143.31 157.12 44.74 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.5 p -71.99 144.22 13.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -80.5 97.41 7.12 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.4 t -93.69 -17.97 22.64 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 p -61.54 -27.75 68.83 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -77.99 -22.29 13.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 O-C-N 121.987 -0.446 . . . . 0.0 112.034 176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 99.1 m-85 -98.9 -19.55 17.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.761 0.791 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -66.97 -14.93 63.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.39 1.076 . . . . 0.0 110.767 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -83.38 -4.04 58.1 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.984 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -100.88 156.88 34.64 Favored Pre-proline 0 C--N 1.314 -0.968 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.92 135.29 68.94 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.608 2.205 . . . . 0.0 111.264 175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 m -55.75 -24.47 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -93.51 -24.9 5.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.851 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.15 93.51 3.9 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.409 0.623 . . . . 0.0 111.045 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.7 mt -120.97 115.83 31.64 Favored Pre-proline 0 C--N 1.289 -2.026 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -67.28 133.61 31.06 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.484 1.456 . . . . 0.0 111.102 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.7 m -114.2 141.26 26.1 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.514 -175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.7 159.19 49.61 Favored 'Trans proline' 0 C--O 1.242 0.708 0 C-N-CA 122.338 2.025 . . . . 0.0 110.464 175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 pt -83.57 -13.56 11.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.944 0.402 . . . . 0.0 110.805 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -70.27 132.41 45.67 Favored 'General case' 0 N--CA 1.423 -1.804 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.45 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 52.8 t80 -96.88 112.83 24.41 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.2 mp -124.05 98.36 39.27 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.19 126.86 22.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 121.867 1.711 . . . . 0.0 111.42 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.73 148.72 33.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.6 t -117.31 131.01 56.89 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-O 120.887 0.375 . . . . 0.0 110.329 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 168.36 26.41 Favored Glycine 0 N--CA 1.422 -2.262 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.8 p -70.91 -8.39 52.57 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.991 0.9 . . . . 0.0 110.745 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.31 -3.61 59.02 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 67.22 27.36 8.43 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 125.912 1.685 . . . . 0.0 112.725 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.77 133.32 48.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.3 m -88.24 129.1 35.45 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -107.79 146.99 31.44 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.376 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -62.66 -28.14 71.01 Favored Glycine 0 CA--C 1.499 -0.964 0 O-C-N 124.57 1.169 . . . . 0.0 112.617 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.3 p30 -172.17 170.03 5.31 Favored 'General case' 0 C--O 1.252 1.221 0 C-N-CA 123.145 0.578 . . . . 0.0 109.898 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.12 -29.07 60.17 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 125.074 1.35 . . . . 0.0 114.197 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 22.4 t -62.36 -44.36 96.66 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.004 0.431 . . . . 0.0 110.318 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -70.31 -37.84 74.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.7 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.2 tp -62.11 -48.91 78.08 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.633 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.6 t -62.86 -41.51 99.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.652 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.9 m -60.39 -49.69 76.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.243 0.544 . . . . 0.0 109.798 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.3 -37.45 87.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.035 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 t -65.68 -58.18 6.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.1 -45.65 86.86 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 123.132 0.573 . . . . 0.0 111.39 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 72' ' ' LYS . 33.8 ttpt -57.43 -33.65 68.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.098 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.6 m -105.18 17.77 23.48 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.853 -174.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 63.56 22.8 13.34 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 123.392 0.677 . . . . 0.0 112.658 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.86 28.94 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.753 -0.736 . . . . 0.0 113.067 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -57.15 -50.96 71.19 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.214 1.007 . . . . 0.0 108.43 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.59 133.84 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.641 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -117.29 160.85 20.45 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.463 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 66.2 t80 -68.48 121.49 16.46 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 30.3 tp -94.38 -60.14 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -158.89 156.84 30.31 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -82.72 166.71 18.86 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.03 168.79 42.1 Favored Glycine 0 C--N 1.273 -2.942 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.4 m -67.73 146.09 54.11 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.3 m . . . . . 0 C--N 1.319 -0.758 0 CA-C-O 119.156 -0.449 . . . . 0.0 110.782 -178.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 N--CA 1.442 -0.829 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -100.74 96.74 7.52 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -164.03 -172.64 2.87 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 71.7 -66.66 0.29 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.566 1.546 . . . . 0.0 112.876 176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 p -78.29 -162.66 0.37 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 122.904 0.481 . . . . 0.0 109.939 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 tt -74.41 77.12 1.9 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.937 0.875 . . . . 0.0 108.748 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.5 m -160.61 83.87 2.01 Favored Pre-proline 0 C--N 1.301 -1.51 0 C-N-CA 125.783 1.633 . . . . 0.0 108.239 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -89.33 78.56 0.98 Allowed 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.451 2.1 . . . . 0.0 108.696 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.74 139.41 53.33 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-O 121.81 0.814 . . . . 0.0 112.306 -173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.11 176.46 8.64 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.639 HG23 ' HB2' ' A' ' 63' ' ' GLU . 5.5 p -66.72 130.94 32.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.37 96.36 9.53 Favored 'General case' 0 N--CA 1.416 -2.167 0 C-N-CA 117.299 -1.761 . . . . 0.0 107.479 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.1 t -88.07 -12.47 44.13 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.202 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.8 m -61.52 -39.66 91.81 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.33 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.8 pt -67.91 -17.69 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.655 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.0 m-85 -99.07 -5.47 30.21 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.115 -0.634 . . . . 0.0 112.201 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -58.82 -21.81 57.23 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.813 0.445 . . . . 0.0 111.976 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -79.24 4.76 14.03 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -118.93 152.03 51.14 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.37 133.06 46.98 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 121.726 1.617 . . . . 0.0 109.684 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 71' ' ' LEU . 15.1 m -57.62 -24.56 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -171.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.8 m -90.11 -25.33 5.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 119.549 -0.861 . . . . 0.0 112.004 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.46 93.87 3.98 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 120.883 0.373 . . . . 0.0 110.808 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 68' ' ' THR . 56.0 mt -119.42 117.25 33.13 Favored Pre-proline 0 C--N 1.295 -1.804 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.95 133.48 31.34 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.527 1.485 . . . . 0.0 109.725 176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.9 m -116.87 150.01 45.08 Favored Pre-proline 0 C--N 1.29 -2.006 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.905 -175.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.18 162.81 36.76 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.506 2.138 . . . . 0.0 111.142 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.7 pt -83.07 -7.29 10.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.264 0.554 . . . . 0.0 109.963 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -64.68 115.2 5.01 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.585 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -90.21 120.15 31.13 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 88.2 mt -133.72 99.06 14.31 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -178.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -62.24 119.92 7.25 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 121.49 1.46 . . . . 0.0 110.954 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.96 152.19 37.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.5 t -114.31 126.21 54.76 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.72 162.64 29.15 Favored Glycine 0 N--CA 1.421 -2.313 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.701 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.0 m -51.21 -25.71 5.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.848 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -88.15 8.32 27.5 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.69 -174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 69.7 29.92 4.03 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 0.0 110.829 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.4 mm -107.22 124.44 63.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.533 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.5 m -81.47 125.7 30.78 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -106.18 155.49 19.41 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.95 -20.96 79.16 Favored Glycine 0 N--CA 1.448 -0.533 0 O-C-N 123.868 0.73 . . . . 0.0 113.586 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.8 p30 -171.81 172.68 4.77 Favored 'General case' 0 C--O 1.252 1.192 0 C-N-CA 123.163 0.585 . . . . 0.0 109.764 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.639 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.52 -33.88 76.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.881 0.738 . . . . 0.0 112.945 -177.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 40.7 t -56.25 -50.96 69.83 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.68 0.392 . . . . 0.0 110.47 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -64.45 -36.03 82.84 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.707 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.6 tp -61.8 -45.79 92.33 Favored 'General case' 0 C--O 1.216 -0.698 0 O-C-N 123.845 0.716 . . . . 0.0 109.484 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.7 t -61.36 -41.47 97.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.397 177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.441 ' HA ' HD12 ' A' ' 43' ' ' ILE . 11.2 m -56.72 -53.09 61.8 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -34.27 77.39 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 177.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 t -58.53 -43.5 89.25 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 122.934 0.494 . . . . 0.0 110.402 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD13 HG12 ' A' ' 40' ' ' VAL . 86.2 mt -72.41 -39.12 68.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.438 . . . . 0.0 110.784 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -65.32 -39.72 92.8 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.022 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -87.3 -0.55 56.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.738 0.304 . . . . 0.0 110.832 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 57.73 68.12 0.88 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.239 1.416 . . . . 0.0 111.834 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.02 11.96 61.86 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.293 -0.867 . . . . 0.0 114.03 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -80.06 -50.18 10.73 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -96.75 117.11 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -125.7 -178.32 4.22 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' HB2' HG12 ' A' ' 30' ' ' VAL . 57.8 t80 -68.87 114.17 6.96 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -89.15 -54.64 4.02 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -159.95 159.5 32.33 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.335 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.28 157.52 30.72 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 165.86 41.33 Favored Glycine 0 C--N 1.293 -1.84 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 151.44 46.35 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.259 1.565 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.02 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -98.02 -76.86 0.52 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.52 -174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.58 -174.07 3.79 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.9 -154.71 0.33 Allowed 'General case' 0 C--O 1.251 1.167 0 O-C-N 123.839 0.712 . . . . 0.0 110.475 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.6 m -127.66 111.32 13.59 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.65 83.3 6.45 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.662 0.744 . . . . 0.0 109.748 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.7 m -78.16 138.8 60.4 Favored Pre-proline 0 N--CA 1.423 -1.797 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.402 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.33 95.33 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.879 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' O ' ' HB3' ' A' ' 79' ' ' PHE . 62.4 tttp -61.39 108.13 0.89 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -96.91 144.16 27.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.643 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.73 159.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -74.77 116.54 15.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.767 0.794 . . . . 0.0 111.122 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.6 t -109.78 -2.44 17.33 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -64.62 -41.12 96.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.45 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.4 pt -68.08 -22.33 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.682 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.5 m-85 -93.12 -8.37 42.83 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.404 -0.519 . . . . 0.0 111.333 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -64.54 -15.3 60.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.324 0.583 . . . . 0.0 110.31 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -81.93 -2.19 50.5 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.061 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -123.18 151.19 61.63 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.19 145.41 78.41 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 121.92 1.747 . . . . 0.0 109.731 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.86 -38.63 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 p -76.59 -26.49 16.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.851 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.17 92.09 3.51 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.114 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.2 mt -122.29 113.81 30.79 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.18 132.52 34.35 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 120.631 0.888 . . . . 0.0 110.091 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.2 m -126.2 144.39 48.91 Favored Pre-proline 0 C--N 1.289 -2.024 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.35 162.96 39.76 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 121.795 1.663 . . . . 0.0 111.196 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 pt -85.96 -1.03 6.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.658 0.742 . . . . 0.0 109.724 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -64.17 128.25 34.97 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.987 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -103.08 108.91 20.27 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.1 mt -123.91 97.45 41.1 Favored Pre-proline 0 C--N 1.292 -1.921 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -59.15 118.59 5.5 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.694 1.596 . . . . 0.0 111.404 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.27 150.42 33.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.7 t -114.49 126.84 55.4 Favored 'General case' 0 C--N 1.281 -2.38 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.142 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.42 164.82 29.6 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 p -67.9 -4.58 13.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.393 0.616 . . . . 0.0 112.201 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.87 0.63 56.4 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 70.35 23.44 5.0 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.257 1.423 . . . . 0.0 111.111 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.9 mm -101.82 132.48 47.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.2 m -86.9 120.13 27.85 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -97.23 152.49 18.8 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.781 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.73 -18.71 77.56 Favored Glycine 0 N--CA 1.441 -0.972 0 O-C-N 124.116 0.885 . . . . 0.0 113.169 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.2 p30 -175.87 173.76 2.26 Favored 'General case' 0 C--O 1.257 1.468 0 C-N-CA 123.565 0.746 . . . . 0.0 109.935 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -64.48 -33.74 76.58 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.992 0.917 . . . . 0.0 110.673 -175.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -45.98 90.86 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.174 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -65.8 -35.54 81.0 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.988 0.423 . . . . 0.0 110.614 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.3 tp -64.46 -46.62 82.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.186 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 35.8 t -61.33 -40.81 95.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.508 178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.1 m -57.69 -51.16 70.65 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.781 0.324 . . . . 0.0 110.197 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -63.6 -35.96 82.23 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.522 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.9 t -65.66 -49.7 67.64 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.519 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.1 mt -64.46 -37.97 89.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.265 0.555 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -60.59 -28.83 68.79 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.42 1.088 . . . . 0.0 110.906 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.0 p -110.45 16.31 21.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.695 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 60.92 24.87 14.88 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.162 0.982 . . . . 0.0 111.639 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.97 31.5 9.84 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.796 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -76.39 -56.78 4.32 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -84.99 129.99 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.625 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -121.26 -179.79 4.17 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 28' ' ' LYS . 74.2 t80 -79.68 126.23 30.65 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.6 tp -96.59 -52.66 3.85 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -164.52 159.62 19.47 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.37 178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.1 153.44 40.79 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.43 172.7 46.93 Favored Glycine 0 N--CA 1.421 -2.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.624 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -64.19 146.93 53.46 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.316 -0.865 0 O-C-N 123.845 0.716 . . . . 0.0 112.235 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.011 0.434 . . . . 0.0 109.906 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.33 160.69 32.74 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.362 -170.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.27 79.1 1.2 Allowed 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -131.42 -28.74 1.84 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.041 -174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.9 t -79.73 -12.45 59.79 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.3 mt -127.84 150.13 49.97 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 m -62.9 120.34 59.87 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.46 145.87 66.33 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.453 2.102 . . . . 0.0 111.963 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.6 128.79 36.65 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 18.9 ptpt -141.96 170.85 14.93 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.569 0.699 . . . . 0.0 112.201 -172.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.422 ' HB ' ' CD1' ' A' ' 79' ' ' PHE . 11.3 p -81.56 151.96 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.75 94.34 5.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.227 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -89.45 -11.18 43.79 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.489 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -60.91 -40.28 92.56 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.725 -175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.468 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 45.8 pt -72.95 -21.1 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.764 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.542 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 98.7 m-85 -87.75 -12.47 45.09 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-O 121.195 0.522 . . . . 0.0 110.736 -177.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -70.49 -14.76 62.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' ILE . 23.4 pttm -78.11 -3.59 43.14 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.675 178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.66 157.59 34.25 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.2 131.11 43.09 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.274 1.983 . . . . 0.0 110.165 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 m -55.53 -24.36 15.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.461 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.14 -25.19 5.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.114 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.86 93.79 3.93 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.882 0.373 . . . . 0.0 110.647 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.8 mt -118.3 124.49 28.55 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -63.03 134.07 44.34 Favored 'Trans proline' 0 C--O 1.247 0.942 0 C-N-CA 121.665 1.577 . . . . 0.0 110.554 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.4 m -107.66 140.62 21.74 Favored Pre-proline 0 C--N 1.291 -1.964 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.616 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -71.07 163.36 39.5 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.078 1.852 . . . . 0.0 110.418 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -82.74 -14.54 11.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.825 0.345 . . . . 0.0 110.663 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.4 m -64.87 119.41 10.61 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.528 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -87.19 122.62 31.23 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.3 mt -135.36 96.46 13.87 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -58.4 119.67 7.07 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.126 1.884 . . . . 0.0 110.489 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.42 148.44 31.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.86 128.61 56.47 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.5 165.95 35.83 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.617 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 m -57.14 -18.97 17.37 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.866 1.266 . . . . 0.0 112.117 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -92.59 6.28 47.86 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 122.101 0.953 . . . . 0.0 109.841 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.7 OUTLIER 61.1 47.04 7.59 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 110.847 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.6 mm -120.53 131.91 71.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.2 m -85.14 131.52 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -112.37 153.55 27.1 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.276 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.59 -27.36 73.87 Favored Glycine 0 N--CA 1.444 -0.828 0 O-C-N 124.014 0.821 . . . . 0.0 113.862 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 34.6 p30 -176.71 -178.67 0.9 Allowed 'General case' 0 C--O 1.256 1.433 0 CA-C-N 116.936 0.368 . . . . 0.0 111.344 177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 29.4 mt-10 -45.74 -51.21 12.92 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 126.47 1.908 . . . . 0.0 111.574 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.5 t -55.51 -53.73 52.79 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.895 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -63.38 -37.93 89.19 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.096 0.474 . . . . 0.0 111.001 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.3 tp -67.03 -48.76 67.36 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.295 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 52.4 t -60.52 -44.46 96.02 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.948 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.9 m -58.65 -50.27 74.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.745 0.307 . . . . 0.0 110.869 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.19 -34.16 75.77 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.1 t -63.31 -48.13 79.33 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.293 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.06 -37.55 81.41 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.139 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -64.55 -34.94 79.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.024 0.44 . . . . 0.0 111.498 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 64.7 p -93.79 1.31 56.5 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.128 0.49 . . . . 0.0 110.644 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 60.12 25.44 14.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.76 1.224 . . . . 0.0 112.54 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.95 22.69 7.82 Favored Glycine 0 N--CA 1.438 -1.174 0 C-N-CA 120.675 -0.774 . . . . 0.0 114.198 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.5 ttp85 -72.49 -53.41 12.16 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.96 129.0 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -134.86 -178.72 5.21 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 29' ' ' LYS . 65.7 t80 -65.95 119.08 10.71 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.4 tp -93.31 -60.41 1.79 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -156.84 153.92 29.02 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -77.48 165.0 24.92 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.05 168.29 40.45 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -68.43 147.59 51.84 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.449 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 60.0 m . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.701 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.91 85.91 5.72 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.447 0.642 . . . . 0.0 111.181 -173.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -160.43 85.9 0.73 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.52 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.05 -80.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.139 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.0 m -88.39 13.64 11.34 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 80.3 mt 71.37 -69.45 0.18 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.973 0.909 . . . . 0.0 109.011 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.4 m -95.35 134.43 24.45 Favored Pre-proline 0 N--CA 1.416 -2.138 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -71.67 78.35 1.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 121.432 1.421 . . . . 0.0 111.393 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -133.47 105.92 7.18 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.284 1.04 . . . . 0.0 112.839 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.542 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . 96.9 mttt -151.14 168.98 23.0 Favored 'General case' 0 C--N 1.272 -2.79 0 N-CA-C 103.429 -2.804 . . . . 0.0 103.429 169.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.42 125.39 26.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.07 105.5 8.19 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.5 t -89.26 -6.58 56.68 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.539 -174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 37' ' ' LYS . 55.4 m -67.4 -36.93 82.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.054 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.57 -16.94 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.666 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 76.6 m-85 -109.85 -13.68 14.42 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 121.397 0.618 . . . . 0.0 109.995 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -71.09 -14.99 62.49 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 122.288 1.042 . . . . 0.0 108.329 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 33' ' ' SER . 55.1 mtpt -72.62 -15.21 61.73 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.143 -1.389 . . . . 0.0 110.16 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.45 152.52 42.77 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.74 133.86 44.21 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.437 1.425 . . . . 0.0 108.687 172.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.16 -25.52 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -75.46 -26.16 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.777 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.59 93.52 3.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 122.241 -0.287 . . . . 0.0 111.371 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.1 mt -123.58 124.55 26.2 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -77.18 134.89 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.403 1.402 . . . . 0.0 110.484 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.1 m -125.81 145.8 53.0 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.83 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -58.71 152.92 53.02 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 123.421 2.747 . . . . 0.0 112.336 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.5 pt -83.85 -17.03 10.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.037 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -68.76 134.23 49.48 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.249 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -90.95 110.73 21.98 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.0 mt -124.43 97.53 39.53 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.3 119.18 6.26 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.047 1.832 . . . . 0.0 111.5 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.43 151.83 29.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 46.0 t -111.84 128.56 56.16 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.81 163.28 23.47 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.441 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.6 m -57.2 -18.76 17.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.145 0.978 . . . . 0.0 112.349 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -86.52 3.5 43.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.414 0.626 . . . . 0.0 109.859 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 69.04 26.71 5.55 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.059 1.343 . . . . 0.0 111.723 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.37 134.33 49.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.41 HG23 ' HA ' ' A' ' 84' ' ' SER . 67.1 m -86.13 127.27 34.68 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -105.97 156.08 18.73 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.989 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.53 -22.32 78.64 Favored Glycine 0 CA--C 1.501 -0.788 0 O-C-N 123.98 0.8 . . . . 0.0 112.996 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.4 p30 -173.0 169.86 4.58 Favored 'General case' 0 C--O 1.255 1.384 0 C-N-CA 123.684 0.793 . . . . 0.0 109.692 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.13 -27.02 65.19 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.286 -175.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 43.1 t -61.86 -44.3 97.1 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -64.7 -40.01 94.64 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.36 -46.75 87.77 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.362 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.3 t -59.77 -38.4 81.73 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 32.8 m -57.97 -48.6 79.49 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -67.47 -34.22 76.73 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.004 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 t -65.09 -39.41 93.13 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.602 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -72.34 -38.65 68.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -59.13 -43.33 91.98 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.79 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 58.3 p -92.61 -13.87 28.99 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.807 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 62.74 75.07 0.41 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.108 1.363 . . . . 0.0 111.75 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.27 8.54 85.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 114.795 -1.093 . . . . 0.0 114.826 174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 64.0 ttt180 -80.46 -62.1 1.78 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.643 0.722 . . . . 0.0 109.51 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.2 118.46 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -132.42 -179.64 5.56 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.542 ' CD2' ' HA ' ' A' ' 29' ' ' LYS . 62.0 t80 -68.16 110.47 4.02 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -85.25 -55.69 3.9 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -159.17 159.81 34.78 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.495 177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.96 152.1 38.81 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.73 168.0 43.63 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.41 ' HA ' HG23 ' A' ' 59' ' ' THR . 25.4 m -57.64 147.5 27.2 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 123.19 0.596 . . . . 0.0 110.26 176.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 81.7 m . . . . . 0 C--N 1.314 -0.937 0 CA-C-O 118.212 -0.899 . . . . 0.0 109.125 178.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 120.821 0.343 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -110.45 156.69 20.48 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 70.33 -61.71 0.45 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.459 1.104 . . . . 0.0 109.271 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -102.97 91.15 4.01 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.7 m -97.53 -14.27 21.17 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.85 -176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -164.51 151.8 11.6 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.402 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -116.52 86.64 18.73 Favored Pre-proline 0 C--N 1.292 -1.894 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -87.44 103.88 0.55 Allowed 'Trans proline' 0 N--CA 1.43 -2.256 0 C-N-CA 122.196 1.931 . . . . 0.0 113.675 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -116.53 130.65 56.87 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -143.51 156.25 44.57 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 63' ' ' GLU . 5.4 p -68.38 106.63 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.429 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.14 93.62 5.22 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.64 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 26.9 t -93.19 -20.77 20.13 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 p -54.05 -35.2 61.75 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.645 1.178 . . . . 0.0 113.959 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.55 -28.93 16.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.095 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.575 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 72.9 m-85 -89.28 -19.8 24.88 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.1 mtpt -60.48 -14.23 18.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.533 0.733 . . . . 0.0 112.343 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -72.74 -25.53 61.24 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.47 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -89.8 152.68 46.99 Favored Pre-proline 0 C--N 1.316 -0.89 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.83 139.01 82.96 Favored 'Trans proline' 0 C--O 1.217 -0.572 0 C-N-CA 122.124 1.883 . . . . 0.0 110.058 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 32.1 m -59.2 -15.72 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -173.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.35 -25.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 120.783 0.325 . . . . 0.0 110.627 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.24 93.91 3.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 122.094 -0.379 . . . . 0.0 110.726 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 68' ' ' THR . 55.6 mt -124.53 107.97 29.2 Favored Pre-proline 0 C--N 1.298 -1.673 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.11 134.36 33.8 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.23 1.953 . . . . 0.0 110.578 177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.1 m -114.66 147.02 37.23 Favored Pre-proline 0 C--N 1.292 -1.931 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.038 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -61.8 152.45 74.38 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.294 1.996 . . . . 0.0 110.093 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.59 -7.71 10.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.1 m -74.91 133.35 41.81 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -92.31 127.05 37.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.8 mp -131.85 99.17 16.94 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 176.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -61.25 118.42 5.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 121.761 1.641 . . . . 0.0 111.196 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.35 152.13 36.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -117.08 128.2 54.91 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.165 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.38 163.09 28.61 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 m -62.23 -13.99 33.63 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.84 0.856 . . . . 0.0 111.733 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -89.37 2.37 54.52 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 122.074 0.94 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 65.75 24.97 11.44 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 124.857 1.263 . . . . 0.0 113.401 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.68 130.72 50.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 175.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.7 m -86.57 132.71 33.83 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.87 151.46 29.09 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.217 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.55 -24.91 72.64 Favored Glycine 0 C--O 1.218 -0.885 0 O-C-N 124.434 1.084 . . . . 0.0 113.054 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.8 p30 -173.74 173.55 3.3 Favored 'General case' 0 C--O 1.259 1.556 0 C-N-CA 124.061 0.944 . . . . 0.0 109.116 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.452 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -65.12 -26.63 68.28 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 123.52 0.512 . . . . 0.0 112.088 -174.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.45 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 38.6 t -56.5 -48.51 77.03 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.084 0.24 . . . . 0.0 110.803 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -67.57 -32.37 73.07 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.954 0.406 . . . . 0.0 110.783 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 52.2 tp -67.53 -46.01 74.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.097 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.575 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 32.0 t -59.2 -44.94 92.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.335 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.427 ' HA ' HD12 ' A' ' 43' ' ' ILE . 29.3 m -55.25 -48.23 74.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.099 0.476 . . . . 0.0 110.745 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -71.49 -34.81 70.49 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.903 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -65.57 -33.53 76.13 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.312 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 36' ' ' LYS . 92.4 mt -74.47 -33.37 62.86 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.27 -50.98 50.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 0.0 110.724 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 p -81.48 -19.89 41.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.525 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.9 t30 63.43 78.91 0.27 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 125.216 1.406 . . . . 0.0 111.933 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.2 90.29 Favored Glycine 0 C--N 1.313 -0.698 0 CA-C-N 114.99 -1.004 . . . . 0.0 115.123 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -73.28 -55.81 5.93 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.293 1.046 . . . . 0.0 109.354 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.9 p -94.54 111.79 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-O 121.69 0.757 . . . . 0.0 109.26 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -112.65 -179.61 3.71 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.44 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -77.78 118.37 20.07 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.1 tp -92.43 -56.81 2.9 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -160.48 161.0 32.71 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.604 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -74.77 151.16 39.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.2 174.51 43.64 Favored Glycine 0 C--N 1.29 -1.974 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.327 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.1 m -69.54 152.32 44.94 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 119.275 -0.393 . . . . 0.0 110.77 -178.341 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.7 m . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.36 75.22 10.25 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -170.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.74 -15.64 18.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -148.98 168.28 23.51 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.5 m 63.07 37.04 11.87 Favored 'General case' 0 C--O 1.249 1.056 0 C-N-CA 123.581 0.753 . . . . 0.0 111.029 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 mp -73.42 138.86 45.49 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -136.47 153.74 76.38 Favored Pre-proline 0 C--N 1.284 -2.26 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.26 40.23 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 124.094 3.196 . . . . 0.0 115.801 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -86.83 106.09 17.48 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -162.97 154.98 18.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 175.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.45 148.76 11.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.62 108.97 5.94 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.732 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 45.7 t -93.85 -5.06 48.91 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 114.139 -1.391 . . . . 0.0 108.372 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 37' ' ' LYS . 3.7 m -65.35 -39.85 92.89 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.427 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -59.05 -28.0 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.452 0.47 . . . . 0.0 111.848 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.619 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -91.22 -33.05 15.54 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.666 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 50.7 mtmt -62.18 -14.38 37.06 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 177.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 33' ' ' SER . 32.3 mmtp -76.42 -5.89 49.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.084 0.469 . . . . 0.0 111.142 179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.32 156.7 40.74 Favored Pre-proline 0 C--N 1.308 -1.196 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.4 135.49 70.47 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.824 1.683 . . . . 0.0 110.533 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.42 -29.42 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.995 0.918 . . . . 0.0 112.902 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.82 -26.11 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.205 0 C-N-CA 120.072 -0.651 . . . . 0.0 111.981 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.02 93.85 3.94 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 121.743 -0.598 . . . . 0.0 111.332 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 68' ' ' THR . 45.2 mt -124.81 132.56 24.33 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -70.52 134.51 26.54 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 121.446 1.431 . . . . 0.0 110.643 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.8 m -116.93 146.43 37.84 Favored Pre-proline 0 C--N 1.297 -1.699 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.148 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 64' ' ' CYS . 9.0 Cg_endo -59.12 146.64 93.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.103 1.869 . . . . 0.0 110.158 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 33.9 pt -80.78 -20.6 11.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.3 m -79.89 138.09 37.07 Favored 'General case' 0 C--O 1.252 1.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.729 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -82.66 108.48 16.06 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 81.1 mt -118.67 98.82 51.34 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.23 120.34 7.96 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.285 1.99 . . . . 0.0 111.88 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.12 146.35 34.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.7 t -106.41 128.21 53.87 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.34 159.94 24.45 Favored Glycine 0 N--CA 1.419 -2.447 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.7 m -61.16 -14.29 23.91 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.652 0.781 . . . . 0.0 112.352 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -85.93 3.86 40.09 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.819 0.847 . . . . 0.0 109.68 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 65.95 36.5 5.88 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.217 1.407 . . . . 0.0 111.925 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.5 131.7 71.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.9 m -84.34 122.43 28.91 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -97.73 152.64 18.91 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.639 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.54 -15.17 72.89 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.0 0.812 . . . . 0.0 114.123 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 173.68 -179.63 0.09 Allowed 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.167 1.387 . . . . 0.0 108.715 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.28 -26.71 62.09 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.408 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 44.4 t -63.41 -42.27 98.74 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -69.63 -30.69 68.47 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.153 0.502 . . . . 0.0 110.0 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.4 tp -69.47 -49.08 58.19 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 30.9 t -61.55 -46.24 90.76 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.058 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.461 HG22 HD12 ' A' ' 43' ' ' ILE . 17.6 p -59.85 -48.51 81.41 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 111.15 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.39 -36.67 84.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.101 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -61.87 -44.56 96.58 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.997 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 87.2 mt -69.62 -45.72 67.89 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.359 0.6 . . . . 0.0 110.209 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -46.81 81.77 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.612 1.165 . . . . 0.0 110.612 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.5 m -91.62 13.29 18.38 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 55.24 60.1 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.35 18.56 76.92 Favored Glycine 0 C--N 1.316 -0.559 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.994 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -63.93 -51.67 63.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.969 0.89 . . . . 0.0 110.359 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.03 122.13 62.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.356 -174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -105.61 174.78 5.73 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 172.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 91.2 t80 -76.76 119.59 20.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 tp -92.27 -53.78 4.09 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.067 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -163.3 166.46 23.04 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.236 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -75.06 149.88 39.04 Favored 'General case' 0 C--O 1.252 1.214 0 O-C-N 123.801 0.688 . . . . 0.0 109.183 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.37 173.95 50.08 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.677 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.9 m -65.65 152.24 44.65 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 122.698 0.399 . . . . 0.0 110.372 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.037 -179.803 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 120.912 0.386 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -87.36 -22.13 25.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.384 0.611 . . . . 0.0 110.155 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.27 129.9 54.24 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.12 35.72 0.8 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.501 0.667 . . . . 0.0 109.944 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.6 p -83.88 6.83 20.14 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 123.7 0.8 . . . . 0.0 111.806 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.08 84.99 7.26 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-O 121.516 0.674 . . . . 0.0 109.548 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -89.08 132.72 37.03 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -74.99 34.46 0.4 Allowed 'Trans proline' 0 N--CA 1.489 1.223 0 C-N-CA 123.574 2.849 . . . . 0.0 113.481 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -102.22 138.02 39.72 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -133.82 175.82 9.11 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -87.45 134.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -89.66 94.6 9.91 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 34.6 t -92.68 -9.34 41.18 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.56 -33.18 72.38 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.6 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.28 -24.87 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.07 174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 60.3 m-85 -92.05 -9.6 42.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.411 -0.516 . . . . 0.0 110.715 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 64.1 mttp -68.98 -14.75 63.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.545 0.688 . . . . 0.0 109.585 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -78.36 -11.05 59.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.534 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -109.98 153.14 43.3 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -64.45 146.72 89.99 Favored 'Trans proline' 0 C--N 1.327 -0.598 0 C-N-CA 121.593 1.529 . . . . 0.0 109.415 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.93 -31.66 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 111.383 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -80.07 -25.79 11.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.29 93.76 3.89 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.071 0.462 . . . . 0.0 111.325 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 64.6 mt -124.68 125.59 25.49 Favored Pre-proline 0 C--N 1.299 -1.602 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' ILE . 3.0 Cg_exo -76.59 133.61 14.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.559 1.506 . . . . 0.0 110.353 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.3 147.72 66.2 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 159.86 49.06 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 121.995 1.796 . . . . 0.0 112.113 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.69 -12.31 14.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.159 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -66.06 132.69 49.11 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.038 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -94.81 110.03 21.94 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 85.8 mt -122.12 97.32 45.73 Favored Pre-proline 0 C--N 1.285 -2.21 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -60.58 122.58 11.49 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.698 1.599 . . . . 0.0 111.873 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.15 150.04 33.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.0 t -115.33 129.77 56.7 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 120.908 0.385 . . . . 0.0 110.155 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.62 165.55 28.57 Favored Glycine 0 N--CA 1.427 -1.93 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.5 p -63.9 -15.0 58.02 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 124.166 0.987 . . . . 0.0 112.344 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.84 1.83 51.06 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.731 0.777 . . . . 0.0 109.276 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 65.86 36.53 6.01 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 125.452 1.501 . . . . 0.0 111.671 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mm -112.96 131.59 64.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.411 HG23 ' HA ' ' A' ' 84' ' ' SER . 79.5 m -82.21 124.59 30.05 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.8 m-85 -105.63 150.48 25.38 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.962 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.93 -15.23 73.9 Favored Glycine 0 N--CA 1.443 -0.844 0 O-C-N 124.302 1.001 . . . . 0.0 113.865 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.7 p30 -179.44 170.56 1.33 Allowed 'General case' 0 C--O 1.252 1.19 0 C-N-CA 124.204 1.002 . . . . 0.0 109.633 175.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -28.68 69.1 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.73 -47.05 82.66 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.068 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -64.95 -35.59 81.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.848 0.356 . . . . 0.0 110.354 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.87 -46.95 88.58 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.001 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.707 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 53.8 t -65.09 -34.56 78.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.546 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.4 m -56.35 -49.46 74.33 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -67.91 -37.75 82.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.534 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.1 t -59.66 -47.01 87.32 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.66 0.384 . . . . 0.0 110.731 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.0 mt -72.03 -39.53 69.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.04 0.447 . . . . 0.0 110.733 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -64.69 -30.61 71.63 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.54 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' ARG . 79.1 p -100.46 -4.47 28.78 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.7 t30 60.24 62.59 1.57 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.306 1.442 . . . . 0.0 112.2 -178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 7.28 86.99 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.139 -0.937 . . . . 0.0 114.449 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 73' ' ' SER . 30.0 ttt180 -65.78 -54.99 19.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.43 124.01 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.8 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -137.4 178.44 7.1 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -62.01 123.04 17.02 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.385 0.674 . . . . 0.0 111.586 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.06 -58.21 1.99 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -158.74 161.51 37.04 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.16 153.9 35.84 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.68 173.7 45.65 Favored Glycine 0 N--CA 1.427 -1.91 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.129 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 59' ' ' THR . 15.4 m -67.48 149.95 49.52 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 C--N 1.308 -1.217 0 CA-C-O 119.06 -0.495 . . . . 0.0 111.606 -178.271 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.158 0.504 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -93.39 89.85 6.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.808 -171.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.04 14.8 1.33 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.425 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.22 -80.59 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.614 1.166 . . . . 0.0 111.756 -176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 m -170.47 157.62 6.05 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 125.27 1.428 . . . . 0.0 107.267 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 25' ' ' LEU . 1.4 pt? -102.19 97.51 7.79 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -132.56 129.51 21.41 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.504 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -172.81 1.64 Allowed 'Trans proline' 0 C--O 1.25 1.105 0 C-N-CA 122.359 2.039 . . . . 0.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -88.12 140.77 29.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -91.13 120.91 32.46 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.31 141.29 16.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -86.13 102.74 14.14 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 118.559 -1.256 . . . . 0.0 108.972 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.1 t -97.03 -8.41 30.49 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -69.1 -32.41 71.8 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.158 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.0 pt -64.98 -28.56 45.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 120.854 0.359 . . . . 0.0 111.437 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.517 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 82.2 m-85 -89.5 -9.96 48.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.178 0.513 . . . . 0.0 110.523 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -66.83 -14.57 62.83 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.718 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.35 -15.8 63.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 43' ' ' ILE . 81.9 m-85 -112.99 151.63 44.27 Favored Pre-proline 0 N--CA 1.433 -1.286 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.92 144.01 75.06 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 122.038 1.825 . . . . 0.0 110.919 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.96 -38.74 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 C-N-CA 124.179 0.992 . . . . 0.0 113.5 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.5 m -79.54 -24.88 12.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.11 93.06 3.65 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.882 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG22 ' A' ' 68' ' ' THR . 37.6 mt -125.52 112.84 25.47 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.07 134.1 35.64 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.661 1.574 . . . . 0.0 109.9 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.6 m -115.55 147.61 39.2 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.726 -177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -64.46 157.42 54.98 Favored 'Trans proline' 0 C--O 1.245 0.847 0 C-N-CA 121.956 1.771 . . . . 0.0 110.439 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.1 pt -91.99 -4.06 10.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.323 0.582 . . . . 0.0 110.184 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -64.34 124.67 22.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -88.49 106.86 18.56 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.964 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 83.0 mt -123.4 96.1 44.39 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.17 118.9 5.8 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.304 1.336 . . . . 0.0 110.946 -177.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.8 m -126.57 145.81 33.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 42.4 t -111.75 123.35 50.05 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-O 120.915 0.388 . . . . 0.0 110.307 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.78 169.3 40.51 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.6 p -66.86 -8.47 29.18 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.04 0.448 . . . . 0.0 112.058 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -87.06 -0.89 57.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.384 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 65.65 39.5 4.87 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.46 1.104 . . . . 0.0 110.85 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.3 mm -116.16 133.03 63.96 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.278 -1.328 . . . . 0.0 108.541 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.3 m -89.01 113.14 24.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.69 152.34 19.58 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.315 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.83 -15.02 73.5 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 123.835 0.709 . . . . 0.0 113.623 -178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.2 p30 179.62 176.47 0.66 Allowed 'General case' 0 C--O 1.255 1.371 0 C-N-CA 124.571 1.148 . . . . 0.0 109.165 175.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -26.71 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.476 0.485 . . . . 0.0 111.597 -175.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.0 t -62.87 -41.04 99.25 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -69.37 -30.37 68.35 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.316 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.9 tp -69.88 -49.34 53.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.969 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.4 t -59.51 -47.19 86.48 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.531 0.733 . . . . 0.0 111.555 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.448 HG22 HD12 ' A' ' 43' ' ' ILE . 5.4 p -59.64 -43.95 93.67 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -65.79 -38.89 90.24 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -62.64 -50.37 71.49 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.253 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.04 -40.83 95.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.013 0.435 . . . . 0.0 110.777 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -57.47 -45.43 84.83 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 124.366 1.066 . . . . 0.0 110.635 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -95.66 17.24 15.33 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.544 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 47.53 60.28 3.59 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.803 1.641 . . . . 0.0 113.771 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.47 15.15 81.74 Favored Glycine 0 C--N 1.312 -0.755 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.973 175.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.89 -60.29 3.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 110.272 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.02 132.24 33.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 121.262 0.553 . . . . 0.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -117.88 173.26 6.86 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.164 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -75.85 119.06 19.32 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.7 tp -93.75 -58.23 2.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -159.53 155.22 26.0 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.386 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -77.36 157.95 30.38 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.04 168.6 40.62 Favored Glycine 0 N--CA 1.417 -2.579 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -66.24 153.68 41.87 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 C--O 1.259 1.597 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.179 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 120.92 0.391 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -113.81 135.57 53.81 Favored 'General case' 0 N--CA 1.428 -1.537 0 O-C-N 121.955 -0.466 . . . . 0.0 110.044 -174.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 107.36 12.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 68.55 -178.61 0.22 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.703 1.201 . . . . 0.0 112.216 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.3 p -92.85 2.52 56.72 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.749 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.7 mt 64.85 -162.25 0.27 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.977 0.911 . . . . 0.0 110.007 -177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 28' ' ' LYS . 16.5 p -117.35 101.99 52.49 Favored Pre-proline 0 N--CA 1.421 -1.9 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -177.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -88.77 34.69 0.38 Allowed 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.228 2.619 . . . . 0.0 107.804 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 26' ' ' SER . 87.8 tttt -67.66 129.22 39.22 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 112.813 -1.994 . . . . 0.0 110.192 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 79' ' ' PHE . 18.2 ptpt -142.33 176.21 9.17 Favored 'General case' 0 N--CA 1.408 -2.541 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.884 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.74 150.86 14.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.0 124.38 26.86 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.07 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 46.2 t -107.78 -5.56 17.26 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.4 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -68.52 -32.39 72.31 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.327 0.651 . . . . 0.0 110.345 -176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.1 pt -70.27 -30.34 42.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.559 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 85.0 m-85 -90.24 -20.58 22.82 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.868 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.5 mtpp -62.21 -14.27 36.27 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 121.437 0.637 . . . . 0.0 112.068 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -81.55 -4.68 56.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.649 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -107.17 152.58 41.17 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.49 134.39 63.61 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.08 1.854 . . . . 0.0 111.03 176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -50.82 -41.23 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.992 0.917 . . . . 0.0 112.744 -175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 p -80.41 -25.62 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.87 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.73 93.15 3.76 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.737 -0.602 . . . . 0.0 111.252 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 59.9 mt -117.58 115.47 37.41 Favored Pre-proline 0 C--N 1.298 -1.656 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.76 133.85 41.09 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.04 1.827 . . . . 0.0 110.544 176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -118.94 142.62 32.25 Favored Pre-proline 0 C--N 1.293 -1.862 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.746 -176.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -59.14 154.44 45.74 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 122.659 2.239 . . . . 0.0 110.959 176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.01 -17.5 11.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-O 120.979 0.419 . . . . 0.0 110.405 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.7 m -65.42 120.37 12.71 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.189 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -85.32 115.85 23.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.44 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.6 mt -128.52 94.53 35.15 Favored Pre-proline 0 C--N 1.288 -2.072 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -58.32 120.46 8.37 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.911 1.741 . . . . 0.0 111.597 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.31 148.78 30.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 50.7 t -112.62 126.46 55.39 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.33 166.32 30.62 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.227 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.4 m -62.17 -12.91 22.41 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.42 0.688 . . . . 0.0 111.985 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.31 1.27 56.7 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.755 0.788 . . . . 0.0 109.43 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 68.58 28.54 5.79 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.128 1.371 . . . . 0.0 111.915 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.14 130.01 56.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 m -83.31 119.23 24.34 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-O 121.525 0.678 . . . . 0.0 109.59 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -99.61 151.82 20.75 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.47 -25.8 72.69 Favored Glycine 0 C--O 1.213 -1.174 0 O-C-N 124.26 0.975 . . . . 0.0 113.535 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.1 p30 -174.67 175.72 2.41 Favored 'General case' 0 C--O 1.256 1.398 0 C-N-CA 123.708 0.803 . . . . 0.0 109.218 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -28.29 68.19 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.51 0.506 . . . . 0.0 112.133 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 41.6 t -56.53 -52.54 64.38 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 123.451 0.469 . . . . 0.0 110.125 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -65.84 -32.4 73.91 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.813 0.34 . . . . 0.0 111.111 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.3 tp -64.51 -48.76 73.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.484 175.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 44.1 t -61.35 -45.32 94.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.416 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.1 m -57.03 -49.34 76.11 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 121.18 0.514 . . . . 0.0 110.647 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.22 -34.48 76.32 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.66 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 t -64.32 -47.75 78.22 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.307 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.58 -38.6 91.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.8 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.81 -39.78 95.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.808 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.1 p -89.6 4.5 49.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.458 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 62.59 30.05 16.99 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.854 0.862 . . . . 0.0 112.582 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.14 27.8 7.59 Favored Glycine 0 N--CA 1.436 -1.362 0 C-N-CA 120.397 -0.906 . . . . 0.0 114.743 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -76.58 -52.44 9.73 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 118.368 1.084 . . . . 0.0 110.793 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -94.07 119.91 42.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.687 -176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -106.39 -179.62 3.99 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.51 ' HB3' ' HA ' ' A' ' 29' ' ' LYS . 66.1 t80 -80.31 119.1 22.59 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.8 tp -91.34 -54.26 3.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -160.12 159.7 32.1 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.682 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -78.96 151.32 31.7 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.13 170.58 35.09 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.473 -0.87 . . . . 0.0 110.997 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.0 m -65.99 145.23 56.13 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.824 -0.607 . . . . 0.0 111.295 -177.648 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.226 -0.134 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -67.93 -37.3 81.49 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 172.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.57 129.9 54.43 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 172.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . -123.01 11.51 9.57 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.08 0.467 . . . . 0.0 110.205 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 m 68.2 -79.89 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.444 1.098 . . . . 0.0 113.428 172.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mp -83.48 -1.09 52.83 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.306 0.574 . . . . 0.0 111.176 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 2.9 p -146.4 123.33 5.88 Favored Pre-proline 0 N--CA 1.422 -1.858 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.245 176.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -86.25 -172.93 1.13 Allowed 'Trans proline' 0 C--O 1.248 0.993 0 C-N-CA 121.907 1.738 . . . . 0.0 110.357 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -89.35 96.48 10.73 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.477 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.89 142.26 35.35 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.257 -175.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 79' ' ' PHE . 14.3 p -58.81 139.43 18.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.143 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.176 -177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -88.58 106.84 18.57 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 42.3 t -99.46 -7.34 26.19 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m -67.11 -45.03 78.44 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.488 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.2 pt -69.12 -15.09 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.175 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.478 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.8 m-85 -96.42 -11.75 25.25 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.162 0.506 . . . . 0.0 110.691 177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 28.8 mtpp -75.04 -14.21 60.57 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -77.72 -4.09 44.47 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.278 0.561 . . . . 0.0 111.259 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -108.38 159.71 29.77 Favored Pre-proline 0 N--CA 1.438 -1.063 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.33 145.05 76.5 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 121.393 1.395 . . . . 0.0 109.348 173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.77 -40.63 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 121.404 0.621 . . . . 0.0 111.282 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.03 -26.93 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.503 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.04 92.99 3.64 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.587 -0.696 . . . . 0.0 111.528 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.8 mt -118.09 119.64 33.27 Favored Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.94 133.66 31.94 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 121.406 1.404 . . . . 0.0 111.206 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.2 m -106.58 139.7 20.6 Favored Pre-proline 0 C--N 1.295 -1.8 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.806 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.52 160.53 35.41 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.383 2.055 . . . . 0.0 110.449 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.5 pt -91.9 -9.06 10.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.118 0.485 . . . . 0.0 111.523 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 130.9 39.56 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -85.39 117.1 24.1 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 95.6 mt -129.28 97.13 26.36 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -63.97 118.83 5.75 Favored 'Trans proline' 0 N--CA 1.44 -1.66 0 C-N-CA 121.506 1.47 . . . . 0.0 110.43 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.88 145.9 34.38 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.8 t -110.83 127.6 55.47 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-O 120.884 0.373 . . . . 0.0 110.48 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 78' ' ' GLN . . . -89.99 161.28 29.15 Favored Glycine 0 N--CA 1.421 -2.336 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.608 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.3 m -54.66 -24.45 21.74 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.856 1.262 . . . . 0.0 112.31 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.54 7.19 34.35 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.701 0.762 . . . . 0.0 110.304 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 68.25 24.6 7.42 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.53 1.132 . . . . 0.0 112.62 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.0 mm -97.49 121.28 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.944 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.0 m -81.71 128.34 33.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.61 150.86 26.92 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.291 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.1 -23.54 76.11 Favored Glycine 0 N--CA 1.445 -0.706 0 O-C-N 124.104 0.877 . . . . 0.0 113.284 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 28.4 p30 -176.52 175.33 1.76 Allowed 'General case' 0 C--O 1.255 1.383 0 CA-C-O 121.091 0.472 . . . . 0.0 111.645 176.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 63' ' ' GLU . 49.2 mt-10 -44.99 -47.82 11.47 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.268 2.227 . . . . 0.0 112.609 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.7 t -56.23 -44.29 79.45 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.837 -176.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -72.19 -39.51 68.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.118 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.7 tp -62.94 -47.29 83.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.964 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 50.4 t -62.84 -41.36 99.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.941 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 90.2 m -57.43 -51.61 68.71 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.856 0.36 . . . . 0.0 110.605 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -68.79 -34.46 75.58 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.515 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.7 t -61.69 -46.18 90.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 77.1 mt -68.81 -44.06 74.31 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -54.6 -56.91 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.674 0.79 . . . . 0.0 111.181 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.7 m -89.47 28.9 1.19 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.788 -176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 p30 50.54 21.6 0.9 Allowed 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 126.29 1.836 . . . . 0.0 115.294 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.35 7.41 34.91 Favored Glycine 0 C--N 1.295 -1.74 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.618 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -60.93 -46.36 90.99 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.976 0.894 . . . . 0.0 109.575 175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.5 p -108.19 119.32 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.742 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 76.3 mt-30 -129.67 -178.6 4.76 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.461 ' HB2' HG12 ' A' ' 30' ' ' VAL . 75.4 t80 -65.71 111.46 3.22 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -87.28 -54.01 4.53 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -162.16 159.81 26.39 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -79.89 158.54 26.66 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.99 177.16 42.29 Favored Glycine 0 N--CA 1.416 -2.698 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 m -70.13 152.18 44.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 80.0 m . . . . . 0 C--N 1.319 -0.75 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.859 -178.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.19 133.66 40.1 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.667 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 57.09 78.38 0.23 Allowed 'General case' 0 C--N 1.321 -0.663 0 O-C-N 124.66 1.225 . . . . 0.0 112.979 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.19 98.37 6.57 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 175.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 m -132.53 150.94 52.08 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.92 130.36 35.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 28' ' ' LYS . 45.7 m -157.15 157.95 30.77 Favored Pre-proline 0 C--N 1.293 -1.889 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -69.88 40.49 0.31 Allowed 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 123.629 2.886 . . . . 0.0 111.516 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 85.2 tttt -93.04 148.89 21.62 Favored 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 125.555 1.542 . . . . 0.0 108.531 -177.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 28' ' ' LYS . 4.0 ttmp? -77.61 151.12 34.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 p -42.4 128.19 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.342 0 O-C-N 124.391 1.057 . . . . 0.0 111.386 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -76.6 94.26 3.73 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.755 0.788 . . . . 0.0 109.69 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 43.4 t -93.9 -15.74 24.68 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.24 -34.82 77.25 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.266 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.2 pt -65.24 -31.61 54.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.853 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.479 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.3 m-85 -87.71 -16.89 33.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.129 0.49 . . . . 0.0 111.159 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 99.0 mttt -66.81 -14.54 62.77 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.454 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -73.98 -12.26 60.58 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.798 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.87 152.1 44.57 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.95 138.74 80.81 Favored 'Trans proline' 0 C--O 1.22 -0.398 0 C-N-CA 122.027 1.818 . . . . 0.0 109.125 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.33 -30.53 35.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.32 -27.03 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.522 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.38 92.99 3.68 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.116 0.484 . . . . 0.0 111.479 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.5 mt -125.09 122.66 25.38 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.83 133.71 24.18 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 121.037 1.158 . . . . 0.0 110.248 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 99.8 m -116.74 139.6 25.79 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -61.58 150.49 85.19 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.238 1.959 . . . . 0.0 112.026 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.1 pt -76.72 -13.17 14.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.418 0.628 . . . . 0.0 109.72 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.2 m -69.01 137.18 53.46 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.68 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -101.25 113.78 27.15 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 4.3 mp -119.76 97.07 49.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.85 118.91 5.85 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.364 1.376 . . . . 0.0 110.299 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.4 m -129.71 146.79 33.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.7 t -109.53 125.81 52.9 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.09 161.58 24.54 Favored Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.5 m -53.3 -24.5 11.85 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.494 1.118 . . . . 0.0 112.616 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -79.34 -1.73 38.27 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.273 0.629 . . . . 0.0 110.576 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 72.49 30.65 1.89 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.853 1.661 . . . . 0.0 110.85 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.74 131.19 61.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.746 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.2 m -81.56 119.21 23.48 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -98.72 152.32 19.79 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -72.07 -19.5 78.49 Favored Glycine 0 N--CA 1.443 -0.869 0 O-C-N 124.094 0.871 . . . . 0.0 113.498 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.0 p30 -177.11 177.19 1.28 Allowed 'General case' 0 C--O 1.255 1.393 0 C-N-CA 123.75 0.82 . . . . 0.0 109.54 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -27.93 64.5 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.442 0.463 . . . . 0.0 111.622 -175.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.7 t -55.76 -52.03 65.34 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.364 0.415 . . . . 0.0 109.906 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -65.35 -36.66 84.68 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.033 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.1 tp -63.12 -48.09 80.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.526 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 46.9 t -59.63 -45.27 92.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.435 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.8 m -57.53 -47.17 82.73 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 121.304 0.573 . . . . 0.0 110.59 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -66.57 -39.33 88.43 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.774 -178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 t -64.63 -38.7 91.89 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.653 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 67' ' ' CYS . 93.1 mt -67.57 -37.01 82.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.782 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -73.52 -43.74 59.32 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.426 0.632 . . . . 0.0 110.961 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.6 m -83.5 0.23 47.3 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.854 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 55.25 71.01 0.57 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.71 1.204 . . . . 0.0 112.689 177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.97 -2.98 39.66 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.582 -0.736 . . . . 0.0 114.895 174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -59.47 -54.46 46.41 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.225 0.536 . . . . 0.0 111.74 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.74 125.04 53.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -128.78 -178.63 4.68 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.62 112.09 8.36 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.1 tp -86.12 -48.73 8.34 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -165.1 161.37 19.57 Favored 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.417 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -75.61 147.16 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.29 165.46 39.85 Favored Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.708 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -61.09 150.82 32.75 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.065 0.546 . . . . 0.0 110.376 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 C--O 1.255 1.363 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -111.33 66.91 0.63 Allowed 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -175.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.78 75.64 10.07 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.353 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -171.35 -71.2 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.885 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.7 t 61.5 72.82 0.5 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.399 1.095 . . . . 0.0 108.36 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.8 mt -73.91 -48.29 31.84 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.493 -173.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 26.7 t -146.55 116.25 4.59 Favored Pre-proline 0 N--CA 1.417 -2.096 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.63 86.69 1.33 Allowed 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.861 1.707 . . . . 0.0 110.137 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -78.15 105.65 9.51 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.43 141.73 43.6 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.821 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 p -83.27 155.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 102.726 -3.064 . . . . 0.0 102.726 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -80.14 94.45 6.01 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 116.661 -2.016 . . . . 0.0 111.322 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 53.9 t -83.17 -17.14 43.93 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 113.352 -1.749 . . . . 0.0 107.887 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -54.34 -47.07 72.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.172 0.989 . . . . 0.0 111.794 -177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.2 pt -68.42 -18.05 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.589 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 97.9 m-85 -94.93 -22.48 17.95 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 110.012 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 57.7 mtpt -65.47 -14.41 60.93 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.855 0.862 . . . . 0.0 110.407 175.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -67.44 -15.39 63.65 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.518 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -107.83 161.44 23.25 Favored Pre-proline 0 C--N 1.318 -0.783 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -52.56 153.64 13.63 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.129 2.553 . . . . 0.0 112.554 175.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -59.76 -41.6 86.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 123.79 0.836 . . . . 0.0 112.922 -173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -96.55 -11.2 8.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 119.495 -0.882 . . . . 0.0 112.833 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.53 92.98 3.77 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.698 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 35' ' ' TYR . 67.8 mt -124.92 127.79 25.02 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -70.86 134.07 24.88 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.147 1.231 . . . . 0.0 111.554 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.3 m -106.46 136.92 19.32 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.047 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.08 162.65 39.12 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.128 1.885 . . . . 0.0 110.961 176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -86.78 -3.37 8.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.333 0.587 . . . . 0.0 110.639 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.7 m -75.8 127.69 33.54 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.469 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -92.25 117.13 29.58 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 87.2 mt -129.77 95.93 27.81 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.6 118.97 5.88 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.96 1.773 . . . . 0.0 111.474 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.0 m -131.17 153.17 38.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.5 t -119.9 130.1 54.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.41 162.98 27.26 Favored Glycine 0 N--CA 1.422 -2.271 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.36 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 m -61.26 -16.22 43.19 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.025 0.93 . . . . 0.0 111.59 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.32 1.61 54.23 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.842 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 68.51 26.41 6.5 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.93 1.292 . . . . 0.0 113.15 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mm -103.87 127.59 57.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.2 m -81.84 138.26 35.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.09 153.36 34.92 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.503 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.37 -26.18 74.56 Favored Glycine 0 N--CA 1.438 -1.226 0 O-C-N 124.642 1.214 . . . . 0.0 112.979 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 31.5 p30 -175.36 177.35 1.85 Allowed 'General case' 0 C--O 1.255 1.352 0 C-N-CA 122.501 0.32 . . . . 0.0 110.886 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -47.51 -46.21 27.17 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.105 1.762 . . . . 0.0 111.626 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.15 -52.32 64.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.79 -177.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -64.53 -38.02 89.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.823 0.344 . . . . 0.0 110.747 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.59 -45.63 89.48 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.731 177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 48.1 t -63.28 -44.81 94.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.792 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.4 m -58.62 -44.92 90.14 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.437 0.637 . . . . 0.0 110.321 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -72.06 -35.51 69.33 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.3 t -62.77 -42.96 99.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.326 -177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD21 ' HG2' ' A' ' 36' ' ' LYS . 89.2 mt -68.65 -42.3 78.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.873 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -58.22 -49.69 76.17 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.212 0.53 . . . . 0.0 111.118 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -89.24 -4.79 58.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.579 -175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 53.35 67.79 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.611 1.164 . . . . 0.0 113.291 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.76 3.75 89.27 Favored Glycine 0 C--N 1.309 -0.92 0 CA-C-N 115.258 -0.883 . . . . 0.0 115.094 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.13 -47.83 72.83 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.01 94.96 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.176 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -106.07 -178.83 3.76 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -72.11 121.9 20.04 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 119.115 0.87 . . . . 0.0 109.347 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.5 tp -95.12 -54.85 3.28 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -161.73 164.19 29.17 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.52 152.22 28.79 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.87 169.36 42.56 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.4 m -69.6 153.27 43.69 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.31 -1.128 0 CA-C-O 118.915 -0.564 . . . . 0.0 111.427 -176.056 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 m . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 120.94 0.4 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.39 101.34 2.51 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.582 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.99 -170.84 0.18 Allowed 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 70.49 10.06 7.08 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.311 1.044 . . . . 0.0 112.831 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m -76.79 91.36 3.5 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -88.13 110.67 20.84 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.258 -176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.3 t -98.06 114.52 65.21 Favored Pre-proline 0 N--CA 1.42 -1.963 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.14 98.65 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.957 2.438 . . . . 0.0 112.288 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -110.97 109.71 19.96 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -149.18 155.43 40.62 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG13 ' CD1' ' A' ' 79' ' ' PHE . 28.5 m -84.89 153.03 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.316 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.03 102.84 15.19 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 48.9 t -89.11 -12.75 40.24 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 36' ' ' LYS . 22.9 m -59.23 -43.54 92.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.2 pt -63.19 -28.19 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.709 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 73.5 m-85 -88.33 -16.72 32.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.931 0.396 . . . . 0.0 111.323 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 66.9 mttm -69.49 -14.81 63.07 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.739 0.78 . . . . 0.0 109.204 174.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.04 6.31 36.73 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.158 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 44.4 m-85 -120.02 154.09 55.46 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -59.82 135.04 60.87 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 121.676 1.584 . . . . 0.0 109.901 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 64.7 t -52.24 -35.67 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.475 1.11 . . . . 0.0 112.468 -175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.1 m -82.15 -25.33 9.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.94 93.59 3.87 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.847 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 68' ' ' THR . 67.2 mt -121.22 109.61 35.04 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.248 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.97 135.25 37.08 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.365 2.043 . . . . 0.0 110.475 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.3 m -116.47 149.94 44.61 Favored Pre-proline 0 C--N 1.298 -1.66 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.456 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -63.96 159.21 43.33 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 122.844 2.362 . . . . 0.0 110.34 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.3 pt -86.28 -3.07 8.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.107 0.48 . . . . 0.0 111.971 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.6 m -82.74 131.1 35.21 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.068 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -88.09 106.24 18.03 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 94.7 mt -117.93 95.16 47.7 Favored Pre-proline 0 C--N 1.285 -2.227 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.3 121.35 9.5 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 121.847 1.698 . . . . 0.0 111.071 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.8 m -128.42 156.44 40.71 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.8 t -120.71 127.07 51.68 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.92 162.12 33.78 Favored Glycine 0 N--CA 1.413 -2.849 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.2 p -59.69 -20.93 59.53 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 125.133 1.373 . . . . 0.0 112.288 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -88.12 5.11 42.8 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.495 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 66.35 39.97 3.84 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 124.884 1.273 . . . . 0.0 111.681 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.57 130.14 72.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.514 -1.221 . . . . 0.0 107.889 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.405 HG23 ' HA ' ' A' ' 84' ' ' SER . 70.4 m -84.51 135.36 34.26 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-O 120.941 0.401 . . . . 0.0 110.576 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.484 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 97.1 m-85 -120.07 156.55 30.75 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.51 -19.35 77.7 Favored Glycine 0 C--O 1.224 -0.481 0 O-C-N 124.25 0.969 . . . . 0.0 113.649 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.9 p30 -177.43 171.97 1.89 Allowed 'General case' 0 C--O 1.256 1.421 0 C-N-CA 123.777 0.831 . . . . 0.0 109.973 175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -31.42 72.59 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.411 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . 37.2 t -56.82 -53.78 53.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.647 174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.78 -32.93 74.85 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.835 0.35 . . . . 0.0 110.686 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.7 tp -62.79 -44.75 95.35 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.086 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.3 t -68.8 -37.09 79.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.077 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.443 ' HA ' HD12 ' A' ' 43' ' ' ILE . 28.0 m -58.8 -45.4 89.99 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.444 0.64 . . . . 0.0 109.803 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' OE2' ' HD3' ' A' ' 72' ' ' LYS . 10.4 tp10 -71.93 -34.14 68.82 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.392 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.4 t -61.89 -51.05 69.77 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.14 0.576 . . . . 0.0 109.927 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.61 -33.67 76.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.375 0.607 . . . . 0.0 110.388 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 59.5 tttp -67.6 -49.73 61.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.998 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -90.21 20.36 4.43 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.6 m120 59.71 34.43 22.08 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.35 4.12 71.4 Favored Glycine 0 C--N 1.32 -0.36 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.895 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -56.98 -50.06 73.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.551 0.691 . . . . 0.0 111.374 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 p -110.59 116.67 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.296 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.004 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -137.08 177.76 7.61 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 30' ' ' VAL . 72.5 t80 -58.67 113.96 2.27 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 118.975 0.807 . . . . 0.0 113.171 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.92 -58.16 2.33 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -151.6 159.04 44.24 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -79.88 150.23 30.68 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.33 164.77 40.51 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.405 ' HA ' HG23 ' A' ' 59' ' ' THR . 16.5 m -62.25 151.53 36.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.7 m . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.085 -0.484 . . . . 0.0 110.616 -177.491 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 CA--C 1.511 -0.538 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' SER . 50.5 mm-40 -106.82 167.19 10.05 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.07 -58.09 2.59 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.414 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.58 0.64 56.68 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.203 0.525 . . . . 0.0 111.672 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 17.1 m -120.08 118.32 30.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 2.4 pt? -74.88 167.9 20.98 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.6 m -94.4 109.01 40.36 Favored Pre-proline 0 C--N 1.299 -1.62 0 CA-C-O 120.78 0.324 . . . . 0.0 110.164 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 6.2 Cg_exo -78.65 -175.77 2.91 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.225 1.95 . . . . 0.0 109.716 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -133.63 146.52 50.99 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.223 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -130.43 175.87 8.61 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.8 p -105.24 140.76 22.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -77.45 105.99 8.93 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 119.428 -0.909 . . . . 0.0 108.648 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 35.2 t -98.42 0.58 45.59 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -49.32 61.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.765 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 34.4 pt -68.66 -15.56 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.489 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.734 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 77.6 m-85 -98.33 -14.66 20.08 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.997 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 68.9 mttm -65.51 -14.72 61.64 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.664 0.745 . . . . 0.0 109.759 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.59 -32.45 71.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.441 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HB2' HG12 ' A' ' 43' ' ' ILE . 49.8 m-85 -100.58 157.44 33.73 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.005 -173.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.54 142.81 79.54 Favored 'Trans proline' 0 C--O 1.217 -0.544 0 C-N-CA 122.183 1.922 . . . . 0.0 110.191 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -57.44 -27.08 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.189 0 C-N-CA 123.559 0.744 . . . . 0.0 112.935 -173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 p -86.31 -26.55 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.061 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.87 97.23 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 122.167 -0.333 . . . . 0.0 111.219 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.432 HG22 ' SG ' ' A' ' 64' ' ' CYS . 48.5 mt -124.35 108.78 29.26 Favored Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.322 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -60.24 135.11 59.82 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 122.759 2.306 . . . . 0.0 110.468 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 71.6 m -124.35 152.65 68.34 Favored Pre-proline 0 C--N 1.296 -1.744 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.501 -174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -60.56 153.2 62.93 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.153 1.902 . . . . 0.0 110.815 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.5 pt -80.13 -9.46 12.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.188 0.518 . . . . 0.0 111.815 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.2 m -81.13 127.43 32.63 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.68 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -86.21 129.04 34.98 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 67.9 mt -133.65 100.19 13.72 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.2 119.71 7.06 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 121.38 1.386 . . . . 0.0 110.526 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.12 149.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.8 t -114.94 129.98 56.82 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.029 -177.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.93 165.13 30.39 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.615 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -54.99 -24.11 22.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.675 1.19 . . . . 0.0 111.641 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.77 7.21 35.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.847 0.832 . . . . 0.0 110.803 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 66.36 24.99 10.44 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.628 1.171 . . . . 0.0 112.848 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.31 131.46 50.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 m -85.67 128.83 34.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.145 0.498 . . . . 0.0 110.046 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.429 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.2 m-85 -110.47 154.93 22.95 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.309 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.58 -26.96 73.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 115.4 0.92 . . . . 0.0 115.4 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 35.2 p30 -178.56 -179.2 0.64 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 117.146 0.473 . . . . 0.0 110.444 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -46.83 -48.08 20.98 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.758 1.623 . . . . 0.0 110.863 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 43' ' ' ILE . 43.6 t -61.55 -52.85 62.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.782 -177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -63.97 -33.82 76.59 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.048 0.452 . . . . 0.0 111.174 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.11 -45.8 79.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.914 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 36.8 t -64.64 -38.94 92.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.353 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.6 m -57.38 -48.33 79.33 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.5 tp10 -70.85 -33.89 71.11 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.936 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.5 t -61.82 -40.62 95.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.13 -40.64 62.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 123.218 0.324 . . . . 0.0 110.46 176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -54.29 -60.2 3.66 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.406 0.682 . . . . 0.0 111.169 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.6 m -78.04 -20.88 51.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.351 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.22 84.33 0.12 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 125.438 1.495 . . . . 0.0 113.039 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.19 -29.26 5.68 Favored Glycine 0 N--CA 1.471 0.987 0 CA-C-N 115.729 -0.669 . . . . 0.0 113.622 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -57.03 -44.69 83.16 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.714 0.806 . . . . 0.0 111.717 179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.41 124.08 72.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.682 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -132.69 -178.69 5.05 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -68.69 113.29 6.04 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -89.67 -55.44 3.64 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -159.8 163.07 34.84 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -84.8 162.64 19.5 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.48 169.48 45.95 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -178.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.2 m -66.34 148.78 51.36 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.2 m . . . . . 0 C--N 1.307 -1.255 0 O-C-N 123.347 0.405 . . . . 0.0 110.624 -177.832 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.0 m . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.24 120.45 34.51 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.26 -61.73 2.12 Favored 'General case' 0 C--O 1.239 0.534 0 O-C-N 123.941 0.775 . . . . 0.0 112.659 -174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -146.42 147.49 31.31 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.776 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.9 t -143.55 128.48 18.45 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.44 108.15 3.16 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.638 0.733 . . . . 0.0 110.342 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -133.23 170.32 11.69 Favored Pre-proline 0 C--N 1.288 -2.092 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.81 -170.97 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.27 0 C-N-CA 121.773 1.648 . . . . 0.0 111.914 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 79' ' ' PHE . 55.0 tptt -75.02 151.9 38.73 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -109.47 160.14 16.46 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.375 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.0 p -111.08 162.42 8.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -75.27 110.17 9.39 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.503 0.668 . . . . 0.0 110.215 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 50.7 t -108.32 -9.66 15.44 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 m -60.57 -40.82 93.04 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 124.752 1.221 . . . . 0.0 111.668 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.6 pt -70.14 -21.54 23.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 87.8 m-85 -94.08 -20.91 19.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.772 0.32 . . . . 0.0 110.821 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 97.6 mttt -66.69 -14.9 63.07 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 121.726 0.774 . . . . 0.0 110.217 176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -75.25 -2.34 27.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.648 177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -118.0 156.95 49.71 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.16 144.04 85.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.771 1.647 . . . . 0.0 110.659 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.4 t -54.89 -33.64 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.719 0.808 . . . . 0.0 112.337 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 35.6 m -82.25 -25.46 9.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.5 93.81 3.89 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.186 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.56 119.74 25.95 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.91 134.25 21.33 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.167 1.245 . . . . 0.0 110.947 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.4 m -117.27 148.29 42.25 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.69 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.19 164.26 35.63 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.459 2.106 . . . . 0.0 111.201 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -89.47 -0.34 8.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.777 0.798 . . . . 0.0 110.145 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.6 m -72.48 128.64 36.22 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.294 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.445 ' CE1' ' HA2' ' A' ' 61' ' ' GLY . 70.7 t80 -96.08 104.39 16.34 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 86.7 mt -116.86 98.01 51.33 Favored Pre-proline 0 C--N 1.285 -2.232 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -60.14 125.2 16.94 Favored 'Trans proline' 0 N--CA 1.446 -1.314 0 C-N-CA 121.382 1.388 . . . . 0.0 110.94 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.38 150.88 31.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 175.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.2 t -117.57 130.49 56.43 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.74 164.9 25.49 Favored Glycine 0 N--CA 1.419 -2.467 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.656 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -55.18 -23.77 23.53 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.642 1.177 . . . . 0.0 111.9 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -86.01 8.56 20.1 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.267 -176.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 64.4 31.16 12.86 Favored 'General case' 0 C--O 1.247 0.956 0 C-N-CA 125.197 1.399 . . . . 0.0 111.337 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -110.4 131.2 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.167 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -85.06 133.5 34.23 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' OH ' ' HG2' ' A' ' 69' ' ' GLU . 99.1 m-85 -112.58 151.15 30.39 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 49' ' ' TYR . . . -71.34 -12.29 72.57 Favored Glycine 0 N--CA 1.45 -0.412 0 O-C-N 124.153 0.908 . . . . 0.0 114.303 -175.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -179.35 172.6 1.18 Allowed 'General case' 0 CA--C 1.491 -1.311 0 C-N-CA 124.329 1.052 . . . . 0.0 109.298 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -28.33 67.77 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 123.761 0.663 . . . . 0.0 112.765 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 51.4 t -59.05 -50.58 73.52 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -64.71 -34.51 78.49 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.759 0.314 . . . . 0.0 111.128 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.94 -46.08 83.11 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.751 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 45.5 t -61.22 -46.17 91.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.964 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.5 m -56.35 -47.41 78.88 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.86 0.362 . . . . 0.0 110.146 178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HG2' ' OH ' ' A' ' 60' ' ' TYR . 7.4 tp10 -68.04 -37.15 81.02 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.866 -177.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.9 t -63.63 -43.74 95.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.521 0.729 . . . . 0.0 110.208 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.431 HD21 ' HE2' ' A' ' 36' ' ' LYS . 88.2 mt -70.61 -43.77 68.64 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.841 178.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' HD3' ' OE2' ' A' ' 69' ' ' GLU . 86.0 tttt -55.3 -44.14 75.48 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 124.094 0.958 . . . . 0.0 110.861 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.1 m -94.14 3.43 55.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.049 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 t30 46.27 74.12 0.15 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.961 1.704 . . . . 0.0 113.85 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.15 -3.07 59.24 Favored Glycine 0 C--N 1.312 -0.776 0 N-CA-C 115.113 0.805 . . . . 0.0 115.113 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -60.87 -57.17 13.79 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.372 0.606 . . . . 0.0 110.609 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.16 124.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -125.68 -178.85 4.4 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.428 ' HD2' ' O ' ' A' ' 28' ' ' LYS . 80.8 t80 -70.92 121.76 18.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -97.15 -53.15 3.58 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -161.95 157.99 24.57 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -83.58 164.15 19.94 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.43 168.72 42.67 Favored Glycine 0 N--CA 1.41 -3.039 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.3 m -64.15 151.76 42.47 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.297 -1.708 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.057 -178.529 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.241 0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -157.14 146.45 20.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -49.79 6.61 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.84 99.81 2.16 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.843 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -84.03 120.33 26.0 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.73 -20.86 52.78 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.505 0.669 . . . . 0.0 110.466 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 8.8 p -107.59 130.99 22.05 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.819 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 12.0 Cg_exo -70.08 99.98 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.3 2.0 . . . . 0.0 108.439 174.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -81.99 143.93 31.24 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.158 0.98 . . . . 0.0 113.116 -171.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -113.09 177.33 4.67 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 174.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' A' ' 63' ' ' GLU . 7.6 p -69.91 126.74 30.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.517 177.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.45 101.8 12.31 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 30.2 t -98.96 -5.93 29.68 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 t -68.46 -39.98 81.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.328 -176.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 30.3 pt -67.11 -16.28 20.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.518 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 70.9 m-85 -103.46 -10.99 18.12 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 98.4 mttt -64.1 -14.79 57.23 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -70.51 -19.6 62.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.864 0.364 . . . . 0.0 111.425 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 39' ' ' PRO . 90.8 m-85 -95.58 168.69 10.42 Favored Pre-proline 0 C--N 1.311 -1.103 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.527 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 6.7 Cg_endo -54.44 160.46 6.86 Favored 'Trans proline' 0 C--N 1.364 1.387 0 C-N-CA 122.771 2.314 . . . . 0.0 112.069 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -70.1 -41.82 79.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -97.29 -13.41 8.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.456 -0.898 . . . . 0.0 113.058 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.527 ' O ' ' HG2' ' A' ' 39' ' ' PRO . . . -124.23 94.06 4.1 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.484 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 35' ' ' TYR . 60.9 mt -122.12 130.35 24.75 Favored Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.38 134.84 29.81 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.596 1.531 . . . . 0.0 110.43 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.1 m -116.62 155.44 48.82 Favored Pre-proline 0 C--N 1.291 -1.94 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.86 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.84 156.93 40.65 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.374 2.049 . . . . 0.0 111.111 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.47 15.03 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-O 121.534 0.683 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -99.76 131.05 45.99 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 61' ' ' GLY . 51.8 t80 -89.21 122.3 32.35 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 93.7 mt -133.26 97.75 16.07 Favored Pre-proline 0 C--N 1.288 -2.081 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.25 119.87 7.31 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 121.703 1.602 . . . . 0.0 111.824 -175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.92 156.07 38.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.3 t -119.63 125.7 49.38 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 120.887 0.375 . . . . 0.0 110.437 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.25 160.6 29.57 Favored Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.481 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.1 m -63.72 -9.53 14.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.121 0.968 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.96 8.2 40.85 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 60.3 44.08 12.87 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 111.599 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -124.4 131.87 72.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.0 m -84.75 133.61 34.35 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -113.68 150.85 32.65 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 49' ' ' TYR . . . -61.33 -27.56 67.87 Favored Glycine 0 C--O 1.221 -0.679 0 O-C-N 124.284 0.99 . . . . 0.0 113.569 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 32.6 p30 -170.99 172.1 5.61 Favored 'General case' 0 CA--C 1.49 -1.361 0 C-N-CA 123.487 0.715 . . . . 0.0 109.092 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -66.57 -28.13 68.28 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -176.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.68 -42.26 96.76 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.737 0.304 . . . . 0.0 110.262 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -65.73 -36.19 82.87 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.306 0.574 . . . . 0.0 110.142 178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.8 tp -63.74 -42.26 97.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.831 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 41.5 t -60.1 -47.86 84.13 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 122.83 0.452 . . . . 0.0 111.265 177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.424 ' CG2' ' HB ' ' A' ' 43' ' ' ILE . 21.7 p -57.36 -46.43 83.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.861 0.362 . . . . 0.0 111.7 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.28 -34.58 70.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.231 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.5 t -61.59 -48.24 81.85 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.102 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.74 -43.14 76.5 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.937 0.399 . . . . 0.0 110.596 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.77 -46.85 77.82 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 124.191 0.996 . . . . 0.0 109.67 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.6 m -92.91 15.83 13.96 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.415 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.1 m120 55.54 30.61 15.55 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.17 3.38 51.23 Favored Glycine 0 C--N 1.316 -0.53 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.688 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -57.2 -45.0 84.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.344 0.658 . . . . 0.0 110.324 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -108.22 133.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.215 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -123.36 -179.78 4.44 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -83.01 110.78 18.27 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.3 tp -83.89 -61.34 1.85 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -154.73 161.77 41.39 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.275 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.36 153.92 40.28 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.97 169.55 45.43 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.07 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.9 m -63.0 152.65 36.23 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.812 0.445 . . . . 0.0 109.901 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 119.381 -0.343 . . . . 0.0 110.91 -178.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.445 -0.687 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.94 -38.56 88.93 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -143.44 163.7 32.35 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.02 -11.64 59.99 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 117.766 0.257 . . . . 0.0 111.247 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m 70.58 176.11 0.28 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.902 1.281 . . . . 0.0 110.103 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.2 mp -78.85 -21.87 46.93 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.552 0.692 . . . . 0.0 109.538 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -151.11 145.15 17.78 Favored Pre-proline 0 N--CA 1.433 -1.325 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.52 116.55 3.41 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 121.888 1.726 . . . . 0.0 108.178 173.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -115.43 140.27 49.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -173.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -90.27 176.03 6.89 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 79' ' ' PHE . 11.1 p -68.95 118.17 12.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.591 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -82.34 95.12 7.52 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-O 122.343 1.068 . . . . 0.0 108.502 174.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 33.1 t -89.38 -12.31 40.73 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.525 -1.67 . . . . 0.0 108.423 -177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -51.52 -46.55 63.33 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.34 1.056 . . . . 0.0 112.27 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.2 pt -73.85 -15.48 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.678 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 94.3 m-85 -96.56 -18.36 19.84 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-O 120.945 0.402 . . . . 0.0 110.102 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' CYS . 60.0 mtpt -66.78 -14.59 62.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.453 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -76.39 -19.25 58.32 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.535 0.683 . . . . 0.0 109.394 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 35' ' ' TYR . 24.1 m-85 -93.96 145.15 29.3 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.502 ' HG2' ' HB3' ' A' ' 42' ' ' ALA . 37.3 Cg_endo -65.59 153.79 76.63 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.089 1.859 . . . . 0.0 111.214 178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -59.27 -25.62 31.18 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.128 0.571 . . . . 0.0 112.18 -175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.52 -25.38 6.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 O-C-N 121.97 -0.456 . . . . 0.0 111.823 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB3' ' HG2' ' A' ' 39' ' ' PRO . . . -126.21 94.02 3.97 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.68 108.3 28.71 Favored Pre-proline 0 C--N 1.298 -1.641 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -70.31 134.32 26.57 Favored 'Trans proline' 0 C--O 1.251 1.126 0 C-N-CA 121.951 1.767 . . . . 0.0 111.43 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 73.9 m -107.53 146.51 33.47 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.915 -175.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -60.02 153.85 55.01 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 122.684 2.256 . . . . 0.0 110.882 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.9 pt -75.13 -24.66 17.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.041 0.448 . . . . 0.0 111.8 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.6 m -77.01 144.15 38.88 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.168 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -96.32 128.4 43.21 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 5.2 mp -134.24 104.37 11.38 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -59.72 120.16 7.8 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.438 1.425 . . . . 0.0 110.495 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.58 152.0 35.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.58 130.24 55.78 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.06 0.457 . . . . 0.0 110.846 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.94 163.81 28.35 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.2 p -63.43 -15.23 57.04 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 123.672 0.789 . . . . 0.0 112.328 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -86.78 4.71 39.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.607 0.717 . . . . 0.0 109.906 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 63.19 43.53 6.29 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.721 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.97 129.11 75.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 79.7 m -85.37 135.56 33.83 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -115.78 156.43 26.04 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.49 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -70.81 -22.57 78.23 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.595 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 50' ' ' LEU . 33.0 p30 -178.27 174.25 1.33 Allowed 'General case' 0 C--O 1.256 1.423 0 C-N-CA 122.915 0.486 . . . . 0.0 110.369 176.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -51.62 -35.97 43.98 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.115 1.366 . . . . 0.0 113.547 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 17.0 t -64.27 -44.08 92.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.48 0.181 . . . . 0.0 111.201 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -68.41 -38.3 81.15 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.0 tp -63.93 -48.85 74.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.959 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 35' ' ' TYR . 42.1 t -60.01 -38.55 82.97 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.215 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.8 m -57.54 -52.86 63.67 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 110.38 -0.229 . . . . 0.0 110.38 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -66.79 -34.34 77.6 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.646 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.7 t -60.68 -46.78 89.05 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 36' ' ' LYS . 84.7 mt -73.48 -41.16 63.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.7 0.286 . . . . 0.0 110.715 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -63.57 -32.01 73.35 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.829 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -102.68 7.45 39.79 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.792 0.329 . . . . 0.0 111.001 178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.8 t30 46.52 75.2 0.12 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.273 1.429 . . . . 0.0 113.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.93 -5.1 26.82 Favored Glycine 0 N--CA 1.471 1.03 0 N-CA-C 115.579 0.991 . . . . 0.0 115.579 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -57.07 -60.48 3.54 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.791 0.805 . . . . 0.0 110.128 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -92.21 121.18 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.448 ' HA ' HE21 ' A' ' 78' ' ' GLN . 0.1 OUTLIER -123.83 171.43 9.66 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -177.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' HB2' HG12 ' A' ' 30' ' ' VAL . 49.8 t80 -70.14 116.05 10.06 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 tp -88.21 -56.24 3.41 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -161.73 161.7 29.4 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -82.25 165.64 20.25 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.12 165.09 40.89 Favored Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 -178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.9 m -66.55 143.65 56.92 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 74.5 m . . . . . 0 C--N 1.311 -1.073 0 C-N-CA 123.103 0.561 . . . . 0.0 112.463 -176.092 . . . . . . . . 0 0 . 1 stop_ save_